LEONA M & HARRY B HELMSLEY CHARITABLE TRUST: Form 990PF, tax year 2023
View the entire original 990 at ProPublica ↗
- Organization
- LEONA M & HARRY B HELMSLEY CHARITABLE TRUST (EIN 13-7184401)
- Tax period
- 2023-04-01 to 2024-03-31
- Filed
- 2025-01-28
- IRS object ID
- 202530289349100408
- Schema version
- 2023v6.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990-PF
- Schedule B
- Accounting Fees Schedule
- All Oth Prog Rltd Investments Sch
- Expenditure Responsibility Stmt
- General Explanation Attachment
- Investments Corp Stock Schedule
- Investments Other Schedule2
- Land Etc Schedule2
- Legal Fees Schedule
- Other Assets Schedule
- Other Decreases Schedule
- Other Expenses Schedule
- Other Income Schedule2
- Other Increases Schedule
- Other Liabilities Schedule
- Other Professional Fees Schedule
- Taxes Schedule
- Transfers Frm Controlled Entities
- Transfers To Controlled Entities
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2025-01-28T09:09:22-06:00 | ReturnTs |
| Tax Period End | 2024-03-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 873231666 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | PKF O'CONNOR DAVIES ADVISORY LLC | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 245 PARK AVENUE 12TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10167 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990PF | ReturnTypeCd |
| Tax Period Begin | 2023-04-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 137184401 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | THE LEONA M AND HARRY B HELMSLEY | BusinessNameLine1Txt |
| Business Name Line2 | CHARITABLE TRUST | BusinessNameLine2Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | LEON | BusinessNameControlTxt |
| Phone | 2126793600 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 230 PARK AVENUE 659 | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10169 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | NICHOLAS J SCHIAVO | PersonNm |
| Person Title | CFO | PersonTitleTxt |
| Phone | 2126793600 | PhoneNum |
| Signature | 2025-01-21 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IRS Responsible Prty Info Curr | 0 | IRSResponsiblePrtyInfoCurrInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | THOMAS BLANEY | PreparerPersonNm |
| PTIN | P00234022 | PTIN |
| Phone | 2122862600 | PhoneNum |
| Preparation | 2025-01-21 | PreparationDt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2023 | TaxYr |
| Build TS | 2025-03-06 01:10:19Z | BuildTS |
Form 990-PF IRS990PF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization501c3 Exempt PF | Yes (X) | Organization501c3ExemptPFInd |
| FMV Assets EOY | $7,300,077,622 | FMVAssetsEOYAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
Analysis Of Revenue And Expenses AnalysisOfRevenueAndExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contri Rcvd Rev And Expnss | $20,000,000 | ContriRcvdRevAndExpnssAmt |
| Interest On Sav Rev And Expnss | $4,018,817 | InterestOnSavRevAndExpnssAmt |
| Interest On Sav Net Invst Incm | $4,018,817 | InterestOnSavNetInvstIncmAmt |
| Dividends Rev And Expnss | $67,095,872 | DividendsRevAndExpnssAmt |
| Dividends Net Invst Incm | $132,636,674 | DividendsNetInvstIncmAmt |
| Net Gain Sale Ast Rev And Expnss | $234,703,900 | NetGainSaleAstRevAndExpnssAmt |
| Gross Sales Price | $576,339,287 | GrossSalesPriceAmt |
| Cap Gain Net Incm Net Invst Incm | $132,680,049 | CapGainNetIncmNetInvstIncmAmt |
| Other Income Rev And Expnss | $59,409,941 | OtherIncomeRevAndExpnssAmt |
| Other Income Net Invst Incm | $31,801,322 | OtherIncomeNetInvstIncmAmt |
| Total Rev And Expnss | $385,228,530 | TotalRevAndExpnssAmt |
| Total Net Invst Incm | $301,136,862 | TotalNetInvstIncmAmt |
| Comp Ofcr Dir Trst Rev And Expnss | $3,982,577 | CompOfcrDirTrstRevAndExpnssAmt |
| Comp Ofcr Dir Trst Net Invst Incm | $1,721,636 | CompOfcrDirTrstNetInvstIncmAmt |
| Comp Ofcr Dir Trst Dsbrs Chrtbl | $2,230,741 | CompOfcrDirTrstDsbrsChrtblAmt |
| Oth Empl Slrs Wgs Rev And Expnss | $18,660,799 | OthEmplSlrsWgsRevAndExpnssAmt |
| Oth Empl Slrs Wgs Net Invst Incm | $3,731,814 | OthEmplSlrsWgsNetInvstIncmAmt |
| Oth Empl Slrs Wgs Dsbrs Chrtbl | $14,681,014 | OthEmplSlrsWgsDsbrsChrtblAmt |
| Pension Empl Bnft Rev And Expnss | $9,268,666 | PensionEmplBnftRevAndExpnssAmt |
| Pension Empl Bnft Net Invst Incm | $1,603,592 | PensionEmplBnftNetInvstIncmAmt |
| Pension Empl Bnft Dsbrs Chrtbl | $7,214,783 | PensionEmplBnftDsbrsChrtblAmt |
| Legal Fees Rev And Expnss | $423,260 | LegalFeesRevAndExpnssAmt |
| Legal Fees Net Invst Incm | $113,927 | LegalFeesNetInvstIncmAmt |
| Legal Fees Dsbrs Chrtbl | $327,915 | LegalFeesDsbrsChrtblAmt |
| Accounting Fees Rev And Expnss | $427,089 | AccountingFeesRevAndExpnssAmt |
| Accounting Fees Net Invst Incm | $116,230 | AccountingFeesNetInvstIncmAmt |
| Accounting Fees Chrtbl Prps | $345,725 | AccountingFeesChrtblPrpsAmt |
| Other Prof Fees Rev And Expnss | $7,146,568 | OtherProfFeesRevAndExpnssAmt |
| Other Prof Fees Net Invst Incm | $4,363,289 | OtherProfFeesNetInvstIncmAmt |
| Other Prof Fees Dsbrs Chrtbl | $2,631,560 | OtherProfFeesDsbrsChrtblAmt |
| Interest Net Invst Incm | $4,793,771 | InterestNetInvstIncmAmt |
| Taxes Rev And Expnss | $9,587,210 | TaxesRevAndExpnssAmt |
| Taxes Net Invst Incm | $2,384,774 | TaxesNetInvstIncmAmt |
| Taxes Dsbrs Chrtbl | $0 | TaxesDsbrsChrtblAmt |
| Deprec And Dpltn Rev And Expnss | $816,356 | DeprecAndDpltnRevAndExpnssAmt |
| Deprec And Dpltn Net Invst Incm | $47,140 | DeprecAndDpltnNetInvstIncmAmt |
| Occupancy Rev And Expnss | $1,761,672 | OccupancyRevAndExpnssAmt |
| Occupancy Net Invst Incm | $25,625 | OccupancyNetInvstIncmAmt |
| Occupancy Dsbrs Chrtbl | $1,535,307 | OccupancyDsbrsChrtblAmt |
| Trav Conf Meeting Rev And Expnss | $2,174,294 | TravConfMeetingRevAndExpnssAmt |
| Trav Conf Meeting Net Invst Incm | $265,868 | TravConfMeetingNetInvstIncmAmt |
| Trav Conf Meeting Dsbrs Chrtbl | $1,991,530 | TravConfMeetingDsbrsChrtblAmt |
| Other Expenses Rev And Expnss | $18,716,551 | OtherExpensesRevAndExpnssAmt |
| Other Expenses Net Invst Incm | $57,271,241 | OtherExpensesNetInvstIncmAmt |
| Other Expenses Dsbrs Chrtbl | $2,427,378 | OtherExpensesDsbrsChrtblAmt |
| Tot Opr Expenses Rev And Expnss | $72,965,042 | TotOprExpensesRevAndExpnssAmt |
| Tot Opr Expenses Net Invst Incm | $76,438,907 | TotOprExpensesNetInvstIncmAmt |
| Tot Opr Expenses Dsbrs Chrtbl | $33,385,953 | TotOprExpensesDsbrsChrtblAmt |
| Contri Paid Rev And Expnss | $527,121,300 | ContriPaidRevAndExpnssAmt |
| Contri Paid Dsbrs Chrtbl | $445,672,622 | ContriPaidDsbrsChrtblAmt |
| Total Expenses Rev And Expnss | $600,086,342 | TotalExpensesRevAndExpnssAmt |
| Total Expenses Net Invst Incm | $76,438,907 | TotalExpensesNetInvstIncmAmt |
| Total Expenses Dsbrs Chrtbl | $479,058,575 | TotalExpensesDsbrsChrtblAmt |
| Excess Revenue Over Expenses | -$214,857,812 | ExcessRevenueOverExpensesAmt |
| Net Investment Income | $224,697,955 | NetInvestmentIncomeAmt |
Form990 PF Balance Sheets Form990PFBalanceSheetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cash BOY | $85,800,732 | CashBOYAmt |
| Cash EOY | $89,496,038 | CashEOYAmt |
| Cash EOYFMV | $89,496,038 | CashEOYFMVAmt |
| Sav And Temp Cash Invst BOY | $143,734,047 | SavAndTempCashInvstBOYAmt |
| Sav And Temp Cash Invst EOY | $55,980,540 | SavAndTempCashInvstEOYAmt |
| Sav And Temp Cash Invst EOYFMV | $55,980,540 | SavAndTempCashInvstEOYFMVAmt |
| Acct Rcvbl | $604,736 | AcctRcvblAmt |
| Acct Rcvbl BOY | $680,960 | AcctRcvblBOYAmt |
| Acct Rcvbl EOY | $604,736 | AcctRcvblEOYAmt |
| Acct Rcvbl EOYFMV | $604,736 | AcctRcvblEOYFMVAmt |
| Prepaid Expenses BOY | $1,129,528 | PrepaidExpensesBOYAmt |
| Prepaid Expenses EOY | $1,033,231 | PrepaidExpensesEOYAmt |
| Prepaid Expenses EOYFMV | $1,033,231 | PrepaidExpensesEOYFMVAmt |
| Corporate Stock BOY | $512,806,017 | CorporateStockBOYAmt |
| Corporate Stock EOY | $643,618,129 | CorporateStockEOYAmt |
| Corporate Stock EOYFMV | $643,618,129 | CorporateStockEOYFMVAmt |
| Other Investments BOY | $6,449,780,993 | OtherInvestmentsBOYAmt |
| Other Investments EOY | $6,446,813,297 | OtherInvestmentsEOYAmt |
| Other Investments EOYFMV | $6,446,813,297 | OtherInvestmentsEOYFMVAmt |
| Land Bldg Equip Cost Or Other Bss | $10,532,026 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $3,861,764 | LandBldgEquipAccumDeprecAmt |
| Land BOY | $6,890,319 | LandBOYAmt |
| Land EOY | $6,670,262 | LandEOYAmt |
| Land EOYFMV | $6,670,262 | LandEOYFMVAmt |
| Other Assets BOY | $56,013,040 | OtherAssetsBOYAmt |
| Other Assets EOY | $55,861,389 | OtherAssetsEOYAmt |
| Other Assets EOYFMV | $55,861,389 | OtherAssetsEOYFMVAmt |
| Total Assets BOY | $7,256,835,636 | TotalAssetsBOYAmt |
| Total Assets EOY | $7,300,077,622 | TotalAssetsEOYAmt |
| Total Assets EOYFMV | $7,300,077,622 | TotalAssetsEOYFMVAmt |
| Accounts Payable BOY | $11,336,884 | AccountsPayableBOYAmt |
| Accounts Payable EOY | $11,499,434 | AccountsPayableEOYAmt |
| Grants Payable BOY | $482,673,051 | GrantsPayableBOYAmt |
| Grants Payable EOY | $564,121,729 | GrantsPayableEOYAmt |
| Other Liabilities BOY | $41,684,887 | OtherLiabilitiesBOYAmt |
| Other Liabilities EOY | $45,857,428 | OtherLiabilitiesEOYAmt |
| Total Liabilities BOY | $535,694,822 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $621,478,591 | TotalLiabilitiesEOYAmt |
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
| No Donor Rstr Net Assests BOY | $6,721,140,814 | NoDonorRstrNetAssestsBOYAmt |
| No Donor Rstr Net Assests EOY | $6,678,599,031 | NoDonorRstrNetAssestsEOYAmt |
| Tot Net Ast Or Fund Balances BOY | $6,721,140,814 | TotNetAstOrFundBalancesBOYAmt |
| Tot Net Ast Or Fund Balances EOY | $6,678,599,031 | TotNetAstOrFundBalancesEOYAmt |
| Total Liabilities Net Ast BOY | $7,256,835,636 | TotalLiabilitiesNetAstBOYAmt |
| Total Liabilities Net Ast EOY | $7,300,077,622 | TotalLiabilitiesNetAstEOYAmt |
Chg In Net Assets Fund Balances ChgInNetAssetsFundBalancesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tot Net Ast Or Fund Balances BOY | $6,721,140,814 | TotNetAstOrFundBalancesBOYAmt |
| Excess Revenue Over Expenses | -$214,857,812 | ExcessRevenueOverExpensesAmt |
| Other Increases | $186,800,511 | OtherIncreasesAmt |
| Subtotal | $6,693,083,513 | SubtotalAmt |
| Other Decreases | $14,484,482 | OtherDecreasesAmt |
| Tot Net Ast Or Fund Balances EOY | $6,678,599,031 | TotNetAstOrFundBalancesEOYAmt |
Cap Gains Loss Tx Invst Incm Detail CapGainsLossTxInvstIncmDetail
Cap Gains Loss Tx Invst Incm CapGainsLossTxInvstIncmGrp (465 entries)
| PropertyPropertyDesc | How AcquiredHowAcquiredCd | Gross Sales PriceGrossSalesPriceAmt | Cost Or Other BasisCostOrOtherBasisAmt | Gain Or LossGainOrLossAmt | Gains Minus Excess Or LossesGainsMinusExcessOrLossesAmt | SoldSoldDt |
|---|---|---|---|---|---|---|
| SALE OF PUBLICLY TRADED SECURITIES | P | $41,971,866 | $14,475,270 | $27,496,596 | $27,496,596 | |
| ACADIAN FRONTIER MARKETS | P | $61,991 | $61,991 | $61,991 | 2023-11-17 | |
| ACADIAN FRONTIER MARKETS | P | $93,958 | $93,958 | $93,958 | 2024-03-01 | |
| ACADIAN FRONTIER MARKETS | P | $141,696 | $141,696 | $141,696 | 2023-07-14 | |
| ACADIAN FRONTIER MARKETS | P | $241,066 | $241,066 | $241,066 | 2023-06-02 | |
| ACADIAN FRONTIER MARKETS | P | $707,008 | $707,008 | $707,008 | 2024-02-16 | |
| ACADIAN FRONTIER MARKETS | P | $1,686,366 | $1,686,366 | $1,686,366 | 2024-02-09 | |
| ACCEL GROWTH FD IV LP | P | $641,959 | $641,959 | $641,959 | 2023-05-02 | |
| ACCEL GROWTH FD IV LP | P | $341,451 | $341,451 | $341,451 | 2023-12-01 | |
| ACCEL GROWTH FD IV LP | P | $338,656 | $338,656 | $338,656 | 2023-06-05 | |
| ACCEL GROWTH FD IV LP | P | $309,496 | $309,496 | $309,496 | 2023-05-31 | |
| ACCEL GROWTH FD IV LP | P | $272,315 | $272,315 | $272,315 | 2023-06-15 | |
| ACCEL GROWTH FD IV LP | P | $247,578 | $247,578 | $247,578 | 2023-12-14 | |
| ACCEL GROWTH FD IV LP | P | $223,412 | $223,412 | $223,412 | 2023-09-11 | |
| ACCEL GROWTH FD IV LP | P | $514,861 | $514,861 | $514,861 | 2023-08-31 | |
| ACCEL GROWTH FUND II LP | P | $368,531 | $368,531 | $368,531 | 2023-09-14 | |
| ACCEL GROWTH FUND II LP | P | $185,061 | $185,061 | $185,061 | 2023-08-02 | |
| ACCEL GROWTH FUND II LP | P | $180,041 | $180,041 | $180,041 | 2023-08-21 | |
| ACCEL GROWTH FUND II LP | P | $174,007 | $174,007 | $174,007 | 2023-12-01 | |
| ACCEL GROWTH FUND II LP | P | $159,662 | $159,662 | $159,662 | 2023-05-22 | |
| ACCEL GROWTH FUND II LP | P | $159,340 | $159,340 | $159,340 | 2023-11-07 | |
| ACCEL GROWTH FUND II LP | P | $133,478 | $133,478 | $133,478 | 2023-05-31 | |
| ACCEL GROWTH FUND III LP | P | $1,176,640 | $1,176,640 | $1,176,640 | 2023-08-04 | |
| ACCEL LEADERS FUND LP | P | $566,375 | $566,375 | $566,375 | 2024-03-21 | |
| ACCEL LEADERS FUND LP | P | $488,445 | $488,445 | $488,445 | 2023-11-29 | |
| ACCEL LEADERS FUND LP | P | $186,078 | $186,078 | $186,078 | 2023-12-08 | |
| ACCEL LEADERS FUND LP | P | $186,078 | $186,078 | $186,078 | 2023-12-11 | |
| ACCEL LEADERS FUND LP | P | $515,517 | $515,517 | $515,517 | 2023-08-04 | |
| ACCEL LEADERS FUND LP | P | $186,078 | -$186,078 | -$186,078 | 2023-12-11 | |
| ANDREESSEN HOROWITZ FD III LP | P | $16,437,071 | $16,437,071 | $16,437,071 | 2023-12-29 | |
| ANDREESSEN HOROWITZ FD III LP | P | $143,082 | $143,082 | $143,082 | 2023-07-14 | |
| ANDREESSEN HOROWITZ FD III LP | P | $216,948 | $216,948 | $216,948 | 2024-03-29 | |
| AH PARALLEL FUND III LP | P | $1,941,818 | $1,941,818 | $1,941,818 | 2023-12-29 | |
| ANDREESSEN HOROWITZ FD IV LP | P | $563,540 | $563,540 | $563,540 | 2024-02-14 | |
| AH PARALLEL FUND IV LP | P | $306,422 | $306,422 | $306,422 | 2024-02-14 | |
| ANDREESSEN HOROWITZ LSV FD I | P | $3,070,384 | $3,070,384 | $3,070,384 | 2024-03-25 | |
| ANDREESSEN HOROWITZ LSV FD I | P | $3,057,987 | $3,057,987 | $3,057,987 | 2024-03-25 | |
| ANDREESSEN HOROWITZ LSV FD I | P | $12,397 | -$12,397 | -$12,397 | 2024-03-25 | |
| ANDREESSEN HOROWITZ LSV FD I | P | $3,057,987 | -$3,057,987 | -$3,057,987 | 2024-03-25 | |
| ANDREESSEN HOROWITZ FUND V LP | P | $559,245 | $559,245 | $559,245 | 2024-03-15 | |
| ANDREESSEN HOROWITZ FUND V LP | P | $39,048 | $39,048 | $39,048 | 2024-03-15 | |
| AH PARALLEL FUND V LP | P | $307,809 | $307,809 | $307,809 | 2024-03-15 | |
| AH PARALLEL FUND V LP | P | $233 | $233 | $233 | 2024-03-15 | |
| AH PARALLEL FUND V LP | P | $465 | -$465 | -$465 | 2024-03-15 | |
| ANGELENO INVESTORS III | P | $2,192,741 | $2,192,741 | $2,192,741 | 2023-12-21 | |
| ARBORETUM VENTURES IV LP | P | $294,556 | $294,556 | $294,556 | 2023-10-19 | |
| BLACKROCK US DEBT INDEX FUND B | P | $16,811 | $15,711 | $1,100 | $1,100 | 2024-02-06 |
| BLACKROCK US DEBT INDEX FUND B | P | $19,874 | $22,596 | -$2,722 | -$2,722 | 2023-05-24 |
| BLACKROCK US DEBT INDEX FUND B | P | $20,186 | $22,964 | -$2,778 | -$2,778 | 2023-08-09 |
| BLACKROCK US DEBT INDEX FUND B | P | $20,087 | $23,849 | -$3,762 | -$3,762 | 2023-10-30 |
| BLACKROCK US DEBT INDEX FUND B | P | $10,000,000 | $9,336,356 | $663,644 | $663,644 | 2023-12-18 |
| BLACKROCK US DEBT INDEX FUND B | P | $10,000,000 | $9,517,648 | $482,352 | $482,352 | 2023-12-11 |
| BLACKROCK US DEBT INDEX FUND B | P | $10,000,000 | $9,552,881 | $447,119 | $447,119 | 2023-12-04 |
| BLACKROCK US DEBT INDEX FUND B | P | $10,000,000 | $10,338,558 | -$338,558 | -$338,558 | 2023-11-27 |
| BLACKROCK US DEBT INDEX FUND B | P | $10,000,000 | $11,283,926 | -$1,283,926 | -$1,283,926 | 2023-11-20 |
| BLACKROCK US DEBT INDEX FUND B | P | $10,000,000 | $11,452,818 | -$1,452,818 | -$1,452,818 | 2023-11-13 |
| BLACKROCK US DEBT INDEX FUND B | P | $10,000,000 | $11,477,585 | -$1,477,585 | -$1,477,585 | 2023-11-06 |
| BLACKROCK US DEBT INDEX FUND B | P | $10,000,000 | $11,676,991 | -$1,676,991 | -$1,676,991 | 2023-11-01 |
| CHATHAM ASSET PARTNERS HIGH YIELD FUND LP | P | $2,064 | $1,048 | $1,016 | $1,016 | 2023-09-30 |
| CHATHAM CO INVEST | P | $72,486 | $229,186 | -$156,700 | -$156,700 | 2023-03-31 |
| CHATHAM CO INVEST | P | $245,370 | $72,486 | $172,884 | $172,884 | 2023-03-31 |
| COLLER INTERNATIONAL PARTNERS VI | P | $161,048 | $161,048 | $161,048 | 2023-09-22 | |
| COLLER INTERNATIONAL PARTNERS VI | P | $256,134 | $256,134 | $256,134 | 2023-12-15 | |
| COLLER INTERNATIONAL PARTNERS VI | P | $278,766 | $278,766 | $278,766 | 2024-03-27 | |
| COLLER INTERNATIONAL PARTNERS VI | P | $315,000 | $315,000 | $315,000 | 2023-06-26 | |
| COLLER INTERNATIONAL PARTNERS VI | P | $628,652 | $628,652 | $628,652 | 2023-11-10 | |
| COLLER INTL PARTNERS VII LP | P | $274,598 | $274,598 | $274,598 | 2023-12-22 | |
| COLLER INTL PARTNERS VII LP | P | $935,000 | $935,000 | $935,000 | 2023-05-18 | |
| COLLER INTL PARTNERS VII LP | P | $1,540,000 | $1,540,000 | $1,540,000 | 2023-10-31 | |
| COLLER INTL PARTNERS VII LP | P | $1,974,500 | $1,974,500 | $1,974,500 | 2023-09-28 | |
| CRESTVIEW PARTNERS III LP | P | $2,492,866 | $2,492,866 | $2,492,866 | 2024-01-12 | |
| CRESTVIEW PARTNERS IV LP | P | $6,168,962 | $6,168,962 | $6,168,962 | 2024-02-27 | |
| EIG ENERGY FUND XVI LP | P | $45,902 | $45,902 | $45,902 | 2023-06-06 | |
| EIG ENERGY FUND XVI LP | P | $119,599 | $119,599 | $119,599 | 2024-02-02 | |
| EIG ENERGY FUND XVI LP | P | $911,617 | $911,617 | $911,617 | 2023-11-10 | |
| ENERGY FUND XV-A LP | P | $84,929 | $84,929 | $84,929 | 2023-11-10 | |
| EIG ENERGY FD XVII LP | P | $74,382 | $74,382 | $74,382 | 2023-09-28 | |
| EIG ENERGY FD XVII LP | P | $172,069 | $172,069 | $172,069 | 2023-06-26 | |
| EIG ENERGY FD XVII LP | P | $172,171 | $172,171 | $172,171 | 2023-08-15 | |
| EIG ENERGY FD XVII LP | P | $185,641 | $185,641 | $185,641 | 2023-10-27 | |
| EMERGENCE CAPITAL PARTNERS III | P | $2,029,399 | $2,029,399 | $2,029,399 | 2023-11-15 | |
| PROJECT ELECTRON LP-TBU | P | $43,582 | $43,582 | $43,582 | 2023-12-06 | |
| EPIRIS FUND II B LP | P | $5,816 | $5,816 | $5,816 | 2023-08-04 | |
| EPIRIS FUND II B LP | P | $9,600 | $9,600 | $9,600 | 2023-11-07 | |
| EPIRIS FUND II B LP | P | $13,026 | $13,026 | $13,026 | 2023-08-04 | |
| EPIRIS FUND II B LP | P | $15,550 | $15,550 | $15,550 | 2024-02-06 | |
| EPIRIS FUND II B LP | P | $20,426 | $20,426 | $20,426 | 2023-12-06 | |
| EPIRIS FUND II B LP | P | $31,955 | $31,955 | $31,955 | 2023-06-22 | |
| EPIRIS FUND III LP | P | $3,301 | -$3,301 | -$3,301 | 2024-03-07 | |
| EPIRIS FUND III LP | P | $19,455 | $19,455 | $19,455 | 2023-12-18 | |
| EPIRIS FUND III LP | P | $43,691 | $43,691 | $43,691 | 2023-10-12 | |
| FDAF DISLOCATED I LP | P | $10,929,899 | -$10,929,899 | -$10,929,899 | 2023-01-05 | |
| FORTISSIMO CAPITAL FUND IV LP | P | $2,670,500 | $2,670,500 | $2,670,500 | 2023-11-28 | |
| FRAZIER LIFE SCIENCES IX LP | P | $348,083 | $348,083 | $348,083 | 2023-10-24 | |
| FRAZIER LIFE SCIENCES IX LP | P | $562,691 | $562,691 | $562,691 | 2024-02-22 | |
| FRAZIER LIFE SCI PUBLIC OVERAGE LP | P | $116,033 | $116,033 | $116,033 | 2023-07-21 | |
| FRAZIER LIFE SCI PUBLIC OVERAGE LP | P | $401,071 | $401,071 | $401,071 | 2024-02-06 | |
| FRAZIER LIFE SCI PUBLIC OVERAGE LP | P | $859,141 | $859,141 | $859,141 | 2024-03-25 | |
| FRAZIER LIFE SCI PUBLIC FD LP | P | $205,532 | $205,532 | $205,532 | 2024-02-06 | |
| FRAZIER LIFE SCI PUBLIC FD LP | P | $324,214 | $324,214 | $324,214 | 2023-12-15 | |
| FRAZIER LIFE SCI PUBLIC FD LP | P | $834,039 | $834,039 | $834,039 | 2024-03-25 | |
| FRAZIER LIFE SCI PUBLIC FD LP | P | $1,099,199 | $1,099,199 | $1,099,199 | 2023-08-16 | |
| FRAZIER LIFE SCIENCES X LP | P | $99,208 | $99,208 | $99,208 | 2023-09-29 | |
| FRAZIER LIFE SCIENCES X LP | P | $355,152 | $355,152 | $355,152 | 2024-01-08 | |
| FRAZIER LIFE SCIENCES X LP | P | $571,281 | $571,281 | $571,281 | 2023-08-15 | |
| FRAZIER LIFE SCIENCES XI LP | P | $221,313 | $221,313 | $221,313 | 2023-08-15 | |
| FRAZIER LIFE SCIENCES XI LP | P | $240,824 | $240,824 | $240,824 | 2024-03-29 | |
| GAVEA INVEST FD V PLUS B LP | P | $294,147 | $294,147 | $294,147 | 2023-09-06 | |
| GENERAL ATLANTIC SERVICE COMPANY LLC | P | $560,323 | -$560,323 | -$560,323 | 2024-01-12 | |
| GENERAL ATLANTIC SERVICE COMPANY LLC | P | $116,591 | -$116,591 | -$116,591 | 2023-09-01 | |
| GENERAL ATLANTIC SERVICE COMPANY LLC | P | $5,090 | $5,090 | $5,090 | 2023-08-14 | |
| GENERAL ATLANTIC SERVICE COMPANY LLC | P | $35,517 | $35,517 | $35,517 | 2023-08-07 | |
| GENERAL ATLANTIC SERVICE COMPANY LLC | P | $89,476 | $89,476 | $89,476 | 2023-07-26 | |
| GENERAL ATLANTIC SERVICE COMPANY LLC | P | $675,902 | $675,902 | $675,902 | 2023-09-20 | |
| GENERAL ATLANTIC SERVICE COMPANY LLC | P | $780,032 | $780,032 | $780,032 | 2023-12-06 | |
| GENERAL ATLANTIC SERVICE COMPANY LLC | P | $12,238,639 | $12,238,639 | $12,238,639 | 2023-05-03 | |
| GA MANAGED ACCOUNT PROGRAM | P | $285,850 | -$285,850 | -$285,850 | 2023-07-31 | |
| GA MANAGED ACCOUNT PROGRAM | P | $16,702 | -$16,702 | -$16,702 | 2023-07-26 | |
| GA MANAGED ACCOUNT PROGRAM | P | $15,953 | -$15,953 | -$15,953 | 2023-08-17 | |
| GA MANAGED ACCOUNT PROGRAM | P | $11,027 | -$11,027 | -$11,027 | 2024-02-20 | |
| GA MANAGED ACCOUNT PROGRAM | P | $2,400 | $2,400 | $2,400 | 2023-08-14 | |
| GA MANAGED ACCOUNT PROGRAM | P | $2,691 | $2,691 | $2,691 | 2023-08-07 | |
| GA MANAGED ACCOUNT PROGRAM | P | $100,250 | $100,250 | $100,250 | 2023-12-01 | |
| GA MANAGED ACCOUNT PROGRAM | P | $109,987 | $109,987 | $109,987 | 2023-04-28 | |
| GA MANAGED ACCOUNT PROGRAM | P | $230,515 | $230,515 | $230,515 | 2023-12-22 | |
| GA MANAGED ACCOUNT PROGRAM | P | $280,928 | $280,928 | $280,928 | 2023-06-26 | |
| GA MANAGED ACCOUNT PROGRAM | P | $352,328 | $352,328 | $352,328 | 2024-02-08 | |
| GA MANAGED ACCOUNT PROGRAM | P | $2,602,251 | $2,602,251 | $2,602,251 | 2024-02-01 | |
| GA MANAGED ACCOUNT PROGRAM | P | $2,628,414 | $2,628,414 | $2,628,414 | 2023-06-15 | |
| GA MANAGED ACCOUNT PROGRAM | P | $12,298,199 | $12,298,199 | $12,298,199 | 2023-05-03 | |
| GSO CAPITAL SOLUTIONS FD III LP | P | $40,637 | $40,637 | $40,637 | 2023-05-24 | |
| GSO CAPITAL SOLUTIONS FD III LP | P | $2,206,780 | $3,039,263 | -$832,483 | -$832,483 | 2023-07-17 |
| GSO CAPITAL SOLUTIONS FD III LP | P | $2,206,780 | $3,039,263 | -$832,483 | -$832,483 | 2023-07-17 |
| GSO CAPITAL SOLUTION | P | $12,952,701 | -$12,952,701 | -$12,952,701 | 2023-08-25 | |
| HIG BIOVENTURES II | P | $2,599,898 | $2,599,898 | $2,599,898 | 2023-09-29 | |
| HIG BRAZIL & LATIN AME PTNRS MASTER B LP | P | $370,738 | $370,738 | $370,738 | 2023-09-28 | |
| HIG BRAZIL & LATIN AME PTNRS MASTER B LP | P | $1,105,465 | $1,105,465 | $1,105,465 | 2023-04-19 | |
| HIG BRAZIL & LATIN AME PTNRS MASTER C LP | P | $370,738 | $370,738 | $370,738 | 2023-09-28 | |
| HIG BRAZIL & LATIN AME PTNRS MASTER C LP | P | $1,105,465 | $1,105,465 | $1,105,465 | 2023-04-19 | |
| HIG CAPITAL PARTNERS V L P | P | $769,340 | $769,340 | $769,340 | 2023-11-28 | |
| HIG CAPITAL PARTNERS V L P | P | $2,174,116 | $2,174,116 | $2,174,116 | 2024-02-16 | |
| HIG CAPITAL PARTNERS V L P | P | $2,445,695 | $2,445,695 | $2,445,695 | 2023-07-26 | |
| H.I.G. GROWTH BUYOUTS & EQUITY FUND II L.P.. | P | $174,007 | $174,007 | $174,007 | 2023-12-01 | |
| H.I.G. GROWTH BUYOUTS & EQUITY FUND II L.P.. | P | $337,752 | $337,752 | $337,752 | 2023-12-29 | |
| H.I.G. GROWTH BUYOUTS & EQUITY FUND II L.P.. | P | $670,766 | $670,766 | $670,766 | 2023-08-28 | |
| H.I.G. GROWTH BUYOUTS & EQUITY FUND II L.P.. | P | $174,007 | -$174,007 | -$174,007 | 2023-12-01 | |
| HIG GROWTH B&EQ FD III LP | P | $428,164 | $428,164 | $428,164 | 2023-07-26 | |
| HIG MIDDLE MKT LBO FD II LP | P | $167,041 | $167,041 | $167,041 | 2023-09-26 | |
| HIG MIDDLE MKT LBO FD II LP | P | $690,013 | $690,013 | $690,013 | 2023-04-21 | |
| HIGHCLERE INTL SMALL CAP FUND | P | $87,119 | $87,119 | $87,119 | 2023-10-31 | |
| HIGHCLERE INTL SMALL CAP FUND | P | $94,205 | $94,205 | $94,205 | 2023-11-30 | |
| HIGHCLERE INTL SMALL CAP FUND | P | $95,900 | $95,900 | $95,900 | 2023-09-30 | |
| HIGHCLERE INTL SMALL CAP FUND | P | $96,735 | $96,735 | $96,735 | 2023-05-31 | |
| HIGHCLERE INTL SMALL CAP FUND | P | $98,466 | $98,466 | $98,466 | 2023-06-30 | |
| HIGHCLERE INTL SMALL CAP FUND | P | $98,589 | $98,589 | $98,589 | 2024-02-29 | |
| HIGHCLERE INTL SMALL CAP FUND | P | $99,042 | $99,042 | $99,042 | 2024-01-31 | |
| HIGHCLERE INTL SMALL CAP FUND | P | $99,346 | $99,346 | $99,346 | 2023-08-31 | |
| HIGHCLERE INTL SMALL CAP FUND | P | $99,834 | $99,834 | $99,834 | 2023-04-30 | |
| HIGHCLERE INTL SMALL CAP FUND | P | $100,113 | $100,113 | $100,113 | 2023-12-31 | |
| HIGHCLERE INTL SMALL CAP FUND | P | $101,098 | $101,098 | $101,098 | 2024-03-31 | |
| HIGHCLERE INTL SMALL CAP FUND | P | $101,460 | $101,460 | $101,460 | 2023-07-31 | |
| HIGHCLERE INTL SMID CAP FUND | P | $42,927 | $42,927 | $42,927 | 2023-10-31 | |
| HIGHCLERE INTL SMID CAP FUND | P | $44,717 | $44,717 | $44,717 | 2023-09-30 | |
| HIGHCLERE INTL SMID CAP FUND | P | $45,669 | $45,669 | $45,669 | 2023-05-31 | |
| HIGHCLERE INTL SMID CAP FUND | P | $46,271 | $46,271 | $46,271 | 2023-11-30 | |
| HIGHCLERE INTL SMID CAP FUND | P | $46,408 | $46,408 | $46,408 | 2023-06-30 | |
| HIGHCLERE INTL SMID CAP FUND | P | $46,503 | $46,503 | $46,503 | 2023-08-31 | |
| HIGHCLERE INTL SMID CAP FUND | P | $46,670 | $46,670 | $46,670 | 2024-02-29 | |
| HIGHCLERE INTL SMID CAP FUND | P | $47,218 | $47,218 | $47,218 | 2024-01-31 | |
| HIGHCLERE INTL SMID CAP FUND | P | $47,332 | $47,332 | $47,332 | 2023-04-30 | |
| HIGHCLERE INTL SMID CAP FUND | P | $47,737 | $47,737 | $47,737 | 2024-03-31 | |
| HIGHCLERE INTL SMID CAP FUND | P | $48,180 | $48,180 | $48,180 | 2023-07-31 | |
| HIGHCLERE INTL SMID CAP FUND | P | $48,401 | $48,401 | $48,401 | 2023-12-31 | |
| HONGSHAN CAP GR FD III LP | P | $545,347 | $545,347 | $545,347 | 2024-02-01 | |
| HONGSHAN CAP GR FD III LP | P | $567,039 | $567,039 | $567,039 | 2023-09-14 | |
| HONGSHAN CAP GR FD III LP | P | $2,679,640 | $2,679,640 | $2,679,640 | 2024-03-14 | |
| HONGSHAN CAP GR FD IV LP | P | $1,763,479 | $1,763,479 | $1,763,479 | 2024-01-11 | |
| HONGSHAN CAP GR FD V LP | P | $144,901 | $144,901 | $144,901 | 2024-01-11 | |
| HONGSHAN CAP GR FD V LP | P | $184,690 | $184,690 | $184,690 | 2023-06-13 | |
| HONGSHAN CAP GR FD V LP | P | $265,310 | $265,310 | $265,310 | 2023-11-30 | |
| HONGSHAN CAP VENT FD IV LP | P | $460,581 | $460,581 | $460,581 | 2024-02-20 | |
| HONGSHAN CAP VENT FD V LP | P | $256,791 | $256,791 | $256,791 | 2023-05-16 | |
| HONGSHAN CAP VENT FD VII LP | P | $140,494 | $140,494 | $140,494 | 2023-08-28 | |
| HONGSHAN CAP VENT FD VII LP | P | $392,473 | $392,473 | $392,473 | 2023-11-24 | |
| IDG CHINA CAPITAL FUND III LP | P | $112,939 | $112,939 | $112,939 | 2023-05-05 | |
| IDG CHINA CAPITAL FUND III LP | P | $162,581 | $162,581 | $162,581 | 2023-12-26 | |
| IDG CHINA VENTURE CAP FD IV LP | P | $1,164,005 | $1,164,005 | $1,164,005 | 2023-09-27 | |
| IDG CHINA VENTURE CAP FD IV LP | P | $3,280,128 | $3,280,128 | $3,280,128 | 2024-03-27 | |
| IDG CHINA VENTURE CAP FD IV LP | P | $8,618,234 | $8,618,234 | $8,618,234 | 2023-12-26 | |
| IDG-ACCEL CHINA GROWTH FUND III L.P. | P | $753,350 | $753,350 | $753,350 | 2023-12-28 | |
| IDG-ACCEL CHINA GROWTH FUND III L.P. | P | $903,149 | $903,149 | $903,149 | 2023-09-21 | |
| IRON POINT RE PARTNERS IV LP | P | $54,545 | $54,545 | $54,545 | 2023-08-31 | |
| IRON POINT RE PARTNERS IV LP | P | $311,033 | $311,033 | $311,033 | 2023-10-31 | |
| IRON POINT RE PARTNERS IV LP | P | $929,694 | $929,694 | $929,694 | 2023-04-28 | |
| IRON POINT RE PARTNERS IV LP | P | $1,037,775 | $1,037,775 | $1,037,775 | 2023-12-29 | |
| IRON POINT RE PARTNERS IV LP | P | $1,616,034 | $1,616,034 | $1,616,034 | 2023-07-31 | |
| JERICHO CAPITAL INTERNATIONAL LTD | P | $9,222,102 | $4,985,910 | $4,236,192 | $4,236,192 | 2023-12-31 |
| JERICHO CAPITAL INTERNATIONAL LTD | P | $175,219,935 | $94,732,298 | $80,487,637 | $80,487,637 | 2023-12-31 |
| PEG SECONDARY PE INVESTORS III LP | P | $291,623 | $291,623 | $291,623 | 2023-06-13 | |
| PEG SECONDARY PE INVESTORS III LP | P | $468,454 | $468,454 | $468,454 | 2023-12-26 | |
| LA CAPITAL GLOBAL EQUITY FUND | P | $13,133 | $13,133 | $13,133 | 2023-05-31 | |
| LA CAPITAL GLOBAL EQUITY FUND | P | $13,309 | $13,309 | $13,309 | 2023-10-31 | |
| LA CAPITAL GLOBAL EQUITY FUND | P | $13,441 | $13,441 | $13,441 | 2023-04-30 | |
| LA CAPITAL GLOBAL EQUITY FUND | P | $13,625 | $13,625 | $13,625 | 2023-09-30 | |
| LA CAPITAL GLOBAL EQUITY FUND | P | $13,794 | $13,794 | $13,794 | 2023-06-30 | |
| LA CAPITAL GLOBAL EQUITY FUND | P | $13,982 | $13,982 | $13,982 | 2023-08-31 | |
| LA CAPITAL GLOBAL EQUITY FUND | P | $14,189 | $14,189 | $14,189 | 2023-11-30 | |
| LA CAPITAL GLOBAL EQUITY FUND | P | $14,231 | $14,231 | $14,231 | 2023-07-31 | |
| LA CAPITAL GLOBAL EQUITY FUND | P | $14,721 | $14,721 | $14,721 | 2023-12-31 | |
| LA CAPITAL GLOBAL EQUITY FUND | P | $15,051 | $15,051 | $15,051 | 2024-01-31 | |
| LA CAPITAL GLOBAL EQUITY FUND | P | $15,537 | $15,537 | $15,537 | 2024-02-29 | |
| LA CAPITAL GLOBAL EQUITY FUND | P | $16,041 | $16,041 | $16,041 | 2024-03-31 | |
| LACM WORLD SMALL CAP EQUITY FUND LP | P | $12,889 | $12,889 | $12,889 | 2023-10-31 | |
| LACM WORLD SMALL CAP EQUITY FUND LP | P | $12,928 | $12,928 | $12,928 | 2023-05-31 | |
| LACM WORLD SMALL CAP EQUITY FUND LP | P | $13,394 | $13,394 | $13,394 | 2023-04-28 | |
| LACM WORLD SMALL CAP EQUITY FUND LP | P | $13,511 | $13,511 | $13,511 | 2023-09-29 | |
| LACM WORLD SMALL CAP EQUITY FUND LP | P | $13,854 | $13,854 | $13,854 | 2023-06-30 | |
| LACM WORLD SMALL CAP EQUITY FUND LP | P | $14,025 | $14,025 | $14,025 | 2023-11-30 | |
| LACM WORLD SMALL CAP EQUITY FUND LP | P | $14,061 | $14,061 | $14,061 | 2023-08-31 | |
| LACM WORLD SMALL CAP EQUITY FUND LP | P | $14,442 | $14,442 | $14,442 | 2023-07-31 | |
| LACM WORLD SMALL CAP EQUITY FUND LP | P | $15,243 | $15,243 | $15,243 | 2024-01-31 | |
| LACM WORLD SMALL CAP EQUITY FUND LP | P | $15,310 | $15,310 | $15,310 | 2023-12-29 | |
| LACM WORLD SMALL CAP EQUITY FUND LP | P | $15,837 | $15,837 | $15,837 | 2024-02-29 | |
| LACM WORLD SMALL CAP EQUITY FUND LP | P | $16,458 | $16,458 | $16,458 | 2024-03-28 | |
| THE MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUST | P | $77,811 | $51,011 | $26,800 | $26,800 | 2024-02-29 |
| THE MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUST | P | $75,832 | $51,681 | $24,151 | $24,151 | 2024-01-31 |
| THE MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUST | P | $75,212 | $51,924 | $23,288 | $23,288 | 2023-12-29 |
| THE MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUST | P | $74,306 | $52,408 | $21,898 | $21,898 | 2023-07-31 |
| THE MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUST | P | $73,095 | $52,717 | $20,378 | $20,378 | 2023-11-30 |
| THE MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUST | P | $73,301 | $52,742 | $20,559 | $20,559 | 2023-08-31 |
| THE MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUST | P | $72,354 | $53,169 | $19,185 | $19,185 | 2023-06-30 |
| THE MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUST | P | $70,779 | $53,699 | $17,080 | $17,080 | 2023-09-29 |
| THE MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUST | P | $69,874 | $54,220 | $15,654 | $15,654 | 2023-05-31 |
| THE MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUST | P | $69,683 | $54,337 | $15,346 | $15,346 | 2023-04-28 |
| THE MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUST | P | $68,728 | $54,553 | $14,175 | $14,175 | 2023-10-31 |
| THE MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUST | P | $79,980 | $80,044 | -$64 | -$64 | 2024-03-28 |
| MHR LONGEVITY FUND LP | P | $3,381,794 | $2,896,439 | $485,355 | $485,355 | 2023-03-21 |
| MHR LONGEVITY FUND LP | P | $4,999,720 | $4,274,989 | $724,731 | $724,731 | 2023-06-01 |
| MHR LONGEVITY FUND LP | P | $5,999,703 | $4,953,794 | $1,045,909 | $1,045,909 | 2023-10-26 |
| MHR LONGEVITY FUND LP | P | $7,280,573 | $6,044,903 | $1,235,670 | $1,235,670 | 2023-08-15 |
| MHR INSTITUTIONAL PTNRS IV LP | P | $59,327 | $59,327 | $59,327 | 2023-04-25 | |
| MHR INSTITUTIONAL PTNRS IV LP | P | $846,247 | $846,247 | $846,247 | 2023-08-22 | |
| ORBIMED ASIA PARTNERS III LP | P | $4,004,245 | $4,004,245 | $4,004,245 | 2024-03-07 | |
| ORBIMED ISRAEL PTNRS II LP | P | $1,171,332 | $1,171,332 | $1,171,332 | 2023-04-21 | |
| ORBIMED PRIVATE INVEST VI LP | P | $0 | $0 | 2023-12-14 | ||
| ORBIMED PRIVATE INVEST VI LP | P | $0 | $0 | 2024-01-10 | ||
| ORBIMED PRIVATE INVEST VI LP | P | $105,137 | $105,137 | $105,137 | 2024-01-10 | |
| ORBIMED PRIVATE INVEST VI LP | P | $118,065 | $118,065 | $118,065 | 2024-03-22 | |
| ORBIMED PRIVATE INVEST VI LP | P | $127,931 | $127,931 | $127,931 | 2023-06-08 | |
| ORBIMED PRIVATE INVEST VI LP | P | $262,761 | $262,761 | $262,761 | 2023-04-27 | |
| ORBIMED PRIVATE INVEST VI LP | P | $313,400 | $313,400 | $313,400 | 2023-12-14 | |
| ORBIMED PRIVATE INVEST VI LP | P | $361,361 | $361,361 | $361,361 | 2024-02-15 | |
| ORBIMED PRIVATE INVEST VII LP | P | $1,303,634 | $1,303,634 | $1,303,634 | 2024-03-26 | |
| ORBIMED PRIVATE INVEST VIII LP | P | $1,496,878 | $1,496,878 | $1,496,878 | 2023-06-15 | |
| ORBIMED PRIVATE INVEST VIII LP | P | $2,663,109 | $2,663,109 | $2,663,109 | 2024-03-12 | |
| PEAK XV PARTNERS V | P | $156,151 | $156,151 | $156,151 | 2023-04-20 | |
| PEAK XV PARTNERS V | P | $178,485 | $178,485 | $178,485 | 2023-12-22 | |
| RIDGEWOOD ENERGY OIL & GAS FD III LP | P | $171,472 | $171,472 | $171,472 | 2023-06-26 | |
| RIDGEWOOD ENERGY OIL & GAS FD III LP | P | $375,446 | $375,446 | $375,446 | 2024-03-22 | |
| S CAPITAL LP | P | $257,700 | $257,700 | $257,700 | 2023-12-19 | |
| SEQUOIA CAPITAL FUND | P | $628,894 | $524,759 | $104,135 | $104,135 | 2022-10-21 |
| SEQUOIA CAPITAL FUND | P | $626,904 | $524,759 | $102,145 | $102,145 | 2022-11-04 |
| SEQUOIA CAPITAL FUND | P | $409,493 | $333,938 | $75,555 | $75,555 | 2022-09-20 |
| SEQUOIA CAPITAL FUND | P | $212,708 | $178,050 | $34,658 | $34,658 | 2022-11-30 |
| SEQUOIA CAPITAL FUND | P | $194,997 | $159,018 | $35,979 | $35,979 | 2022-07-31 |
| SEQUOIA CAPITAL FUND | P | $94,986 | $79,509 | $15,477 | $15,477 | 2022-11-30 |
| SEQUOIA CAPITAL FUND | P | $58,499 | $47,705 | $10,794 | $10,794 | 2022-08-26 |
| SEQUOIA CAPITAL FUND | P | $25,798 | $21,038 | $4,760 | $4,760 | 2022-08-26 |
| SEQUOIA CAPITAL FUND | P | $25,213 | $21,038 | $4,175 | $4,175 | 2022-10-21 |
| SEQUOIA CAPITAL FUND | P | $25,133 | $21,038 | $4,095 | $4,095 | 2022-11-30 |
| SEQUOIA CAPITAL FUND | P | $24,796 | $21,038 | $3,758 | $3,758 | 2023-01-31 |
| SEQUOIA CAPITAL FUND | P | $24,796 | $21,038 | $3,758 | $3,758 | 2022-12-31 |
| SEQUOIA CAPITAL FUND | P | $24,035 | $21,038 | $2,997 | $2,997 | 2023-03-31 |
| SEQUOIA CAPITAL FUND | P | $7,122 | $7,114 | $8 | $8 | 2023-09-30 |
| SEQUOIA CAPITAL FUND | P | $21,038 | $20,947 | $91 | $91 | 2023-03-31 |
| SEQUOIA CAPITAL FUND | P | $21,038 | $20,951 | $87 | $87 | 2022-08-26 |
| SEQUOIA CAPITAL FUND | P | $21,038 | $20,951 | $87 | $87 | 2022-10-21 |
| SEQUOIA CAPITAL FUND | P | $21,038 | $20,951 | $87 | $87 | 2022-11-30 |
| SEQUOIA CAPITAL FUND | P | $21,038 | $20,951 | $87 | $87 | 2022-12-31 |
| SEQUOIA CAPITAL FUND | P | $21,038 | $20,951 | $87 | $87 | 2023-01-31 |
| SEQUOIA CAPITAL FUND | P | $20,909 | $22,926 | -$2,017 | -$2,017 | 2023-05-15 |
| SEQUOIA CAPITAL FUND | P | $35,610 | $35,881 | -$271 | -$271 | 2023-12-31 |
| SEQUOIA CAPITAL FUND | P | $42,053 | $42,007 | $46 | $46 | 2023-10-31 |
| SEQUOIA CAPITAL FUND | P | $47,705 | $47,508 | $197 | $197 | 2022-08-26 |
| SEQUOIA CAPITAL FUND | P | $43,950 | $47,547 | -$3,597 | -$3,597 | 2023-07-31 |
| SEQUOIA CAPITAL FUND | P | $43,950 | $48,414 | -$4,464 | -$4,464 | 2023-04-28 |
| SEQUOIA CAPITAL FUND | P | $53,400 | $53,837 | -$437 | -$437 | 2024-02-21 |
| SEQUOIA CAPITAL FUND | P | $63,079 | $63,559 | -$480 | -$480 | 2024-01-31 |
| SEQUOIA CAPITAL FUND | P | $63,079 | $63,631 | -$552 | -$552 | 2023-11-30 |
| SEQUOIA CAPITAL FUND | P | $63,079 | $67,155 | -$4,076 | -$4,076 | 2023-08-31 |
| SEQUOIA CAPITAL FUND | P | $63,079 | $68,241 | -$5,162 | -$5,162 | 2023-06-16 |
| SEQUOIA CAPITAL FUND | P | $71,220 | $71,762 | -$542 | -$542 | 2023-11-06 |
| SEQUOIA CAPITAL FUND | P | $71,220 | $77,049 | -$5,829 | -$5,829 | 2023-06-30 |
| SEQUOIA CAPITAL FUND | P | $79,509 | $79,181 | $328 | $328 | 2022-11-30 |
| SEQUOIA CAPITAL FUND | P | $79,509 | $80,114 | -$605 | -$605 | 2023-12-31 |
| SEQUOIA CAPITAL FUND | P | $87,900 | $87,805 | $95 | $95 | 2023-09-19 |
| SEQUOIA CAPITAL FUND | P | $89,000 | $89,728 | -$728 | -$728 | 2024-02-29 |
| SEQUOIA CAPITAL FUND | P | $87,900 | $96,380 | -$8,480 | -$8,480 | 2023-05-15 |
| SEQUOIA CAPITAL FUND | P | $106,800 | $107,612 | -$812 | -$812 | 2024-02-01 |
| SEQUOIA CAPITAL FUND | P | $142,440 | $143,605 | -$1,165 | -$1,165 | 2024-02-29 |
| SEQUOIA CAPITAL FUND | P | $142,440 | $156,161 | -$13,721 | -$13,721 | 2023-04-30 |
| SEQUOIA CAPITAL FUND | P | $159,018 | $158,361 | $657 | $657 | 2022-07-31 |
| SEQUOIA CAPITAL FUND | P | $174,920 | $174,730 | $190 | $190 | 2023-09-19 |
| SEQUOIA CAPITAL FUND | P | $178,050 | $177,315 | $735 | $735 | 2022-11-30 |
| SEQUOIA CAPITAL FUND | P | $178,000 | $179,455 | -$1,455 | -$1,455 | 2024-03-31 |
| SEQUOIA CAPITAL FUND | P | $213,660 | $215,407 | -$1,747 | -$1,747 | 2024-02-21 |
| SEQUOIA CAPITAL FUND | P | $318,036 | $320,636 | -$2,600 | -$2,600 | 2024-02-21 |
| SEQUOIA CAPITAL FUND | P | $333,938 | $332,559 | $1,379 | $1,379 | 2022-09-20 |
| SEQUOIA CAPITAL FUND | P | $356,100 | $359,011 | -$2,911 | -$2,911 | 2024-02-01 |
| SEQUOIA CAPITAL FUND | P | $391,710 | $394,913 | -$3,203 | -$3,203 | 2024-03-31 |
| SEQUOIA CAPITAL FUND | P | $397,545 | $400,568 | -$3,023 | -$3,023 | 2023-11-17 |
| SEQUOIA CAPITAL FUND | P | $508,858 | $512,728 | -$3,870 | -$3,870 | 2023-11-06 |
| SEQUOIA CAPITAL FUND | P | $477,054 | $516,097 | -$39,043 | -$39,043 | 2023-07-31 |
| SEQUOIA CAPITAL FUND | P | $524,759 | $522,592 | $2,167 | $2,167 | 2022-10-21 |
| SEQUOIA CAPITAL FUND | P | $524,759 | $522,592 | $2,167 | $2,167 | 2022-11-04 |
| SEQUOIA CAPITAL FUND | P | $1,160,831 | $1,170,322 | -$9,491 | -$9,491 | 2024-03-22 |
| SEQUOIA CAPITAL GLOBAL GROWTH FD III - ENDURANCE PARTNERS LP | P | $1,578,466 | $1,578,466 | $1,578,466 | 2023-12-14 | |
| SEQUOIA CAPITAL GLOBAL GROWTH FD III - ENDURANCE PARTNERS LP | P | $1,491,943 | $1,491,943 | $1,491,943 | 2023-12-08 | |
| SEQUOIA CAPITAL GLOBAL GROWTH FD III - ENDURANCE PARTNERS LP | P | $1,471,819 | $1,471,819 | $1,471,819 | 2023-12-04 | |
| SEQUOIA CAPITAL GLOBAL GROWTH FD III - ENDURANCE PARTNERS LP | P | $1,466,554 | $1,466,554 | $1,466,554 | 2023-11-30 | |
| SEQUOIA CAPITAL GLOBAL GROWTH FD III - ENDURANCE PARTNERS LP | P | $1,434,034 | $1,434,034 | $1,434,034 | 2023-06-28 | |
| SEQUOIA CAPITAL GLOBAL GROWTH FD III - ENDURANCE PARTNERS LP | P | $1,376,040 | $1,376,040 | $1,376,040 | 2023-06-27 | |
| SEQUOIA CAPITAL GLOBAL GROWTH FD III - ENDURANCE PARTNERS LP | P | $1,353,030 | $1,353,030 | $1,353,030 | 2023-06-08 | |
| SEQUOIA CAPITAL GLOBAL GROWTH FD III - ENDURANCE PARTNERS LP | P | $615,323 | $615,323 | $615,323 | 2024-03-01 | |
| SEQUOIA CAPITAL GLOBAL GROWTH FD III - ENDURANCE PARTNERS LP | P | $425,044 | $425,044 | $425,044 | 2024-01-11 | |
| SEQUOIA CAPITAL GLOBAL GROWTH FD III - ENDURANCE PARTNERS LP | P | $170,131 | $170,131 | $170,131 | 2023-09-27 | |
| SEQUOIA CAPITAL GLOBAL GROWTH FD III - ENDURANCE PARTNERS LP | P | $294,498 | $294,498 | $294,498 | 2024-03-05 | |
| SEQUOIA CAPITAL GLOBAL GROWTH FD III - ENDURANCE PARTNERS LP | P | $400,047 | $400,047 | $400,047 | 2023-06-07 | |
| SEQUOIA CAP GBL GR FD | P | $763,899 | $763,899 | $763,899 | 2024-03-01 | |
| SEQUOIA CAP GBL GR FD | P | $260,781 | $260,781 | $260,781 | 2024-03-05 | |
| SEQUOIA CAP GBL GR FD | P | $306,458 | $306,458 | $306,458 | 2023-09-27 | |
| SEQUOIA CAP GBL GR FD | P | $484,514 | $484,514 | $484,514 | 2023-05-23 | |
| SEQUOIA CAP GBL GROWTH FD II | P | $1,238,639 | $1,238,639 | $1,238,639 | 2024-01-11 | |
| SEQUOIA CAP GBL GROWTH FD II | P | $790,194 | $790,194 | $790,194 | 2023-11-20 | |
| SEQUOIA CAP GBL GROWTH FD II | P | $766,541 | $766,541 | $766,541 | 2023-11-13 | |
| SEQUOIA CAP GBL GROWTH FD II | P | $758,718 | $758,718 | $758,718 | 2023-11-07 | |
| SEQUOIA CAP GBL GROWTH FD II | P | $719,783 | $719,783 | $719,783 | 2023-08-08 | |
| SEQUOIA CAP GBL GROWTH FD II | P | $711,141 | $711,141 | $711,141 | 2023-09-05 | |
| SEQUOIA CAP GBL GROWTH FD II | P | $695,494 | $695,494 | $695,494 | 2023-08-29 | |
| SEQUOIA CAP GBL GROWTH FD II | P | $164,365 | $164,365 | $164,365 | 2023-09-27 | |
| SEQUOIA CAP GBL GROWTH FD II | P | $484,298 | $484,298 | $484,298 | 2024-03-05 | |
| SEQUOIA US E EXPANSION FUND I | P | $287,317 | -$287,317 | -$287,317 | 2022-12-31 | |
| SEQUOIA CAP US GR FD VIII LP | P | $248,987 | $248,987 | $248,987 | 2024-02-08 | |
| SEQUOIA CAP US GR FD VIII LP | P | $35,306 | $35,306 | $35,306 | 2024-01-30 | |
| SEQUOIA CAP US GR FD VIII LP | P | $388,842 | $388,842 | $388,842 | 2023-12-14 | |
| SEQUOIA CAP US GROWTH FD VII LP | P | $490,651 | $490,651 | $490,651 | 2023-12-14 | |
| SEQUOIA CAP US GROWTH FD VII LP | P | $489,349 | $489,349 | $489,349 | 2023-12-08 | |
| SEQUOIA CAP US GROWTH FD VII LP | P | $483,019 | $483,019 | $483,019 | 2023-12-04 | |
| SEQUOIA CAP US GROWTH FD VII LP | P | $481,363 | $481,363 | $481,363 | 2023-11-30 | |
| SEQUOIA CAP US GROWTH FD VII LP | P | $471,133 | $471,133 | $471,133 | 2023-06-28 | |
| SEQUOIA CAP US GROWTH FD VII LP | P | $452,890 | $452,890 | $452,890 | 2023-06-27 | |
| SEQUOIA CAP US GROWTH FD VII LP | P | $445,652 | $445,652 | $445,652 | 2023-06-08 | |
| SEQUOIA CAP US GROWTH FD VII LP | P | $361,878 | $361,878 | $361,878 | 2023-08-08 | |
| SEQUOIA CAP US GROWTH FD VII LP | P | $277,360 | $277,360 | $277,360 | 2023-11-20 | |
| SEQUOIA CAP US GROWTH FD VII LP | P | $266,861 | $266,861 | $266,861 | 2023-11-13 | |
| SEQUOIA CAP US GROWTH FD VII LP | P | $264,138 | $264,138 | $264,138 | 2023-11-07 | |
| SEQUOIA CAP US GROWTH FD VII LP | P | $250,583 | $250,583 | $250,583 | 2023-08-08 | |
| SEQUOIA CAP US GROWTH FD VII LP | P | $247,574 | $247,574 | $247,574 | 2023-09-05 | |
| SEQUOIA CAP US GROWTH FD VII LP | P | $242,127 | $242,127 | $242,127 | 2023-08-29 | |
| SEQUOIA CAP US GROWTH FD VII LP | P | $208,725 | $208,725 | $208,725 | 2023-06-07 | |
| SEQUOIA CAP US GROWTH FD VII LP | P | $169,544 | $169,544 | $169,544 | 2023-05-22 | |
| SEQUOIA CAP US GROWTH FD VII LP | P | $158,500 | $158,500 | $158,500 | 2023-05-17 | |
| SEQUOIA CAP US GROWTH FD VII LP | P | $1,308 | -$1,308 | -$1,308 | 2023-08-07 | |
| SEQUOIA CAP US GR FUND IX LP | P | $109,870 | $109,870 | $109,870 | 2023-12-05 | |
| SEQUOIA CAP US GROWTH FD VI LP | P | $704,494 | $704,494 | $704,494 | 2023-08-25 | |
| SEQUOIA CAP US GROWTH FD VI LP | P | $684,604 | $684,604 | $684,604 | 2023-08-30 | |
| SEQUOIA CAP US GROWTH FD VI LP | P | $507,592 | $507,592 | $507,592 | 2023-08-16 | |
| SEQUOIA CAP US GROWTH FD VI LP | P | $486,637 | $486,637 | $486,637 | 2023-08-22 | |
| SEQUOIA CAP US GROWTH FD VI LP | P | $486,637 | $486,637 | $486,637 | 2023-08-21 | |
| SEQUOIA CAP US GROWTH FD VI LP | P | $405,664 | $405,664 | $405,664 | 2023-09-05 | |
| SEQUOIA CAP US GROWTH FD VI LP | P | $259,879 | $259,879 | $259,879 | 2023-11-20 | |
| SEQUOIA CAP US GROWTH FD VI LP | P | $242,794 | $242,794 | $242,794 | 2023-11-13 | |
| SEQUOIA CAP US GROWTH FD VI LP | P | $240,337 | $240,337 | $240,337 | 2023-11-07 | |
| SEQUOIA CAP US GROWTH FD VI LP | P | $228,109 | $228,109 | $228,109 | 2023-08-08 | |
| SEQUOIA CAP US GROWTH FD VI LP | P | $225,395 | $225,395 | $225,395 | 2023-09-05 | |
| SEQUOIA CAP US GROWTH FD VI LP | P | $220,481 | $220,481 | $220,481 | 2023-08-29 | |
| SEQUOIA CAP US GROWTH FD VI LP | P | $195,805 | $195,805 | $195,805 | 2024-03-01 | |
| SEQUOIA CAP US GROWTH FD VI LP | P | $405,664 | -$405,664 | -$405,664 | 2023-09-05 | |
| SEQUOIA CAPITAL U.S. VENTURE FUND XIV L.P.. | P | $1,542,538 | $1,542,538 | $1,542,538 | 2023-08-16 | |
| SEQUOIA CAPITAL U.S. VENTURE FUND XIV L.P.. | P | $1,483,792 | $1,483,792 | $1,483,792 | 2023-08-22 | |
| SEQUOIA CAPITAL U.S. VENTURE FUND XIV L.P.. | P | $1,483,792 | $1,483,792 | $1,483,792 | 2023-08-21 | |
| SEQUOIA CAPITAL U.S. VENTURE FUND XIV L.P.. | P | $1,435,175 | $1,435,175 | $1,435,175 | 2023-08-25 | |
| SEQUOIA CAPITAL U.S. VENTURE FUND XIV L.P.. | P | $1,413,082 | $1,413,082 | $1,413,082 | 2023-08-30 | |
| SEQUOIA CAPITAL U.S. VENTURE FUND XIV L.P.. | P | $1,245,562 | $1,245,562 | $1,245,562 | 2023-09-05 | |
| SEQUOIA CAPITAL U.S. VENTURE FUND XIV L.P.. | P | $713,589 | $713,589 | $713,589 | 2023-11-20 | |
| SEQUOIA CAPITAL U.S. VENTURE FUND XIV L.P.. | P | $671,663 | $671,663 | $671,663 | 2023-11-13 | |
| SEQUOIA CAPITAL U.S. VENTURE FUND XIV L.P.. | P | $665,176 | $665,176 | $665,176 | 2023-11-07 | |
| SEQUOIA CAPITAL U.S. VENTURE FUND XIV L.P.. | P | $632,892 | $632,892 | $632,892 | 2023-08-08 | |
| SEQUOIA CAPITAL U.S. VENTURE FUND XIV L.P.. | P | $625,726 | $625,726 | $625,726 | 2023-09-05 | |
| SEQUOIA CAPITAL U.S. VENTURE FUND XIV L.P.. | P | $612,752 | $612,752 | $612,752 | 2023-08-29 | |
| SEQUOIA CAPITAL U.S. VENTURE FUND XIV L.P.. | P | $1,245,562 | -$1,245,562 | -$1,245,562 | 2023-09-05 | |
| THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUE | P | $77,882 | $56,580 | $21,302 | $21,302 | 2024-03-28 |
| THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUE | P | $76,640 | $59,264 | $17,376 | $17,376 | 2023-12-29 |
| THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUE | P | $75,760 | $59,365 | $16,395 | $16,395 | 2024-02-29 |
| THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUE | P | $75,792 | $59,390 | $16,402 | $16,402 | 2024-01-31 |
| THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUE | P | $74,806 | $59,763 | $15,043 | $15,043 | 2023-07-31 |
| THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUE | P | $73,114 | $59,975 | $13,139 | $13,139 | 2023-11-30 |
| THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUE | P | $73,207 | $60,050 | $13,157 | $13,157 | 2023-08-31 |
| THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUE | P | $72,128 | $60,243 | $11,885 | $11,885 | 2023-09-30 |
| THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUE | P | $71,467 | $60,479 | $10,988 | $10,988 | 2023-06-30 |
| THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUE | P | $71,068 | $60,630 | $10,438 | $10,438 | 2023-04-28 |
| THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUE | P | $69,126 | $60,882 | $8,244 | $8,244 | 2023-10-31 |
| THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUE | P | $68,852 | $61,106 | $7,746 | $7,746 | 2023-05-31 |
| SPDR S&P 500 ETF TRUST | P | $25,091,453 | $25,566,371 | -$474,918 | -$474,918 | 2023-12-04 |
| STARWOOD GLOBAL OPP FD XI LP | P | $386,971 | $386,971 | $386,971 | 2023-12-15 | |
| VENTURE LENDING & LEASING VII LLC | P | $541,673 | $541,673 | $541,673 | 2023-06-06 | |
| VENTURE LENDING & LEASING VIII LLC | P | $599,367 | $599,367 | $599,367 | 2023-06-06 | |
| ACADIAN FRONTIER MARKETS | P | $3,149,477 | -$3,149,477 | -$3,149,477 | ||
| ACADIAN FRONTIER MARKETS | P | $187,389 | -$187,389 | -$187,389 | ||
| ACADIAN FRONTIER MARKETS | P | $10,180 | -$10,180 | -$10,180 | ||
| ACADIAN FRONTIER MARKETS | P | $139,443 | -$139,443 | -$139,443 | ||
| ACADIAN FRONTIER MARKETS | P | $490,824 | -$490,824 | -$490,824 | ||
| ACADIAN FRONTIER MARKETS | P | $45,353 | -$45,353 | -$45,353 | ||
| ACADIAN FRONTIER MARKETS | P | $502,258 | -$502,258 | -$502,258 | ||
| ACADIAN FRONTIER MARKETS | P | $45,698 | -$45,698 | -$45,698 | ||
| ACADIAN FRONTIER MARKETS | P | $598,000 | -$598,000 | -$598,000 | ||
| ACADIAN FRONTIER MARKETS | P | $46,322 | -$46,322 | -$46,322 | ||
| ACADIAN FRONTIER MARKETS | P | $3,056,144 | -$3,056,144 | -$3,056,144 | ||
| ACADIAN FRONTIER MARKETS | P | $46,183 | -$46,183 | -$46,183 | ||
| ACADIAN FRONTIER MARKETS | P | $77,786 | -$77,786 | -$77,786 | ||
| ACADIAN FRONTIER MARKETS | P | $46,472 | -$46,472 | -$46,472 | ||
| ACADIAN FRONTIER MARKETS | P | $120,255 | -$120,255 | -$120,255 | ||
| ACADIAN FRONTIER MARKETS | P | $74,636 | -$74,636 | -$74,636 | ||
| ACADIAN FRONTIER MARKETS | P | $92,393 | -$92,393 | -$92,393 | ||
| ACADIAN FRONTIER MARKETS | P | $1,705 | -$1,705 | -$1,705 | ||
| ACADIAN FRONTIER MARKETS | P | $26,772 | -$26,772 | -$26,772 | ||
| ACADIAN FRONTIER MARKETS | P | $3,852 | -$3,852 | -$3,852 | ||
| ACADIAN FRONTIER MARKETS | P | $46,005 | -$46,005 | -$46,005 | ||
| ACADIAN FRONTIER MARKETS | P | $142,267 | -$142,267 | -$142,267 | ||
| ACADIAN FRONTIER MARKETS | P | $135,500 | -$135,500 | -$135,500 | ||
| ACADIAN FRONTIER MARKETS | P | $4,140 | -$4,140 | -$4,140 | ||
| ACADIAN FRONTIER MARKETS | P | $54,177 | -$54,177 | -$54,177 | ||
| ACADIAN FRONTIER MARKETS | P | $3,297 | -$3,297 | -$3,297 | ||
| ACADIAN FRONTIER MARKETS | P | $730 | -$730 | -$730 | ||
| ACADIAN FRONTIER MARKETS | P | $631 | -$631 | -$631 | ||
| ACADIAN FRONTIER MARKETS | P | $136 | -$136 | -$136 | ||
| ACADIAN FRONTIER MARKETS | P | $1,927 | -$1,927 | -$1,927 | ||
| ACADIAN FRONTIER MARKETS | P | $60,704 | $60,704 | $60,704 | ||
| ACADIAN FRONTIER MARKETS | P | $20,977 | $20,977 | $20,977 | ||
| ACADIAN FRONTIER MARKETS | P | $26,896 | $26,896 | $26,896 | ||
| ACADIAN FRONTIER MARKETS | P | $521,242 | $521,242 | $521,242 | ||
| ACADIAN FRONTIER MARKETS | P | $1,260 | $1,260 | $1,260 | ||
| ACADIAN FRONTIER MARKETS | P | $62,366 | $62,366 | $62,366 | ||
| ACADIAN FRONTIER MARKETS | P | $1,118 | $1,118 | $1,118 | ||
| ACADIAN FRONTIER MARKETS | P | $43,755 | $43,755 | $43,755 | ||
| ACADIAN FRONTIER MARKETS | P | $1 | $1 | $1 | ||
| ACADIAN FRONTIER MARKETS | P | $1,870 | $1,870 | $1,870 | ||
| GENERAL ATLANTIC SERVICE COMPANY LLC | P | $2,205 | -$2,205 | -$2,205 | ||
| GENERAL ATLANTIC SERVICE COMPANY LLC | P | $31,869 | $31,869 | $31,869 | ||
| GENERAL ATLANTIC SERVICE COMPANY LLC | P | $286,390 | $286,390 | $286,390 | ||
| CRESTVIEW PARTNERS III LP | P | $27,043 | $27,043 | $27,043 | ||
| HIG MIDDLE MKT LBO FD II LP | P | $2,245,125 | $2,245,125 | $2,245,125 | ||
| HIG MIDDLE MKT LBO FD II LP | P | $552,608 | $552,608 | $552,608 | ||
| GENERAL ATLANTIC SERVICE COMPANY LLC | P | $56,092 | $56,092 | $56,092 | ||
| CRESTVIEW PARTNERS IV LP | P | $22,328 | $22,328 | $22,328 | ||
| HIG MIDDLE MKT LBO FD III LP | P | $100,602 | $100,602 | $100,602 | ||
| ACADIAN FRONTIER MARKETS | P | $24,965,982 | -$24,965,982 | -$24,965,982 | ||
| GSO III | P | $234,621 | $234,621 | $234,621 | ||
| GSO III AIV-1 | P | $515,966 | -$515,966 | -$515,966 | ||
| GSO III AIV-2 | P | $484,356 | -$484,356 | -$484,356 | ||
| GSO III AIV-3 | P | $463,790 | -$463,790 | -$463,790 | ||
| GSO III AIV-5 | P | $711,774 | -$711,774 | -$711,774 | ||
| GSO III AIV-6 | P | $39,883 | -$39,883 | -$39,883 | ||
| ACADIAN FRONTIER MARKETS | P | $227,186 | -$227,186 | -$227,186 | ||
| K-1 ADJUSTMENTS, NET OF UBI AND RELATED AMOUNTS ABOVE | P | -$116,807,506 | -$116,807,506 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Capital Gain Net Income | $132,680,049 | CapitalGainNetIncomeAmt |
Excise Tax Based On Invst Incm ExciseTaxBasedOnInvstIncmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Investment Income Excise Tax | $3,123,302 | InvestmentIncomeExciseTaxAmt |
| Tax Under Section511 | $0 | TaxUnderSection511Amt |
| Subtotal | $3,123,302 | SubtotalAmt |
| Subtitle A Tax | $0 | SubtitleATaxAmt |
| Tax Based On Investment Income | $3,123,302 | TaxBasedOnInvestmentIncomeAmt |
| Estimated Plus Ovpmt Incm Tx | $9,523,536 | EstimatedPlusOvpmtIncmTxAmt |
| Exempt Frgn Org Tax Wthld At Srce | $0 | ExemptFrgnOrgTaxWthldAtSrceAmt |
| Extsn Request Income Tax Paid | $0 | ExtsnRequestIncomeTaxPaidAmt |
| Backup Withholding Withheld | $0 | BackupWithholdingWithheldAmt |
| Total Payments And Credits | $9,523,536 | TotalPaymentsAndCreditsAmt |
| Form2220 Attached | Yes (X) | Form2220AttachedInd |
| Es Penalty | $0 | EsPenaltyAmt |
| Overpayment | $6,400,234 | OverpaymentAmt |
| Applied To ES Tax | $6,400,234 | AppliedToESTaxAmt |
| Refund | $0 | RefundAmt |
Statements Regarding Acty StatementsRegardingActyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Legislative Political Acty | 0 | LegislativePoliticalActyInd |
| More Than100 Spent | 0 | MoreThan100SpentInd |
| Form1120 POL Filed | 0 | Form1120POLFiledInd |
| Section4955 Organization Tax | $0 | Section4955OrganizationTaxAmt |
| Section4955 Managers Tax | $0 | Section4955ManagersTaxAmt |
| Tax Reimbursed | $0 | TaxReimbursedAmt |
| Activities Not Previously Rpt | 0 | ActivitiesNotPreviouslyRptInd |
| Changes To Articles Or Bylaws | 0 | ChangesToArticlesOrBylawsInd |
| Unrelated Bus Incm Over Limit | Yes (1) | UnrelatedBusIncmOverLimitInd |
| Form990 T Filed | Yes (1) | Form990TFiledInd |
| Organization Dissolved Etc | 0 | OrganizationDissolvedEtcInd |
| Section508e Rqr Satisfied | Yes (1) | Section508eRqrSatisfiedInd |
| At Least5000 In Assets | Yes (1) | AtLeast5000InAssetsInd |
| Org Report Or Register State | NY | OrgReportOrRegisterStateCd |
| Form990 PF Filed With Atty Gen | Yes (1) | Form990PFFiledWithAttyGenInd |
| Private Operating Foundation | 0 | PrivateOperatingFoundationInd |
| New Substantial Contributors | 0 | NewSubstantialContributorsInd |
| Own Controlled Entity | Yes (1) | OwnControlledEntityInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Comply With Public Insp Rqr | Yes (1) | ComplyWithPublicInspRqrInd |
| Website Address | HELMSLEYTRUST.ORG | WebsiteAddressTxt |
Persons With Books Name PersonsWithBooksName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | NICHOLAS J SCHIAVO CFO | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 2126793600 | PhoneNum |
Location Of Books US Address LocationOfBooksUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 230 PARK AVENUE SUITE 659 | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10169 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Foreign Accounts Question | Yes (1) | ForeignAccountsQuestionInd |
| Foreign Country | AS | ForeignCountryCd |
| Foreign Country | AU | ForeignCountryCd |
| Foreign Country | BE | ForeignCountryCd |
| Foreign Country | CA | ForeignCountryCd |
| Foreign Country | DA | ForeignCountryCd |
| Foreign Country | FI | ForeignCountryCd |
| Foreign Country | FR | ForeignCountryCd |
| Foreign Country | GM | ForeignCountryCd |
| Foreign Country | HK | ForeignCountryCd |
| Foreign Country | ID | ForeignCountryCd |
| Foreign Country | IT | ForeignCountryCd |
| Foreign Country | JA | ForeignCountryCd |
| Foreign Country | NL | ForeignCountryCd |
| Foreign Country | NZ | ForeignCountryCd |
| Foreign Country | NO | ForeignCountryCd |
| Foreign Country | PO | ForeignCountryCd |
| Foreign Country | SN | ForeignCountryCd |
| Foreign Country | SF | ForeignCountryCd |
| Foreign Country | KS | ForeignCountryCd |
| Foreign Country | SP | ForeignCountryCd |
| Foreign Country | SW | ForeignCountryCd |
| Foreign Country | SZ | ForeignCountryCd |
| Foreign Country | TW | ForeignCountryCd |
| Foreign Country | UK | ForeignCountryCd |
Statements Regarding Acty4720 StatementsRegardingActy4720Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Sale Or Exch Disqualified Prsn | Yes (1) | SaleOrExchDisqualifiedPrsnInd |
| Brrw Or Lend Disqualified Prsn | 0 | BrrwOrLendDisqualifiedPrsnInd |
| Furn Goods Disqualified Prsn | Yes (1) | FurnGoodsDisqualifiedPrsnInd |
| Pay Comp Disqualified Prsn | Yes (1) | PayCompDisqualifiedPrsnInd |
| Transfer Ast Disqualified Prsn | 0 | TransferAstDisqualifiedPrsnInd |
| Payment To Government Official | 0 | PaymentToGovernmentOfficialInd |
| Acts Fail To Qlfy As Exceptions | 0 | ActsFailToQlfyAsExceptionsInd |
| Uncorrected Prior Acts | 0 | UncorrectedPriorActsInd |
| Undistributed Income PY | 0 | UndistributedIncomePYInd |
| Business Holdings | Yes (1) | BusinessHoldingsInd |
| Excess Business Holdings | 0 | ExcessBusinessHoldingsInd |
| Jeopardy Investments | 0 | JeopardyInvestmentsInd |
| Uncorrected PY Jeopardy Invst | 0 | UncorrectedPYJeopardyInvstInd |
| Influence Legislation | 0 | InfluenceLegislationInd |
| Influence Election | 0 | InfluenceElectionInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Noncharitable Purpose | 0 | NoncharitablePurposeInd |
| Transactions Fail To Qlfy As Exc | 0 | TransactionsFailToQlfyAsExcInd |
| Maintained Expenditure Rspns | Yes (1) | MaintainedExpenditureRspnsInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | Yes (1) | SubjToTaxRmnrtnExPrchtPymtInd |
Officer Dir Trst Key Empl Info OfficerDirTrstKeyEmplInfoGrp
Officer Dir Trst Key Empl OfficerDirTrstKeyEmplGrp (8 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | TitleTitleTxt | Average Hrs Per Wk Devoted To PosAverageHrsPerWkDevotedToPosRt | CompensationCompensationAmt | Employee Benefit ProgramEmployeeBenefitProgramAmt | Expense Account Other AllwncExpenseAccountOtherAllwncAmt |
|---|---|---|---|---|---|---|---|---|
| SANDOR FRANKEL | ||||||||
| C/O TRUST 230 PARK AVENUE | NEW YORK | NY | 10169 | TRUSTEE | 25.00 | $150,000 | $0 | $0 |
| DAVID PANZIRER | ||||||||
| C/O TRUST 230 PARK AVENUE | NEW YORK | NY | 10169 | TRUSTEE | 35.00 | $150,000 | $0 | $0 |
| WALTER PANZIRER | ||||||||
| C/O TRUST 230 PARK AVENUE | NEW YORK | NY | 10169 | TRUSTEE | 32.00 | $150,000 | $0 | $0 |
| SARAH E PAUL | ||||||||
| C/O TRUST 230 PARK AVENUE | NEW YORK | NY | 10169 | CHIEF EXECUTIVE OFFICER | 40.00 | $918,521 | $213,448 | $0 |
| JACQUELINE F BAUSCH | ||||||||
| C/O TRUST 230 PARK AVENUE | NEW YORK | NY | 10169 | GENERAL COUNSEL | 40.00 | $592,495 | $94,658 | $0 |
| ROSALIND M HEWSENIAN | ||||||||
| C/O TRUST 230 PARK AVENUE | NEW YORK | NY | 10169 | CHIEF INVESTMENT OFFICER THRU 12/31/23 | 40.00 | $1,148,308 | $175,873 | $0 |
| JOSHUA W FENTON | ||||||||
| C/O TRUST 230 PARK AVENUE | NEW YORK | NY | 10169 | CHIEF INVESTMENT OFFICER FROM 1/1/24 | 40.00 | $794,891 | $190,587 | $0 |
| NICHOLAS J SCHIAVO | ||||||||
| C/O TRUST 230 PARK AVENUE | NEW YORK | NY | 10169 | CHIEF FINANCIAL OFFICER | 40.00 | $472,114 | $121,468 | $0 |
Compensation Highest Paid Empl CompensationHighestPaidEmplGrp (5 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | TitleTitleTxt | Average Hrs Per Wk Devoted To PosAverageHrsPerWkDevotedToPosRt | CompensationCompensationAmt | Employee BenefitsEmployeeBenefitsAmt | Expense AccountExpenseAccountAmt |
|---|---|---|---|---|---|---|---|---|
| AL Y KIM | ||||||||
| C/O TRUST 230 PARK AVENUE | NEW YORK | NY | 10169 | DIRECTOR OF INVESTME | 40.00 | $735,817 | $187,033 | $0 |
| MEENAKSHI C LAKSHMAN | ||||||||
| C/O TRUST 230 PARK AVENUE | NEW YORK | NY | 10169 | DIR. OF STRATEGY & R | 40.00 | $728,700 | $185,916 | $0 |
| CHRISTOPHER J RAPCEWICZ | ||||||||
| C/O TRUST 230 PARK AVENUE | NEW YORK | NY | 10169 | DIR. OF RISK MNGMT. | 40.00 | $735,462 | $167,904 | $0 |
| MAUREEN E RAYHILL | ||||||||
| C/O TRUST 230 PARK AVENUE | NEW YORK | NY | 10169 | DIRECTOR OF HUMAN RE | 40.00 | $458,150 | $96,071 | $0 |
| BRIAN B CHUN | ||||||||
| C/O TRUST 230 PARK AVENUE | NEW YORK | NY | 10169 | DIRECTOR OF INVESTME | 40.00 | $454,231 | $80,661 | $0 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Employee Paid Over50k | 104 | OtherEmployeePaidOver50kCnt |
Compensation Of Hghst Pd Cntrct CompensationOfHghstPdCntrctGrp (5 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Service TypeServiceTypeTxt | CompensationCompensationAmt | Address Line1ForeignAddress/AddressLine1Txt | CityForeignAddress/CityNm | CountryForeignAddress/CountryCd | Foreign PostalForeignAddress/ForeignPostalCd |
|---|---|---|---|---|---|---|---|---|---|
| CRESTVIEW III | |||||||||
| 590 MADISON AVENUE 36TH FLOOR | NEW YORK | NY | 10022 | INVESTMENT MANAGEMENT | $3,690,235 | ||||
| HIGHCLERE INTERNATIONAL INVESTORS | |||||||||
| INVESTMENT MANAGEMENT | $1,729,940 | 2 MANCHESTER SQUARE | LONDON | UK | W1U 3PA | ||||
| IFP GLOBAL FRANCHISE | |||||||||
| INVESTMENT MANAGEMENT | $1,241,609 | LEVEL 1 10 PORTMAN SQUARE | LONDON | UK | W1H 6AZ | ||||
| MARATHON GLOBAL | |||||||||
| INVESTMENT MANAGEMENT | $880,955 | ORION HOUSE 5 UPPER ST MARTINS LANE | UK | WC2H 9EA | |||||
| SILCHESTER INTL | |||||||||
| 780 3RD AVE 4201 | NEW YORK | NY | 10017 | INVESTMENT MANAGEMENT | $879,842 | ||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contractor Paid Over50k | 53 | ContractorPaidOver50kCnt |
Summary Of Direct Chrtbl Acty SummaryOfDirectChrtblActyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Description1 | FOR THE PRODUCTION OF WEBSITE, VIDEO AND OTHER DESIGN SUPPORT TO COMMUNICATE IMPACT IN FURTHERANCE OF THE FOUNDATION'S MISSION. | Description1Txt |
| Expenses1 | $1,217,774 | Expenses1Amt |
| Description2 | FOR TECHNICAL SUPPORT TO GRANTEES TO MEET THEIR STRATEGIC AND COMMUNICATIONS NEEDS TO DRIVE FURTHER IMPACT OF THEIR CHARITABLE WORK. | Description2Txt |
| Expenses2 | $170,066 | Expenses2Amt |
| Description3 | FOR CONVENING EXPERTS TO EXPLORE PROGRAM PRIORITIES, SHARE RESEARCH AND IDEAS, AND BRAINSTORM NEW AREAS OF IMPACT IN SUPPORT OF THE FOUNDATION'S MISSION. | Description3Txt |
| Expenses3 | $249,368 | Expenses3Amt |
Sum Of Program Related Invst SumOfProgramRelatedInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Description1 | STARTUP HEALTH T1D PRI LP - CATALYZING SEED AND EARLY STAGE COMPANIES DEVELOPING INNOVATIVE T1D CARE SOLUTIONS | Description1Txt |
| Expenses1 | $2,500,000 | Expenses1Amt |
| Description2 | THETIS PHARMACEUTICALS, LLC - DEVELOPMENT OF A NOVEL RESOLVIN E1 THERAPY FOR TREATMENT OF CROHN'S DISEASE | Description2Txt |
| Expenses2 | $880,756 | Expenses2Amt |
| All Other Program Rltd Invst Tot | $1,187,500 | AllOtherProgramRltdInvstTotAmt |
| Total | $4,568,256 | TotalAmt |
Minimum Investment Return MinimumInvestmentReturnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Average Monthly FMV Of Sec | $6,913,612,076 | AverageMonthlyFMVOfSecAmt |
| Average Monthly Cash Balances | $199,653,289 | AverageMonthlyCashBalancesAmt |
| FMV All Other Noncharitable Ast | $429,267 | FMVAllOtherNoncharitableAstAmt |
| Total FMV Of Unused Assets | $7,113,694,632 | TotalFMVOfUnusedAssetsAmt |
| Reduction Claimed | $0 | ReductionClaimedAmt |
| Acquisition Indebtedness | $0 | AcquisitionIndebtednessAmt |
| Adjusted Total FMV Of Unused Ast | $7,113,694,632 | AdjustedTotalFMVOfUnusedAstAmt |
| Cash Deemed Charitable | $106,705,419 | CashDeemedCharitableAmt |
| Net Vl Noncharitable Assets | $7,006,989,213 | NetVlNoncharitableAssetsAmt |
| Minimum Investment Return | $350,349,461 | MinimumInvestmentReturnAmt |
Distributable Amount DistributableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Minimum Investment Return | $350,349,461 | MinimumInvestmentReturnAmt |
| Tax Based On Investment Income | $3,123,302 | TaxBasedOnInvestmentIncomeAmt |
| Income Tax | $189,633 | IncomeTaxAmt |
| Total Tax | $3,312,935 | TotalTaxAmt |
| Distributable Before Adj | $347,036,526 | DistributableBeforeAdjAmt |
| Recoveries Qualfied Distri | $7,742,969 | RecoveriesQualfiedDistriAmt |
| Distributable Before Ded | $354,779,495 | DistributableBeforeDedAmt |
| Deduction From Distributable | $0 | DeductionFromDistributableAmt |
| Distributable As Adjusted | $354,779,495 | DistributableAsAdjustedAmt |
PF Qualifying Distributions PFQualifyingDistributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expenses And Contributions | $479,058,575 | ExpensesAndContributionsAmt |
| Program Related Invst Total | $4,568,256 | ProgramRelatedInvstTotalAmt |
| Charitable Assets Acquis Paid | $570,169 | CharitableAssetsAcquisPaidAmt |
| Qualifying Distributions | $484,197,000 | QualifyingDistributionsAmt |
Undistributed Income UndistributedIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Distributable As Adjusted | $354,779,495 | DistributableAsAdjustedAmt |
| Undistributed Income PY | $168,607 | UndistributedIncomePYAmt |
| Total For Prior Years | $0 | TotalForPriorYearsAmt |
| Total Excess Distribution Cyov | $0 | TotalExcessDistributionCyovAmt |
| Qualifying Distributions | $484,197,000 | QualifyingDistributionsAmt |
| Applied To Year1 | $168,607 | AppliedToYear1Amt |
| Applied To Prior Years | $0 | AppliedToPriorYearsAmt |
| Treated As Distri From Corpus | $0 | TreatedAsDistriFromCorpusAmt |
| Applied To Current Year | $354,779,495 | AppliedToCurrentYearAmt |
| Remaining Distri From Corpus | $129,248,898 | RemainingDistriFromCorpusAmt |
| Excess Distri Cyov App CY Corpus | $0 | ExcessDistriCyovAppCYCorpusAmt |
| Excess Distribution Cyov App CY | $0 | ExcessDistributionCyovAppCYAmt |
| Total Corpus | $129,248,898 | TotalCorpusAmt |
| Prior Year Undistributed Incm | $0 | PriorYearUndistributedIncmAmt |
| Prior Year Deficiency Or Tax | $0 | PriorYearDeficiencyOrTaxAmt |
| Taxable1 | $0 | Taxable1Amt |
| Taxable2 | $0 | Taxable2Amt |
| Undistributed Income CY | $0 | UndistributedIncomeCYAmt |
| Corpus Distri170b1 E Or4942g3 | $0 | CorpusDistri170b1EOr4942g3Amt |
| Excess Distri Cyov From Yr5 | $0 | ExcessDistriCyovFromYr5Amt |
| Excess Distri Cyov To Next Yr | $129,248,898 | ExcessDistriCyovToNextYrAmt |
| Excess From Current Year | $129,248,898 | ExcessFromCurrentYearAmt |
Supplementary Information SupplementaryInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Only Contri To Preselected | Yes (X) | OnlyContriToPreselectedInd |
Grant Or Contribution Pd Dur Yr GrantOrContributionPdDurYrGrp (594 entries)
| Address Line1RecipientUSAddress/AddressLine1Txt | CityRecipientUSAddress/CityNm | State AbbreviationRecipientUSAddress/StateAbbreviationCd | ZIPRecipientUSAddress/ZIPCd | Recipient RelationshipRecipientRelationshipTxt | Recipient Foundation StatusRecipientFoundationStatusTxt | Grant Or Contribution PurposeGrantOrContributionPurposeTxt | AmtAmt | Address Line1RecipientForeignAddress/AddressLine1Txt | CityRecipientForeignAddress/CityNm | CountryRecipientForeignAddress/CountryCd | Address Line2RecipientUSAddress/AddressLine2Txt | Address Line2RecipientForeignAddress/AddressLine2Txt | Foreign PostalRecipientForeignAddress/ForeignPostalCd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A GLIMMER OF HOPE FOUNDATION | |||||||||||||
| 3103 BEE CAVES ROAD | AUSTIN | TX | 78746 | N/A | PF | EMPOWERING FAMILIES TO BUILD RESILIENCE AND REDUCE POVERTY | $2,053,426 | ||||||
| ACADEMISCH ZIEKENHUIS LEIDEN | |||||||||||||
| N/A | GOV | SAFETY AND EFFICACY OF IMMUNE INTERVENTION WITH TOLEROGENIC DENDRITIC CELLS IN PATIENTS WITH EARLY T1D (D-SENSE II) | $230,038 | 2 ALBINUSDREEF | LEIDEN | NL | |||||||
| ACTION4DIABETES | |||||||||||||
| N/A | PC | PHILIPPINES T1D TASK FORCE | $156,500 | 9 PARKFIELD ROAD | TAUNTON | UK | |||||||
| ACUMEN AMERICA LLC | |||||||||||||
| 40 WORTH STREET | NEW YORK | NY | 10013 | N/A | PC | SUPPLEMENTAL SUPPORT TO ADDRESS SOCIAL DETERMINANTS OF HEALTH FOR PEOPLE WITH INSULIN REQUIRING DIABETES | $502,312 | ||||||
| ADI NEGEV-NAHALAT ERAN RA | |||||||||||||
| N/A | PC | REHABILITATION WARD EQUIPMENT PROJECT | $150,000 | MERHAVIM REGIONAL COUNCIL | OFAKIM | IS | |||||||
| ALBERT EINSTEIN COLLEGE OF MEDICINE | |||||||||||||
| 1300 MORRIS PARK AVENUE | BRONX | NY | 104611975 | N/A | PC | PRECLINICAL ACTIVITIES TO ADVANCE D-PEPTIDES AS AN ANTIGEN-SPECIFIC IMMUNOTHERAPY FOR TYPE 1 DIABETES | $494,612 | ||||||
| ALBERT EINSTEIN COLLEGE OF MEDICINE | |||||||||||||
| 1300 MORRIS PARK AVENUE | BRONX | NY | 104611975 | N/A | PC | PRECLINICAL ACTIVITIES TO ADVANCE D-PEPTIDES AS AN ANTIGEN-SPECIFIC IMMUNOTHERAPY FOR TYPE 1 DIABETES | $556,499 | ||||||
| ALBERT EINSTEIN COLLEGE OF MEDICINE | |||||||||||||
| 1300 MORRIS PARK AVENUE | BRONX | NY | 104611975 | N/A | PC | PROMOTE DIABETES TECHNOLOGY USE IN YOUNG ADULTS FROM UNDERREPRESENTED MINORITY GROUPS WITH T1D PILOT STUDY | $168,556 | ||||||
| ALEH - HELP FOR THE SPECIAL CHILD | |||||||||||||
| N/A | PC | EMERGENCY EQUIPMENT | $50,000 | 111 ABARBANEL ST | BNEI BRAK | IS | |||||||
| ALIMENTIV INC | |||||||||||||
| N/A | NC | DEVELOPMENT OF A NEXT GENERATION BIOMARKER TOOL TO ACCELERATE THE DEVELOPMENT OF EFFECTIVE ANTI-FIBROTIC THERAPIES | $267,835 | 100 DUNDAS STREET | LONDON | CA | |||||||
| ALLIANCE OF COMMUNITY HEALTH PLANS FOUNDATION INC | |||||||||||||
| 1825 EYE STREET NW 401 | WASHINGTON | DC | 20006 | N/A | SOI | COLLABORATING WITH HEALTH PLANS TO OVERCOME BARRIERS TO COVERAGE AND UTILIZATION OF CONTINUOUS GLUCOSE MONITORING (CGM) | $500,000 | ||||||
| ALVIN AILEY DANCE FOUNDATION INC | |||||||||||||
| THE JOAN WEILL CENTER FOR DANCE | NEW YORK | NY | 10019 | N/A | PC | GENERAL OPERATING SUPPORT | $10,000 | ||||||
| ALYN HOSPITAL - REHABILITATION CENTER FOR CHILDREN AND YOUTH | |||||||||||||
| N/A | PC | CREATION OF EMERGENCY MEDICAL AIR-RAID SHELTER | $150,000 | 84 SHMARYAHU LEVIN ST | JERUSALEM | IS | |||||||
| ALYN HOSPITAL - REHABILITATION CENTER FOR CHILDREN AND YOUTH | |||||||||||||
| N/A | PC | ALYN CENTER FOR INNOVATION IN PEDIATRIC REHABILITATION RESEARCH | $694,034 | 84 SHMARYAHU LEVIN ST | JERUSALEM | IS | |||||||
| AMC MEDICAL RESEARCH BV | |||||||||||||
| N/A | PC | IDENTIFICATION OF BIOMARKERS FOR PATIENT STRATIFICATION IN PERIANAL FISTULIZING DISEASE | $50,570 | MEIBERGDREEF 9 | AMSTERDAM | NL | |||||||
| AMC MEDICAL RESEARCH BV | |||||||||||||
| N/A | PC | A PROSPECTIVE RANDOMIZED STUDY OF TREATMENT SELECTION BASED ON EPIGENETIC MARKERS IN CROHNS DISEASE: OMICROHN | $1,607,013 | MEIBERGDREEF 9 | AMSTERDAM | NL | |||||||
| AMC MEDICAL RESEARCH BV | |||||||||||||
| N/A | PC | DEVELOPMENT AND VALIDATION OF AN EPIGENETIC BIOMARKER THAT PREDICTS TREATMENT SUCCESS AND ALLOWS PERSONALIZED MANAGEMENT IN CROHNS DISEASE | $197,373 | MEIBERGDREEF 9 | AMSTERDAM | NL | |||||||
| AMERICAN CAMPING ASSOCIATION INC | |||||||||||||
| 5000 STATE ROAD 67 NORTH | MARTINSVILLE | IN | 46151 | N/A | PC | ACA PROFESSIONAL DEVELOPMENT 2022-2024 | $51,040 | ||||||
| AMERICAN COLLEGE OF DIABETOLOGY INC | |||||||||||||
| PO BOX 87633 | FAYETTEVILLE | NC | 28304 | N/A | PC | IMPROVE THE DIABETES TRAINING OPPORTUNITIES FOR PCPS | $981,349 | ||||||
| AMERICAN DIABETES ASSOCIATION INC | |||||||||||||
| 2451 CRYSTAL DRIVE SUITE 900 | ARLINGTON | VA | 22202 | N/A | PC | TRAINING AND MENTORSHIP PROGRAMS | $805,382 | ||||||
| AMERICAN DIABETES ASSOCIATION INC | |||||||||||||
| 2451 CRYSTAL DRIVE SUITE 900 | ARLINGTON | VA | 22202 | N/A | PC | 2022-2024 TYPE 1 DIABETES CAMP INITIATIVE | $399,368 | ||||||
| AMERICAN DIABETES ASSOCIATION INC | |||||||||||||
| 2451 CRYSTAL DRIVE SUITE 900 | ARLINGTON | VA | 22202 | N/A | PC | MENTAL HEALTH EDUCATION PROGRAM PHASE 2 (2022 2024) | $278,350 | ||||||
| AMERICAN DIABETES ASSOCIATION INC | |||||||||||||
| 2451 CRYSTAL DRIVE SUITE 900 | ARLINGTON | VA | 22202 | N/A | PC | MENTAL HEALTH EDUCATION PROGRAM PHASE 2 (2022 2024) | $337,310 | ||||||
| AMERICAN FRIENDS OF MAGEN DAVID ADOM | |||||||||||||
| 20 WEST 36TH STREET | NEW YORK | NY | 10018 | N/A | PC | EMERGENCY SUPPORT FOR MAGEN DAVID ADOM | $152,000 | ||||||
| AMERICAN GASTROENTEROLOGICAL ASSOCIATION INSTITUTE | |||||||||||||
| 4930 DEL RAY AVE | BETHESDA | MD | 20814 | N/A | PC | AMPLIFYING LEARNING FROM THE CEDARS-SINAI ADVANCED DIETARY IBD EDUCATION AND TRAINING (DIET) PROGRAM: BEYOND MALNUTRITION | $74,768 | ||||||
| AMERICAN HEART ASSOCIATION INC | |||||||||||||
| 7272 GREENVILLE AVENUE | DALLAS | TX | 75231 | N/A | PC | MISSION: LIFELINE STROKE IOWA | $2,105,298 | ||||||
| AMERICAN HEART ASSOCIATION INC | |||||||||||||
| 7272 GREENVILLE AVENUE | DALLAS | TX | 75231 | N/A | PC | AMERICAN HEART ASSOCIATION CENTER FOR TELEHEALTH | $4,194,494 | ||||||
| AMERICAN HEART ASSOCIATION INC | |||||||||||||
| 7272 GREENVILLE AVENUE | DALLAS | TX | 75231 | N/A | PC | HEARTCORPS: AHA'S RURAL PUBLIC HEALTH WORKFORCE DEVELOPMENT INITIATIVE | $286,146 | ||||||
| AMERICAN HEART ASSOCIATION INC | |||||||||||||
| 7272 GREENVILLE AVENUE | DALLAS | TX | 75231 | N/A | PC | MISSION: LIFELINE STROKE MONTANA AND POST-ACUTE STROKE CARE QUALITY STANDARDS FIELD TESTING | $1,024,257 | ||||||
| AMERICAN HEART ASSOCIATION INC | |||||||||||||
| 7272 GREENVILLE AVENUE | DALLAS | TX | 75231 | N/A | PC | POST-ACUTE STROKE CARE: IMPLEMENTING QUALITY STANDARDS IN MONTANA, NEBRASKA AND NORTH DAKOTA | $723,366 | ||||||
| AMERICAN SAMOA MEDICAL CENTER AUTHORITY | |||||||||||||
| PO BOX LBJ | PAGO PAGO | AS | 96799 | N/A | GOV | MRI AT LBJ TROPICAL MEDICAL CENTER | $1,878,805 | ||||||
| AMERICANS FOR BEN-GURION UNIVERSITY | |||||||||||||
| 1001 AVENUE OF THE AMERICAS 19TH | NEW YORK CITY | NY | 10018 | N/A | PC | GENERAL OPERATING SUPPORT | $10,000 | FLOOR | |||||
| AMERICANS FOR BEN-GURION UNIVERSITY | |||||||||||||
| 1001 AVENUE OF THE AMERICAS 19TH | NEW YORK CITY | NY | 10018 | N/A | PC | GENERAL OPERATING SUPPORT | $20,000 | FLOOR | |||||
| AMERICARES FOUNDATION INC | |||||||||||||
| 88 HAMILTON AVE | STAMFORD | CT | 06840 | N/A | PC | MATERNAL, NEWBORN, AND CHILD HEALTH INTERVENTIONS | $749,599 | ||||||
| APHP ST ANTOINE HOSPITAL | |||||||||||||
| N/A | GOV | FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE AS RELAY AFTER ANTI-TNF WITHDRAWAL (MIRACLE) | $367,129 | 184 RUE DU FAUBOURG SAINT-ANTOINE | PARIS | FR | |||||||
| ARAD MUNICIPALITY | |||||||||||||
| N/A | GOV | ARAD OCCUPATIONAL REHABILITATION CENTER | $183,236 | 6 HAPALMACH STREET | ARAD | IS | |||||||
| ARAD MUNICIPALITY | |||||||||||||
| N/A | GOV | EMERGENCY FUNDING FOR SAFETY AND SECURITY EQUIPMENT | $166,407 | 6 HAPALMACH STREET | ARAD | IS | |||||||
| ASIAN HEALTH CARE FOUNDATION | |||||||||||||
| N/A | PC | IMPROVING ACCESS TO DIAGNOSTICS FOR CROHN'S DISEASE PATIENTS LIVING BELOW THE POVERTY LINE IN SOUTHERN INDIA | $83,381 | 6-3-661 SOMAJIGUDA | HYDERABAD | IN | |||||||
| ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTS | |||||||||||||
| 125 SOUTH WACKER DRIVE SUITE 600 | CHICAGO | IL | 60606 | N/A | NC | EXPANSION OF THE DANATECH PLATFORM | $831,327 | ||||||
| ASSOCIATION SANTE DIABETE | |||||||||||||
| N/A | PC | IMPROVE THE MANAGEMENT OF DIABETES (ESPECIALLY T1D) AND THE SUPPORT TO PEOPLE AFFECTED BY THE DISEASE IN BURKINA FASO, MALI, AND THE UNION OF COMOROS | $475,984 | 5 RUE FEDERICO GARCIA LORCA | GRENOBLE | FR | |||||||
| AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD | |||||||||||||
| N/A | PC | FECAL MICROBIOTA TRANSPLANTATION (FMT) IN CROHN'S DISEASE: THE MIRO (MICROBIOTA RESTORATION) STUDY. | $410,936 | LEVEL 2 | FITZROY | AS | |||||||
| AVERA MCKENNAN HOSPITAL AND UNIVERSITY HEALTH CENTER | |||||||||||||
| 1325 S CLIFF AVENUE | SIOUX FALLS | SD | 57105 | N/A | PC | AVERA BEHAVIORAL HEALTH CENTER EXPANSION | $1,500,000 | ||||||
| AVERA MCKENNAN HOSPITAL AND UNIVERSITY HEALTH CENTER | |||||||||||||
| 1325 S CLIFF AVENUE | SIOUX FALLS | SD | 57105 | N/A | PC | AVERA BEHAVIORAL HEALTH CENTER EXPANSION | $1,000,000 | ||||||
| BALLAD RESEARCH INSTITUTE | |||||||||||||
| 3525 JOHN HOPKINS COURT | SAN DIEGO | CA | 92121 | N/A | PC | CD127-HIGH T-CELL POPULATIONS AS BIOMARKERS | $325,801 | ||||||
| BANNER HEALTH FOUNDATION | |||||||||||||
| 2901 N CENTRAL AVENUE | PHOENIX | AZ | 85012 | N/A | PC | BANNER HEALTH WYOMING ULTRASOUND REVITALIZATION PROJECT | $1,869,864 | ||||||
| BAR ILAN UNIVERSITY | |||||||||||||
| N/A | PC | THE LEONA M. AND HARRY B. HELMSLEY ENERGY PROTOTYPE LAB AT BAR-ILAN UNIVERSITY | $3,216,875 | MAX VE-ANNA WEBB ST | RAMAT GAN | IS | |||||||
| BARZILAI MEDICAL CENTER | |||||||||||||
| N/A | GOV | EMERGENCY FUNDING FOR EQUIPMENT | $776,930 | HAHISTADROUT ST 2 | ASHKELON | IS | |||||||
| BAYLOR COLLEGE OF MEDICINE | |||||||||||||
| OFFICE OF RESEARCH | HOUSTON | TX | 77030 | N/A | PC | PILOT STUDY TO ADDRESS DIABETES HEALTH-RELATED QUALITY OF LIFE | $566,062 | ||||||
| BAYLOR COLLEGE OF MEDICINE | |||||||||||||
| OFFICE OF RESEARCH | HOUSTON | TX | 77030 | N/A | PC | PILOT STUDY TO ADDRESS DIABETES HEALTH-RELATED QUALITY OF LIFE | $520,313 | ||||||
| BAYLOR COLLEGE OF MEDICINE | |||||||||||||
| OFFICE OF RESEARCH | HOUSTON | TX | 77030 | N/A | PC | PREDICTIVE ANALYTICS AND TARGETED INTERVENTIONS: SHIFTING THE PARADIGM FROM REACTIVE TO PROACTIVE DIABETES CARE | $532,841 | ||||||
| BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | |||||||||||||
| 1201 NINTH AVENUE | SEATTLE | WA | 981012795 | N/A | PC | TRUCULTURE SAMPLE ANALYSIS FOR TN22 HCQ | $297,957 | ||||||
| BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | |||||||||||||
| 1201 NINTH AVENUE | SEATTLE | WA | 981012795 | N/A | PC | LINKING DISEASE MECHANISM AND CLINICAL TRIAL DESIGN VIA RAPIDLY CONDUCTED IMMUNOTHERAPY TRIALS IN T1D | $809,757 | ||||||
| BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | |||||||||||||
| 1201 NINTH AVENUE | SEATTLE | WA | 981012795 | N/A | PC | LINKING DISEASE MECHANISM AND CLINICAL TRIAL DESIGN VIA RAPIDLY CONDUCTED IMMUNOTHERAPY TRIALS IN T1D | $131,733 | ||||||
| BEN-GURION UNIVERSITY OF THE NEGEV | |||||||||||||
| N/A | PC | EMERGENCY PREPAREDNESS FOR BEN GURION UNIVERSITY OF THE NEGEV | $450,000 | BEN-GURION BLVD 1 | BEER SHEVA | IS | |||||||
| BEN-GURION UNIVERSITY OF THE NEGEV | |||||||||||||
| N/A | PC | ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: COBMINDEX GOES FORWARD- A SMARTPHONE APPLICATION FOR ADDED PSYCHOLOGICAL WELLBEING IN CD | $938,641 | BEN-GURION BLVD 1 | BEER SHEVA | IS | |||||||
| BERKSHIRE THEATRE GROUP INC | |||||||||||||
| 111 SOUTH STREET | PITTSFIELD | MA | 01201 | N/A | PC | GENERAL OPERATING SUPPORT FOR THE DAVID AND SUSIE AUERBACH REHEARSAL STUDIO | $17,500 | ||||||
| BETH ISRAEL DEACONESS MEDICAL CENTER INC | |||||||||||||
| 330 BROOKLINE AVENUE | BOSTON | MA | 022155491 | N/A | PC | PROACTIVE OPTIMIZATION OF INFLIXIMAB USING A PHARMACOKINETIC DASHBOARD VERSUS STANDARD OF CARE IN PATIENTS WITH CROHNS DISEASE: THE OPTIMIZE TRIAL | $797,851 | ||||||
| BEYOND TYPE 1 | |||||||||||||
| 400 CONCAR DRIVE OFFICE 03-155 | SAN MATEO | CA | 94402 | N/A | PC | CAPACITY BUILDING SUPPORT | $1,060,000 | ||||||
| BEYOND TYPE 1 | |||||||||||||
| 400 CONCAR DRIVE OFFICE 03-155 | SAN MATEO | CA | 94402 | N/A | PC | CAPACITY BUILDING SUPPORT | $940,000 | ||||||
| BEYOND TYPE 1 | |||||||||||||
| 400 CONCAR DRIVE OFFICE 03-155 | SAN MATEO | CA | 94402 | N/A | PC | DIABETIC KETOACIDOSIS (DKA) CAMPAIGN PHASE 3 | $149,166 | ||||||
| BIGHORN VALLEY HEALTH CENTER INC | |||||||||||||
| 10 4TH STREET WEST SUITE B | HARDIN | MT | 59034 | N/A | PC | WYOMING ULTRASOUND REVITALIZATION PROJECT | $260,119 | ||||||
| BILLINGS CLINIC FOUNDATION | |||||||||||||
| 2917 TENTH AVENUE NORTH | BILLINGS | MT | 59101 | N/A | PC | BILLINGS CLINIC CODY ULTRASOUND PROJECT | $172,365 | ||||||
| BILLINGS CLINIC FOUNDATION | |||||||||||||
| 2917 TENTH AVENUE NORTH | BILLINGS | MT | 59101 | N/A | PC | EXPANDING ECMO SERVICES AT BILLINGS CLINIC | $620,341 | ||||||
| BIPARTISAN POLICY CENTER INC | |||||||||||||
| 1225 I ST NW 1000 | WASHINGTON | DC | 20005 | N/A | PC | STRENGTHENING RURAL HEALTH CARE DELIVERY AND SERVICES | $622,296 | ||||||
| BLUE CIRCLE HEALTH INC | |||||||||||||
| THE CORPORATION TRUST CENTER 1209 | WILMINGTON | DE | 19801 | N/A | PC | DEVELOPMENT OF BLUE CIRCLE HEALTH | $2,000,000 | ORANGE STREET | |||||
| BLUE CIRCLE HEALTH INC | |||||||||||||
| THE CORPORATION TRUST CENTER 1209 | WILMINGTON | DE | 19801 | N/A | PC | DEVELOPMENT OF BLUE CIRCLE HEALTH | $1,740,266 | ORANGE STREET | |||||
| BLUE CIRCLE HEALTH INC | |||||||||||||
| THE CORPORATION TRUST CENTER 1209 | WILMINGTON | DE | 19801 | N/A | PC | DEVELOPMENT OF BLUE CIRCLE HEALTH | $1,975,490 | ORANGE STREET | |||||
| BLUE CIRCLE HEALTH INC | |||||||||||||
| THE CORPORATION TRUST CENTER 1209 | WILMINGTON | DE | 19801 | N/A | PC | DEVELOPMENT OF BLUE CIRCLE HEALTH | $3,480,533 | ORANGE STREET | |||||
| BLUE CIRCLE HEALTH INC | |||||||||||||
| THE CORPORATION TRUST CENTER 1209 | WILMINGTON | DE | 19801 | N/A | PC | DEVELOPMENT OF BLUE CIRCLE HEALTH | $1,740,267 | ORANGE STREET | |||||
| BNAI ZION MEDICAL CENTER | |||||||||||||
| N/A | GOV | PURCHASE OF A CT SCANNER FOR BNAI ZION MEDICAL CENTER | $1,300,000 | 47 GOLOMB ST | HAIFA | IS | |||||||
| BOARD OF REGENTS NEVADA SYSTEM OF HIGHER EDUCATION | |||||||||||||
| 2601 ENTERPRISE ROAD | RENO | NV | 89512 | N/A | PC | ULTRASOUND TRAINING INITIATIVE IN NEVADA | $197,208 | ||||||
| BOARD OF REGENTS NEVADA SYSTEM OF HIGHER EDUCATION | |||||||||||||
| 2601 ENTERPRISE ROAD | RENO | NV | 89512 | N/A | PC | CARDIORESPIRATORY CARE SCIENCE DEGREE PROGRAM | $64,655 | ||||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | |||||||||||||
| 443 VIA ORTEGA | STANFORD | CA | 94305 | N/A | PC | DIABETESWISE FOR EXERCISE | $344,015 | ||||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | |||||||||||||
| 443 VIA ORTEGA | STANFORD | CA | 94305 | N/A | PC | DIABDOCS NATIONAL K12: SUPPLEMENT | $402,980 | ||||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | |||||||||||||
| 443 VIA ORTEGA | STANFORD | CA | 94305 | N/A | PC | MICROBIOME-BASED THERAPEUTICS FOR CROHNS DISEASE | $1,006,531 | ||||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | |||||||||||||
| 443 VIA ORTEGA | STANFORD | CA | 94305 | N/A | PC | DEVELOPMENT OF A CONTINUOUS MULTIANALYTE SENSOR FOR T1D | $1,483,787 | ||||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | |||||||||||||
| 443 VIA ORTEGA | STANFORD | CA | 94305 | N/A | PC | INVESTIGATING THE ROLE OF THE HUMAN EXPOSOME IN CROHNS DISEASE | $836,979 | ||||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | |||||||||||||
| 443 VIA ORTEGA | STANFORD | CA | 94305 | N/A | PC | EXPANSION & EVALUATION OF ECHO FOR PEOPLE WITH DIABETES ON INTENSIVE INSULIN THERAPY (IIT) | $341,879 | ||||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | |||||||||||||
| 443 VIA ORTEGA | STANFORD | CA | 94305 | N/A | PC | DEVELOPMENT OF PERSONALIZED DECISION SUPPORT TOOL USING NETIOB TO HELP MANAGE EXERCISE FOR PEOPLE WITH T1D | $379,194 | ||||||
| BOSTON SYMPHONY ORCHESTRA INC | |||||||||||||
| 301 MASSACHUSETTS AVENUE | BOSTON | MA | 02115 | N/A | PC | GENERAL OPERATING SUPPORT | $10,000 | ||||||
| BOULDER CITY HOSPITAL INC | |||||||||||||
| 901 ADAMS BLVD | BOULDER CITY | NV | 89005 | N/A | PC | BOULDER CITY HOSPITAL EQUIPMENT REVITALIZATION PROJECT | $34,997 | ||||||
| BRIDGES TO PROSPERITY INC | |||||||||||||
| 1031 33RD STREET | DENVER | CO | 80205 | N/A | PC | TRANSFORMATIVE CONNECTIVITY IN RURAL ZAMBIA | $1,915,763 | ||||||
| BRIDGES TO PROSPERITY INC | |||||||||||||
| 1031 33RD STREET | DENVER | CO | 80205 | N/A | PC | TRANSFORMATIVE CONNECTIVITY IN RURAL ETHIOPIA | $2,648,126 | ||||||
| CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST | |||||||||||||
| N/A | GOV | THE UK IBD BIORESOURCE: TRANSLATING TODAYS SCIENCE INTO TOMORROWS TREATMENTS IN CROHNS DISEASE | $1,230,080 | HILLS ROAD | CAMBRIDGE | UK | |||||||
| CAMPBELL COUNTY HOSPITAL DISTRICT | |||||||||||||
| 501 SOUTH BURMA AVE | GILLETTE | WY | 82717 | N/A | PC | CAMPBELL COUNTY HEALTH ULTRASOUND PROJECT | $599,884 | ||||||
| CANDID | |||||||||||||
| 32 OLD SLIP 24TH FLOOR | NEW YORK | NY | 10005 | N/A | PC | GENERAL OPERATING SUPPORT | $25,974 | ||||||
| CARDIFF UNIVERSITY | |||||||||||||
| N/A | PC | T1D-PLUS: AN ADAPTIVE TRIAL PLATFORM FOR THE STUDY OF COMBINATION THERAPIES IN NEW-ONSET T1D | $944,873 | 30-36 NEWPORT RD | WALES | UK | |||||||
| CARE-FOR-RARE FOUNDATION | |||||||||||||
| N/A | PC | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES: MUNICH STUDIES | $655,603 | DR VON HAUNERSCHES KINDERSPITAL | MUNICH | GM | KLINIKUM DER UNIVERSITAT MUNCHEN | ||||||
| CASTLE ROCK SPECIAL HOSPITAL DISTRICT | |||||||||||||
| 1400 UINTA DRIVE | GREEN RIVER | WY | 82935 | N/A | GOV | WYOMING ULTRASOUND REVITALIZATION PROJECT | $117,688 | ||||||
| CATHOLIC RELIEF SERVICES-USCCB | |||||||||||||
| 228 W LEXINGTON ST | BALTIMORE | MD | 21201 | N/A | PC | EXPANDING COMMUNITY RECOVERY AND RESILIENCE | $1,617,611 | ||||||
| CATHOLIC RELIEF SERVICES-USCCB | |||||||||||||
| 228 W LEXINGTON ST | BALTIMORE | MD | 21201 | N/A | PC | HELPING MOTHERS AND NEWBORNS SURVIVE AND THRIVE | $1,845,255 | ||||||
| CEDARS-SINAI MEDICAL CENTER | |||||||||||||
| 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | N/A | PC | A MULTIDISCIPLINARY PREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABDOMINAL SURGERY | $202,791 | ||||||
| CEDARS-SINAI MEDICAL CENTER | |||||||||||||
| 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | N/A | PC | A MULTIDISCIPLINARY PREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABDOMINAL SURGERY | $200,041 | ||||||
| CEDARS-SINAI MEDICAL CENTER | |||||||||||||
| 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | N/A | PC | LONG-TERM RESPONSES TO SARS-COV-2 VACCINATION IN A DIVERSE INFLAMMATORY BOWEL DISEASE POPULATION: A MULTI-OMIC STUDY | $364,763 | ||||||
| CEDARS-SINAI MEDICAL CENTER | |||||||||||||
| 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | N/A | PC | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES: CEDARS-SINAI | $115,500 | ||||||
| CENTRAL MONTANA MEDICAL FACILITIES INC | |||||||||||||
| 408 WENDELL AVE | LEWISTOWN | MT | 59457 | N/A | PC | CANCER CENTER AT CENTRAL MONTANA MEDICAL CENTER | $3,690,035 | ||||||
| CENTRE HOSPITALIER REGIONAL DE NANCY | |||||||||||||
| N/A | GOV | PREVENTION OF EXTRA-INTESTINAL MANIFESTATIONS AND COMORBIDITIES IN CROHNS DISEASE: THE NEMO PROJECT | $95,277 | 29 AVENUE MAL DE LATTRE TASSIGNY | NANCY | FR | |||||||
| CHANCELLOR MASTERS & SCHOLARS OF THE UNIVERSITY OF OXFORD | |||||||||||||
| N/A | PC | THE CELLULAR LANDSCAPE OF MONOGENIC INFLAMMATORY BOWEL DISEASE IN VEOIBD | $244,860 | UNIVERSITY OFFICES WELLINGTON | OXFORD | UK | SQUARE | ||||||
| CHANCELLOR MASTERS & SCHOLARS OF THE UNIVERSITY OF OXFORD | |||||||||||||
| N/A | PC | INTERROGATING THE MECHANISM OF HYPERSENSITIVITY TO ANTIBODY-BASED DRUGS FOR DEVELOPMENT OF A NOVEL ANTI-TNF BIOLOGIC FOR CROHNS DISEASE | $221,420 | UNIVERSITY OFFICES WELLINGTON | OXFORD | UK | SQUARE | ||||||
| CHEYENNE HEALTH & WELLNESS CENTER | |||||||||||||
| 2508 E FOX FARM RD 1-1A | CHEYENNE | WY | 82007 | N/A | PC | WYOMING ULTRASOUND REVITALIZATION PROJECT | $78,892 | ||||||
| CHEYENNE REGIONAL MEDICAL CENTER FOUNDATION | |||||||||||||
| 214 EAST 23RD STREET | CHEYENNE | WY | 82001 | N/A | PC | CHEYENNE REGIONAL MEDICAL CENTER WYOMING ULTRASOUND REVITALIZATION PROJECT | $1,490,918 | ||||||
| CHI HEALTH FOUNDATION | |||||||||||||
| 12809 WEST DODGE ROAD | OMAHA | NE | 68154 | N/A | PC | ECMO SUPPORT AT CHI HEALTH CREIGHTON UNIVERSITY MEDICAL CENTER-BERGAN MERCY | $2,165,669 | ||||||
| CHILDREN'S HOSPITAL CORPORATION | |||||||||||||
| ATTN RESEARCH FINANCE | BOSTON | MA | 022414413 | N/A | PC | MOLECULAR AND SPATIAL SINGLE-CELL REMODELING IN PEDIATRIC CROHNS DISEASE | $374,591 | ||||||
| CHILDREN'S HOSPITAL CORPORATION | |||||||||||||
| ATTN RESEARCH FINANCE | BOSTON | MA | 022414413 | N/A | PC | MOLECULAR AND SPATIAL SINGLE-CELL REMODELING IN PEDIATRIC CROHNS DISEASE | $374,591 | ||||||
| CHILDREN'S HOSPITAL CORPORATION | |||||||||||||
| ATTN RESEARCH FINANCE | BOSTON | MA | 022414413 | N/A | PC | NOVEL GLUCOSE BINDERS FOR THE DEVELOPMENT OF GLUCOSE RESPONSIVE INSULIN (GRI) | $665,654 | ||||||
| CHILDREN'S HOSPITAL CORPORATION | |||||||||||||
| ATTN RESEARCH FINANCE | BOSTON | MA | 022414413 | N/A | PC | NOVEL GLUCOSE BINDERS FOR THE DEVELOPMENT OF GLUCOSE RESPONSIVE INSULIN (GRI) | $666,216 | ||||||
| CHILDREN'S HOSPITAL CORPORATION | |||||||||||||
| ATTN RESEARCH FINANCE | BOSTON | MA | 022414413 | N/A | PC | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES: BOSTON STUDIES | $1,399,726 | ||||||
| CHILDREN'S HOSPITAL CORPORATION | |||||||||||||
| ATTN RESEARCH FINANCE | BOSTON | MA | 022414413 | N/A | PC | DEVELOPMENT OF NOVEL GLUCOSE RESPONSIVE GLUCAGON (GRG) DELIVERY SYSTEM FOR THE PREVENTION OF HYPOGLYCEMIA FOR PEOPLE WITH T1D | $1,255,105 | ||||||
| CHILDREN'S HOSPITAL CORPORATION | |||||||||||||
| ATTN RESEARCH FINANCE | BOSTON | MA | 022414413 | N/A | PC | DEVELOPMENT OF NOVEL GLUCOSE RESPONSIVE GLUCAGON (GRG) DELIVERY SYSTEM FOR THE PREVENTION OF HYPOGLYCEMIA FOR PEOPLE WITH T1D | $1,072,041 | ||||||
| CHILDREN'S HOSPITAL LOS ANGELES | |||||||||||||
| SABAN RESEARCH INSTITUTE | LOS ANGELES | CA | 90027 | N/A | PC | BEYOND COYOT1: EXPANSION OF PATIENT-CENTERED VIRTUAL CARE | $679,025 | ||||||
| CHILDREN'S HOSPITAL MEDICAL CENTER | |||||||||||||
| 3333 BURNET AVENUE | CINCINNATI | OH | 45229 | N/A | PC | DELIVERY SYSTEM REDESIGN TO IMPROVE CARE FOR LOW-INCOME YOUTH WITH T1D | $1,009,535 | ||||||
| CHILDREN'S HOSPITAL MEDICAL CENTER | |||||||||||||
| 3333 BURNET AVENUE | CINCINNATI | OH | 45229 | N/A | PC | PRECISION CROHNS DISEASE MANAGEMENT UTILIZING PREDICTIVE PROTEIN PANELS | $88,791 | ||||||
| CHILDREN'S HOSPITAL MEDICAL CENTER | |||||||||||||
| 3333 BURNET AVENUE | CINCINNATI | OH | 45229 | N/A | PC | COMPARISON OF STANDARD-OF-CARE VS. A PATIENT-CENTRIC NONCONTRAST ABBREVIATED MR ENTEROGRAPHY PROTOCOL | $402,142 | ||||||
| CHILDREN'S HOSPITAL MEDICAL CENTER | |||||||||||||
| 3333 BURNET AVENUE | CINCINNATI | OH | 45229 | N/A | PC | ARTIFICIAL INTELLIGENCE PREDICTION OF MEANINGFUL OUTCOMES IN NEWLY DIAGNOSED SMALL BOWEL CROHNS DISEASE | $1,421,241 | ||||||
| CHILDREN'S MERCY HOSPITAL | |||||||||||||
| 2401 GILLHAM ROAD | KANSAS CITY | MO | 64108 | N/A | PC | TYPE 1 DIABETES RAPID LEARNING LAB | $1,399,624 | ||||||
| CITY PARKS FOUNDATION | |||||||||||||
| 830 FIFTH AVENUE | NEW YORK | NY | 10065 | N/A | PC | NYC GREEN FUND | $305,108 | ||||||
| CIVICA FOUNDATION | |||||||||||||
| 2912 WEST EXECUTIVE PARKWAY | LEHI | UT | 84043 | N/A | PC | AFFORDABLE INSULIN | $2,500,000 | ||||||
| CIVICA FOUNDATION | |||||||||||||
| 2912 WEST EXECUTIVE PARKWAY | LEHI | UT | 84043 | N/A | PC | AFFORDABLE INSULIN | $2,500,000 | ||||||
| CLALIT HEALTH SERVICES | |||||||||||||
| N/A | PC | MEDICAL EQUIPMENT FOR EMEK MEDICAL CENTER | $1,103,070 | 101 ARLOZOROV STREET | TEL AVIV | IS | |||||||
| CLALIT HEALTH SERVICES | |||||||||||||
| N/A | PC | ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM MANAGEMENT | $138,626 | 101 ARLOZOROV STREET | TEL AVIV | IS | |||||||
| CLALIT HEALTH SERVICES | |||||||||||||
| N/A | PC | EMERGENCY SUPPORT FOR SOROKA MEDICAL CENTER: MEDICAL EQUIPMENT | $2,000,000 | 101 ARLOZOROV STREET | TEL AVIV | IS | |||||||
| CLALIT HEALTH SERVICES | |||||||||||||
| N/A | PC | A PHOTON COUNTING DETECTOR-CT DEVICE FOR SOROKA MEDICAL CENTER | $2,159,000 | 101 ARLOZOROV STREET | TEL AVIV | IS | |||||||
| CLALIT HEALTH SERVICES | |||||||||||||
| N/A | PC | CLINICAL TRIAL TO EVALUATE A NOVEL MDI-BGM DECISION SUPPORT SYSTEM | $418,217 | 101 ARLOZOROV STREET | TEL AVIV | IS | |||||||
| CLALIT HEALTH SERVICES | |||||||||||||
| N/A | PC | ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: BIOMARKER-BASED MULTIDISCIPLINARY TEAM APPROACH TO IMPROVE EARLY CROHN'S DISEASE OUTCOMES | $452,465 | 101 ARLOZOROV STREET | TEL AVIV | IS | |||||||
| CLALIT HEALTH SERVICES | |||||||||||||
| N/A | PC | THE INFLAMMATORY BOWEL DISEASE MEDITERRANEAN DIET (IBDMED) MICROBIOME-TARGETING NUTRITIONAL EDUCATION PROGRAM FOR CD CONTROL AND PREVENTION | $667,139 | 101 ARLOZOROV STREET | TEL AVIV | IS | |||||||
| CLALIT HEALTH SERVICES | |||||||||||||
| N/A | PC | THE INFLAMMATORY BOWEL DISEASE MEDITERRANEAN DIET (IBDMED) MICROBIOME-TARGETING NUTRITIONAL EDUCATION PROGRAM FOR CD CONTROL AND PREVENTION | $243,216 | 101 ARLOZOROV STREET | TEL AVIV | IS | |||||||
| CLINTON HEALTH ACCESS INITIATIVE INC | |||||||||||||
| 383 DORCHESTER AVENUE SUITE 400 | BOSTON | MA | 02127 | N/A | PC | MARKET SHAPING TO IMPROVE ACCESS TO DIABETES CARE | $1,243,053 | ||||||
| CLINTON HEALTH ACCESS INITIATIVE INC | |||||||||||||
| 383 DORCHESTER AVENUE SUITE 400 | BOSTON | MA | 02127 | N/A | PC | IMPROVING MEDICAL OXYGEN PRODUCTION AND UTILIZATION | $3,057,795 | ||||||
| COMMONWEALTH HEALTHCARE CORPORATION | |||||||||||||
| N/A | GOV | CNMI CHCC MRI/MEDICAL EQUIPMENT UPGRADE PROJECT | $6,440,191 | 1178 HINEMLU ST GARAPAN | SAIPAN | CQ | 96950 | ||||||
| COMMUNITY CENTERS INCDBA BARBARA'S HOUSE | |||||||||||||
| 2 ST ROCH AVENUE | GREENWICH | CT | 06830 | N/A | PC | GENERAL OPERATING SUPPORT | $45,000 | ||||||
| COMMUNITY SERVICE SOCIETY OF NEW YORK (CSS) | |||||||||||||
| 633 THIRD AVENUE | NEW YORK | NY | 10017 | N/A | PC | KEEP NEW YORK COVERED (KNYC) | $550,000 | ||||||
| CONSORCI INSTITUT D'INVESTIGACIONES BIOMEDICAS AUGUST PI I SUNYER | |||||||||||||
| N/A | GOV | EARLY DETECTION OF PERIANAL FISTULIZING DISEASE- PATHOPHYSIOLOGY AND IMAGING | $261,570 | ROSSELL 149 | BARCELONA | SP | |||||||
| CONVERGENT IMPACT INC | |||||||||||||
| 3223 ARAPAHOE AVE | BOULDER | CO | 80303 | N/A | PC | COLLABORATIVE ON HOUSING FOR HEALTH | $1,795,546 | ||||||
| CORK UNIVERSITY FOUNDATION | |||||||||||||
| N/A | PC | ENDOSCOPIC MULTIMODAL ASSESSMENT USING ADVANCED IMAGING INTEGRATED AI TO PREDICT RECURRENCE IN POST-OPERATIVE CROHNS DISEASE - PROSPERS | $642,744 | WESTERN ROAD | CORK | EI | |||||||
| CORNELL UNIVERSITY | |||||||||||||
| PO BOX 22 | ITHACA | NY | 148510022 | N/A | PC | SPONSORSHIP FOR THE 25TH ANNIVERSARY ADHERENT INVASIVE E. COLI (AIEC) MEETING | $15,000 | ||||||
| CORPORATION FOR SUPPORTIVE HOUSING | |||||||||||||
| 61 BROADWAY | NEW YORK CITY | NY | 10006 | N/A | PC | HEALTH-ENRICHED SERVICES PILOTS FOR SUPPORTIVE HOUSING | $1,200,000 | ||||||
| COUNCIL ON FOUNDATIONS INC | |||||||||||||
| 1255 23RD ST NW | WASHINGTON | DC | 20037 | N/A | PC | GENERAL OPERATING SUPPORT | $34,000 | ||||||
| COUNCIL ON THE ENVIRONMENT INC | |||||||||||||
| 100 GOLD ST SUITE 3300 | NEW YORK | NY | 10038 | N/A | PC | GENERAL OPERATING SUPPORT | $15,000 | ||||||
| COZAD HOSPITAL DISTRICT NO 2 | |||||||||||||
| 300 EAST 12TH STREET | COZAD | NE | 69130 | N/A | GOV | TELE-EMERGENCY AT COZAD COMMUNITY HEALTH SYSTEM | $141,545 | ||||||
| CRITICAL PATH INSTITUTE | |||||||||||||
| 1840 E RIVER ROAD | TUCSON | AZ | 85718 | N/A | PC | T1D CONSORTIUM 2.0 | $266,741 | ||||||
| CROHN'S & COLITIS FOUNDATION INC | |||||||||||||
| 733 THIRD AVENUE SUITE 510 | NEW YORK | NY | 10017 | N/A | PC | IBD VENTURES ACADEMIC INCUBATOR | $1,180,400 | ||||||
| CROHN'S & COLITIS FOUNDATION INC | |||||||||||||
| 733 THIRD AVENUE SUITE 510 | NEW YORK | NY | 10017 | N/A | PC | TRAINING AWARDS PROGRAM - CLASS OF 2021 | $1,067,400 | ||||||
| CROHN'S & COLITIS FOUNDATION INC | |||||||||||||
| 733 THIRD AVENUE SUITE 510 | NEW YORK | NY | 10017 | N/A | PC | ACCELERATING ENROLLMENT IN IBD CLINICAL TRIALS | $712,850 | ||||||
| CROHN'S & COLITIS FOUNDATION INC | |||||||||||||
| 733 THIRD AVENUE SUITE 510 | NEW YORK | NY | 10017 | N/A | PC | APPLICATION OF MACHINE LEARNING TO PRECISION NUTRITION IN CROHNS DISEASE | $595,677 | ||||||
| CROHN'S & COLITIS FOUNDATION INC | |||||||||||||
| 733 THIRD AVENUE SUITE 510 | NEW YORK | NY | 10017 | N/A | PC | SYSTEMATIZING IMPROVEMENT INTERVENTIONS OF URGENT CARE MANAGEMENT IN CROHNS DISEASE | $588,266 | ||||||
| CROHN'S & COLITIS FOUNDATION INC | |||||||||||||
| 733 THIRD AVENUE SUITE 510 | NEW YORK | NY | 10017 | N/A | PC | SYSTEMATIZING IMPROVEMENT INTERVENTIONS OF URGENT CARE MANAGEMENT IN CROHNS DISEASE | $588,266 | ||||||
| CROHN'S & COLITIS FOUNDATION INC | |||||||||||||
| 733 THIRD AVENUE SUITE 510 | NEW YORK | NY | 10017 | N/A | PC | SPONSORSHIP FOR THE 2024 CROHNS & COLITIS CONGRESS PRESENTED BY THE CROHNS & COLITIS FOUNDATION AND THE AMERICAN GASTROENTEROLOGICAL ASSOCIATION | $200,000 | ||||||
| CROHN'S AND COLITIS CANADA | |||||||||||||
| N/A | PC | IMPLEMENTING A MULTIMODAL RCT INTERVENTION TO IMPROVE THE TRANSITION OF PATIENTS WITH CROHNS DISEASE FROM PEDIATRIC TO ADULT CARE | $284,646 | 60 ST CLAIR AVE EAST SUITE 600 | TORONTO | CA | |||||||
| CROHN'S AND COLITIS CANADA | |||||||||||||
| N/A | PC | IMPLEMENTATION OF NATIONWIDE TELEMEDICINE NETWORK TO MITIGATE GEOGRAPHIC DISPARITIES IN ACCESS TO HEALTHCARE FOR CD PATIENTS LIVING IN CANADA | $562,426 | 60 ST CLAIR AVE EAST SUITE 600 | TORONTO | CA | |||||||
| CROHN'S AND COLITIS UK | |||||||||||||
| N/A | PC | 2021 & 2022 OPERATING SUPPORT FOR CROHN'S AND COLITIS UK: KNOWLEDGE AND EVIDENCE PERSONNEL | $75,900 | 1 BISHOPS SQUARE | HATFIELD | UK | |||||||
| CROHN'S COLITIS CURE | |||||||||||||
| N/A | PC | DEVELOPMENT OF "CCCARE-P", A PEDIATRIC-SPECIFIC CROHNS DISEASE ELECTRONIC MEDICAL RECORD TO DRIVE CARE CONSISTENCY AND ENHANCE TRANSITIONS IN CARE | $115,418 | 1 OCONNELL STREET | SYDNEY | AS | |||||||
| CROOK COUNTY MEDICAL SERVICES DISTRICT | |||||||||||||
| 713 W OAK ST | SUNDANCE | WY | 82729 | N/A | GOV | WYOMING ULTRASOUND REVITALIZATION PROJECT | $437,000 | ||||||
| DARTMOUTH- HITCHCOCK CLINIC | |||||||||||||
| ONE MEDICAL CENTER DRIVE | LEBANON | NH | 03756 | N/A | PC | CAPACITY BUILDING FOR DARTMOUTH-HITCHCOCK'S VIRTUAL IBD TELEMEDICINE NETWORK PROGRAM | $509,790 | ||||||
| DE LA SALLE SOLIDARIETA INTERNAZIONALE - ETS | |||||||||||||
| N/A | PC | ETHIOPIAN CATHOLIC UNIVERSITY DIAGNOSTIC LABORATORY | $94,780 | VIA AUREALIA 476 | ROME | IT | |||||||
| DE LA SALLE SOLIDARIETA INTERNAZIONALE - ETS | |||||||||||||
| N/A | PC | EXPAND DEVELOPMENT OF LASALLIAN UNIVERSITY OF AFRICA | $784,080 | VIA AUREALIA 476 | ROME | IT | |||||||
| DIABETES NSW | |||||||||||||
| N/A | PC | IMPROVEMENTS IN OUTCOMES FOR YOUNG PEOPLE WITH DIABETES IN LESS-RESOURCED COUNTRIES, THROUGH EXPANSION AND COUNTRY-SPECIFIC DATA-DRIVEN INITIATIVES | $1,700,835 | 26 ARUNDEL ST | SYDNEY | AS | |||||||
| DREAMED DIABETES LTD | |||||||||||||
| N/A | NC | INCREASING ACCESS TO DECISION SUPPORT TOOLS FOR IMPROVED INSULIN DOSING FOR PEOPLE WITH DIABETES | $1,350,000 | 14 KAPLAN ST | PETAH TIKVA | IS | |||||||
| DUKE UNIVERSITY | |||||||||||||
| C/O OFFICE OF RESEARCH SUPPORT | DURHAM | NC | 277054677 | N/A | PC | UTILIZING AMINO ACIDS AND GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE IN PANCREATIC ALPHA CELLS TO PREVENT INSULIN-INDUCED HYPOGLYCEMIA IN T1D | $203,497 | ||||||
| DUKE UNIVERSITY | |||||||||||||
| C/O OFFICE OF RESEARCH SUPPORT | DURHAM | NC | 277054677 | N/A | PC | UTILIZING AMINO ACIDS AND GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE IN PANCREATIC ALPHA CELLS TO PREVENT INSULIN-INDUCED HYPOGLYCEMIA IN T1D | $71,503 | ||||||
| DUNDY COUNTY HOSPITAL | |||||||||||||
| 1313 N CHEYENNE ST | BENKELMAN | NE | 69021 | N/A | GOV | TELE-EMERGENCY SERVICES AT DUNDY COUNTY HOSPITAL | $29,310 | ||||||
| EHLERS-DANLOS RESEARCH FOUNDATION | |||||||||||||
| 1829 REISTERSTOWN ROAD | PIKESVILLE | MD | 21208 | N/A | PC | GENERAL OPERATING SUPPORT | $5,000 | ||||||
| EMORY UNIVERSITY | |||||||||||||
| 1599 CLIFTON ROAD NE | ATLANTA | GA | 303224250 | N/A | PC | CARDIAC ARREST REGISTRY TO ENHANCE SURVIVAL (CARES) HELMSLEY STATE EXPANSION | $313,686 | ||||||
| EZRATH NASHIM SARAH HERZOG MEMORIAL HOSPITAL | |||||||||||||
| N/A | PC | CONSTRUCTION OF A NEW MENTAL HEALTH FACILITY AT HERZOG MEDICAL CENTER | $2,384,174 | 92 GIVAT SHAUL ST | JERUSALEM | IS | |||||||
| FAIRVIEW HEALTH SERVICES | |||||||||||||
| 2450 RIVERSIDE AVE | MINNEAPOLIS | MN | 55454 | N/A | PC | IMPROVING SURVIVAL OUTCOMES THROUGH UNIVERSITY OF MINNESOTA MEDICAL CENTER ECMO CENTER OF EXCELLENCE | $1,960,000 | ||||||
| FAIRVIEW HEALTH SERVICES | |||||||||||||
| 2450 RIVERSIDE AVE | MINNEAPOLIS | MN | 55454 | N/A | PC | IMPROVING SURVIVAL OUTCOMES THROUGH UNIVERSITY OF MINNESOTA MEDICAL CENTER ECMO CENTER OF EXCELLENCE | $4,889,200 | ||||||
| FEDERAL INSTITUTE OF TECHNOLOGY ZURICH ETHZ | |||||||||||||
| N/A | PC | SPATIAL BIOLOGY OF CROHNS COLITIS | $536,228 | RAMISTRASSE 101 | ZURICH | SZ | |||||||
| FJC | |||||||||||||
| 225 WEST 39TH STREET | NEW YORK | NY | 10018 | N/A | PC | NYC FUND TO END YOUTH & FAMILY HOMELESSNESS, A PROJECT OF FJC. | $300,000 | ||||||
| FJC | |||||||||||||
| 225 WEST 39TH STREET | NEW YORK | NY | 10018 | N/A | PC | THE WELLNESS CLASSROOM, A PROJECT OF FJC - A FOUNDATION OF PHILANTHROPIC FUNDS | $1,000,000 | ||||||
| FOR INSPIRATION AND RECOGNITION OF SCIENCE AND TECHNOLOGY | |||||||||||||
| 200 BEDFORD STREET | MANCHESTER | NH | 03101 | N/A | PC | FIRST SENIOR MENTOR PROGRAM | $200,000 | ||||||
| FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS FIND | |||||||||||||
| N/A | PC | ACESS TO CGMS FOR EQUITY IN DIABETES MANAGEMENT - THE ACCEDE PROJECT | $1,275,100 | CAMPUS BIOTECH | GENEVA | SZ | |||||||
| FRANCISCAN CARE SERVICES INC | |||||||||||||
| 430 N MONITOR ST | WEST POINT | NE | 68788 | N/A | PC | TELE-EMERGENCY SERVICES AT FRANCISCAN HEALTHCARE | $17,093 | ||||||
| FRANCISCAN CARE SERVICES INC | |||||||||||||
| 430 N MONITOR ST | WEST POINT | NE | 68788 | N/A | PC | TELE-EMERGENCY SERVICES AT FRANCISCAN HEALTHCARE | $42,729 | ||||||
| FRIENDS OF CRAWFORD PARK INC | |||||||||||||
| 7 RYE RIDGE PLAZA | RYE BROOK | NY | 10573 | N/A | PC | GENERAL OPERATING SUPPORT | $5,000 | ||||||
| FRIENDS OF THE ISRAEL DEFENSE FORCES | |||||||||||||
| 60 EAST 42 STREET | NEW YORK | NY | 10165 | N/A | PC | IMPACT! SCHOLARSHIP PROGRAM | $503,200 | ||||||
| FUENTE LATINA INC | |||||||||||||
| 7300 BISCAYNE BLVD SUITE 200 | MIAMI | FL | 33138 | N/A | PC | MEDIA FELLOWSHIPS TO ISRAEL | $200,000 | ||||||
| FUND FOR PUBLIC HOUSING INC | |||||||||||||
| 90 CHURCH STREET | NEW YORK | NY | 10007 | N/A | PC | DEVELOPING AND ACTIVATING GREENSPACE USING THE CONNECTED COMMUNITIES' PARTICIPATORY PROCESS AT FOUR NYCHA DEVELOPMENTS | $1,630,000 | ||||||
| GALILEE MEDICAL CENTER | |||||||||||||
| N/A | GOV | PURCHASING A CT SCANNER FOR GALILEE MEDICAL CENTER | $991,768 | GALILEE MEDICAL CENTER | NAHARIYA | IS | |||||||
| GALILEE MEDICAL CENTER | |||||||||||||
| N/A | GOV | RENOVATION OF TWO FLOORS OF THE INTERNAL MEDICINE BUILDING AT GALILEE MEDICAL CENTER | $2,200,000 | GALILEE MEDICAL CENTER | NAHARIYA | IS | |||||||
| GATES PHILANTHROPY PARTNERS | |||||||||||||
| PO BOX 60555 | CITY OF INDUSTRY | CA | 91716 | N/A | PC | POLIO ERADICATION FUND SUPPORT | $1,000,000 | ||||||
| GEISINGER CLINIC | |||||||||||||
| 100 NORTH ACADEMY AVE | DANVILLE | PA | 178223057 | N/A | PC | STUDY OF PRE-IMPLEMENTATION OUTCOMES REQUIRED TO IMPLEMENT PREVENTIVESCREENING AT WELL-CHILD VISITS | $72,007 | ||||||
| GENOME RESEARCH LIMITED FOR THE WELLCOME SANGER INSTITUTE | |||||||||||||
| N/A | PC | SCIBD-RESPONSE: MASSIVE-SCALE SINGLE-CELL RNA-SEQUENCING TO IDENTIFY TRANSCRIPTOMIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPIES IN CROHNS DISEASE | $397,123 | WELLCOME GENOME CAMPUS | CAMBRIDGE | UK | |||||||
| GENOME RESEARCH LIMITED FOR THE WELLCOME SANGER INSTITUTE | |||||||||||||
| N/A | PC | SCIBD-RESPONSE: MASSIVE-SCALE SINGLE-CELL RNA-SEQUENCING TO IDENTIFY TRANSCRIPTOMIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPIES IN CROHNS DISEASE | $251,522 | WELLCOME GENOME CAMPUS | CAMBRIDGE | UK | |||||||
| GEORGETOWN UNIVERSITY | |||||||||||||
| 37TH O STREET NW | WASHINGTON | DC | 20057 | N/A | PC | ADVANCING ACCESS TO HIGH QUALITY, AFFORDABLE DIABETES CARE THROUGH PRIVATE HEALTH INSURANCE REGULATION | $418,301 | ||||||
| GEORGIA TECH RESEARCH CORPORATION | |||||||||||||
| 505 10TH STREET NW | ATLANTA | GA | 303320420 | N/A | SOIII FI | LONGITUDINAL TRACKING AND REFERENCE-BASED INTERPRETATION OF SINGLE-CELL CHARACTERISTICS IN TREATMENT NAVE PATIENTS WITH CROHNS DISEASE | $485,617 | ||||||
| GEORGIA TECH RESEARCH CORPORATION | |||||||||||||
| 505 10TH STREET NW | ATLANTA | GA | 303320420 | N/A | SOIII FI | LONGITUDINAL TRACKING AND REFERENCE-BASED INTERPRETATION OF SINGLE-CELL CHARACTERISTICS IN TREATMENT NAVE PATIENTS WITH CROHNS DISEASE | $480,848 | ||||||
| GHANA RURAL INTEGRATED DEVELOPMENT | |||||||||||||
| N/A | PC | LEYAATA HOSPITAL MEDICAL HOUSING | $751,636 | 7774 10 SIDEROAD | MILTON | CA | |||||||
| GIRLS WITH GUTS | |||||||||||||
| 6024 RIDGE AVENUE | PHILADELPHIA | PA | 19128 | N/A | PC | 2021 & 2022 OPERATING SUPPORT TO PROVIDE POST-OPERATIVE AND INFUSION KITS FOR WOMEN WITH INFLAMMATORY BOWEL DISEASE | $77,164 | ||||||
| GLENROCK HOSPITAL DISTRICT | |||||||||||||
| 925 WEST BIRCH | GLENROCK | WY | 82637 | N/A | GOV | WYOMING ULTRASOUND REVITALIZATION PROJECT | $63,635 | ||||||
| GLOBAL SOLIDARITY FUND | |||||||||||||
| 425 LEXINGTON AVE | NEW YORK | NY | 10017 | N/A | PC | JOB CREATION IN ETHIOPIA | $1,508,200 | ||||||
| GRANTMAKERS FOR EFFECTIVE ORGANIZATIONS | |||||||||||||
| 1310 L STREET NW | WASHINGTON | DC | 20005 | N/A | PC | GENERAL OPERATING SUPPORT | $18,920 | ||||||
| GRANTMAKERS IN HEALTH | |||||||||||||
| 1100 CONNECTICUT AVENUE NW | WASHINGTON | DC | 20036 | N/A | PC | GENERAL OPERATING SUPPORT | $24,640 | ||||||
| GUARDIAN ORG FOUNDATION | |||||||||||||
| 900 17TH STREET NW SUITE 250 | WASHINGTON | DC | 20006 | N/A | PC | A GROWING CRISIS: NON-COMMUNICABLE DISEASES, AN INDEPENDENT JOURNALISM SERIES BY THE GUARDIAN | $625,000 | ||||||
| HADASSAH MEDICAL ORGANIZATION | |||||||||||||
| N/A | PC | EQUIPPING HADASSAH HOSPITAL'S OPERATING ROOMS | $2,000,000 | EIN KEREM ADDRESS KALMAN YAAKOV MAN | JERUSALEM | IS | STREET | ||||||
| HADASSAH MEDICAL ORGANIZATION | |||||||||||||
| N/A | PC | CREATING AND EQUIPPING A NEW COMPREHENSIVE DIAGNOSTIC AND INTERVENTIONAL IMAGING CENTER | $1,136,000 | EIN KEREM ADDRESS KALMAN YAAKOV MAN | JERUSALEM | IS | STREET | ||||||
| HEALTH ADVOCACY SUMMIT INC | |||||||||||||
| 1962 DOCKSIDE DRIVE | GREENWOOD | IN | 46143 | N/A | PC | CROHNS AND COLITIS YOUNG ADULTS NETWORK LEARNING COMMUNITY, ROUNDTABLE ON ADOLESCENTS AND YOUNG ADULTS WITH IBD | $60,060 | ||||||
| HEALTH RESEARCH ALLIANCE INC | |||||||||||||
| 65 TW ALEXANDER DRIVE | RESEARCH TRIANGLE PARK | NC | 27709 | N/A | PC | GENERAL OPERATING SUPPORT | $44,300 | ||||||
| HEBREW UNIVERSITY OF JERUSALEM | |||||||||||||
| N/A | PC | METHYLATION PATTERNS OF CELL-FREE DNA AS A NOVEL BIOMARKER IN CROHNS DISEASE | $362,703 | OFFICE OF THE PRESIDENT | JERUSALEM | IS | |||||||
| HELEN KELLER INTERNATIONAL | |||||||||||||
| ONE DAG HAMMARSKJOLD PLAZA | NEW YORK | NY | 10017 | N/A | PC | A CONTINUED PATH TO RESILIENCE AND EMPOWERMENT | $1,441,293 | ||||||
| HELEN KELLER INTERNATIONAL | |||||||||||||
| ONE DAG HAMMARSKJOLD PLAZA | NEW YORK | NY | 10017 | N/A | PC | A CONTINUED PATH TO RESILIENCE AND EMPOWERMENT | $1,652,490 | ||||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | |||||||||||||
| N/A | PC | GPPAD COORDINATION CENTER CONTINUATION | $778,887 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | ||||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | |||||||||||||
| N/A | PC | GPPAD COORDINATION CENTER CONTINUATION | $745,207 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | ||||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | |||||||||||||
| N/A | PC | THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL | $1,310,340 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | ||||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | |||||||||||||
| N/A | PC | THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL | $2,240,499 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | ||||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | |||||||||||||
| N/A | PC | THE GPPAD-05 STUDY: ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | $1,956,717 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | ||||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | |||||||||||||
| N/A | PC | THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | $1,849,482 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | ||||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | |||||||||||||
| N/A | PC | THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | $1,044,591 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | ||||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | |||||||||||||
| N/A | PC | CONTINUATION OF THE GPPAD-02-STUDY: IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS | $2,114,441 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | ||||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | |||||||||||||
| N/A | PC | CONTINUATION OF THE GPPAD-02-STUDY: IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS | $2,929,862 | DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | GESUNDHEIT UND UMWELT GMBH | ||||||
| HENRY J KAISER FAMILY FOUNDATION | |||||||||||||
| 185 BERRY STREET NO 2000 | SAN FRANCISCO | CA | 94107 | N/A | PC | KAISER HEALTH NEWS RURAL HEALTH DESK | $1,458,159 | ||||||
| HERLEV OG GENTOFTE HOSPITAL | |||||||||||||
| N/A | GOV | TARGETING GIP/GLP-2 RECEPTORS TO PREVENT HYPOGLYCEMIA IN T1D | $145,339 | HERLEV AND GENTOFTE HOSPITAL | HERLEV | DA | |||||||
| HERLEV OG GENTOFTE HOSPITAL | |||||||||||||
| N/A | GOV | UTILIZATION OF INTERACTION BETWEEN AMINO ACIDS & GIP IN PANCREATIC CELLS | $81,534 | HERLEV AND GENTOFTE HOSPITAL | HERLEV | DA | |||||||
| HOLY ROSARY HEALTHCARE FOUNDATION | |||||||||||||
| 2600 WILSON STREET | MILES CITY | MT | 59301 | N/A | PC | HOLY ROSARY HEALTHCARE COMPREHENSIVE CANCER CENTER | $2,000,000 | ||||||
| HOT SPRINGS COUNTY HOSPITAL DISTRICT | |||||||||||||
| 150 E ARAPAHOE ST | THERMOPOLIS | WY | 82443 | N/A | GOV | WYOMING ULTRASOUND REVITALIZATION PROJECT | $346,794 | ||||||
| HUMAN CELL ATLAS INCORPORATED | |||||||||||||
| 415 MAIN ST | CAMBRIDGE | MA | 02142 | N/A | PC | 2023 HUMAN CELL ATLAS GENERAL MEETING | $50,000 | ||||||
| HUMBOLDT COUNTY MEMORIAL HOSPITAL | |||||||||||||
| 1000 N 15TH ST | HUMBOLDT | IA | 50548 | N/A | GOV | TELE-EMERGENCY SERVICES AT HUMBOLDT COUNTY MEMORIAL HOSPITAL | $117,600 | ||||||
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | |||||||||||||
| 1 GUSTAVE L LEVY PL | NEW YORK CITY | NY | 10029 | N/A | PC | NEXT PHASE OF STEM CELL TRANSPLANT FOR REFRACTORY CROHNS DISEASE | $305,349 | ||||||
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | |||||||||||||
| 1 GUSTAVE L LEVY PL | NEW YORK CITY | NY | 10029 | N/A | PC | NEXT PHASE OF STEM CELL TRANSPLANT FOR REFRACTORY CROHNS DISEASE | $404,688 | ||||||
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | |||||||||||||
| 1 GUSTAVE L LEVY PL | NEW YORK CITY | NY | 10029 | N/A | PC | DEFINING THE PRE-DISEASE PHASE OF CROHNS DISEASE: PREDICT AND PREVENT | $1,623,623 | ||||||
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | |||||||||||||
| 1 GUSTAVE L LEVY PL | NEW YORK CITY | NY | 10029 | N/A | PC | SPATIAL MAPPING OF FIBROMUSCULAR CROHNS DISEASE: FROM GENETIC TO SENESCENT SIGNALS | $1,085,802 | ||||||
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | |||||||||||||
| 1 GUSTAVE L LEVY PL | NEW YORK CITY | NY | 10029 | N/A | PC | THE MELODY TRIAL: MODULATING EARLY LIFE MICROBIOME THROUGH DIETARY INTERVENTION IN CROHN'S DISEASE | $759,619 | ||||||
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | |||||||||||||
| 1 GUSTAVE L LEVY PL | NEW YORK CITY | NY | 10029 | N/A | PC | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES: MOUNT SINAI STUDIES | $220,000 | ||||||
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | |||||||||||||
| 1 GUSTAVE L LEVY PL | NEW YORK CITY | NY | 10029 | N/A | PC | PROMOTE BIRTH EQUITY THROUGH COMMUNITY-BASED DOULA CARE FOR NYCS MOST VULNERABLE MEMBERS, HOMELESS AND JUSTICE-INVOLVED PREGNANT PERSONS. | $672,617 | ||||||
| ICHUD HATZALAH ISRAEL 1221 (RA) | |||||||||||||
| N/A | PC | PROVIDING SUPPORT FOR EMERGENCY PREPAREDNESS | $600,000 | 78 YIRMIYAHU ST | JERUSALEM | IS | |||||||
| ICHUD HATZALAH ISRAEL 1221 (RA) | |||||||||||||
| N/A | PC | EMERGENCY FUNDING FOR RESPONSE TO ATTACKS ON ISRAEL | $1,300,000 | 78 YIRMIYAHU ST | JERUSALEM | IS | |||||||
| ICHUD HATZALAH ISRAEL 1221 (RA) | |||||||||||||
| N/A | PC | PROVIDING SUPPORT, RECOVERY AND RESPECTFUL HANDLING OF FALLEN WAR VICTIMS | $350,000 | 78 YIRMIYAHU ST | JERUSALEM | IS | |||||||
| IDA COUNTY IOWA COMMUNITY HOSPITAL | |||||||||||||
| 701 EAST SECOND STREET | IDA GROVE | IA | 51445 | N/A | PC | TELE-EMERGENCY SERVICES AT HORN MEMORIAL HOSPITAL | $114,569 | ||||||
| INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG | |||||||||||||
| N/A | GOV | GPPAD BIOBANK - SINT1A | $11,424 | 1 RUE LOUIS RECH | DUDELANGE | LU | |||||||
| INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG | |||||||||||||
| N/A | GOV | BIOBANKING FOR THE PRIMARY ORAL INSULIN TRIAL | $60,914 | 1 RUE LOUIS RECH | DUDELANGE | LU | |||||||
| INSTITUTE FOR COMMUNITY LIVING INC | |||||||||||||
| 125 BROAD STREET | NEW YORK CITY | NY | 10004 | N/A | PC | PILOTING A THREE-YEAR IMT/ACT STEP-DOWN PROJECT | $749,790 | ||||||
| INSULIN FOR LIFE USA INC | |||||||||||||
| 2555 SW 76TH STREET | GAINESVILLE | FL | 32608 | N/A | PC | INSULIN FOR LIFE USA STRENGTHENING ORGANIZATIONAL CAPACITY | $341,606 | ||||||
| INTERNATIONAL ALLIANCE FOR DIABETES ACTION INC | |||||||||||||
| 75 STATE STREET | BOSTON | MA | 02109 | N/A | PC | SEED FUNDING SUPPORT | $714,053 | ||||||
| INTERNATIONAL BOWEL ULTRASOUND GROUP EV | |||||||||||||
| N/A | NC | THE EXTENT STUDY (CALCULATING THE LEMANN INDEX USING INTESTINAL ULTRASOUND) | $379,100 | HARKORTSTR 1 | MUNSTER | GM | |||||||
| INTERNATIONAL BOWEL ULTRASOUND GROUP EV | |||||||||||||
| N/A | NC | DEVELOPMENT OF ELEARNING PLATFORM FOR STANDARDIZATION AND DISSEMINATION OF INTESTINAL ULTRASOUND EDUCATION GLOBALLY (IBUS EIUS ED) | $672,500 | HARKORTSTR 1 | MUNSTER | GM | |||||||
| INTERNATIONAL BOWEL ULTRASOUND GROUP EV | |||||||||||||
| N/A | NC | DEVELOPMENT OF AN INTESTINAL ULTRASOUND SCORE TO EVALUATE INFLAMMATION AND TREATMENT RESPONSE IN CD. USE-IT: A PROSPECTIVE, MULTICENTER STUDY | $375,221 | HARKORTSTR 1 | MUNSTER | GM | |||||||
| INTERNATIONAL WATER MANAGEMENT INSTITUTE | |||||||||||||
| N/A | PC | DIGITAL INNOVATIONS FOR A WATER SECURE AFRICA | $1,999,629 | 127 SUNIL MAWATHA | BATTARAMULLA | CE | |||||||
| IOWA DEPARTMENT OF PUBLIC HEALTH | |||||||||||||
| 321 EAST 12TH | DES MOINES | IA | 50319 | N/A | GOV | IOWA FIRST RESPONDER AED INITIATIVE | $58,968 | ||||||
| ISRAEL EMERGENCY ALLIANCE | |||||||||||||
| PO BOX 341069 | LOS ANGELES | CA | 90034 | N/A | PC | SUPPORT OF LEGAL EFFORTS TO COMBAT ANTISEMITISM, AND SOCIAL MEDIA EXPANSION | $250,000 | ||||||
| IVINSON MEMORIAL HOSPITAL | |||||||||||||
| 255 N 30TH ST | LARAMIE | WY | 82070 | N/A | PC | WYOMING ULTRASOUND REVITALIZATION PROJECT | $550,348 | ||||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | |||||||||||||
| 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | N/A | PC | EXERCISE IN DIABETES INITIATIVE: PEDIATRIC STUDY | $283,542 | ||||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | |||||||||||||
| 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | N/A | PC | EDUCATIONAL INTERVENTION TO SUPPORT DIABETES GUIDANCE FOR EXERCISE (EDGE) | $620,243 | ||||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | |||||||||||||
| 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | N/A | PC | PREGNANCY DATA REPOSITORY TO ASSESS MANAGEMENT OF TYPE 1 DIABETES WITH DIABETES TECHNOLOGY (PRAM-T1D) | $1,449,344 | ||||||
| JDRF INTERNATIONAL | |||||||||||||
| 200 VESEY STREET | NEW YORK | NY | 10281 | N/A | PC | HELMSLEY AND JDRF CO-FUNDED WORKSHOPS | $49,192 | ||||||
| JDRF INTERNATIONAL | |||||||||||||
| 200 VESEY STREET | NEW YORK | NY | 10281 | N/A | PC | JOINING FORCES: BUILDING A SHARED 'GRAND ACCESS STRATEGY' FOR SAVING T1D LIVES | $500,000 | ||||||
| JDRF INTERNATIONAL | |||||||||||||
| 200 VESEY STREET | NEW YORK | NY | 10281 | N/A | PC | AUTOIMMUNITY SCREENING FOR KIDS (ASK) PROGRAM TRANSITION TOWARDS A SUSTAINABLE SCREENING FOR T1D AND CELIAC DISEASE IN COLORADO (ASK RENEWAL 2022) | $555,046 | ||||||
| JERUSALEM COLLEGE OF TECHNOLOGY | |||||||||||||
| N/A | PC | HELMSLEY FACULTY OF LIFE AND HEALTH SCIENCES BUILDING | $1,300,000 | 21 HAVAAD HALEUMI ST | JERUSALEM | IS | |||||||
| JERUSALEM COLLEGE OF TECHNOLOGY | |||||||||||||
| N/A | PC | EMERGENCY SUPPORT FOR STUDENTS AT THE JERUSALEM COLLEGE OF TECHNOLOGY. | $500,000 | 21 HAVAAD HALEUMI ST | JERUSALEM | IS | |||||||
| JOHNS HOPKINS UNIVERSITY | |||||||||||||
| 733 NORTH BROADWAY MRB 117 | BALTIMORE | MD | 21205 | N/A | PC | DEVELOPMENT OF AN APTAMER-BASED BIOSENSOR FOR CONTINUOUS INSULIN MONITORING | $567,091 | ||||||
| JOHNS HOPKINS UNIVERSITY | |||||||||||||
| 733 NORTH BROADWAY MRB 117 | BALTIMORE | MD | 21205 | N/A | PC | TARGETED, SUSTAINED RELEASE ANTIFIBROTIC THERAPIES FOR CROHNS DISEASE PATIENTS | $568,782 | ||||||
| JOHNSON COUNTY HOSPITAL DISTRICT | |||||||||||||
| 497 WEST LOTT STREET | BUFFALO | WY | 82834 | N/A | GOV | JOHNSON COUNTY HEALTHCARE CENTER ULTRASOUND EQUIPMENT | $476,613 | ||||||
| JOSLIN DIABETES CENTER INC | |||||||||||||
| ONE JOSLIN PLACE | BOSTON | MA | 02215 | N/A | PC | AN INTEGRATED CARE MODEL FOR OLDER ADULTS WITH INSULIN-TREATED DIABETES | $941,354 | ||||||
| JUVENILE DIABETES RESEARCH FOUNDATION CANADA | |||||||||||||
| N/A | PC | JDRF CANADA PSYCHOSOCIAL HEALTH INITIATIVE | $19,000 | 235 YORKLAND BLVD SUITE 600 | TORONTO | CA | |||||||
| KAISER FOUNDATION HEALTH PLAN OF GEORGIA INC | |||||||||||||
| 1375 PEACHTREE STREET NE | ATLANTA | GA | 30309 | N/A | PC | EXPANSION OF THE T1DES PILOT TO A PUBLIC HOSPITAL | $291,280 | ||||||
| KATHOLIEKE UNIVERSITEIT TE LEUVEN | |||||||||||||
| N/A | PC | EDENT1FI | $855,018 | WAAISTRAAT 6 BOX 5105 | LEUVEN | BE | |||||||
| KATHOLIEKE UNIVERSITEIT TE LEUVEN | |||||||||||||
| N/A | PC | AN ENTEROCHROMAFFIN CELL AND MACROPHAGE ATLAS OF THE HUMAN GUT | $246,662 | WAAISTRAAT 6 BOX 5105 | LEUVEN | BE | |||||||
| KATHOLIEKE UNIVERSITEIT TE LEUVEN | |||||||||||||
| N/A | PC | COMBINATION THERAPY OF DIET WITH BIOLOGICALS FOR CROHNS DISEASE: THE OATS STUDY | $770,816 | WAAISTRAAT 6 BOX 5105 | LEUVEN | BE | |||||||
| KIMBALL COUNTY HOSPITAL | |||||||||||||
| 505 S BURG STREET | KIMBALL | NE | 69145 | N/A | GOV | PINE BLUFFS HEALTH CLINIC: WYOMING ULTRASOUND REVITALIZATION PROJECT | $5,252 | ||||||
| KING'S COLLEGE LONDON | |||||||||||||
| N/A | PC | RESOLVING HARMFUL ACCUMULATION OF INNATE LYMPHOID CELLS DURING CROHNS DISEASE. | $447,521 | 150 STAMFORD STREET | LONDON | UK | |||||||
| KING'S COLLEGE LONDON | |||||||||||||
| N/A | PC | IDENTIFYING THE ROLE OF FOOD ADDITIVE EMULSIFIERS IN CROHN'S DISEASE: A RANDOMIZED CONTROLLED TRIAL | $531,295 | 150 STAMFORD STREET | LONDON | UK | |||||||
| KING'S COLLEGE LONDON | |||||||||||||
| N/A | PC | IDENTIFYING THE ROLE OF FOOD ADDITIVE EMULSIFIERS IN CROHN'S DISEASE: A RANDOMIZED CONTROLLED TRIAL | $195,494 | 150 STAMFORD STREET | LONDON | UK | |||||||
| KMR ADVANCEMENT OF MEDICAL CENTERS LTD | |||||||||||||
| N/A | PC | PROPOSAL FOR BUILDING OF PRINCIPAL INFRASTRUCTURE FOR ALL 20 FLOORS OF THE HELMSLEY HEALTH DISCOVERY TOWER | $1,000,000 | 8 HAALIYAH ST | HAIFA | IS | |||||||
| LIFESCAPE FOUNDATION | |||||||||||||
| 2011 W 26TH ST SUITE 201 | SIOUX FALLS | SD | 57105 | N/A | PC | GENERAL OPERATING SUPPORT | $7,500 | ||||||
| LIVING GOODS | |||||||||||||
| 1423 BROADWAY 1054 | OAKLAND | CA | 94612 | N/A | PC | DIGITIZING COMMUNITY HEALTH | $1,100,222 | ||||||
| LIVING WATER INTERNATIONAL | |||||||||||||
| 4001 GREENBRIAR DRIVE | STAFFORD | TX | 77477 | N/A | PC | SCALING INTEGRATED WASH SERVICES | $2,838,602 | ||||||
| LUCAS COUNTY HEALTH CENTER | |||||||||||||
| 1200 NORTH 7TH STREET | CHARITON | IA | 50049 | N/A | PC | AVERA ECARE EMERGENCY VIRTUAL HEALTH AT LUCAS COUNTY HEALTH CENTER | $17,970 | ||||||
| MACCABI HEALTHCARE SERVICES | |||||||||||||
| N/A | PC | MOBILE MAMMOGRAPHY UNIT | $31,500 | 27 HAMERED ST | TEL AVIV | IS | |||||||
| MACCABI HEALTHCARE SERVICES | |||||||||||||
| N/A | PC | URGENT PROCUREMENT OF MEDICAL EQUIPMENT FOR WOUNDED SOLDIERS AND CIVILIANS | $492,958 | 27 HAMERED ST | TEL AVIV | IS | |||||||
| MADISON COUNTY MEMORIAL HOSPITAL | |||||||||||||
| 300 W HUTCHINGS STREET | WINTERSET | IA | 50273 | N/A | GOV | IMPLEMENTATION OF EEMERGENCY AT MADISON COUNTY HEALTH CARE SYSTEM | $15,187 | ||||||
| MARY C WHEELER SCHOOL INC | |||||||||||||
| 216 HOPE STREET | PROVIDENCE | RI | 02906 | N/A | PC | GENERAL OPERATING SUPPORT: THE WHEELER FUND. | $10,000 | ||||||
| MASS GENERAL BRIGHAM FOR THE BRIGHAM AND WOMEN'S HOSPITAL | |||||||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | N/A | PC | PEN-PLUS EXPANSION | $9,013,397 | ||||||
| MASS GENERAL BRIGHAM FOR THE BRIGHAM AND WOMEN'S HOSPITAL | |||||||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | N/A | PC | 2023 WOMEN'S HEALTH LUNCHEON | $20,000 | ||||||
| MASS GENERAL BRIGHAM FOR THE BRIGHAM AND WOMEN'S HOSPITAL | |||||||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | N/A | PC | INVESTIGATION OF ANTI-GM-CSF AUTOANTIBODIES AS A DISEASE DETERMINANT IN CROHNS DISEASE | $499,459 | ||||||
| MASS GENERAL BRIGHAM FOR THE BRIGHAM AND WOMEN'S HOSPITAL | |||||||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | N/A | PC | BUILDING A GLOBAL PARTNERSHIP TO ACHIEVE UNIVERSAL ACCESS FOR T1D AND OTHER SEVERE CHRONIC NONCOMMUNICABLE DISEASES | $1,785,375 | ||||||
| MASS GENERAL BRIGHAM FOR THE MASSACHUSETTS GENERAL HOSPITAL | |||||||||||||
| 55 FRUIT STREET | BOSTON | MA | 021142696 | N/A | PC | MICROBES, MOLECULES, AND CHEMISTRY: DYSBIOSIS IN CROHNS DISEASE | $1,728,414 | ||||||
| MASS GENERAL BRIGHAM FOR THE MASSACHUSETTS GENERAL HOSPITAL | |||||||||||||
| 55 FRUIT STREET | BOSTON | MA | 021142696 | N/A | PC | WIRELESS INFRARED IMAGING CAPSULE FOR PINPOINTING INFLAMMATION IN CROHNS DISEASE | $752,326 | ||||||
| MASS GENERAL BRIGHAM FOR THE MASSACHUSETTS GENERAL HOSPITAL | |||||||||||||
| 55 FRUIT STREET | BOSTON | MA | 021142696 | N/A | PC | CROHN'S DISEASE IN SOUTH ASIANS: DEFINING DISEASE BIOLOGY FOR PREVENTION AND BETTER TREATMENT | $705,894 | ||||||
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | |||||||||||||
| 77 MASSACHUSETTS AVENUE | CAMBRIDGE | MA | 02139 | N/A | PC | COMPUTATIONAL MODELING TO IMPROVE GLUCOSE-RESPONSIVE GLUCAGON DESIGNS | $251,447 | ||||||
| MAYO CLINIC | |||||||||||||
| 200 FIRST STREET SW | ROCHESTER | MN | 55905 | N/A | PC | MILITARY SCIENCES MEDICAL TRAINING 2022-2024 | $250,000 | ||||||
| MAYO CLINIC | |||||||||||||
| 200 FIRST STREET SW | ROCHESTER | MN | 55905 | N/A | PC | DEVELOPMENT OF A NEXT-GENERATION BIOMARKER TOOL TO ACCELERATE THE DEVELOPMENT OF EFFECTIVE ANTI-FIBROTIC THERAPIES | $334,407 | ||||||
| MDECINS SANS FRONTIERES USA INC | |||||||||||||
| 40 RECTOR STREET | NEW YORK | NY | 10006 | N/A | PC | GENERAL OPERATING SUPPORT | $5,000 | ||||||
| MEDICAL UNIVERSITY OF SOUTH CAROLINA | |||||||||||||
| 179 ASHLEY AVENUE | CHARLESTON | SC | 29425 | N/A | GOV | ENGINEERED DENDRITIC CELL BASED ROBUST ANTIGEN SPECIFIC THERAPY FOR TYPE 1 DIABETES | $412,500 | ||||||
| MEDICINE BOW RURAL HEALTH CARE DISTRICT | |||||||||||||
| 514 IDAHO DR | MEDICINE BOW | WY | 82329 | N/A | PC | WYOMING ULTRASOUND REVITALIZATION PROJECT | $19,017 | ||||||
| MEDICINES DEVELOPMENT FOR GLOBAL HEALTH (MDGH) | |||||||||||||
| N/A | PC | ADVANCING THE FIGHT AGAINST ONCHOCERCIASIS | $1,014,170 | 18 KAVANAGH STREET SOUTHBANK | SOUTHBANK | AS | |||||||
| MEDICINES FOR HUMANITY INC | |||||||||||||
| 800 HINGHAM STREET | ROCKLAND | MA | 02370 | N/A | PC | MAI MBELEKI II EXPANSION | $436,472 | ||||||
| MEMORIAL HOSPITAL OF CARBON COUNTY | |||||||||||||
| 2221 W ELM STREET | RAWLINS | WY | 82301 | N/A | GOV | MEMORIAL HOSPITAL OF CARBON COUNTY ULTRASOUND EQUIPMENT | $598,152 | ||||||
| MEMORIAL HOSPITAL OF CONVERSE COUNTY | |||||||||||||
| 111 S 5TH STREET | DOUGLAS | WY | 82633 | N/A | GOV | WYOMING ULTRASOUND REVITALIZATION PROJECT | $559,262 | ||||||
| MEMORIAL HOSPITAL OF SWEETWATER COUNTY FOUNDATION | |||||||||||||
| 1200 COLLEGE DRIVE | ROCK SPRINGS | WY | 82901 | N/A | PC | WYOMING ULTRASOUND REVITALIZATION PROJECT | $551,594 | ||||||
| MIDDLE EAST MEDIA AND RESEARCH INSTITUTE INC | |||||||||||||
| PO BOX 27837 | WASHINGTON | DC | 20038 | N/A | PC | HIRING ADDITIONAL TRANSLATORS/ANALYSTS | $420,000 | ||||||
| MIDDLE EAST MEDIA AND RESEARCH INSTITUTE INC | |||||||||||||
| PO BOX 27837 | WASHINGTON | DC | 20038 | N/A | PC | THE INTERCONNECTED IRAN-RUSSIA-CHINA AXIS | $300,000 | ||||||
| MIDDLE EAST MEDIA AND RESEARCH INSTITUTE INC | |||||||||||||
| PO BOX 27837 | WASHINGTON | DC | 20038 | N/A | PC | TARGETED ADS FOR UNIVERSITY CAMPUS NEWSPAPERS | $108,500 | ||||||
| MINERAL COUNTY HOSPITAL DISTRICT | |||||||||||||
| 200 SOUTH A STREET | HAWTHORNE | NV | 89415 | N/A | GOV | USDA COMMUNITY FACILITY DIRECT LOAN PROGRAM APPLICATION | $350,000 | ||||||
| MONROE COUNTY HOSPITAL | |||||||||||||
| 6580 165TH STREET | ALBIA | IA | 52531 | N/A | GOV | EPHARMACY AT MONROE COUNTY HOSPITAL & CLINICS | $7,031 | ||||||
| MONTANA PEDIATRICS | |||||||||||||
| 259 W FRONT STREET | MISSOULA | MT | 59802 | N/A | PC | CREATING A STATEWIDE MODEL OF CARE FOR CHILDREN WITH T1D | $1,086,286 | ||||||
| MONUMENT HEALTH STURGIS HOSPITAL | |||||||||||||
| 2140 JUNCTION AVE | STURGIS | SD | 57785 | N/A | PC | EEMERGENCY AT MONUMENT HEALTH STURGIS HOSPITAL | $16,568 | ||||||
| MONUMENT HEALTH INC | |||||||||||||
| 353 FAIRMONT BLVD | RAPID CITY | SD | 57701 | N/A | SOIII FI | NICU EQUIPMENT | $2,066,019 | ||||||
| NATIONAL ASSOCIATION OF SCHOOL NURSES INC | |||||||||||||
| 1100 WAYNE AVE | SILVER SPRING | MD | 20910 | N/A | PC | PROVIDING COORDINATED CARE AND CAPTURING OUTCOMES FOR STUDENTS WITH T1D SCHOOL NURSE-LED PILOT PROJECT | $891,762 | ||||||
| NATIONAL COMMITTEE FOR QUALITY ASSURANCE | |||||||||||||
| 1100 13TH ST NW | WASHINGTON | DC | 20005 | N/A | PC | NCQA DIABETES RECOGNITION PROGRAM REFRESH & DIABETES MEASURE DEVELOPMENT | $885,819 | ||||||
| NATIONAL PARK FOUNDATION | |||||||||||||
| 1500 K ST NW | WASHINGTON | DC | 20005 | N/A | PC | BERING LAND BRIDGE VISITOR CENTER | $1,163,270 | ||||||
| NATIONAL PARK FOUNDATION | |||||||||||||
| 1500 K ST NW | WASHINGTON | DC | 20005 | N/A | PC | BADLANDS NATIONAL PARK CEDAR PASS VISITOR CENTER | $1,850,000 | ||||||
| NATIONAL PARK FOUNDATION | |||||||||||||
| 1500 K ST NW | WASHINGTON | DC | 20005 | N/A | PC | LITTLE BIGHORN BATTLEFIELD NATIONAL MONUMENT VISITOR CENTER | $869,558 | ||||||
| NATURAL AREAS CONSERVANCY INC | |||||||||||||
| 1234 FIFTH AVENUE | NEW YORK | NY | 10029 | N/A | PC | ACTIVATING AND SUSTAINING NYC NATURE TRAIL NETWORK (PHASE 3) | $336,672 | ||||||
| NCD ALLIANCE | |||||||||||||
| N/A | PC | 2023-2025 PARTNERSHIP | $1,911,525 | 31-33 AVENUE GIUSEPPE MOTTA | GENEVA | SZ | |||||||
| NCD ALLIANCE | |||||||||||||
| N/A | PC | GENERAL OPERATING SUPPORT - NCD ALLIANCE SUPPORTERS GROUP | $42,500 | 31-33 AVENUE GIUSEPPE MOTTA | GENEVA | SZ | |||||||
| NEBRASKA METHODIST HOSPITAL FOUNDATION | |||||||||||||
| 8701 WEST DODGE ROAD | OMAHA | NE | 68114 | N/A | PC | NICU EQUIPMENT | $290,000 | ||||||
| NEVADA DEPARTMENT OF HEALTH AND HUMAN SERVICES | |||||||||||||
| 301 CENTENNIAL MALL SOUTH | LINCOLN | NE | 68508 | N/A | GOV | NEBRASKA FIRST RESPONDER AED PROJECT | $309,887 | ||||||
| NEVADA DEPARTMENT OF HEALTH AND HUMAN SERVICES | |||||||||||||
| 4126 TECHNOLOGY WAY | CARSON CITY | NV | 89706 | N/A | GOV | NEVADA VIRTUAL CRISIS CARE | $1,230,038 | ||||||
| NEVADA DEPARTMENT OF HEALTH AND HUMAN SERVICES | |||||||||||||
| 4126 TECHNOLOGY WAY | CARSON CITY | NV | 89706 | N/A | GOV | NEVADA FIRST RESPONDER AED PROJECT | $223,920 | ||||||
| NEVADA HEALTH CENTERS INC | |||||||||||||
| 3325 RESEARCH WAY | CARSON CITY | NV | 89706 | N/A | PC | QUALITY ULTRASOUND SERVICES AND TRAINING PROGRAM | $81,967 | ||||||
| NEVADA RURAL HOSPITAL PARTNERS FOUNDATION INC | |||||||||||||
| 4600 KIETZKE LANE | RENO | NV | 89502 | N/A | PC | SONOGRAPHER AND TECHNOLOGIST TRAINING FOR RURAL NEVADA HOSPITALS | $27,500 | ||||||
| NEW DESTINY HOUSING CORPORATION | |||||||||||||
| 12 W 37TH STREET 7TH FLOOR | NEW YORK | NY | 10018 | N/A | PC | PILOTING AFTERCARE INTERVENTIONTO IMPROVE HOUSING AND HEALTH STABILITYFOR FORMERLY HOMELESS DOMESTIC VIOLENCE SURVIVORS | $398,456 | ||||||
| NEW GROUND INC | |||||||||||||
| 70 ACORN LANE | LEVITTOWN | NY | 11756 | N/A | PC | GENERAL OPERATING SUPPORT | $5,000 | ||||||
| NEW VENTURE FUND | |||||||||||||
| 1828 L STREET NW | WASHINGTON | DC | 20036 | N/A | PC | TYPE 1 DIABETES CAMPS PROJECT (2022 - 2024) | $1,468,813 | ||||||
| NEW YORK CITY BALLET INC | |||||||||||||
| DAVID H KOCH THEATER | NEW YORK | NY | 10023 | N/A | PC | GENERAL OPERATING SUPPORT FOR NEW COMBINATIONS FUND | $15,000 | ||||||
| NEW YORK CITY HEALTH AND HOSPITALS CORPORATION | |||||||||||||
| 125 WORTH STREET | NEW YORK | NY | 10013 | N/A | PC | EXPRESSCARE TELE-BEHAVIORAL HEALTH SERVICE LAUNCH AND TAILORED SERVICE STRATEGIES FOR HIGH NEEDS PATIENTS IN NYC | $867,832 | ||||||
| NEW YORK UNIVERSITY SCHOOL OF MEDICINE | |||||||||||||
| 550 1ST AVENUE | NEW YORK | NY | 10016 | N/A | PC | TAMALE EDUCATION AND INNOVATION CENTER FOR HEALTH | $3,692,303 | ||||||
| NEW YORK UNIVERSITY | |||||||||||||
| 665 BROADWAY | NEW YORK | NY | 10012 | N/A | PC | ANALYSIS OF MEDICAID AND RELATED DATA ON CARE TO HOMELESS SHELTER PATIENTS | $100,123 | ||||||
| NIOBRARA COUNTY HOSPITAL DISTRICT | |||||||||||||
| 921 S BALLANCEE AVE | LUSK | WY | 82225 | N/A | GOV | WYOMING ULTRASOUND REVITALIZATION PROJECT | $147,400 | ||||||
| NORTH BIG HORN HOSPITAL | |||||||||||||
| 1115 LANE 12 | LOVELL | WY | 82431 | N/A | PC | NORTH BIG HORN HOSPITAL WYOMING ULTRASOUND REVITALIZATION PROJECT | $153,800 | ||||||
| NORTH DAKOTA DEPARTMENT OF HEALTH | |||||||||||||
| 600 E BOULEVARD AVENUE | BISMARCK | ND | 585050200 | N/A | GOV | NORTH DAKOTA LAW ENFORCEMENT AED PROJECT | $27,500 | ||||||
| NURU INTERNATIONAL | |||||||||||||
| 2020 PENNSYLVANIA AVE NW | WASHINGTON | DC | 20006 | N/A | PC | EXPANSION OF AGRIBUSINESS COOPERATIVES | $2,250,000 | ||||||
| OAKLAND UNIVERSITY | |||||||||||||
| 2200 NORTH SQUIRREL ROAD | ROCHESTER | MI | 48309 | N/A | GOV | A COMPREHENSIVE STUDY OF T1D EXOMES (PHASE 1) | $738,313 | ||||||
| OREGON HEALTH & SCIENCE UNIVERSITY | |||||||||||||
| 3181 SW SAM JACKSON PARK ROAD | PORTLAND | OR | 972393098 | N/A | GOV | NICH BAY AREA EXPANSION | $749,644 | ||||||
| OREGON HEALTH & SCIENCE UNIVERSITY | |||||||||||||
| 3181 SW SAM JACKSON PARK ROAD | PORTLAND | OR | 972393098 | N/A | GOV | NICH BAY AREA EXPANSION | $654,234 | ||||||
| PALO ALTO VETERANS INSTITUTE FOR RESEARCH | |||||||||||||
| 3801 MIRANDA AVENUE | PALO ALTO | CA | 943040038 | N/A | PC | CELL ATLAS OF HUMAN INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S DISEASE | $292,821 | ||||||
| PALO ALTO VETERANS INSTITUTE FOR RESEARCH | |||||||||||||
| 3801 MIRANDA AVENUE | PALO ALTO | CA | 943040038 | N/A | PC | CELL ATLAS OF HUMAN INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S DISEASE | $292,821 | ||||||
| PANORAMA GLOBAL | |||||||||||||
| 2101 FOURTH AVENUE SUITE 2100 | SEATTLE | WA | 98121 | N/A | PC | PANORAMA - TYPE 1 DIABETES GLOBAL ACCESS MICRO-GRANT FUND | $1,167,087 | ||||||
| PANORAMA GLOBAL | |||||||||||||
| 2101 FOURTH AVENUE SUITE 2100 | SEATTLE | WA | 98121 | N/A | PC | PANORAMA - TYPE 1 DIABETES GLOBAL ACCESS MICRO-GRANT FUND | $64,900 | ||||||
| PATH | |||||||||||||
| 2201 WESTLAKE AVENUE | SEATTLE | WA | 98121 | N/A | PC | THE DIABETES CAREPAK PROJECT: ENABLING HIGH-QUALITY DIABETES SELF-CARE | $967,457 | ||||||
| PAWNEE COUNTY MEMORIAL HOSPITAL | |||||||||||||
| 600 I STREET | PAWNEE CITY | NE | 68420 | N/A | GOV | ECARE PHARMACY AT PAWNEE COUNTY MEMORIAL HOSPITAL | $7,139 | ||||||
| PENNINGTON COUNTY HEALTH AND HUMAN SERVICES | |||||||||||||
| 321 KANSAS CITY STREET | RAPID CITY | SD | 57701 | N/A | GOV | PENNINGTON COUNTY CRISIS STABILIZATION UNIT | $1,000,000 | ||||||
| PERKINS COUNTY HOSPITAL DISTRICT | |||||||||||||
| 900 LINCOLN AVE | GRANT | NE | 69140 | N/A | GOV | TELE-EMERGENCY SERVICES FOR PERKINS COUNTY HEALTH SERVICES | $36,761 | ||||||
| PHILANTHROPY NEW YORK INC | |||||||||||||
| 320 EAST 43RD STREET | NEW YORK | NY | 10017 | N/A | PC | GENERAL OPERATING SUPPORT | $39,250 | ||||||
| PHILLIPS COUNTY HOSPITAL ASSOCIATION | |||||||||||||
| 311 S 8TH AVENUE EAST | MALTA | MT | 59538 | N/A | PC | TELE-EMERGENCY AND TELE-PHARMACY AT PHILLIPS COUNTY | $64,193 | ||||||
| PIONEER MEDICAL CENTER | |||||||||||||
| 301 WEST 7TH AVE | BIG TIMBER | MT | 59011 | N/A | PC | TELE-PHARMACY AT PIONEER MEDICAL CENTER | $24,968 | ||||||
| PLATTE VALLEY HEALTHCARE PROJECT | |||||||||||||
| 1300 W MAIN ST | SARATOGA | WY | 82331 | N/A | PC | NORTH PLATTE VALLEY MEDICAL CENTER ULTRASOUND PROJECT | $64,362 | ||||||
| PORT CHESTER CARVER CENTER INC | |||||||||||||
| 400 WESTCHESTER AVE | PORT CHESTER | NY | 10573 | N/A | PC | GENERAL OPERATING SUPPORT | $5,000 | ||||||
| POWELL VALLEY HEALTH CARE INC | |||||||||||||
| 777 AVE H | POWELL | WY | 82435 | N/A | PC | WYOMING ULTRASOUND REVITALIZATION PROJECT | $349,300 | ||||||
| PRESIDENT AND FELLOWS OF HARVARD COLLEGE | |||||||||||||
| 1033 MASSACHUSETTS AVENUE | CAMBRIDGE | MA | 021385366 | N/A | PC | PRE-SYMPTOMATIC AUTOANTIBODY AND VIRAL PROFILE OF US MILITARY PERSONNEL WITH ADULT-ONSET TYPE 1 DIABETES | $146,368 | ||||||
| PROJECT CONCERN ZAMBIA LIMITED | |||||||||||||
| N/A | PC | EMPOWERED CHILDREN AND ADOLESCENTS PROGRAM PLUS | $975,702 | PLOT 37/1P | LUSAKA | ZA | |||||||
| PULITZER CENTER ON CRISIS REPORTING | |||||||||||||
| 1779 MASSACHUSETTS AVE NW | WASHINGTON | DC | 20036 | N/A | PC | BUILDING RESILIENCE THROUGH JOURNALISM AND EDUCATION | $310,123 | ||||||
| RAMBAM HEALTH CORPORATION | |||||||||||||
| N/A | PC | MICROBIAL AND DIETARY EFFECTS ON IMMUNE COMPOSITION AND FUNCTION IN PATIENTS WITH CROHN'S | $1,186,800 | HAALIA HASNIA 8 | HAIFA | IS | |||||||
| REACHANOTHER FOUNDATION | |||||||||||||
| 1900 NE 3RD ST STE 106-307 | BEND | OR | 97701 | N/A | PC | EXPANDING PEDIATRIC NEUROSURGERY CAPACITY IN ETHIOPIA | $2,667,559 | ||||||
| REGENTS OF THE UNIVERSITY OF MICHIGAN | |||||||||||||
| 3003 SOUTH STATE STREET | ANN ARBOR | MI | 48109 | N/A | PC | HEALTH ECONOMIC ANALYSIS OF AUTOMATED INSULIN DELIVERY SYSTEMS | $403,877 | ||||||
| REGENTS OF THE UNIVERSITY OF MICHIGAN | |||||||||||||
| 3003 SOUTH STATE STREET | ANN ARBOR | MI | 48109 | N/A | PC | A SYSTEM BIOLOGY APPROACH TO UNDERSTANDING PERSISTENT SYMPTOMS IN QUIESCENT CROHNS DISEASE | $142,264 | ||||||
| REGENTS OF THE UNIVERSITY OF MICHIGAN | |||||||||||||
| 3003 SOUTH STATE STREET | ANN ARBOR | MI | 48109 | N/A | PC | EVALUATION OF A GUT-SPECIFIC ANTIFIBROTIC THERAPEUTIC IN PRE-CLINICAL MODELS OF CROHNS DISEASE | $187,370 | ||||||
| REGENTS OF THE UNIVERSITY OF MICHIGAN | |||||||||||||
| 3003 SOUTH STATE STREET | ANN ARBOR | MI | 48109 | N/A | PC | USING NATURAL LANGUAGE PROCESSING OF CLINICAL DOCUMENTATION TO IMPROVE PERSONALIZATION OF CARE IN CROHN'S DISEASE | $369,880 | ||||||
| REGENTS OF THE UNIVERSITY OF MINNESOTA | |||||||||||||
| 401 EAST RIVER ROAD | MINNEAPOLIS | MN | 554552070 | N/A | GOV | MINNESOTA FIRST RESPONDER AED PROJECT | $4,885,390 | ||||||
| REGENTS OF THE UNIVERSITY OF MINNESOTA | |||||||||||||
| 401 EAST RIVER ROAD | MINNEAPOLIS | MN | 554552070 | N/A | GOV | THERAPEUTIC USE OF PEPTIDE:MHC MABS FOR T1D | $272,555 | ||||||
| REGENTS OF THE UNIVERSITY OF MINNESOTA | |||||||||||||
| 401 EAST RIVER ROAD | MINNEAPOLIS | MN | 554552070 | N/A | GOV | PRECLINICAL DEVELOPMENT OF A MONOCLONAL ANTIBODY TO SERPINB13 | $308,267 | ||||||
| REGENTS OF THE UNIVERSITY OF MINNESOTA | |||||||||||||
| 401 EAST RIVER ROAD | MINNEAPOLIS | MN | 554552070 | N/A | GOV | STANDARDIZED MICROBIOTA TRANSPLANT THERAPY IN CROHNS DISEASE. PILOT TRIAL. | $988,042 | ||||||
| REGENTS OF THE UNIVERSITY OF MINNESOTA | |||||||||||||
| 401 EAST RIVER ROAD | MINNEAPOLIS | MN | 554552070 | N/A | GOV | DEVELOPING OXYGEN SUPER-SATURATED SALINE FOR DEPLOYMENT IN MEDICAL EMERGENCIES | $190,677 | ||||||
| REGENTS OF THE UNIVERSITY OF MINNESOTA | |||||||||||||
| 401 EAST RIVER ROAD | MINNEAPOLIS | MN | 554552070 | N/A | GOV | ENGINEERING ANTIGEN-SPECIFIC REGULATORY T CELLS FOR USE IN TYPE 1 DIABETES (PHASE 3) | $502,750 | ||||||
| REGENTS OF UNIVERSITY OF CALIFORNIA BERKELEY | |||||||||||||
| 190 DOE | BERKELEY | CA | 94720 | N/A | PC | DEVELOPING MICROBIOME EDITING TOOLS TO ADVANCE UNDERSTANDING OF THE MICROBIAL INFLUENCE ON CROHN'S DISEASE | $1,225,929 | ||||||
| RENOWN HEALTH FOUNDATION | |||||||||||||
| 1155 MILL ST | RENO | NV | 89502 | N/A | PC | RENOWN HEALTH TO BRING EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) TO NORTHERN NEVADA | $2,211,453 | ||||||
| RIVER'S EDGE HOSPITAL AND CLINIC | |||||||||||||
| 1900 N SUNRISE DRIVE | ST PETER | MN | 56082 | N/A | GOV | TELE-EMERGENCY SERVICES FOR RIVER'S EDGE HOSPITAL | $43,913 | ||||||
| ROUNDABOUT THEATRE COMPANY INC | |||||||||||||
| 231 W 39TH STREET 1200 | NEW YORK | NY | 10018 | N/A | PC | GENERAL OPERATING SUPPORT | $5,000 | ||||||
| SAFE WATER NETWORK | |||||||||||||
| 122 EAST 42ND STREET | NEW YORK | NY | 10168 | N/A | PC | SCALING AFFORDABLE SAFELY MANAGED WATER SUPPLY | $1,552,050 | ||||||
| SAGE BIONETWORKS | |||||||||||||
| 2901 THIRD AVE | SEATTLE | WA | 981213014 | N/A | PC | EXTENSION OF VEOIBD DATA COORDINATION TO ACCELERATE DISCOVERY OF PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES | $73,424 | ||||||
| SAINT LOUIS UNIVERSITY | |||||||||||||
| 221 NORTH GRAND BOULEVARD | SAINT LOUIS | MO | 63103 | N/A | PC | IDENTIFY AND VALIDATE POTENTIAL THERAPEUTIC TARGETS TO PREVENT HYPOGLYCEMIA IN TYPE 1 DIABETES | $608,000 | ||||||
| SAVE A LAB RESCUE | |||||||||||||
| 165 ELLERY AVE | MIDDLETOWN | RI | 02842 | N/A | PC | GENERAL OPERATING SUPPORT | $5,000 | ||||||
| SCHWARTZREISMAN SCIENCE EDUCATION CENTER REHOVOT (RA) | |||||||||||||
| N/A | PC | THE HELMSLEY CAMPUS FOR SCIENCE EDUCATION IN NETIVOT | $1,500,000 | HERZL ST 234 | REHOVOT | IS | |||||||
| SCHWARTZREISMAN SCIENCE EDUCATION CENTER REHOVOT (RA) | |||||||||||||
| N/A | PC | THE HELMSLEY CAMPUS FOR SCIENCE EDUCATION IN NETIVOT | $1,982,305 | HERZL ST 234 | REHOVOT | IS | |||||||
| SEATTLE CHILDREN'S HOSPITAL | |||||||||||||
| PO BOX 5731 M/S S-200 | SEATTLE | WA | 981455005 | N/A | PC | EXPANDING USE OF ENGINEERED TREGS IN T1D THERAPY (PHASE 4) | $602,243 | ||||||
| SHAARE ZEDEK MEDICAL CENTER | |||||||||||||
| N/A | PC | DEVELOPMENT OF THE HELMSLEY SURGICAL WING | $5,000,000 | 12 SHMUEL BAIT STREET | JERUSALEM | IS | |||||||
| SHAARE ZEDEK MEDICAL CENTER | |||||||||||||
| N/A | PC | LINEAR ACCELERATORS FOR THE RADIOTHERAPY INSTITUTE | $5,200,000 | 12 SHMUEL BAIT STREET | JERUSALEM | IS | |||||||
| SHAARE ZEDEK MEDICAL CENTER | |||||||||||||
| N/A | PC | PREVENTION OF INFLAMMATORY BOWEL DISEASES IN PERSONS AT RISK: THE PIONIR TRIAL (PREVENTING IBD ONSET IN INDIVIDUALS AT RISK) | $174,719 | 12 SHMUEL BAIT STREET | JERUSALEM | IS | |||||||
| SHAARE ZEDEK MEDICAL CENTER | |||||||||||||
| N/A | PC | ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: COMBINING MULTI-TIER ADMINISTRATIVE DATA FOR FACILITATING DISEASE FREE MANAGEMENT | $934,083 | 12 SHMUEL BAIT STREET | JERUSALEM | IS | |||||||
| SHALVA - ISRAEL ASSOC TO RELIEVE THE HANDICAPPED CHILD AND FAMILY | |||||||||||||
| N/A | PC | EQUIPMENT AND INFRASTRUCTURE FOR NATIONAL CRISIS CENTER | $100,000 | 1 SHALVA ROAD | JERUSALEM | IS | |||||||
| SHARE TRUST INC | |||||||||||||
| 310 DEDHAM ST | DOVER | MA | 02030 | N/A | PC | BUILDING COMMUNITY DRIVEN COLLECTIVE ACTION | $1,114,361 | ||||||
| SHERIDAN COUNTY MEMORIAL HOSPITAL FOUNDATION | |||||||||||||
| 1401 WEST 5TH ST | SHERIDAN | WY | 82801 | N/A | PC | WYOMING ULTRASOUND REVITALIZATION PROJECT | $675,676 | ||||||
| SHERIDAN COUNTY MEMORIAL HOSPITAL FOUNDATION | |||||||||||||
| 1401 WEST 5TH ST | SHERIDAN | WY | 82801 | N/A | PC | SHERIDAN MEMORIAL HOSPITAL EMPATH AND CRISIS STABILIZATION UNIT | $2,500,000 | ||||||
| SIGHTSAVERS INC | |||||||||||||
| 1 BOSTON PLACE | BOSTON | MA | 02108 | N/A | PC | TRACHOMA ELIMINATION IN ZAMBIA | $2,193,748 | ||||||
| SIMULATION IN MOTION MONTANA INC | |||||||||||||
| C/O MONTANA MEDICAL ASSOCIATION | HELENA | MT | 59601 | N/A | PC | SIM-MT BUSINESS DEVELOPMENT AND SUSTAINABILITY | $400,000 | ||||||
| SIMULATION IN MOTION MONTANA INC | |||||||||||||
| C/O MONTANA MEDICAL ASSOCIATION | HELENA | MT | 59601 | N/A | PC | SIM-MT BUSINESS DEVELOPMENT AND SUSTAINABILITY | $100,000 | ||||||
| SNV NETHERLANDS DEVELOPMENT ORGANISATION | |||||||||||||
| N/A | PC | HEALTHY FUTURE FOR ALL (HF4A) IMPROVING WATER, SANITATION, HYGIENE AND NUTRITION | $962,857 | PARKSTRAAT 83 | DEN HAAG | NL | |||||||
| SOCIAL SCIENCE RESEARCH COUNCIL | |||||||||||||
| ONE PIERREPONT PLAZA 15TH FLOOR | BROOKLYN | NY | 11201 | N/A | PC | DATA2GO.NYC REVAMP AND DATA CLINIC | $261,421 | ||||||
| SOCIETY FOR THE PRESERVATION OF NEW ENGLAND ANTIQUITIES | |||||||||||||
| 151 ESSEX STREET | HAVERHILL | MA | 01832 | N/A | PC | GENERAL OPERATING SUPPORT | $35,000 | ||||||
| SOLIDARIDAD NETWORK FOUNDATION LIMITED | |||||||||||||
| N/A | PC | HOOVES FOR SUSTAINABILITY (H4S) | $795,998 | 163 KUDU ROAD | LUSAKA | ZA | |||||||
| SOUTH BIG HORN COUNTY HOSPITAL DISTRICT | |||||||||||||
| 388 US HWY 20 SOUTH | BASIN | WY | 82410 | N/A | GOV | THREE RIVERS HEALTH ULTRASOUND PROJECT | $199,845 | ||||||
| SOUTH LINCOLN HOSPITAL DISTRICT | |||||||||||||
| 711 ONYX ST | KEMMERER | WY | 83101 | N/A | GOV | WYOMING ULTRASOUND REVITALIZATION PROJECT | $291,933 | ||||||
| SOUTH LINCOLN HOSPITAL DISTRICT | |||||||||||||
| 711 ONYX ST | KEMMERER | WY | 83101 | N/A | GOV | TELE-EMERGENCY AT SOUTH LINCOLN MEDICAL CENTER | $26,976 | ||||||
| SOUTHCENTRAL FOUNDATION | |||||||||||||
| 4501 DIPLOMACY DR | ANCHORAGE | AL | 99508 | N/A | PC | FWWI NU'IJU TRANSFORMATIONAL LIVING COMMUNITY PROGRAM | $903,283 | ||||||
| SPLASH INTERNATIONAL | |||||||||||||
| 7511 GREENWOOD AVE NORTH | SEATTLE | WA | 98103 | N/A | PC | WASH IN SCHOOLS FOR EVERYONE | $597,840 | ||||||
| ST LUKE HEALTH CARE FOUNDATION | |||||||||||||
| 28W609 HICKORY LN | WEST CHICAGO | IL | 60185 | N/A | PC | HOPE CENTER FOR WOMEN AND CHILDREN | $3,026,254 | ||||||
| ST JOHN'S HOSPITAL FOUNDATION | |||||||||||||
| 555 E BROADWAY | JACKSON | MS | 83001 | N/A | PC | WYOMING ULTRASOUND REVITALIZATION PROJECT | $273,054 | ||||||
| ST PETER'S HEALTH FOUNDATION | |||||||||||||
| 2475 BROADWAY STREET | HELENA | MT | 59601 | N/A | PC | TRANSCRANIAL MAGNETIC STIMULATION (TMS) SUITE | $288,057 | ||||||
| ST ROSE DOMINICAN HEALTH FOUNDATION | |||||||||||||
| 102 E LAKE MEAD PARKWAY | HENDERSON | NV | 89015 | N/A | SOI | DIGNITY HEALTH - ST. ROSE DOMINICAN - SIENA CAMPUS ECMO PROGRAM | $4,925,243 | ||||||
| ST ROSE DOMINICAN HEALTH FOUNDATION | |||||||||||||
| 102 E LAKE MEAD PARKWAY | HENDERSON | NV | 89015 | N/A | SOI | DIGNITY HEALTH-ST. ROSE DOMINICAN - SIENA CAMPUS CATH LAB REVITALIZATION PROJECT | $1,443,217 | ||||||
| STAR VALLEY MEDICAL CENTER CHARITABLE FOUNDATION | |||||||||||||
| 901 ADAMS | AFTON | WY | 83110 | N/A | PC | STAR VALLEY HEALTH ULTRASOUND PROJECT | $320,890 | ||||||
| STATE OF NEVADA DEPARTMENT OF DIVISION OF STATE PARKS | |||||||||||||
| 901 S STEWART ST SUITE 5005 | CARSON CITY | NV | 89701 | N/A | GOV | VALLEY OF FIRE VISITOR CENTER | $3,500,000 | ||||||
| STATE OF NEVADA DEPARTMENT OF DIVISION OF STATE PARKS | |||||||||||||
| 901 S STEWART ST SUITE 5005 | CARSON CITY | NV | 89701 | N/A | GOV | ICE AGE FOSSIL STATE PARK TRAILS AND OUTDOOR AMENITIES | $3,500,000 | ||||||
| STICHTING ACCESS TO MEDICINE FOUNDATION | |||||||||||||
| N/A | PC | EXPANDING ACCESS TO T1D CARE | $875,000 | NARITAWEG 227 SUITE A | AMSTERDAM | NL | |||||||
| STICHTING HEALTH ACTION INTERNATIONAL | |||||||||||||
| N/A | PC | ADDRESSING THE CHALLENGE AND CONSTRAINTS OF INSULIN SOURCES AND SUPPLY (ACCISS) STUDY PHASE III | $1,245,075 | OVERTOOM 60/II | AMSTERDAM | NL | |||||||
| STICHTING PHARMACCESS INTERNATIONAL | |||||||||||||
| N/A | PC | SAFECARE: A BUSINESS MODEL FOR HEALTHCARE QUALITY | $774,350 | AHTC TOWER C4 PAASHEUVELWEG 25 | AMSTERDAM | NL | |||||||
| STICHTING THE OCEAN CLEANUP | |||||||||||||
| N/A | PC | DEVELOP AND SCALE TECHNOLOGIES TO RID THE OCEANS OF PLASTICS | $5,000,000 | BATAVIERENSTRAAT 15 | ROTTERDAM | NL | |||||||
| SUBLETTE COUNTY HEALTH FOUNDATION | |||||||||||||
| PO BOX 627 | PINEDALE | WY | 82941 | N/A | SOI | SUBLETTE COUNTY HOSPITAL DISTRICT RADIOLOGY EQUIPMENT PROJECT | $1,017,308 | ||||||
| SUPPORTIVE HOUSING NETWORK OF NEW YORK INC | |||||||||||||
| 247 W 37TH ST | NEW YORK CITY | NY | 10018 | N/A | PC | TRAINING ACADEMY AND COMMUNITY OF PRACTICE FOR SUPPORTIVE HOUSING PROVIDERS | $300,000 | ||||||
| T1D EXCHANGE INC | |||||||||||||
| 101 FEDERAL STREET SUITE 440 | BOSTON | MA | 02110 | N/A | PC | DRIVING EQUITABLE HEALTH AND PSYCHOSOCIAL OUTCOMES FOR INDIVIDUALS LIVING WITH TD THROUGH THE T1D EXCH. QUALITY IMPROVEMENT COLLAB. AND REGISTRY | $650,000 | ||||||
| T1D EXCHANGE INC | |||||||||||||
| 101 FEDERAL STREET SUITE 440 | BOSTON | MA | 02110 | N/A | PC | DRIVING EQUITABLE HEALTH AND PSYCHOSOCIAL OUTCOMES FOR INDIVIDUALS LIVING WITH TD THROUGH THE T1D EXCH. QUALITY IMPROVEMENT COLLAB. AND REGISTRY | $2,567,417 | ||||||
| T1D EXCHANGE INC | |||||||||||||
| 101 FEDERAL STREET SUITE 440 | BOSTON | MA | 02110 | N/A | PC | DRIVING EQUITABLE HEALTH AND PSYCHOSOCIAL OUTCOMES FOR INDIVIDUALS LIVING WITH TD THROUGH THE T1D EXCH. QUALITY IMPROVEMENT COLLAB. AND REGISTRY | $1,920,614 | ||||||
| T1D EXCHANGE INC | |||||||||||||
| 101 FEDERAL STREET SUITE 440 | BOSTON | MA | 02110 | N/A | PC | DRIVING EQUITABLE HEALTH AND PSYCHOSOCIAL OUTCOMES FOR INDIVIDUALS LIVING WITH TD THROUGH THE T1D EXCHANGE QUALITY IMPROVEMENT COLLAB. AND REGISTRY | $1,283,708 | ||||||
| TECHNISCHE UNIVERSITAET MUENCHEN | |||||||||||||
| N/A | GOV | COST-EFFECTIVENESS OF PUBLIC HEALTH SCREENING FOR PRE-SYMPTOMATIC TYPE 1 DIABETES WITH AND WITHOUT TREATMENT FOR PREVENTION OF TYPE 1 DIABETES | $127,031 | ARCISSTRABE 21 | MUNCHEN | GM | |||||||
| TECHNISCHE UNIVERSITAT DRESDEN | |||||||||||||
| N/A | GOV | FR1DA IN SACHSEN | $60,079 | HELMHOLTZSTR 10 | DRESDEN | GM | |||||||
| TECHNISCHE UNIVERSITAT DRESDEN | |||||||||||||
| N/A | GOV | GENOMIC INFLUENCE OF MATERNAL TYPE 1 DIABETES - UNDERSTANDING PROTECTION AGAINST TYPE 1 DIABETES | $210,829 | HELMHOLTZSTR 10 | DRESDEN | GM | |||||||
| TEL AVIV SOURASKY MEDICAL CENTER - ICHILOV HOSPITAL | |||||||||||||
| N/A | GOV | IBD GENETICS RESEARCH ROLE OF PROTEASE-ACTIVATED RECEPTOR 2 (PAR2) IN INFLAMMATORY GASTROINTESTINAL DISORDERS | $346,330 | WEIZMAN 6 | TEL AVIV | IS | |||||||
| TEL-AVIV UNIVERSITY | |||||||||||||
| N/A | PC | HELMSLEY MEDICAL SIMULATION CENTER | $3,000,000 | TEL AVIV UNIVERSITY | TEL AVIV | IS | |||||||
| THE ACADEMIC COLLEGE AT TEL-HAI | |||||||||||||
| N/A | PC | THE HELMSLEY RESEARCH AND INNOVATION WING IN THE TEL-HAI COMPUTER SCIENCE BUILDING. | $900,000 | TEL-HAI COLLEGE | UPPER GALILEE | IS | |||||||
| THE ASPEN INSTITUTE INC | |||||||||||||
| 2300 N STREET | WASHINGTON | DC | 20037 | N/A | PC | BUILDING VISIONARY AND EFFECTIVE TEAMS TO ACCELERATE PROGRESS AGAINST TYPE 1 DIABETES (T1D) AND OTHER NON-COMMUNICABLE DISEASES (NCDS) | $998,081 | ||||||
| THE ASSOCIATION FOR THE RESIDENT AND COMMUNITY IN RAMAT HANEGEV | |||||||||||||
| N/A | PC | RAMAT HANEGEV SENIOR CITIZEN CENTER | $136,393 | 2012100 HALUTZ | RAMAT HANEGEV | IS | |||||||
| THE ASSOCIATION FOR THE RESIDENT AND COMMUNITY IN RAMAT HANEGEV | |||||||||||||
| N/A | PC | EMERGENCY PREPAREDNESS FOR COMMUNITIES IN THE RAMAT HANEGEV COUNCIL REGION OF SOUTHERN ISRAEL | $432,000 | 2012100 HALUTZ | RAMAT HANEGEV | IS | |||||||
| THE BANQUET | |||||||||||||
| 900 E 8TH ST | SIOUX FALLS | SD | 57103 | N/A | PC | GENERAL OPERATING SUPPORT | $25,000 | ||||||
| THE BINYAMIN FUND INC | |||||||||||||
| 445 CENTRAL AVENUE | CEDARHURST | NY | 11516 | N/A | PC | EMERGENCY PREPAREDNESS FOR COMMUNITIES IN BINYAMIN REGIONAL COUNCIL | $500,000 | ||||||
| THE BROAD INSTITUTE INC | |||||||||||||
| 415 MAIN STREET | CAMBRIDGE | MA | 02142 | N/A | PC | NOVEL THERAPEUTIC APPROACHES FOR CROHNS DISEASE | $1,500,000 | ||||||
| THE BROAD INSTITUTE INC | |||||||||||||
| 415 MAIN STREET | CAMBRIDGE | MA | 02142 | N/A | PC | NOVEL THERAPEUTIC APPROACHES FOR CROHNS DISEASE | $1,500,000 | ||||||
| THE CENTER FOR EFFECTIVE PHILANTHROPY INC | |||||||||||||
| 675 MASSACHUSETTS AVENUE | CAMBRIDGE | MA | 02139 | N/A | PC | GENERAL OPERATING SUPPORT | $49,800 | ||||||
| THE CHINESE UNIVERSITY OF HONG KONG | |||||||||||||
| N/A | PC | IBD GIVES-21: GLOBAL IBD VISUALIZATION OF EPIDEMIOLOGY STUDIES IN THE 21ST CENTURY | $249,337 | PI CHIU BUILDING | SHATIN | HK | |||||||
| THE CITY OF HOPE | |||||||||||||
| 1500 E DUARTE RD | DUARTE | CA | 91010 | N/A | PC | GENETIC PROTECTION BY HLA-DQ6 IN T1D | $116,445 | ||||||
| THE CITY OF HOPE | |||||||||||||
| 1500 E DUARTE RD | DUARTE | CA | 91010 | N/A | PC | CD318 MEDIATED REGULATION OF ISLET AUTOANTIGEN SPECIFIC T CELL IMMUNITY | $165,000 | ||||||
| THE CITY OF HOPE | |||||||||||||
| 1500 E DUARTE RD | DUARTE | CA | 91010 | N/A | PC | THE HELMSLEY CHARITABLE TRUST GEORGE S. EISENBARTH NPOD AWARD FOR TEAM SCIENCE | $400,000 | ||||||
| THE CLEVELAND CLINIC FOUNDATION | |||||||||||||
| 9500 EUCLID AVENUE | CLEVELAND | OH | 44195 | N/A | PC | ENDPOINT DEVELOPMENT FOR OSTOMY CLINICAL TRIALS (ENDO-TRIAL) CONSORTIUM | $1,031,896 | ||||||
| THE CLEVELAND CLINIC FOUNDATION | |||||||||||||
| 9500 EUCLID AVENUE | CLEVELAND | OH | 44195 | N/A | PC | MECHANOBIOLOGY OF THE INTESTINAL EPITHELIAL BARRIER DISRUPTION IN CROHNS DISEASE | $429,712 | ||||||
| THE CLEVELAND CLINIC FOUNDATION | |||||||||||||
| 9500 EUCLID AVENUE | CLEVELAND | OH | 44195 | N/A | PC | THE MILESTONE INITIATIVE: EDUCATION INNOVATION FOR ADVANCED IBD FELLOWS IN THE USA | $331,133 | ||||||
| THE CLEVELAND CLINIC FOUNDATION | |||||||||||||
| 9500 EUCLID AVENUE | CLEVELAND | OH | 44195 | N/A | PC | DEVELOPMENT OF A NEXT-GENERATION BIOMARKER TOOL TO ACCELERATE THE DEVELOPMENT OF EFFECTIVE ANTI-FIBROTIC THERAPIES | $1,355,310 | ||||||
| THE CLEVELAND CLINIC FOUNDATION | |||||||||||||
| 9500 EUCLID AVENUE | CLEVELAND | OH | 44195 | N/A | PC | DEVELOPMENT OF AN INTESTINAL ULTRASOUND INDEX AND A HISTOPATHOLOGY INDEX FOR STRICTURING SMALL BOWEL CROHNS DISEASE | $111,750 | ||||||
| THE DIATRIBE FOUNDATION | |||||||||||||
| 804 HAIGHT STREET | SAN FRANCISCO | CA | 94117 | N/A | PC | DIATRIBE LEARN MENTAL HEALTH SERIES | $100,285 | ||||||
| THE END FUND INC | |||||||||||||
| 2 PARK AVENUE 18TH FLOOR | NEW YORK | NY | 10016 | N/A | PC | REACHING THE LAST MILE FUND EXPANSION | $4,130,500 | ||||||
| THE GOVERNORS OF THE UNIVERSITY OF CALGARY | |||||||||||||
| N/A | PC | QUANTITATIVE PROTEOMIC PROFILING OF FIBROSTENOTIC CROHNS DISEASE PATIENTS | $247,654 | 2500 UNIVERSITY DRIVE NW | CALGARY | CA | |||||||
| THE GOVERNORS OF THE UNIVERSITY OF CALGARY | |||||||||||||
| N/A | PC | VISUALIZATION OF COVID-19 VACCINE SEROLOGY IN CROHNS DISEASE: A KNOWLEDGE TRANSLATION STRATEGY | $89,047 | 2500 UNIVERSITY DRIVE NW | CALGARY | CA | |||||||
| THE GOVERNORS OF THE UNIVERSITY OF CALGARY | |||||||||||||
| N/A | PC | INTERLEUKIN-4 ACTIVATED MACROPHAGES (M(IL4)) FOR PERSONALIZED CELLULAR IMMUNOTHERAPY TO TREAT IBD | $137,153 | 2500 UNIVERSITY DRIVE NW | CALGARY | CA | |||||||
| THE GOVERNORS OF THE UNIVERSITY OF CALGARY | |||||||||||||
| N/A | PC | INTERLEUKIN-4 ACTIVATED MACROPHAGES (M(IL4)) FOR PERSONALIZED CELLULAR IMMUNOTHERAPY TO TREAT IBD | $126,154 | 2500 UNIVERSITY DRIVE NW | CALGARY | CA | |||||||
| THE GOVERNORS OF THE UNIVERSITY OF CALGARY | |||||||||||||
| N/A | PC | THE CHANGING EPIDEMIOLOGY AND DEMOGRAPHICS OF CROHNS DISEASE IN THE WESTERN WORLD OVER THE NEXT DECADE | $121,036 | 2500 UNIVERSITY DRIVE NW | CALGARY | CA | |||||||
| THE GOVERNORS OF THE UNIVERSITY OF CALGARY | |||||||||||||
| N/A | PC | THE CHANGING EPIDEMIOLOGY AND DEMOGRAPHICS OF CROHNS DISEASE IN THE WESTERN WORLD OVER THE NEXT DECADE | $191,883 | 2500 UNIVERSITY DRIVE NW | CALGARY | CA | |||||||
| THE HEALTH & HOUSING CONSORTIUM INC | |||||||||||||
| STADIUM STATION | BRONX | NY | 10452 | N/A | PC | NYC HEALTH & HOUSING CONSORTIUM: STRATEGIZING FOR SUSTAINABILITY | $150,000 | ||||||
| THE HOLE IN THE WALL GANG FUND INC | |||||||||||||
| 555 LONG WHARF DRIVE | NEW HAVEN | CT | 06511 | N/A | PC | GENERAL OPERATING SUPPORT | $5,000 | ||||||
| THE HOPE CENTER | |||||||||||||
| 615 KANSAS CITY STREET | RAPID CITY | SD | 57701 | N/A | PC | GENERAL OPERATING SUPPORT | $25,000 | ||||||
| THE HOSPITAL FOR SICK CHILDREN | |||||||||||||
| N/A | PC | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES-TORONTO STUDIES | $548,276 | 555 UNIVERSITY AVE | TORONTO | CA | |||||||
| THE IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE | |||||||||||||
| N/A | PC | IMMUNOLOGICAL MECHANISMS UNDERLYING THE GENETIC BASIS FOR NATURAL T1D PROTECTION | $380,592 | EXHIBITION RD | LONDON | UK | |||||||
| THE JEWISH AGENCY FOR ISRAEL | |||||||||||||
| N/A | PC | THE JEWISH AGENCY SECURITY FUND (THE FUND) | $161,477 | 48 KING GEORGE STREET | JERUSALEM | IS | |||||||
| THE LANIADO KIRIAT SANZ HOSPITAL | |||||||||||||
| N/A | PC | NEW MATERNITY FLOOR C | $2,150,000 | DIVREI KHAYIM ST 16 | NATANIYA | IS | |||||||
| THE LEGATUM INSTITUTE FOUNDATION | |||||||||||||
| C/O GENEVA GLOBAL 1536 E LANCASTER | PAOLI | PA | 19301 | N/A | PC | TO CONCLUDE PHASE TWO OF THE PROJECT: THE PRODUCTION, DISSEMINATION AND PROMOTION OF THE UNITED STATES PROSPERITY INDEX | $71,831 | AVE | |||||
| THE MAX STERN ACADEMIC COLLEGE OF EMEK YEZREEL LTD (CC) | |||||||||||||
| N/A | PC | OPPORTUNITY FOR SUCCESS SCHOLARSHIPS FOR ETHIOPIAN-ISRAELIS PURSUING NURSING DEGREES | $220,000 | YEZREEL VALLEY | YEZREEL VALLEY | IS | |||||||
| THE MILKEN INSTITUTE | |||||||||||||
| 1250 FOURTH STREET | SANTA MONICA | CA | 90401 | N/A | PC | FASTERCURES LEADERSLINK PROGRAM EXPANSION | $250,000 | ||||||
| THE NATURE CONSERVANCY | |||||||||||||
| 4245 NORTH FAIRFAX DRIVE SUITE 100 | ARLINGTON | VA | 22203 | N/A | PC | FUTURE FOREST NYC PHASE III | $352,196 | ||||||
| THE RECTOR AND VISITORS OF THE UNIVERSITY OF VIRGINIA | |||||||||||||
| OFFICE OF SPONSORED PROGRAMS | CHARLOTTESVILLE | VA | 229044195 | N/A | PC | TYPE 1 DIABETES RISK PREDICTION: INTEGRATION OF PHYSIOLOGY WITH GENETICS | $206,088 | ||||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA AT IRVINE | |||||||||||||
| 120 THEORY SUITE 200 | IRVINE | CA | 926971050 | N/A | PC | DEVELOPMENT OF A MULTI-ANALYTE SENSOR - GLUCOSE, LACTATE, OXYGEN, KETONES, INSULIN FOR PEOPLE WITH T1D | $461,893 | ||||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES | |||||||||||||
| UCLA OFFICE OF CONTRACTS AND GRANTS | LOS ANGELES | CA | 900951406 | N/A | PC | GLUCOSE RESPONSIVE GLUCAGON (GRG) FOR THE REDUCTION OF HYPOGLYCEMIA FOR PEOPLE WITH T1D | $568,851 | ||||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO | |||||||||||||
| 9500 GILMAN DRIVE | LA JOLLA | CA | 92093 | N/A | PC | MECHANISM OF ACTION AND SAFETY STUDY OF LIVER TARGETED INSULIN | $545,759 | ||||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO | |||||||||||||
| 490 ILLINOIS STREET FOURTH FLOOR | SAN FRANCISCO | CA | 94143 | N/A | PC | PREGNANCY IN INFLAMMATORY BOWEL DISEASE AND NEONATAL OUTCOMES (PIANO) | $241,173 | ||||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO | |||||||||||||
| 490 ILLINOIS STREET FOURTH FLOOR | SAN FRANCISCO | CA | 94143 | N/A | PC | PREGNANCY IN INFLAMMATORY BOWEL DISEASE AND NEONATAL OUTCOMES (PIANO) | $241,173 | ||||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO | |||||||||||||
| 490 ILLINOIS STREET FOURTH FLOOR | SAN FRANCISCO | CA | 94143 | N/A | PC | IDENTIFICATION AND ANALYSIS OF EXTREME FORMS OF TYPE 1 DIABETES, ESTABLISHMENT OF A DATA COMMONS | $648,749 | ||||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SANTA BARBARA | |||||||||||||
| UC SANTA BARBARA | SANTA BARBARA | CA | 93106 | N/A | PC | EXERCISE SPECIFIC AID ALGORITHM FOR TYPE 1 DIABETES | $832,906 | ||||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | |||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | ASK THE EXPERTS | $575,810 | F428 | |||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | |||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | IMPACT OF MENSTRUATION ON GLYCEMIC RESPONSE AND EXERCISE | $413,258 | F428 | |||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | |||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | FAILED GENETIC PROTECTION: T1D IN THE PRESENCE OF DQB1*06:02 | $266,200 | F428 | |||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | |||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | IMPLEMENTATION OF EARLY STAGE T1D EDUCATION AND SUPPORT (ESTES) | $453,311 | F428 | |||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | |||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | CGM IN PRIMARY CARE - REFER OR LEARN: IMPLEMENTATION AND EVALUATION | $676,014 | F428 | |||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | |||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | EXPLORING THE GENOMIC MECHANISM BEHIND THE MATERNAL PROTECTION FROM T1D | $179,943 | F428 | |||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | |||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | T AND B CELL RECEPTOR ATLAS ACROSS TISSUES AND STAGES OF TYPE 1 DIABETES | $501,000 | F428 | |||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | |||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | MAPPING THE B CELL HETEROGENEITY IN TYPE 1 DIABETES AT THE SINGLE-CELL LEVEL | $300,000 | F428 | |||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | |||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | PREPARE 4 AID: PRIMARY CARE PRAGMATIC, REAL WORLD EXPERIENCE FOR AUTOMATED INSULIN DELIVERY | $1,441,282 | F428 | |||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | |||||||||||||
| UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | N/A | PC | DIABETIC KETOACIDOSIS TRENDS AND RESOURCE UTILIZATION AT DIAGNOSIS OF TYPE 1 DIABETES IN THE UNITED STATES | $157,700 | F428 | |||||
| THE SCRIPPS RESEARCH INSTITUTE | |||||||||||||
| 10550 NORTH TORREY PINES ROAD | LA JOLLA | CA | 92037 | N/A | PC | GUT-RETAINED NRF2/ARE ACTIVATORS FOR IBD | $2,265,175 | ||||||
| THE SCRIPPS RESEARCH INSTITUTE | |||||||||||||
| 10550 NORTH TORREY PINES ROAD | LA JOLLA | CA | 92037 | N/A | PC | TRANSLATION OF MICROBIOTA MECHANISMS ON NOD2 FOR CROHNS DISEASE THERAPIES | $494,231 | ||||||
| THE SDEROT DEVELOPMENT FOUNDATION | |||||||||||||
| N/A | PC | ESTABLISHING A WARM HOME COMPLEX FOR CHILDREN AT RISK IN SDEROT | $2,421,222 | 6 BAR LEV STREET | SDEROT | IS | |||||||
| THE SHEBA FUND FOR HEALTH SERVICES AND RESEARCH (RA) | |||||||||||||
| N/A | PC | EMERGENCY FUNDING FOR EQUIPMENT | $976,000 | TEL-HASHOMER | RAMAT GAN | IS | |||||||
| THE SHEBA FUND FOR HEALTH SERVICES AND RESEARCH (RA) | |||||||||||||
| N/A | PC | THE HELMSLEY CENTER FOR INNOVATIVE SURGICAL TRAINING | $4,395,700 | TEL-HASHOMER | RAMAT GAN | IS | |||||||
| THE SHEBA FUND FOR HEALTH SERVICES AND RESEARCH (RA) | |||||||||||||
| N/A | PC | ISRAEL IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: CAPSULE & OMICS FOR PREDICTING EXACERBATION OF CROHNS DISEASE (CORE-CD) | $704,764 | TEL-HASHOMER | RAMAT GAN | IS | |||||||
| THE SONIA NABETA FOUNDATION INC | |||||||||||||
| 4705 5TH STREET UNIT 405 | LONG ISLAND CITY | NY | 11101 | N/A | PC | PROJECT BODA-BODA | $184,889 | ||||||
| THE TEL AVIV JAFFA ACADEMIC COLLEGE | |||||||||||||
| N/A | PC | NEED-BASED SCHOLARSHIPS FOR NURSING STUDENTS | $266,667 | RABENU YERUHAM ST 2 POB 8401 | TEL AVIV YAFFO | IS | |||||||
| THE TEL AVIV JAFFA ACADEMIC COLLEGE | |||||||||||||
| N/A | PC | SCHOLARSHIP SUPPORT FOR ULTRA-ORTHODOX (HAREDI) MEN PURSUING B.S. DEGREES IN NURSING | $253,818 | RABENU YERUHAM ST 2 POB 8401 | TEL AVIV YAFFO | IS | |||||||
| THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | |||||||||||||
| 615 WEST 131ST STREET | NEW YORK | NY | 100273922 | N/A | PC | COMBINATORIAL PERTURBATION OF CELLULAR NETWORK IN CROHNS DISEASE | $334,798 | ||||||
| THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | |||||||||||||
| 615 WEST 131ST STREET | NEW YORK | NY | 100273922 | N/A | PC | COMBINATORIAL PERTURBATION OF CELLULAR NETWORK IN CROHNS DISEASE | $351,258 | ||||||
| THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | |||||||||||||
| 615 WEST 131ST STREET | NEW YORK | NY | 100273922 | N/A | PC | ADDING HEALTH QUESTIONS TO THE POVERTY TRACKER TO SURVEY THEHEALTHCARE NEEDS AND UTILIZATION PREFERENCES OF LOW-INCOMENEW YORKERS | $143,021 | ||||||
| THE UNIVERSITY OF ADELAIDE | |||||||||||||
| N/A | PC | ENDIA EXPANDED SUPPORT | $163,010 | THE UNIVERSITY OF ADELAIDE | ADELAIDE | AS | |||||||
| THE UNIVERSITY OF ADELAIDE | |||||||||||||
| N/A | PC | ENDIA SCIENCE CONTINUATION | $181,471 | THE UNIVERSITY OF ADELAIDE | ADELAIDE | AS | |||||||
| THE UNIVERSITY OF ADELAIDE | |||||||||||||
| N/A | PC | PANCREATIC EXOCRINE FUNCTION AND THE PROGRESSION TO TYPE 1 DIABETES IN YOUNG CHILDREN | $217,136 | THE UNIVERSITY OF ADELAIDE | ADELAIDE | AS | |||||||
| THE UNIVERSITY OF CHICAGO | |||||||||||||
| 5801 SOUTH ELLIS AVENUE | CHICAGO | IL | 60637 | N/A | PC | IMMUNO-PHARMACOGENOMICS TO UNDERSTAND AND PREDICT RESPONSE TO BIOLOGICS IN CROHN'S DISEASE | $106,296 | ||||||
| THE UNIVERSITY OF CHICAGO | |||||||||||||
| 5801 SOUTH ELLIS AVENUE | CHICAGO | IL | 60637 | N/A | PC | IMMUNO-PHARMACOGENOMICS TO UNDERSTAND AND PREDICT RESPONSE TO BIOLOGICS IN CROHN'S DISEASE | $106,296 | ||||||
| THE UNIVERSITY OF CHICAGO | |||||||||||||
| 5801 SOUTH ELLIS AVENUE | CHICAGO | IL | 60637 | N/A | PC | DEVELOPMENT AND DISSEMINATION OF AN IBD MONITORING AND PREVENTION PROGRAM WITH A FOCUS ON INTESTINAL ULTRASOUND | $784,751 | ||||||
| THE UNIVERSITY OF EDINBURGH | |||||||||||||
| N/A | PC | HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHN'S DISEASE | $212,881 | BHF CENTRE FOR CARDIOVASCULAR | EDINBURGH | UK | SCIENCES | ||||||
| THE UNIVERSITY OF EDINBURGH | |||||||||||||
| N/A | PC | HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHN'S DISEASE | $444,246 | BHF CENTRE FOR CARDIOVASCULAR | EDINBURGH | UK | SCIENCES | ||||||
| THE UNIVERSITY OF EDINBURGH | |||||||||||||
| N/A | PC | UNDERSTANDING ALPHA CELL DYSFUNCTION AND CORRECTING GLUCAGON SECRETION IN TYPE 1 DIABETES. | $159,623 | BHF CENTRE FOR CARDIOVASCULAR | EDINBURGH | UK | SCIENCES | ||||||
| THE UNIVERSITY OF EDINBURGH | |||||||||||||
| N/A | PC | UNDERSTANDING ALPHA CELL DYSFUNCTION AND CORRECTING GLUCAGON SECRETION IN TYPE 1 DIABETES. | $179,714 | BHF CENTRE FOR CARDIOVASCULAR | EDINBURGH | UK | SCIENCES | ||||||
| THE UNIVERSITY OF EDINBURGH | |||||||||||||
| N/A | PC | MITOCHONDRIAL DAMPS AS MECHANISTIC BIOMARKERS OF MUCOSAL INFLAMMATION IN CROHNS DISEASE (MUSIC) | $172,204 | BHF CENTRE FOR CARDIOVASCULAR | EDINBURGH | UK | SCIENCES | ||||||
| THE UNIVERSITY OF MANCHESTER | |||||||||||||
| N/A | PC | A MAP OF THE INTESTINE FOLLOWING REGULATORY T CELL INFUSION INTO PATIENTS WITH ACTIVE CROHNS DISEASE AT SINGLE-CELL AND SPATIAL RESOLUTION | $1,113,915 | OXFORD RD | MANCHESTER | UK | |||||||
| THE UNIVERSITY OF QUEENSLAND | |||||||||||||
| N/A | NC | LIPOSOMAL ANTIGEN-SPECIFIC IMMUNOTHERAPY OF RECENT-ONSET TYPE 1 DIABETES | $1,261,871 | CUMBRAE STEWART BUILDING 72 | BRISBANE | AS | |||||||
| THE UNIVERSITY OF QUEENSLAND | |||||||||||||
| N/A | NC | GUT MICROBIAL METABOLITES DURING EARLY-LIFE DEVELOPMENT AS PREDICTORS OF ISLET AUTOIMMUNITY | $156,746 | CUMBRAE STEWART BUILDING 72 | BRISBANE | AS | |||||||
| THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | |||||||||||||
| 5323 HARRY HINES BOULEVARD | DALLAS | TX | 753909020 | N/A | GOV | IMMUNE CHECKPOINT ENGINEERED BETA CELL AS AN ANTIGEN-SPECIFIC IMMUNOTHERAPY FOR THE TREATMENT OF TYPE I DIABETES | $275,000 | ||||||
| THE UNIVERSITY OF WESTERN AUSTRALIA | |||||||||||||
| N/A | PC | CGM ASSESSMENTS OF ENDIA CHILDREN | $58,241 | 35 STIRLING HIGHWAY | CRAWLEY | AS | |||||||
| THE WEIZMANN INSTITUTE OF SCIENCE | |||||||||||||
| N/A | PC | THE QUANTUM MATERIALS DEVICES FABRICATION LAB | $1,750,000 | 234 HERZEL ST | REHOVOT | IS | |||||||
| THE WEIZMANN INSTITUTE OF SCIENCE | |||||||||||||
| N/A | PC | EARLY CHILDHOOD DEVELOPMENT AND COMMUNITY CENTER AT THE WEIZMANN INSTITUTE OF SCIENCE | $3,000,000 | 234 HERZEL ST | REHOVOT | IS | |||||||
| THE WEIZMANN INSTITUTE OF SCIENCE | |||||||||||||
| N/A | PC | DECODING THE CLINICAL IMPACT OF HOST AND MICROBIAL INTESTINAL PROTEOMIC LANDSCAPE IN CROHNS DISEASE | $961,620 | 234 HERZEL ST | REHOVOT | IS | |||||||
| THE WEIZMANN INSTITUTE OF SCIENCE | |||||||||||||
| N/A | PC | DECODING PERSONALIZED NUTRITIONAL, MICROBIOME AND HOST PATTERNS IMPACTING CLINICAL AND PROGNOSTIC FEATURES IN CROHNS DISEASE | $947,483 | 234 HERZEL ST | REHOVOT | IS | |||||||
| TOWNSEND HEALTH SYSTEMS INC | |||||||||||||
| 110 NORTH OAK | TOWNSEND | MT | 59644 | N/A | PC | TELE-PHARMACY AT BILLINGS CLINIC BROADWATER | $15,112 | ||||||
| TRICKLE UP PROGRAM INC | |||||||||||||
| 104 WEST 27TH STREET 12TH FLOOR | NEW YORK | NY | 10001 | N/A | PC | GENERAL OPERATING SUPPORT | $25,000 | ||||||
| TROPICAL GASTROENTEROLOGY AND NUTRITION LIMITED | |||||||||||||
| N/A | PC | 1ST CONVENING OF THE IBD AFRICA GENETICS CONSORTIUM | $29,471 | 26 COPPER ROAD | LUSAKA | ZA | |||||||
| TRUSTEES AND FRIENDS OF AGRICULTURAL RESEARCH AT THE VOLCANI CENTER | |||||||||||||
| N/A | PC | PROTECTING FARMERS AND AGRICULTURAL WORKERS ACROSS THE WESTERN NEGEV | $1,000,000 | HA MACABIM 68 PO BOX 15159 | RISHON LEZION | IS | |||||||
| TRUSTEES OF INDIANA UNIVERSITY | |||||||||||||
| 509 EAST 3RD STREET | BLOOMINGTON | IN | 474013654 | N/A | GOV | MOLECULAR DESIGN AND TESTING OF GLUCOSE-RESPONSIVE THERAPIES | $1,128,685 | ||||||
| TRUSTEES OF INDIANA UNIVERSITY | |||||||||||||
| 509 EAST 3RD STREET | BLOOMINGTON | IN | 474013654 | N/A | GOV | COLLABORATIVE EFFORT TO VALIDATE MICRORNA AS BIOMARKERS OF T1D | $426,380 | ||||||
| TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | |||||||||||||
| OFFICE OF RESEARCH SERVICES | PHILADELPHIA | PA | 191046205 | N/A | PC | ENGINEERING CAR REGULATORY T CELLS TO PROVIDE DURABLE TOLERANCE TO ALLOGENIC ISLET TRANSPLANTS | $407,000 | ||||||
| TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | |||||||||||||
| OFFICE OF RESEARCH SERVICES | PHILADELPHIA | PA | 191046205 | N/A | PC | THE ULTRA PROCESSED WESTERN DIET, THE GUT MICROBIOME, AND DIETARY XENOBIOTIC EXPOSURE IN CROHNS DISEASE | $293,370 | ||||||
| TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | |||||||||||||
| OFFICE OF RESEARCH SERVICES | PHILADELPHIA | PA | 191046205 | N/A | PC | THE ULTRA PROCESSED WESTERN DIET, THE GUT MICROBIOME, AND DIETARY XENOBIOTIC EXPOSURE IN CROHNS DISEASE | $285,079 | ||||||
| TZAFON MEDICAL CENTER | |||||||||||||
| N/A | GOV | VASCULAR ANGIOGRAPHY INSTITUTE | $752,574 | THE BARUCH PADEH MEDICAL CENTER | TIBERIAS | IS | PORIYA | ||||||
| TZAFON MEDICAL CENTER | |||||||||||||
| N/A | GOV | THE HELMSLEY REHABILITATION CENTER OF THE NORTH | $5,431,730 | THE BARUCH PADEH MEDICAL CENTER | TIBERIAS | IS | PORIYA | ||||||
| UNITED JEWISH APPEAL FEDERATION | |||||||||||||
| 130 EAST 59TH STREET | NEW YORK | NY | 10022 | N/A | PC | GENERAL OPERATING SUPPORT | $5,000 | ||||||
| UNITED JEWISH APPEAL FEDERATION | |||||||||||||
| 130 EAST 59TH STREET | NEW YORK | NY | 10022 | N/A | PC | GENERAL OPERATING SUPPORT | $5,000 | ||||||
| UNITED NATIONS DEVELOPMENT PROGRAMME | |||||||||||||
| 1 UNITED NATIONS PLAZA | NEW YORK | NY | 10017 | N/A | PC | INCREASING ACCESS TO HEALTHCARE FOR PEOPLE LIVING WITH DIABETES AND OTHER NCDS | $339,777 | ||||||
| UNITED STATES AFRICAN DEVELOPMENT FOUNDATION | |||||||||||||
| 1400 I STREET NW | WASHINGTON | DC | 20005 | N/A | GOV | LIVELIHOOD IMPROVEMENT PROGRAM | $1,283,255 | ||||||
| UNITED STATES FUND FOR UNICEF | |||||||||||||
| 125 MAIDEN LANE | NEW YORK | NY | 10038 | N/A | PC | ACCELERATING GLOBAL FOCUS ON NCDS AND PEN-PLUS COUNTRY PROGRAMS | $784,421 | ||||||
| UNIVERSITE CATHOLIQUE DE LOUVAIN | |||||||||||||
| N/A | PC | SEARCH FOR MECHANISMS RESPONSIBLE FOR THE IMPAIRED GLUCAGON SECRETION IN T1D AND FOR STRATEGIES TO CORRECT THEM | $450,921 | PLACE DE LUNIVERSITE 1 | LOUVAINLANEUVE | BE | |||||||
| UNIVERSITE DE GENEVE | |||||||||||||
| N/A | GOV | PRECLINICAL TESTING OF S100A9 TO IMPROVE GLYCEMIC CONTROL IN TYPE 1 DIABETES | $1,373,247 | RUE MICHEL SERVET 1 | GENEVE | SZ | |||||||
| UNIVERSITE LIBRE DE BRUXELLES | |||||||||||||
| N/A | GOV | GENERATION OF NEW ANTI- FXYD2A PROBES AND PRECLINICAL VALIDATION FOR HUMAN BETA CELL IMAGING | $213,582 | AVENUE FRANKLIN ROOSEVELT 50 | BRUSSELS | BE | |||||||
| UNIVERSITY AT BUFFALO PEDIATRIC ASSOCIATES P C | |||||||||||||
| 1001 MAIN STREET | BUFFALO | NY | 14203 | N/A | PC | FINANCIAL VIABILITY OF TELEHEALTH SERVICES FOR UNDERSERVED T1D PEDIATRIC POPULATIONS | $272,233 | ||||||
| UNIVERSITY COLLEGE LONDON | |||||||||||||
| N/A | PC | SPIT-C: USING SALIVA TO PREDICT CROHNS DISEASE | $60,000 | GOWER STREET | LONDON | UK | |||||||
| UNIVERSITY HOSPITALS HEALTH SYSTEM INC | |||||||||||||
| 11100 EUCLID AVENUE | CLEVELAND | OH | 44106 | N/A | PC | TYPE 1 DIABETES FINANCIAL TOOLKIT FOR EMERGING ADULTS | $707,339 | ||||||
| UNIVERSITY MEDICAL CENTER OF SOUTHERN NEVADA | |||||||||||||
| 1800 W CHARLESTON BLVD | LAS VEGAS | NV | 89102 | N/A | GOV | DEVELOPMENT OF AN EXTRACORPOREAL LIFE SUPPORT (ECLS) PROGRAM AT UNIVERSITY MEDICAL CENTER OF SOUTHERN NEVADA | $719,072 | ||||||
| UNIVERSITY OF BIRMINGHAM | |||||||||||||
| N/A | PC | CREATING AN OPTIMISED ANTIGEN-SPECIFIC IMMUNOTHERAPY FOR TYPE 1 DIABETES | $506,886 | INSTITUTE OF IMMUNOLOGY AND | BIRMINGHAM | UK | IMMUNOTHERAPY | ||||||
| UNIVERSITY OF BIRMINGHAM | |||||||||||||
| N/A | PC | DEFINING THE EFFICACY AND MECHANISMS OF PEPTIDE IMMUNOTHERAPY FOR TYPE 1 DIABETES: AN EXPERIMENTAL MEDICINE STUDY | $80,506 | INSTITUTE OF IMMUNOLOGY AND | BIRMINGHAM | UK | IMMUNOTHERAPY | ||||||
| UNIVERSITY OF CAMBRIDGE | |||||||||||||
| N/A | PC | DOES BIOCHEMISTRY AT THE CENTRE OF LIFE DRIVE CROHN'S DISEASE? | $1,045,519 | THE OLD SCHOOLS | OXFORD | UK | |||||||
| UNIVERSITY OF CAMBRIDGE | |||||||||||||
| N/A | PC | DOES THE WESTERN DIET TRIGGER CROHN'S DISEASE VIA OSMOTIC STRESS? | $583,311 | THE OLD SCHOOLS | OXFORD | UK | |||||||
| UNIVERSITY OF CAMBRIDGE | |||||||||||||
| N/A | PC | CLOSED LOOP INSULIN DELIVERY IN NEWLY DIAGNOSED YOUTH WITH TYPE 1 DIABETES AGES 10 TO 18 YEARS (PART 2) | $500,000 | THE OLD SCHOOLS | OXFORD | UK | |||||||
| UNIVERSITY OF CAMBRIDGE | |||||||||||||
| N/A | PC | EPIGENETIC REGULATION OF INTESTINAL EPITHELIAL MHC CLASS 1 SIGNALLING - ANOVEL MECHANISM IN THE PATHOGENESIS OF CROHNS DISEASE | $713,088 | THE OLD SCHOOLS | OXFORD | UK | |||||||
| UNIVERSITY OF CINCINNATI | |||||||||||||
| 51 GOODMAN DRIVE SUITE 500 | CINCINNATI | OH | 45221 | N/A | GOV | STUDIES ON THE ROLE OF C-PEPTIDE TO REGULATE BLOOD GLUCOSE DURING SLEEP AND EXERCISE | $416,500 | ||||||
| UNIVERSITY OF EXETER | |||||||||||||
| N/A | PC | B CELL SIGNATURES IN TYPE 1 DIABETES | $251,607 | NORTHCOTE HOUSE THE QUEENS DRIVE | EXETER | UK | |||||||
| UNIVERSITY OF EXETER | |||||||||||||
| N/A | PC | UNCOVERING NEW GENETIC MECHANISMS UNDERLYING EXTREME EARLY-ONSET TYPE 1 DIABETES | $669,554 | NORTHCOTE HOUSE THE QUEENS DRIVE | EXETER | UK | |||||||
| UNIVERSITY OF EXETER | |||||||||||||
| N/A | PC | STIMULATED GLUCAGON LEVELS AS A BIOMARKER OF HYPOGLYCEMIA RISK IN TYPE 1 DIABETES | $307,674 | NORTHCOTE HOUSE THE QUEENS DRIVE | EXETER | UK | |||||||
| UNIVERSITY OF EXETER | |||||||||||||
| N/A | PC | EXTREMELY EARLY ONSET TYPE 1 DIABETES (EXE T1D) PHASE 2: FROM OBSERVATION TO MECHANISM | $345,527 | NORTHCOTE HOUSE THE QUEENS DRIVE | EXETER | UK | |||||||
| UNIVERSITY OF FLORIDA | |||||||||||||
| 219 GRINTER HALL | GAINESVILLE | FL | 326115500 | N/A | GOV | GENERATING AUTOANTIGEN-SPECIFIC ANTIBODY-PRODUCING HYBRIDOMAS AS A RENEWABLE SOURCE OF ISLET AUTOANTIBODIES | $54,094 | ||||||
| UNIVERSITY OF FLORIDA | |||||||||||||
| 219 GRINTER HALL | GAINESVILLE | FL | 326115500 | N/A | GOV | UNDERSTANDING T1D AND INSULIN-REQUIRING DIABETES IN FEDERALLY QUALIFIED HEALTH CENTERS (FQHC): A NATIONAL NEEDS ASSESSMENT | $741,600 | ||||||
| UNIVERSITY OF GLASGOW COURT | |||||||||||||
| N/A | PC | COMBINATION THERAPY WITH BIOLOGICS AND PARTIAL ENTERAL NUTRITION IN ADULTS WITH ACTIVE ILEOCOLONIC CROHNS DISEASE: THE BIOPIC STUDY | $1,231,291 | UNIVERSITY AVENUE | GLASGOW | UK | |||||||
| UNIVERSITY OF IOWA | |||||||||||||
| DIVISION OF SPONSORED PROGRAMS | IOWA CITY | IA | 52442 | N/A | GOV | SIMULATION IN MOTION IOWA (SIM-IA) | $33,833 | ||||||
| UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | |||||||||||||
| 55 LAKE AVENUE NORTH | WORCESTER | MA | 01655 | N/A | GOV | DIETA ANTI-INFLAMATORIA: A CROHNS DISEASE MANAGEMENT STRATEGY TAILORED FOR PUERTO RICANS | $881,959 | ||||||
| UNIVERSITY OF MELBOURNE | |||||||||||||
| N/A | PC | ANIMAL AND CLINICAL EVALUATION OF A NOVEL CONTINUOUS KETONE SENSOR | $880,551 | LEVEL 4 ALAN GILBERT BUILDING | VICTORIA | AS | |||||||
| UNIVERSITY OF MELBOURNE | |||||||||||||
| N/A | PC | USE OF WHEY PROTEIN TO REDUCE RISK OF HYPOGLYCEMIA DURING EXERCISE FOR PEOPLE WITH T1D | $203,056 | LEVEL 4 ALAN GILBERT BUILDING | VICTORIA | AS | |||||||
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | |||||||||||||
| 104 AIRPORT DRIVE SUITE 2200 CB | CHAPEL HILL | NC | 275991350 | N/A | GOV | PILOTING INTEGRATION OF PORTABLE ULTRASOUNDS | $893,092 | 1350 | |||||
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | |||||||||||||
| 104 AIRPORT DRIVE SUITE 2200 CB | CHAPEL HILL | NC | 275991350 | N/A | GOV | GENOMIC AND MICROBIAL SIGNATURES PREDICT POST-OPERATIVE CROHNS DISEASE OUTCOMES | $149,796 | 1350 | |||||
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | |||||||||||||
| 104 AIRPORT DRIVE SUITE 2200 CB | CHAPEL HILL | NC | 275991350 | N/A | GOV | GENOMIC AND MICROBIAL SIGNATURES PREDICT POST-OPERATIVE CROHNS DISEASE OUTCOMES | $581,625 | 1350 | |||||
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | |||||||||||||
| 104 AIRPORT DRIVE SUITE 2200 CB | CHAPEL HILL | NC | 275991350 | N/A | GOV | FREQUENCY AND TITER OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AUTO-ANTIBODIES IN PATIENTS WITH CROHN'S-LIKE DISEASE OF THE POUCH | $260,103 | 1350 | |||||
| UNIVERSITY OF NORTH DAKOTA | |||||||||||||
| SCHOOL OF MEDICINE HEALTH SCIENCES | GRAND FORKS | ND | 58202 | N/A | GOV | SIMULATION IN MOTION (SIM) CONSORTIUM | $14,808 | ||||||
| UNIVERSITY OF NOTRE DAME DU LAC | |||||||||||||
| 940 GRACE HALL | NOTRE DAME | IN | 465565708 | N/A | PC | GLUCOSE-BINDING MOTIFS FROM DYNAMIC COMBINATORIAL LANDSCAPES | $373,873 | ||||||
| UNIVERSITY OF NOTRE DAME DU LAC | |||||||||||||
| 940 GRACE HALL | NOTRE DAME | IN | 465565708 | N/A | PC | DEVELOPMENT OF A NOVEL GLUCOSE-RESPONSIVE GLUCAGON DELIVERY SYSTEM | $143,127 | ||||||
| UNIVERSITY OF OULU | |||||||||||||
| N/A | PC | MATERNAL AND PATERNAL TYPE 1 DIABETES MECHANISMS FOR THE DISTINCT RECURRENCE RISK IN THE OFFSPRING | $137,453 | PO BOX 8000 | OULU | FI | |||||||
| UNIVERSITY OF PITTSBURGH | |||||||||||||
| 3420 FORBES AVENUE | PITTSBURGH | PA | 152603203 | N/A | PC | SINGLE CELL MULTIMODAL OMICS ANALYSIS OF COLONOSCOPIC BIOPSY-DERIVED IMMUNE CELLS IN CROHNS DISEASE | $280,115 | ||||||
| UNIVERSITY OF PITTSBURGH | |||||||||||||
| 3420 FORBES AVENUE | PITTSBURGH | PA | 152603203 | N/A | PC | SINGLE CELL MULTIMODAL OMICS ANALYSIS OF COLONOSCOPIC BIOPSY-DERIVED IMMUNE CELLS IN CROHNS DISEASE | $243,196 | ||||||
| UNIVERSITY OF PITTSBURGH | |||||||||||||
| 3420 FORBES AVENUE | PITTSBURGH | PA | 152603203 | N/A | PC | ANALOGUE VS HUMAN INSULIN FOR YOUTH WITH TYPE 1 DIABETES IN LOW-RESOURCE SETTINGS: A RANDOMIZED CONTROLLED TRIAL (ANHUT1D TRIAL) | $998,931 | ||||||
| UNIVERSITY OF TEXAS SYSTEM FOR THE UNIVERSITY OF TEXAS AT AUSTIN | |||||||||||||
| 3925 WEST BRAKER LANE | AUSTIN | TX | 787595316 | N/A | GOV | INCREASING ACCESS TO CROHNS DISEASE CLINICAL CARE FOR THE IBD CENTER AT UT HEALTH AUSTIN | $198,646 | ||||||
| UNIVERSITY OF TEXAS SYSTEM FOR THE UNIVERSITY OF TEXAS AT AUSTIN | |||||||||||||
| 3925 WEST BRAKER LANE | AUSTIN | TX | 787595316 | N/A | GOV | INCREASING ACCESS TO CROHNS DISEASE CLINICAL CARE FOR THE IBD CENTER AT UT HEALTH AUSTIN | $196,411 | ||||||
| UNIVERSITY OF TOLEDO | |||||||||||||
| 3000 ARLINGTON AVENUE | TOLEDO | OH | 436142595 | N/A | GOV | TYPE 1 DIABETES CAR TREG THERAPEUTIC APPROACH | $91,848 | ||||||
| UNIVERSITY OF TOLEDO | |||||||||||||
| 3000 ARLINGTON AVENUE | TOLEDO | OH | 436142595 | N/A | GOV | TYPE 1 DIABETES CAR TREG THERAPEUTIC APPROACH | $18,632 | ||||||
| UNIVERSITY OF UTAH | |||||||||||||
| 201 S PRESIDENTS CIRCLE | SALT LAKE CITY | UT | 84112 | N/A | PC | INDUCTION OF PERIPHERAL TOLERANCE TO BETA CELL ANTIGENS BY SPECIFIC TARGETING OF LANGERIN+ DENDRITIC CELLS | $290,806 | ||||||
| UNIVERSITY OF VIRGINIA LAW SCHOOL FOUNDATION | |||||||||||||
| 580 MASSIE ROAD | CHARLOTTESVILLE | VA | 22903 | N/A | PC | GENERAL OPERATING SUPPORT FOR THE CATHERINE MURPHY KEATING '87 RESTRICTED FUND | $50,000 | ||||||
| UNIVERSITY OF VIRGINIA LAW SCHOOL FOUNDATION | |||||||||||||
| 580 MASSIE ROAD | CHARLOTTESVILLE | VA | 22903 | N/A | PC | GENERAL OPERATING SUPPORT FOR THE CATHERINE MURPHY KEATING '87 RESTRICTED FUND | $50,000 | ||||||
| UNIVERSITY OF WASHINGTON | |||||||||||||
| OFFICE OF SPONSORED PROGRAMS | SEATTLE | WA | 981959472 | N/A | GOV | DESIGN OF ISLET TARGETED AGONISTS OF PD1 AND CTLA4 | $378,764 | ||||||
| UNIVERSITY OF WASHINGTON | |||||||||||||
| OFFICE OF SPONSORED PROGRAMS | SEATTLE | WA | 981959472 | N/A | GOV | SKIN PATHOLOGY IN PEOPLE WITH T1D: IMPACT OF INSULIN INFUSION VIA PUMP | $111,932 | ||||||
| UNIVERSITY OF WESTERN ONTARIO | |||||||||||||
| N/A | PC | ENDPOINT DEVELOPMENT FOR OSTOMY CLINICAL TRIALS (ENDO-TRIAL) CONSORTIUM | $919,293 | 339 WINDERMERE RD | LONDON | CA | |||||||
| UNIVERSITY OF WYOMING FOUNDATION | |||||||||||||
| 222 S 22ND ST | LARAMIE | WY | 82070 | N/A | PC | ULTRASOUND TRAINING INITIATIVE IN WYOMING | $641,903 | ||||||
| UPPSALA UNIVERSITET | |||||||||||||
| N/A | GOV | ALPHA-CELL SIGNALING FOR GLUCAGON SECRETION | $229,347 | BOX 256 | UPPSALA | SW | |||||||
| UPTIME GLOBAL | |||||||||||||
| N/A | PC | RESULTS-BASED SAFE WATER SERVICES | $350,000 | 23-38 HYTHE BRIDGE STREET | OXFORD | UK | |||||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | |||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | MRI OF THE PANCREAS IN T1D | $196,582 | ||||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | |||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | MRI OF THE PANCREAS IN T1D | $176,459 | ||||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | |||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | ISOLATING ISLETS TO UNDERSTAND HYPOGLYCEMIA IN TYPE 1 DIABETES | $200,000 | ||||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | |||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | ISOLATING ISLETS TO UNDERSTAND HYPOGLYCEMIA IN TYPE 1 DIABETES | $36,595 | ||||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | |||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | COMBINATORIAL SINGLE CELL STRATEGIES FOR A CROHN'S DISEASE GUT CELL ATLAS | $290,049 | ||||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | |||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | ADAPTING FAMS TO OPTIMIZE CGM USE AMONG EMERGING ADULTS WITH TYPE 1 DIABETES | $68,349 | ||||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | |||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | DEVELOPMENT OF AN ADMINISTRATIVE CORE AND COLLABORATIVE DATA REPOSITORY FOR THE GUT CELL ATLAS | $496,512 | ||||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | |||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | SCREENING HUMAN ISLETS TO IDENTIFY SMALL MOLECULES ENHANCING GLUCAGON SECRETION UNDER HYPOGLYCEMIA | $221,931 | ||||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | |||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | DEFINING MOLECULAR MECHANISMS OF CELL DYSFUNCTION IN TYPE 1 DIABETES TO DEVELOP NEWAPPROACHES TO PREVENT HYPOGLYCEMIA | $170,401 | ||||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | |||||||||||||
| OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | N/A | PC | EXPANSION OF PANCREATLAS CONNECTIVITY PLATFORM AND PHENOTYPING OF HANDEL SAMPLES BY CUTTING-EDGE SINGLE CELL MULTIOME TECHNOLOGY | $145,749 | ||||||
| VANDERBILT UNIVERSITY | |||||||||||||
| SPONSORED PROGRAMS ADMINISTRATION | NASHVILLE | TN | 372032417 | N/A | PC | NORMALIZING HYPOGLYCEMIA-INDUCED GLUCAGON SECRETION IN T1D THROUGH PHARMACOLOGICAL RESTORATION OF ALPHA-CELL CALCIUM HANDLING | $275,000 | ||||||
| VAYU HEALTH | |||||||||||||
| 19 ALISO WAY | PORTOLA VALLEY | CA | 94028 | N/A | PC | VAYU HEALTH PHASE 2 - SCALE AND SPREAD OF VALUE BASED PAYMENT ECOSYSTEM FOR MEDICAID BENEFICIARIES LIVING WITH TYPE 1 AND TYPE 2 DIABETES | $1,888,240 | ||||||
| VAYU HEALTH | |||||||||||||
| 19 ALISO WAY | PORTOLA VALLEY | CA | 94028 | N/A | PC | FEASIBILITY PILOT TO DESIGN A VALUE BASED PAYMENT ECOSYSTEM TO IMPROVE HEALTH AND EQUITY FOR MEDICAID BENEFICIARIES LIVING WITH T1D AND T2D | $705,194 | ||||||
| VETERANS MEMORIAL HOSPITAL | |||||||||||||
| 40 1ST STREET SE | WAUKON | IA | 52172 | N/A | GOV | ECARE PHARMACY AND EMERGENCY SERVICES AT VETERANS MEMORIAL HOSPITAL | $30,504 | ||||||
| VILLAGES OF HOPE AFRICA SOCIETY | |||||||||||||
| N/A | PC | INFRASTRUCTURE IMPROVEMENTS AND EXPANSION | $253,122 | 2450 MILLTOWER COURT | MISSISSAUGA | CA | |||||||
| VIVLI INC | |||||||||||||
| 101 MIDDLESEX TURNPIKE SUITE 6 | BURLINGTON | MA | 018034914 | N/A | PC | DATA SHARING PLATFORM FOR T1-DEXI DATASETS | $120,000 | ||||||
| WARREN MEMORIAL HOSPITAL | |||||||||||||
| 905 2ND ST | FRIEND | NE | 68359 | N/A | GOV | TELE-EMERGENCY SERVICES AT FRIEND COMMUNITY HEALTHCARE SYSTEM | $25,335 | ||||||
| WASHINGTON UNIVERSITY | |||||||||||||
| CAMPUS BOX 1054 | SAINT LOUIS | MO | 631304862 | N/A | PC | CELLULAR BIOMARKERS FOR PEDIATRIC CROHNS DISEASE | $338,970 | ||||||
| WASHINGTON UNIVERSITY | |||||||||||||
| CAMPUS BOX 1054 | SAINT LOUIS | MO | 631304862 | N/A | PC | RESTORATION OF NORMAL GLUCAGON SECRETORY DYNAMICS BY DIRECT MANIPULATION OF ALPHA CELL SIGNALING | $330,000 | ||||||
| WATER4 INC | |||||||||||||
| 2405 NW 10TH STREET | OKLAHOMA CITY | OK | 73107 | N/A | PC | SCALING THE NUMA MODEL TO DELIVER SAFE, SUSTAINABLE WATER | $1,673,164 | ||||||
| WEST PARK HOSPITAL DISTRICT | |||||||||||||
| 707 SHERIDAN AVENUE | CODY | WY | 82414 | N/A | GOV | CODY REGIONAL HEALTH ULTRASOUND PROJECT | $466,486 | ||||||
| WILDLIFE CONSERVATION SOCIETY | |||||||||||||
| 2300 SOUTHERN BOULEVARD | BRONX | NY | 10460 | N/A | PC | GENERAL OPERATING SUPPORT FOR ELEPHANTS | $10,000 | ||||||
| WIND RIVER FAMILY AND COMMUNITY HEALTH CARE SYSTEM | |||||||||||||
| 14 GREAT PLAINS RD | ARAPAHOE | WY | 82510 | N/A | GOV | WYOMING ULTRASOUND REVITALIZATION INITIATIVE | $391,802 | ||||||
| WNET FOR THE WLIW-21 PUBLIC BROADCASTING | |||||||||||||
| 825 EIGHTH AVENUE | NEW YORK | NY | 100197435 | N/A | PC | GENERAL OPERATING SUPPORT | $5,000 | ||||||
| WORLD HEALTH ORGANIZATION | |||||||||||||
| N/A | PC | STRENGTHENING INTEGRATED PREVENTION AND CONTROL OF CHRONIC AND SEVERE NCDS IN THE WHO AFRICAN REGION, USING T1D, SCD, ARF, AND RHD AS ENTRY POINTS | $2,862,039 | AVENUE APPIA 20 | GENEVA | SZ | |||||||
| WYOMING COMMUNITY FOUNDATION | |||||||||||||
| 1472 NORTH 5TH STREET | LARAMIE | WY | 82072 | N/A | PC | ENHANCING ULTRASOUND CAPABILITIES IN WYOMING | $361,581 | ||||||
| WYOMING DEPARTMENT OF HEALTH | |||||||||||||
| 6101 YELLOWSTONE RD SUITE 400 | CHEYENNE | WY | 82009 | N/A | GOV | WYOMING FIRST RESPONDER AED PROJECT | $16,000 | ||||||
| YAD SARAH | |||||||||||||
| N/A | PC | EMERGENCY EQUIPMENT PURCHASES | $300,000 | 124 HERZL BLVD | JERUSALEM | IS | |||||||
| YALE UNIVERSITY | |||||||||||||
| OFFICE OF SPONSORED PROJECTS | NEW HAVEN | CT | 065208327 | N/A | PC | EXPOSOMICS FOR EARLY LIFE CROHNS DISEASE | $414,595 | ||||||
| YALE UNIVERSITY | |||||||||||||
| OFFICE OF SPONSORED PROJECTS | NEW HAVEN | CT | 065208327 | N/A | PC | EXPOSOMICS FOR EARLY LIFE CROHNS DISEASE | $298,606 | ||||||
| YALE UNIVERSITY | |||||||||||||
| OFFICE OF SPONSORED PROJECTS | NEW HAVEN | CT | 065208327 | N/A | PC | TARGETING NEWLY DISCOVERED HOST-MICROBIOTA INTERACTION NODES TO TREAT OR PREVENT CROHNS DISEASE | $792,237 | ||||||
| YITZHAK SHAMIR MEDICAL CENTER | |||||||||||||
| N/A | GOV | SHAMIR UNDERGROUND EMERGENCY HOSPITAL EQUIPMENT | $500,000 | BEER YAAKOV | TZRIFIN | IS | |||||||
| YOUNG MEN'S CHRISTIAN ASSOCIATION RETIREMENT FUND | |||||||||||||
| 120 BROADWAY | NEW YORK | NY | 10271 | N/A | SOI | GENERAL OPERATING SUPPORT | $7,500 | ||||||
| YOUNG MEN'S CHRISTIAN ASSOCIATION RETIREMENT FUND | |||||||||||||
| 120 BROADWAY | NEW YORK | NY | 10271 | N/A | SOI | GENERAL OPERATING SUPPORT | $10,000 | ||||||
| YOUTH DEVELOPMENT ORGANIZATION INC | |||||||||||||
| 15 UNION STREET 563 | LAWRENCE | MA | 01840 | N/A | PC | CAPACITY BUILDING PROJECT SUPPORT 2022 | $200,000 | ||||||
| ZIV MEDICAL CENTER ZEFAT | |||||||||||||
| N/A | GOV | EMERGENCY EQUIPMENT FOR ZIV MEDICAL CENTER | $500,000 | RAMBAM ST | ZEFAT | IS | |||||||
| ZIV MEDICAL CENTER ZEFAT | |||||||||||||
| N/A | GOV | PRESSURE CHAMBER FOR HYPERBARIC THERAPY, ZIV MEDICAL CENTER, SAFED. | $2,120,034 | RAMBAM ST | ZEFAT | IS | |||||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Grant Or Contri Pd Dur Yr | $445,672,622 | TotalGrantOrContriPdDurYrAmt |
Grant Or Contri Apprv For Fut GrantOrContriApprvForFutGrp (603 entries)
| Address Line1RecipientForeignAddress/AddressLine1Txt | CityRecipientForeignAddress/CityNm | CountryRecipientForeignAddress/CountryCd | Recipient RelationshipRecipientRelationshipTxt | Recipient Foundation StatusRecipientFoundationStatusTxt | Grant Or Contribution PurposeGrantOrContributionPurposeTxt | AmtAmt | Address Line1RecipientUSAddress/AddressLine1Txt | CityRecipientUSAddress/CityNm | State AbbreviationRecipientUSAddress/StateAbbreviationCd | ZIPRecipientUSAddress/ZIPCd | Address Line2RecipientUSAddress/AddressLine2Txt | Address Line2RecipientForeignAddress/AddressLine2Txt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INSTITUTE FOR MONITORING PEACE AND CULTURAL TOLERANCE IN SCHOOL EDUCATION | ||||||||||||
| 2 JABOTINSKY ST | RAMAT GAN | IS | N/A | PC | TRANSFORMING EDUCATION FOR PEACE: A NATIONWIDE AWARENESS CAMPAIGN ON INCITEMENT IN PALESTINIAN/UNRWA TEXTBOOKS. | $150,000 | ||||||
| A GLIMMER OF HOPE FOUNDATION | ||||||||||||
| N/A | PF | EMPOWERING FAMILIES TO BUILD RESILIENCE AND REDUCE POVERTY | $1,446,574 | 3103 BEE CAVES ROAD | AUSTIN | TX | 78746 | |||||
| ACADEMISCH ZIEKENHUIS LEIDEN | ||||||||||||
| 2 ALBINUSDREEF | LEIDEN | NL | N/A | GOV | SAFETY AND EFFICACY OF IMMUNE INTERVENTION WITH TOLEROGENIC DENDRITIC CELLS IN PATIENTS WITH EARLY T1D (D-SENSE II) | $238,910 | ||||||
| ACADEMISCH ZIEKENHUIS LEIDEN | ||||||||||||
| 2 ALBINUSDREEF | LEIDEN | NL | N/A | GOV | SAFETY AND EFFICACY OF IMMUNE INTERVENTION WITH TOLEROGENIC DENDRITIC CELLS IN PATIENTS WITH EARLY T1D (D-SENSE II) | $93,238 | ||||||
| ACTION4DIABETES | ||||||||||||
| 9 PARKFIELD ROAD | TAUNTON | UK | N/A | PC | PHILIPPINES T1D TASK FORCE | $222,500 | ||||||
| ACTION4DIABETES | ||||||||||||
| 9 PARKFIELD ROAD | TAUNTON | UK | N/A | PC | PHILIPPINES T1D TASK FORCE | $284,390 | ||||||
| ALBERT EINSTEIN COLLEGE OF MEDICINE | ||||||||||||
| N/A | PC | ENHANCING THE COMMUNITY HEALTH WORKER MODEL TO PROMOTE DIABETES TECHNOLOGY USE IN ADULTS FROM UNDERREPRESENTED MINORITY GROUPS WITH T1D PILOT STUDY | $173,613 | 1300 MORRIS PARK AVENUE | BRONX | NY | 104611975 | |||||
| ALIMENTIV INC | ||||||||||||
| 100 DUNDAS STREET | LONDON | CA | N/A | NC | DEVELOPMENT OF A NEXT GENERATION BIOMARKER TOOL TO ACCELERATE THE DEVELOPMENT OF EFFECTIVE ANTI-FIBROTIC THERAPIES | $259,951 | ||||||
| ALLIANCE OF COMMUNITY HEALTH PLANS FOUNDATION INC | ||||||||||||
| N/A | SOI | COLLABORATING WITH HEALTH PLANS TO OVERCOME BARRIERS TO COVERAGE AND UTILIZATION OF CONTINUOUS GLUCOSE MONITORING : LAYING THE FOUNDATION | $539,349 | 1825 EYE STREET NW 401 | WASHINGTON | DC | 20006 | |||||
| ALLIANCE OF COMMUNITY HEALTH PLANS FOUNDATION INC | ||||||||||||
| N/A | SOI | COLLABORATING WITH HEALTH PLANS TO OVERCOME BARRIERS TO COVERAGE AND UTILIZATION OF CONTINUOUS GLUCOSE MONITORING : LAYING THE FOUNDATION | $500,000 | 1825 EYE STREET NW 401 | WASHINGTON | DC | 20006 | |||||
| AMC MEDICAL RESEARCH BV | ||||||||||||
| MEIBERGDREEF 9 | AMSTERDAM | NL | N/A | PC | IDENTIFICATION OF BIOMARKERS FOR PATIENT STRATIFICATION IN PERIANAL FISTULIZING DISEASE | $225,500 | ||||||
| AMC MEDICAL RESEARCH BV | ||||||||||||
| MEIBERGDREEF 9 | AMSTERDAM | NL | N/A | PC | A PROSPECTIVE RANDOMIZED STUDY OF TREATMENT SELECTION BASED ON EPIGENETIC MARKERS IN CROHNS DISEASE: OMICROHN | $1,532,103 | ||||||
| AMC MEDICAL RESEARCH BV | ||||||||||||
| MEIBERGDREEF 9 | AMSTERDAM | NL | N/A | PC | A PROSPECTIVE RANDOMIZED STUDY OF TREATMENT SELECTION BASED ON EPIGENETIC MARKERS IN CROHNS DISEASE: OMICROHN | $1,476,985 | ||||||
| AMC MEDICAL RESEARCH BV | ||||||||||||
| MEIBERGDREEF 9 | AMSTERDAM | NL | N/A | PC | IDENTIFICATION OF BIOMARKERS FOR PATIENT STRATIFICATION IN PERIANAL FISTULIZING DISEASE | $306,900 | ||||||
| AMERICAN COLLEGE OF DIABETOLOGY INC | ||||||||||||
| N/A | PC | IMPROVE THE DIABETES TRAINING OPPORTUNITIES FOR PCPS | $1,200,436 | PO BOX 87633 | FAYETTEVILLE | NC | 28304 | |||||
| AMERICAN DIABETES ASSOCIATION INC | ||||||||||||
| N/A | PC | TRAINING AND MENTORSHIP PROGRAMS | $805,382 | 2451 CRYSTAL DRIVE SUITE 900 | ARLINGTON | VA | 22202 | |||||
| AMERICAN DIABETES ASSOCIATION INC | ||||||||||||
| N/A | PC | TRAINING AND MENTORSHIP PROGRAMS | $805,382 | 2451 CRYSTAL DRIVE SUITE 900 | ARLINGTON | VA | 22202 | |||||
| AMERICAN DIABETES ASSOCIATION INC | ||||||||||||
| N/A | PC | 2022-2024 TYPE 1 DIABETES CAMP INITIATIVE | $399,368 | 2451 CRYSTAL DRIVE SUITE 900 | ARLINGTON | VA | 22202 | |||||
| AMERICAN GASTROENTEROLOGICAL ASSOCIATION INSTITUTE | ||||||||||||
| N/A | PC | AMPLIFYING LEARNING FROM THE CEDARS-SINAI ADVANCED DIETARY IBD EDUCATION AND TRAINING (DIET) PROGRAM: BEYOND MALNUTRITION | $64,189 | 4930 DEL RAY AVE | BETHESDA | MD | 20814 | |||||
| AMERICAN HEART ASSOCIATION INC | ||||||||||||
| N/A | PC | MISSION: LIFELINE STROKE IOWA | $2,521,277 | 7272 GREENVILLE AVENUE | DALLAS | TX | 75231 | |||||
| AMERICAN HEART ASSOCIATION INC | ||||||||||||
| N/A | PC | POST-ACUTE STROKE CARE: IMPLEMENTING QUALITY STANDARDS IN MONTANA, NEBRASKA AND NORTH DAKOTA | $379,458 | 7272 GREENVILLE AVENUE | DALLAS | TX | 75231 | |||||
| AMERICAN HEART ASSOCIATION INC | ||||||||||||
| N/A | PC | AMERICAN HEART ASSOCIATION CENTER FOR TELEHEALTH | $6,966,024 | 7272 GREENVILLE AVENUE | DALLAS | TX | 75231 | |||||
| AMERICAN HEART ASSOCIATION INC | ||||||||||||
| N/A | PC | HEARTCORPS: AHA'S RURAL PUBLIC HEALTH WORKFORCE DEVELOPMENT INITIATIVE | $871,217 | 7272 GREENVILLE AVENUE | DALLAS | TX | 75231 | |||||
| AMERICAN HEART ASSOCIATION INC | ||||||||||||
| N/A | PC | AMERICAN HEART ASSOCIATION CENTER FOR TELEHEALTH | $4,816,553 | 7272 GREENVILLE AVENUE | DALLAS | TX | 75231 | |||||
| AMERICAN HEART ASSOCIATION INC | ||||||||||||
| N/A | PC | HEARTCORPS: AHA'S RURAL PUBLIC HEALTH WORKFORCE DEVELOPMENT INITIATIVE | $850,098 | 7272 GREENVILLE AVENUE | DALLAS | TX | 75231 | |||||
| AMERICAN PHARMACISTS ASSOCIATION FOUNDATION | ||||||||||||
| N/A | PC | PROJECT IMPACT CGM: EXPANDING ACCESS TO CGM THROUGH COMMUNITY PHARMACIES | $1,502,893 | 2215 CONSTITUTION AVE NW | WASHINGTON | DC | 20037 | |||||
| ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | ||||||||||||
| N/A | PC | IMPLEMENTATION AND DISSEMINATION OF TOOLS TO HARNESS CGM DATA TO ACCELERATE ADOPTION OF POPULATION HEALTH IN T1D | $2,325,006 | 225 EAST CHICAGO AVENUE BOX 205 | CHICAGO | IL | 60611 | |||||
| ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | ||||||||||||
| N/A | PC | IMPLEMENTATION AND DISSEMINATION OF TOOLS TO HARNESS CGM DATA TO ACCELERATE ADOPTION OF POPULATION HEALTH IN T1D | $1,542,882 | 225 EAST CHICAGO AVENUE BOX 205 | CHICAGO | IL | 60611 | |||||
| ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | ||||||||||||
| N/A | PC | IMPLEMENTATION AND DISSEMINATION OF TOOLS TO HARNESS CGM DATA TO ACCELERATE ADOPTION OF POPULATION HEALTH IN T1D | $1,245,216 | 225 EAST CHICAGO AVENUE BOX 205 | CHICAGO | IL | 60611 | |||||
| ANTHOS HOME INC | ||||||||||||
| N/A | PC | LAUNCHING ANTHOS HOME, WITH SPECIALIZED FOCUS ON HOUSING HIGH-NEED PATIENTS | $1,500,000 | 238 SEELEY ST | BROOKLYN | NY | 11218 | |||||
| ANTHOS HOME INC | ||||||||||||
| N/A | PC | LAUNCHING ANTHOS HOME, WITH SPECIALIZED FOCUS ON HOUSING HIGH-NEED PATIENTS | $3,000,000 | 238 SEELEY ST | BROOKLYN | NY | 11218 | |||||
| ANTHOS HOME INC | ||||||||||||
| N/A | PC | LAUNCHING ANTHOS HOME, WITH SPECIALIZED FOCUS ON HOUSING HIGH-NEED PATIENTS | $500,000 | 238 SEELEY ST | BROOKLYN | NY | 11218 | |||||
| APHP ST ANTOINE HOSPITAL | ||||||||||||
| 184 RUE DU FAUBOURG SAINT-ANTOINE | PARIS | FR | N/A | GOV | FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE AS RELAY AFTER ANTI-TNF WITHDRAWAL (MIRACLE) | $421,681 | ||||||
| ARAD MUNICIPALITY | ||||||||||||
| 6 HAPALMACH STREET | ARAD | IS | N/A | GOV | ARAD OCCUPATIONAL REHABILITATION CENTER | $106,764 | ||||||
| ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTS | ||||||||||||
| N/A | NC | EXPANSION OF THE DANATECH PLATFORM | $855,546 | 125 SOUTH WACKER DRIVE SUITE 600 | CHICAGO | IL | 60606 | |||||
| ASSOCIATION SANTE DIABETE | ||||||||||||
| 5 RUE FEDERICO GARCIA LORCA | GRENOBLE | FR | N/A | PC | STRENGTHEN THE CARE AND SUPPORT OF PATIENTS WITH TYPE 1 DIABETES IN MALI, BURKINA FASO, AND THE UNION OF THE COMOROS | $587,221 | ||||||
| ASSOCIATION SANTE DIABETE | ||||||||||||
| 5 RUE FEDERICO GARCIA LORCA | GRENOBLE | FR | N/A | PC | STRENGTHEN THE CARE AND SUPPORT OF PATIENTS WITH TYPE 1 DIABETES IN MALI, BURKINA FASO, AND THE UNION OF THE COMOROS | $325,558 | ||||||
| ASSOCIATION SANTE DIABETE | ||||||||||||
| 5 RUE FEDERICO GARCIA LORCA | GRENOBLE | FR | N/A | PC | STRENGTHEN THE CARE AND SUPPORT OF PATIENTS WITH TYPE 1 DIABETES IN MALI, BURKINA FASO, AND THE UNION OF THE COMOROS | $587,221 | ||||||
| AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD | ||||||||||||
| LEVEL 2 | FITZROY | AS | N/A | PC | FECAL MICROBIOTA TRANSPLANTATION (FMT) IN CROHN'S DISEASE: THE MIRO (MICROBIOTA RESTORATION) STUDY. | $209,377 | ||||||
| AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD | ||||||||||||
| LEVEL 2 | FITZROY | AS | N/A | PC | FECAL MICROBIOTA TRANSPLANTATION (FMT) IN CROHN'S DISEASE: THE MIRO (MICROBIOTA RESTORATION) STUDY. | $315,421 | ||||||
| AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD | ||||||||||||
| LEVEL 2 | FITZROY | AS | N/A | PC | FECAL MICROBIOTA TRANSPLANTATION (FMT) IN CROHN'S DISEASE: THE MIRO (MICROBIOTA RESTORATION) STUDY. | $315,421 | ||||||
| BALLAD RESEARCH INSTITUTE | ||||||||||||
| N/A | PC | CD127-HIGH T-CELL POPULATIONS IN AUTOANTIBODY POSITIVE CHILDREN | $315,380 | 3525 JOHN HOPKINS COURT | SAN DIEGO | CA | 92121 | |||||
| BALLAD RESEARCH INSTITUTE | ||||||||||||
| N/A | PC | CD127-HIGH T-CELL POPULATIONS IN AUTOANTIBODY POSITIVE CHILDREN | $243,390 | 3525 JOHN HOPKINS COURT | SAN DIEGO | CA | 92121 | |||||
| BAR ILAN UNIVERSITY | ||||||||||||
| MAX VE-ANNA WEBB ST | RAMAT GAN | IS | N/A | PC | THE LEONA M. AND HARRY B. HELMSLEY ENERGY PROTOTYPE LAB AT BAR-ILAN UNIVERSITY | $3,348,125 | ||||||
| BAYLOR COLLEGE OF MEDICINE | ||||||||||||
| N/A | PC | PREDICTIVE ANALYTICS AND TARGETED INTERVENTIONS: SHIFTING THE PARADIGM FROM REACTIVE TO PROACTIVE DIABETES CARE | $547,540 | OFFICE OF RESEARCH | HOUSTON | TX | 77030 | |||||
| BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | ||||||||||||
| N/A | PC | LINKING DISEASE MECHANISM AND CLINICAL TRIAL DESIGN VIA RAPIDLY CONDUCTED IMMUNOTHERAPY TRIALS IN T1D | $288,200 | 1201 NINTH AVENUE | SEATTLE | WA | 981012795 | |||||
| BEN-GURION UNIVERSITY OF THE NEGEV | ||||||||||||
| BEN-GURION BLVD 1 | BEER SHEVA | IS | N/A | PC | CONSTRUCTION OF THE LEONA B. AND HARRY M. HELMSLEY CHARITABLE TRUST COMPUTER SCIENCE BUILDING | $5,785,714 | ||||||
| BEN-GURION UNIVERSITY OF THE NEGEV | ||||||||||||
| BEN-GURION BLVD 1 | BEER SHEVA | IS | N/A | PC | ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: COBMINDEX GOES FORWARD- A SMARTPHONE APPLICATION FOR ADDED PSYCHOLOGICAL WELLBEING IN CROHN'S DISEASE. | $765,436 | ||||||
| BEN-GURION UNIVERSITY OF THE NEGEV | ||||||||||||
| BEN-GURION BLVD 1 | BEER SHEVA | IS | N/A | PC | CONSTRUCTION OF THE LEONA B. AND HARRY M. HELMSLEY CHARITABLE TRUST COMPUTER SCIENCE BUILDING | $10,542,857 | ||||||
| BETH ISRAEL DEACONESS MEDICAL CENTER INC | ||||||||||||
| N/A | PC | PROACTIVE OPTIMIZATION OF INFLIXIMAB USING A PHARMACOKINETIC DASHBOARD VERSUS STANDARD OF CARE IN PATIENTS WITH CROHNS DISEASE: THE OPTIMIZE TRIAL | $797,851 | 330 BROOKLINE AVENUE | BOSTON | MA | 022155491 | |||||
| BEYOND TYPE 1 | ||||||||||||
| N/A | PC | CAPACITY BUILDING SUPPORT | $1,200,000 | 400 CONCAR DRIVE OFFICE 03-155 | SAN MATEO | CA | 94402 | |||||
| BEYOND TYPE 1 | ||||||||||||
| N/A | PC | CAPACITY BUILDING SUPPORT | $1,200,000 | 400 CONCAR DRIVE OFFICE 03-155 | SAN MATEO | CA | 94402 | |||||
| BILLINGS CLINIC FOUNDATION | ||||||||||||
| N/A | PC | EXPANDING ECMO SERVICES AT BILLINGS CLINIC | $449,629 | 2917 TENTH AVENUE NORTH | BILLINGS | MT | 59101 | |||||
| BILLINGS CLINIC FOUNDATION | ||||||||||||
| N/A | PC | BILLINGS CLINIC SURGICAL INTENSIVE CARE UNIT | $2,000,000 | 2917 TENTH AVENUE NORTH | BILLINGS | MT | 59101 | |||||
| BILLINGS CLINIC FOUNDATION | ||||||||||||
| N/A | PC | EXPANDING ECMO SERVICES AT BILLINGS CLINIC | $485,826 | 2917 TENTH AVENUE NORTH | BILLINGS | MT | 59101 | |||||
| BILLINGS CLINIC FOUNDATION | ||||||||||||
| N/A | PC | BILLINGS CLINIC SURGICAL INTENSIVE CARE UNIT | $5,000,000 | 2917 TENTH AVENUE NORTH | BILLINGS | MT | 59101 | |||||
| BIPARTISAN POLICY CENTER INC | ||||||||||||
| N/A | PC | STRENGTHENING RURAL HEALTH CARE DELIVERY AND SERVICES | $609,887 | 1225 I ST NW 1000 | WASHINGTON | DC | 20005 | |||||
| BIPARTISAN POLICY CENTER INC | ||||||||||||
| N/A | PC | STRENGTHENING RURAL HEALTH CARE DELIVERY AND SERVICES | $633,819 | 1225 I ST NW 1000 | WASHINGTON | DC | 20005 | |||||
| BLUE CIRCLE HEALTH INC | ||||||||||||
| N/A | PC | DEVELOPMENT OF BLUE CIRCLE HEALTH | $4,470,844 | THE CORPORATION TRUST CENTER 1209 | WILMINGTON | DE | 19801 | ORANGE STREET | ||||
| BLUE CIRCLE HEALTH INC | ||||||||||||
| N/A | PC | DEVELOPMENT OF BLUE CIRCLE HEALTH | $4,470,843 | THE CORPORATION TRUST CENTER 1209 | WILMINGTON | DE | 19801 | ORANGE STREET | ||||
| BLUE CIRCLE HEALTH INC | ||||||||||||
| N/A | PC | DEVELOPMENT OF BLUE CIRCLE HEALTH | $3,975,887 | THE CORPORATION TRUST CENTER 1209 | WILMINGTON | DE | 19801 | ORANGE STREET | ||||
| BOARD OF REGENTS NEVADA SYSTEM OF HIGHER EDUCATION | ||||||||||||
| N/A | PC | ULTRASOUND TRAINING INITIATIVE IN NEVADA | $197,208 | 2601 ENTERPRISE ROAD | RENO | NV | 89512 | |||||
| BOARD OF REGENTS NEVADA SYSTEM OF HIGHER EDUCATION | ||||||||||||
| N/A | PC | CARDIORESPIRATORY CARE SCIENCE DEGREE PROGRAM | $137,345 | 2601 ENTERPRISE ROAD | RENO | NV | 89512 | |||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | ||||||||||||
| N/A | PC | DEVELOPMENT OF PERSONALIZED DECISION SUPPORT TOOL USING NETIOB TO HELP MANAGE EXERCISE FOR PEOPLE WITH T1D | $758,218 | 443 VIA ORTEGA | STANFORD | CA | 94305 | |||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | ||||||||||||
| N/A | PC | DIABETESWISE FOR EXERCISE | $835,639 | 443 VIA ORTEGA | STANFORD | CA | 94305 | |||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | ||||||||||||
| N/A | PC | DIABDOCS NATIONAL K12: SUPPLEMENT | $402,980 | 443 VIA ORTEGA | STANFORD | CA | 94305 | |||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | ||||||||||||
| N/A | PC | MICROBIOME-BASED THERAPEUTICS FOR CROHNS DISEASE | $1,006,687 | 443 VIA ORTEGA | STANFORD | CA | 94305 | |||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | ||||||||||||
| N/A | PC | DEVELOPMENT OF PERSONALIZED DECISION SUPPORT TOOL USING NETIOB TO HELP MANAGE EXERCISE FOR PEOPLE WITH T1D | $1,069,498 | 443 VIA ORTEGA | STANFORD | CA | 94305 | |||||
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | ||||||||||||
| N/A | PC | DIABDOCS NATIONAL K12: SUPPLEMENT | $193,790 | 443 VIA ORTEGA | STANFORD | CA | 94305 | |||||
| BREAKING GROUND HOUSING DEVELOPMENT FUND CORPORATION | ||||||||||||
| N/A | PC | PILOTING AND EVALUATING THE HEALTH EFFECTS OF ACCELERATED PLACEMENTS INTO PERMANENT SUPPORTIVE HOUSING | $567,155 | 505 EIGHTH AVENUE 5TH FLOOR | NEW YORK | NY | 10018 | |||||
| BREAKING GROUND HOUSING DEVELOPMENT FUND CORPORATION | ||||||||||||
| N/A | PC | PILOTING AND EVALUATING THE HEALTH EFFECTS OF ACCELERATED PLACEMENTS INTO PERMANENT SUPPORTIVE HOUSING | $585,924 | 505 EIGHTH AVENUE 5TH FLOOR | NEW YORK | NY | 10018 | |||||
| BRIDGES TO PROSPERITY INC | ||||||||||||
| N/A | PC | TRANSFORMATIVE CONNECTIVITY IN RURAL ZAMBIA | $2,306,101 | 1031 33RD STREET | DENVER | CO | 80205 | |||||
| BRIDGES TO PROSPERITY INC | ||||||||||||
| N/A | PC | TRANSFORMATIVE CONNECTIVITY IN RURAL ZAMBIA | $2,359,636 | 1031 33RD STREET | DENVER | CO | 80205 | |||||
| CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST | ||||||||||||
| HILLS ROAD | CAMBRIDGE | UK | N/A | GOV | THE UK IBD BIORESOURCE: TRANSLATING TODAYS SCIENCE INTO TOMORROWS TREATMENTS IN CROHNS DISEASE | $657,605 | ||||||
| CARDIFF UNIVERSITY | ||||||||||||
| 30-36 NEWPORT RD | CARDIFF | UK | N/A | PC | T1D-PLUS: AN ADAPTIVE TRIAL PLATFORM FOR THE STUDY OF COMBINATION THERAPIES IN NEW-ONSET T1D | $892,873 | ||||||
| CARDIFF UNIVERSITY | ||||||||||||
| 30-36 NEWPORT RD | CARDIFF | UK | N/A | PC | T1D-PLUS: AN ADAPTIVE TRIAL PLATFORM FOR THE STUDY OF COMBINATION THERAPIES IN NEW-ONSET T1D | $632,664 | ||||||
| CARE-FOR-RARE FOUNDATION | ||||||||||||
| DR VON HAUNERSCHES KINDERSPITAL | MUNICH | GM | N/A | PC | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES: MUNICH STUDIES | $667,252 | KLINIKUM DER UNIVERSITAT MUNCHEN | |||||
| CATHOLIC RELIEF SERVICES-USCCB | ||||||||||||
| N/A | PC | HELPING MOTHERS AND NEWBORNS SURVIVE AND THRIVE | $1,337,724 | 228 W LEXINGTON ST | BALTIMORE | MD | 21201 | |||||
| CATHOLIC RELIEF SERVICES-USCCB | ||||||||||||
| N/A | PC | EXPANDING COMMUNITY RECOVERY AND RESILIENCE | $1,808,630 | 228 W LEXINGTON ST | BALTIMORE | MD | 21201 | |||||
| CATHOLIC RELIEF SERVICES-USCCB | ||||||||||||
| N/A | PC | HELPING MOTHERS AND NEWBORNS SURVIVE AND THRIVE | $1,273,764 | 228 W LEXINGTON ST | BALTIMORE | MD | 21201 | |||||
| CATHOLIC RELIEF SERVICES-USCCB | ||||||||||||
| N/A | PC | EXPANDING COMMUNITY RECOVERY AND RESILIENCE | $1,073,759 | 228 W LEXINGTON ST | BALTIMORE | MD | 21201 | |||||
| CEDARS-SINAI MEDICAL CENTER | ||||||||||||
| N/A | PC | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES: CEDARS-SINAI | $115,500 | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | |||||
| CEDARS-SINAI MEDICAL CENTER | ||||||||||||
| N/A | PC | A MULTIDISCIPLINARY PREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABDOMINAL SURGERY | $219,514 | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | |||||
| CEDARS-SINAI MEDICAL CENTER | ||||||||||||
| N/A | PC | A MULTIDISCIPLINARY PREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABDOMINAL SURGERY | $211,815 | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | |||||
| CEDARS-SINAI MEDICAL CENTER | ||||||||||||
| N/A | PC | THE ADVANCED DIETARY IBD EDUCATION AND TRAINING (DIET) PROGRAM: BEYOND MALNUTRITION | $519,768 | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | |||||
| CEDARS-SINAI MEDICAL CENTER | ||||||||||||
| N/A | PC | THE ADVANCED DIETARY IBD EDUCATION AND TRAINING (DIET) PROGRAM: BEYOND MALNUTRITION | $733,694 | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | |||||
| CENTER FOR HEALTH CARE STRATEGIES INC | ||||||||||||
| N/A | PC | CGM MEDICAID ACCESS ACCELERATOR - TARGETED RESOURCES AND TECHNICAL ASSISTANCE TO IMPROVE CARE FOR PEOPLE LIVING WITH DIABETES WHO USE INSULIN | $1,002,514 | 300 AMERICAN METRO BLVD | HAMILTON | NJ | 08619 | |||||
| CENTER FOR HEALTH CARE STRATEGIES INC | ||||||||||||
| N/A | PC | IDENTIFYING OPPORTUNITIES TO SUPPORT T1D AUTOANTIBODY SCREENING IN MEDICAID PROGRAMS AND HEALTH CARE SYSTEMS THAT SERVE MEDICAID BENEFICIARIES | $149,672 | 300 AMERICAN METRO BLVD | HAMILTON | NJ | 08619 | |||||
| CENTER FOR HEALTH CARE STRATEGIES INC | ||||||||||||
| N/A | PC | CGM MEDICAID ACCESS ACCELERATOR - TARGETED RESOURCES AND TECHNICAL ASSISTANCE TO IMPROVE CARE FOR PEOPLE LIVING WITH DIABETES WHO USE INSULIN | $626,707 | 300 AMERICAN METRO BLVD | HAMILTON | NJ | 08619 | |||||
| CENTRE HOSPITALIER REGIONAL DE NANCY | ||||||||||||
| 29 AVENUE MAL DE LATTRE TASSIGNY | NANCY | FR | N/A | GOV | PREVENTION OF EXTRA-INTESTINAL MANIFESTATIONS AND COMORBIDITIES IN CROHNS DISEASE: THE NEMO PROJECT | $103,796 | ||||||
| CENTRE HOSPITALIER REGIONAL DE NANCY | ||||||||||||
| 29 AVENUE MAL DE LATTRE TASSIGNY | NANCY | FR | N/A | GOV | PREVENTION OF EXTRA-INTESTINAL MANIFESTATIONS AND COMORBIDITIES IN CROHNS DISEASE: THE NEMO PROJECT | $153,102 | ||||||
| CHANCELLOR MASTERS & SCHOLARS OF THE UNIVERSITY OF OXFORD | ||||||||||||
| UNIVERSITY OFFICES WELLINGTON | OXFORD | UK | N/A | PC | THE CELLULAR LANDSCAPE OF MONOGENIC INFLAMMATORY BOWEL DISEASE IN VEOIBD | $244,860 | SQUARE | |||||
| CHANCELLOR MASTERS & SCHOLARS OF THE UNIVERSITY OF OXFORD | ||||||||||||
| UNIVERSITY OFFICES WELLINGTON | OXFORD | UK | N/A | PC | ALPHA CELL FUNCTION IN PEOPLE WITH TYPE 1 DIABETES WITH AND WITHOUT SEVERE HYPOGLYCEMIA | $202,677 | SQUARE | |||||
| CHANCELLOR MASTERS & SCHOLARS OF THE UNIVERSITY OF OXFORD | ||||||||||||
| UNIVERSITY OFFICES WELLINGTON | OXFORD | UK | N/A | PC | INTERROGATING THE MECHANISM OF HYPERSENSITIVITY TO ANTIBODY-BASED DRUGS FOR DEVELOPMENT OF A NOVEL ANTI-TNF BIOLOGIC FOR CROHNS DISEASE | $93,443 | SQUARE | |||||
| CHANCELLOR MASTERS & SCHOLARS OF THE UNIVERSITY OF OXFORD | ||||||||||||
| UNIVERSITY OFFICES WELLINGTON | OXFORD | UK | N/A | PC | ALPHA CELL FUNCTION IN PEOPLE WITH TYPE 1 DIABETES WITH AND WITHOUT SEVERE HYPOGLYCEMIA | $515,981 | SQUARE | |||||
| CHI HEALTH FOUNDATION | ||||||||||||
| N/A | PC | ECMO SUPPORT AT CHI HEALTH CREIGHTON UNIVERSITY MEDICAL CENTER-BERGAN MERCY | $229,460 | 12809 WEST DODGE ROAD | OMAHA | NE | 68154 | |||||
| CHI HEALTH FOUNDATION | ||||||||||||
| N/A | PC | ECMO SUPPORT AT CHI HEALTH CREIGHTON UNIVERSITY MEDICAL CENTER-BERGAN MERCY | $229,460 | 12809 WEST DODGE ROAD | OMAHA | NE | 68154 | |||||
| CHILDREN'S HOSPITAL CORPORATION | ||||||||||||
| N/A | PC | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES: BOSTON STUDIES | $1,470,081 | ATTN RESEARCH FINANCE | BOSTON | MA | 022414413 | |||||
| CHILDREN'S HOSPITAL LOS ANGELES | ||||||||||||
| N/A | PC | BEYOND COYOT1: EXPANSION OF PATIENT-CENTERED VIRTUAL CARE | $684,686 | SABAN RESEARCH INSTITUTE | LOS ANGELES | CA | 90027 | |||||
| CHILDREN'S HOSPITAL MEDICAL CENTER | ||||||||||||
| N/A | PC | ARTIFICIAL INTELLIGENCE PREDICTION OF MEANINGFUL OUTCOMES IN NEWLY DIAGNOSED SMALL BOWEL CROHNS DISEASE | $1,093,319 | 3333 BURNET AVENUE | CINCINNATI | OH | 45229 | |||||
| CHILDREN'S HOSPITAL MEDICAL CENTER | ||||||||||||
| N/A | PC | ROLE OF PPAR-ALPHA IN PROMOTING BRUSH BORDER MATURITY OF INTESTINAL ENTEROCYTES | $439,601 | 3333 BURNET AVENUE | CINCINNATI | OH | 45229 | |||||
| CHILDREN'S HOSPITAL MEDICAL CENTER | ||||||||||||
| N/A | PC | COMPARISON OF STANDARD-OF-CARE VS. A PATIENT-CENTRIC NONCONTRAST ABBREVIATED MR ENTEROGRAPHY PROTOCOL | $963,282 | 3333 BURNET AVENUE | CINCINNATI | OH | 45229 | |||||
| CHILDREN'S HOSPITAL MEDICAL CENTER | ||||||||||||
| N/A | PC | COMPARISON OF STANDARD-OF-CARE VS. A PATIENT-CENTRIC NONCONTRAST ABBREVIATED MR ENTEROGRAPHY PROTOCOL | $1,016,595 | 3333 BURNET AVENUE | CINCINNATI | OH | 45229 | |||||
| CHILDREN'S HOSPITAL MEDICAL CENTER | ||||||||||||
| N/A | PC | COMPARISON OF STANDARD-OF-CARE VS. A PATIENT-CENTRIC NONCONTRAST ABBREVIATED MR ENTEROGRAPHY PROTOCOL | $407,932 | 3333 BURNET AVENUE | CINCINNATI | OH | 45229 | |||||
| CHILDREN'S HOSPITAL MEDICAL CENTER | ||||||||||||
| N/A | PC | DELIVERY SYSTEM REDESIGN TO IMPROVE CARE FOR LOW-INCOME YOUTH WITH T1D | $725,157 | 3333 BURNET AVENUE | CINCINNATI | OH | 45229 | |||||
| CHILDREN'S HOSPITAL OF PHILADELPHIA | ||||||||||||
| N/A | PC | LEVERAGING HLA PROTECTION AND HUMORAL IMMUNITY TO DEVELOP MICROBIAL THERAPEUTICS THAT PREVENT T1D | $228,375 | 2716 SOUTH STREET | PHILADELPHIA | PA | 191462305 | |||||
| CITY PARKS FOUNDATION | ||||||||||||
| N/A | PC | NYC GREEN FUND | $500,000 | 830 FIFTH AVENUE | NEW YORK | NY | 10065 | |||||
| CITY PARKS FOUNDATION | ||||||||||||
| N/A | PC | NYC GREEN FUND | $500,000 | 830 FIFTH AVENUE | NEW YORK | NY | 10065 | |||||
| CLALIT HEALTH SERVICES | ||||||||||||
| 101 ARLOZOROV STREET | TEL AVIV | IS | N/A | PC | ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM MANAGEMENT | $145,605 | ||||||
| CLALIT HEALTH SERVICES | ||||||||||||
| 101 ARLOZOROV STREET | TEL AVIV | IS | N/A | PC | CLINICAL TRIAL TO EVALUATE A NOVEL MDI-BGM DECISION SUPPORT SYSTEM | $1,472,591 | ||||||
| CLALIT HEALTH SERVICES | ||||||||||||
| 101 ARLOZOROV STREET | TEL AVIV | IS | N/A | PC | ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: BIOMARKER-BASED MULTIDISCIPLINARY TEAM APPROACH TO IMPROVE EARLY CROHN'S DISEASE OUTCOMES | $463,512 | ||||||
| CLALIT HEALTH SERVICES | ||||||||||||
| 101 ARLOZOROV STREET | TEL AVIV | IS | N/A | PC | A NEW NEONATAL CENTER FOR ISRAELS SOUTHERN PERIPHERY AT SOROKA MEDICAL CENTER | $3,358,835 | ||||||
| CLALIT HEALTH SERVICES | ||||||||||||
| 101 ARLOZOROV STREET | TEL AVIV | IS | N/A | PC | A NEW NEONATAL CENTER FOR ISRAELS SOUTHERN PERIPHERY AT SOROKA MEDICAL CENTER | $2,541,165 | ||||||
| CLINTON HEALTH ACCESS INITIATIVE INC | ||||||||||||
| N/A | PC | IMPROVING MEDICAL OXYGEN PRODUCTION AND UTILIZATION | $2,811,261 | 383 DORCHESTER AVENUE SUITE 400 | BOSTON | MA | 02127 | |||||
| CLINTON HEALTH ACCESS INITIATIVE INC | ||||||||||||
| N/A | PC | IMPROVING MEDICAL OXYGEN PRODUCTION AND UTILIZATION | $1,166,919 | 383 DORCHESTER AVENUE SUITE 400 | BOSTON | MA | 02127 | |||||
| CONVERGENT IMPACT INC | ||||||||||||
| N/A | PC | COLLABORATIVE ON HOUSING FOR HEALTH | $992,300 | 3223 ARAPAHOE AVE | BOULDER | CO | 80303 | |||||
| CONVERGENT IMPACT INC | ||||||||||||
| N/A | PC | COLLABORATIVE ON HOUSING FOR HEALTH | $1,212,300 | 3223 ARAPAHOE AVE | BOULDER | CO | 80303 | |||||
| COREWELL HEALTH | ||||||||||||
| N/A | PC | EXPANDING ACCESS TO ROBOTIC PCI AND ESTABLISHING A MULTI-STATE NETWORK TO STUDY THE FEASIBILITY OF TELEROBOTIC HEART ATTACK AND STROKE INTERVENTIONS | $3,104,271 | 100 MICHIGAN ST NE | GRAND RAPIDS | MI | 49503 | |||||
| COREWELL HEALTH | ||||||||||||
| N/A | PC | EXPANDING ACCESS TO ROBOTIC PCI AND ESTABLISHING A MULTI-STATE NETWORK TO STUDY THE FEASIBILITY OF TELEROBOTIC HEART ATTACK AND STROKE INTERVENTIONS | $2,081,202 | 100 MICHIGAN ST NE | GRAND RAPIDS | MI | 49503 | |||||
| CORK UNIVERSITY FOUNDATION | ||||||||||||
| WESTERN ROAD | CORK | EI | N/A | PC | ENDOSCOPIC MULTIMODAL ASSESSMENT USING ADVANCED IMAGING INTEGRATED AI TO PREDICT RECURRENCE IN POST-OPERATIVE CROHNS DISEASE - PROSPERS | $663,503 | ||||||
| CORK UNIVERSITY FOUNDATION | ||||||||||||
| WESTERN ROAD | CORK | EI | N/A | PC | ENDOSCOPIC MULTIMODAL ASSESSMENT USING ADVANCED IMAGING INTEGRATED AI TO PREDICT RECURRENCE IN POST-OPERATIVE CROHNS DISEASE - PROSPERS | $941,943 | ||||||
| CORPORATION FOR SUPPORTIVE HOUSING | ||||||||||||
| N/A | PC | HEALTH-ENRICHED SERVICES PILOTS FOR SUPPORTIVE HOUSING | $1,000,000 | 61 BROADWAY | NEW YORK CITY | NY | 10006 | |||||
| CORPORATION FOR SUPPORTIVE HOUSING | ||||||||||||
| N/A | PC | HEALTH-ENRICHED SERVICES PILOTS FOR SUPPORTIVE HOUSING | $800,000 | 61 BROADWAY | NEW YORK CITY | NY | 10006 | |||||
| COZAD HOSPITAL DISTRICT NO 2 | ||||||||||||
| N/A | GOV | TELE-EMERGENCY AT COZAD COMMUNITY HEALTH SYSTEM | $35,283 | 300 EAST 12TH STREET | COZAD | NE | 69130 | |||||
| COZAD HOSPITAL DISTRICT NO 2 | ||||||||||||
| N/A | GOV | TELE-EMERGENCY AT COZAD COMMUNITY HEALTH SYSTEM | $17,570 | 300 EAST 12TH STREET | COZAD | NE | 69130 | |||||
| CRITICAL PATH INSTITUTE | ||||||||||||
| N/A | PC | TRANSLATIONAL THERAPEUTICS ACCELERATOR: DEVELOPING KINASE INHIBITORS OF THE UNFOLDED PROTEIN RESPONSE TO TREAT T1D | $500,000 | 1840 EAST RIVER ROAD | TUCSON | AZ | 85718 | |||||
| CRITICAL PATH INSTITUTE | ||||||||||||
| N/A | PC | T1D CONSORTIUM 2.0 | $266,741 | 1840 EAST RIVER ROAD | TUCSON | AZ | 85718 | |||||
| CROHN'S & COLITIS FOUNDATION INC | ||||||||||||
| N/A | PC | IBD VENTURES ACADEMIC INCUBATOR | $1,180,400 | 733 THIRD AVENUE SUITE 510 | NEW YORK | NY | 10017 | |||||
| CROHN'S & COLITIS FOUNDATION INC | ||||||||||||
| N/A | PC | APPLICATION OF MACHINE LEARNING TO PRECISION NUTRITION IN CROHNS DISEASE | $342,493 | 733 THIRD AVENUE SUITE 510 | NEW YORK | NY | 10017 | |||||
| CROHN'S & COLITIS FOUNDATION INC | ||||||||||||
| N/A | PC | ACCELERATING ENROLLMENT IN IBD CLINICAL TRIALS | $744,245 | 733 THIRD AVENUE SUITE 510 | NEW YORK | NY | 10017 | |||||
| CROHN'S & COLITIS FOUNDATION INC | ||||||||||||
| N/A | PC | APPLICATION OF MACHINE LEARNING TO PRECISION NUTRITION IN CROHNS DISEASE | $626,728 | 733 THIRD AVENUE SUITE 510 | NEW YORK | NY | 10017 | |||||
| CROHN'S & COLITIS FOUNDATION INC | ||||||||||||
| N/A | PC | ACCELERATING ENROLLMENT IN IBD CLINICAL TRIALS | $375,484 | 733 THIRD AVENUE SUITE 510 | NEW YORK | NY | 10017 | |||||
| CROHN'S AND COLITIS CANADA | ||||||||||||
| 60 ST CLAIR AVE EAST SUITE 600 | TORONTO | CA | N/A | PC | IMPLEMENTATION OF NATIONWIDE TELEMEDICINE NETWORK TO MITIGATE GEOGRAPHIC DISPARITIES IN ACCESS TO HEALTHCARE FOR CD PATIENTS LIVING IN CANADA | $374,912 | ||||||
| CROHN'S AND COLITIS CANADA | ||||||||||||
| 60 ST CLAIR AVE EAST SUITE 600 | TORONTO | CA | N/A | PC | IMPLEMENTING A MULTIMODAL RCT INTERVENTION TO IMPROVE THE TRANSITION OF PATIENTS WITH CROHNS DISEASE FROM PEDIATRIC TO ADULT CARE | $297,612 | ||||||
| DARTMOUTH- HITCHCOCK CLINIC | ||||||||||||
| N/A | PC | CAPACITY BUILDING FOR DARTMOUTH-HITCHCOCK'S VIRTUAL IBD TELEMEDICINE NETWORK PROGRAM | $525,177 | ONE MEDICAL CENTER DRIVE | LEBANON | NH | 03756 | |||||
| DIABETES NSW | ||||||||||||
| 26 ARUNDEL ST | SYDNEY | AS | N/A | PC | IMPROVEMENTS IN OUTCOMES FOR YOUNG PEOPLE WITH DIABETES IN LESS-RESOURCED COUNTRIES, THROUGH EXPANSION AND COUNTRY-SPECIFIC DATA-DRIVEN INITIATIVES | $4,299,165 | ||||||
| DUNDY COUNTY HOSPITAL | ||||||||||||
| N/A | GOV | TELE-EMERGENCY SERVICES AT DUNDY COUNTY HOSPITAL | $11,725 | 1313 N CHEYENNE ST | BENKELMAN | NE | 69021 | |||||
| EMORY UNIVERSITY | ||||||||||||
| N/A | PC | CARDIAC ARREST REGISTRY TO ENHANCE SURVIVAL (CARES) HELMSLEY STATE EXPANSION | $302,430 | 1599 CLIFTON ROAD NE | ATLANTA | GA | 303224250 | |||||
| EMORY UNIVERSITY | ||||||||||||
| N/A | PC | CARDIAC ARREST REGISTRY TO ENHANCE SURVIVAL (CARES) HELMSLEY STATE EXPANSION | $283,099 | 1599 CLIFTON ROAD NE | ATLANTA | GA | 303224250 | |||||
| FAIRVIEW HEALTH SERVICES | ||||||||||||
| N/A | PC | IMPROVING SURVIVAL OUTCOMES THROUGH UNIVERSITY OF MINNESOTA MEDICAL CENTER ECMO CENTER OF EXCELLENCE | $3,176,500 | 2450 RIVERSIDE AVE | MINNEAPOLIS | MN | 55454 | |||||
| FEDERAL INSTITUTE OF TECHNOLOGY ZURICH ETHZ | ||||||||||||
| RAMISTRASSE 101 | ZURICH | SZ | N/A | PC | SPATIAL BIOLOGY OF CROHNS COLITIS | $421,278 | ||||||
| FJC | ||||||||||||
| N/A | PC | THE WELLNESS CLASSROOM, A PROJECT OF FJC - A FOUNDATION OF PHILANTHROPIC FUNDS | $1,000,000 | 225 WEST 39TH STREET | NEW YORK | NY | 10018 | |||||
| FJC | ||||||||||||
| N/A | PC | NYC FUND TO END YOUTH & FAMILY HOMELESSNESS, A PROJECT OF FJC. | $300,000 | 225 WEST 39TH STREET | NEW YORK | NY | 10018 | |||||
| FJC | ||||||||||||
| N/A | PC | THE WELLNESS CLASSROOM, A PROJECT OF FJC - A FOUNDATION OF PHILANTHROPIC FUNDS | $1,000,000 | 225 WEST 39TH STREET | NEW YORK | NY | 10018 | |||||
| FOR INSPIRATION AND RECOGNITION OF SCIENCE AND TECHNOLOGY (FIRST) | ||||||||||||
| N/A | PC | FIRST SENIOR MENTOR PROGRAM | $200,000 | 200 BEDFORD STREET | MANCHESTER | NH | 03101 | |||||
| FOR INSPIRATION AND RECOGNITION OF SCIENCE AND TECHNOLOGY (FIRST) | ||||||||||||
| N/A | PC | FIRST SENIOR MENTOR PROGRAM | $200,000 | 200 BEDFORD STREET | MANCHESTER | NH | 03101 | |||||
| FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS FIND | ||||||||||||
| CAMPUS BIOTECH | GENEVA | SZ | N/A | PC | ACESS TO CGMS FOR EQUITY IN DIABETES MANAGEMENT - THE ACCEDE PROJECT | $1,118,735 | ||||||
| GALILEE MEDICAL CENTER | ||||||||||||
| GALILEE MEDICAL CENTER | NAHARIYA | IS | N/A | GOV | RENOVATION OF TWO FLOORS OF THE INTERNAL MEDICINE BUILDING AT GALILEE MEDICAL CENTER | $2,200,000 | ||||||
| GATES PHILANTHROPY PARTNERS | ||||||||||||
| N/A | PC | POLIO ERADICATION FUND SUPPORT | $1,000,000 | PO BOX 60555 | CITY OF INDUSTRY | CA | 91716 | |||||
| GATES PHILANTHROPY PARTNERS | ||||||||||||
| N/A | PC | POLIO ERADICATION FUND SUPPORT | $1,000,000 | PO BOX 60555 | CITY OF INDUSTRY | CA | 91716 | |||||
| GENOME RESEARCH LIMITED FOR THE WELLCOME SANGER INSTITUTE | ||||||||||||
| WELLCOME GENOME CAMPUS | CAMBRIDGE | UK | N/A | PC | SCIBD-RESPONSE: MASSIVE-SCALE SINGLE-CELL RNA-SEQUENCING TO IDENTIFY TRANSCRIPTOMIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPIES IN CROHNS DISEASE | $402,672 | ||||||
| GENOME RESEARCH LIMITED FOR THE WELLCOME SANGER INSTITUTE | ||||||||||||
| WELLCOME GENOME CAMPUS | CAMBRIDGE | UK | N/A | PC | SCIBD-RESPONSE: MASSIVE-SCALE SINGLE-CELL RNA-SEQUENCING TO IDENTIFY TRANSCRIPTOMIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPIES IN CROHNS DISEASE | $187,672 | ||||||
| GENOME RESEARCH LIMITED FOR THE WELLCOME SANGER INSTITUTE | ||||||||||||
| WELLCOME GENOME CAMPUS | CAMBRIDGE | UK | N/A | PC | SCIBD-RESPONSE: MASSIVE-SCALE SINGLE-CELL RNA-SEQUENCING TO IDENTIFY TRANSCRIPTOMIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPIES IN CROHNS DISEASE | $143,892 | ||||||
| GEORGETOWN UNIVERSITY | ||||||||||||
| N/A | PC | ADVANCING ACCESS TO HIGH QUALITY, AFFORDABLE DIABETES CARE THROUGH PRIVATE HEALTH INSURANCE REGULATION | $432,998 | 37TH O STREET NW | WASHINGTON | DC | 20057 | |||||
| GEORGIA TECH RESEARCH CORPORATION | ||||||||||||
| N/A | SOIII FI | LONGITUDINAL TRACKING AND REFERENCE-BASED INTERPRETATION OF SINGLE-CELL CHARACTERISTICS IN TREATMENT NAVE PATIENTS WITH CROHNS DISEASE | $485,616 | 505 10TH STREET NW | ATLANTA | GA | 303320420 | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | GPPAD BIOSAMPLE RFP | $1,046,486 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | EUROPEAN PRE-T1D REGISTRY | $196,089 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | GPPAD COORDINATION CENTER CONTINUATION | $1,000,684 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | $1,188,316 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | CONTINUATION OF THE GPPAD-02-STUDY: IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS | $1,927,629 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL | $2,029,929 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | FR1DA ORAL INSULIN INTERVENTION TRIAL AMENDMENT | $228,040 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | GPPAD COORDINATION CENTER CONTINUATION | $1,042,232 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | $1,188,316 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | THE GPPAD-05 STUDY: ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | $2,348,061 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL | $2,466,113 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | CONTINUATION 2 OF THE GPPAD-02-STUDY: IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS | $3,500,510 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | GPPAD DRIED BLOOD SPOT OMICS TO PREDICT HEALTH AND AUTOIMMUNITY OUTCOMES IN CHILDREN | $162,877 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | GPPAD BIOSAMPLE RFP | $95,294 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | GPPAD COORDINATION CENTER CONTINUATION | $1,042,232 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | $1,466,731 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL | $2,466,114 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | CONTINUATION 2 OF THE GPPAD-02-STUDY: IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS | $3,500,510 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | THE GPPAD-05 STUDY: ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | $4,557,698 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | $1,466,732 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | CONTINUATION 2 OF THE GPPAD-02-STUDY: IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS | $3,640,094 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | THE GPPAD-05 STUDY: ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | $4,557,698 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | $1,348,365 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | CONTINUATION 2 OF THE GPPAD-02-STUDY: IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS | $3,640,094 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | THE GPPAD-05 STUDY: ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | $5,772,918 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | $1,348,365 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | CONTINUATION 2 OF THE GPPAD-02-STUDY: IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS | $3,982,146 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | THE GPPAD-05 STUDY: ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | $5,772,917 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | $1,761,496 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | CONTINUATION 2 OF THE GPPAD-02-STUDY: IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS | $3,982,146 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | THE GPPAD-05 STUDY: ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | $5,928,622 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | $1,761,496 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | THE GPPAD-05 STUDY: ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | $5,928,622 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | THE GPPAD-05 STUDY: ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | $4,903,870 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | $526,471 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | THE GPPAD-05 STUDY: ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | $4,903,869 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | THE GPPAD-05 STUDY: ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | $3,470,012 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | THE GPPAD-05 STUDY: ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | $3,470,011 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | THE GPPAD-05 STUDY: ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | $1,676,154 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | THE GPPAD-05 STUDY: ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | $1,676,153 | GESUNDHEIT UND UMWELT GMBH | |||||
| HELMHOLTZ ZENTRUM MUNCHEN (GMBH) | ||||||||||||
| DEUTSCHES FORSCHUNGSZENTRUM FUR | NEUHERBERG | GM | N/A | PC | CONTINUATION 2 OF THE GPPAD-02-STUDY: IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS | $1,310,183 | GESUNDHEIT UND UMWELT GMBH | |||||
| HERLEV OG GENTOFTE HOSPITAL | ||||||||||||
| HERLEV AND GENTOFTE HOSPITAL | HERLEV | DA | N/A | GOV | TARGETING GIP/GLP-2 RECEPTORS TO PREVENT HYPOGLYCEMIA IN T1D | $140,000 | ||||||
| HERLEV OG GENTOFTE HOSPITAL | ||||||||||||
| HERLEV AND GENTOFTE HOSPITAL | HERLEV | DA | N/A | GOV | UTILIZATION OF INTERACTION BETWEEN AMINO ACIDS & GIP IN PANCREATIC CELLS | $135,722 | ||||||
| HIGH QUALITY MEDICAL EDUCATION | ||||||||||||
| N/A | PC | POINT-OF-CARE ULTRASOUND (POCUS) TRAINING FOR MINNESOTA RURAL PROVIDERS | $1,705,225 | 4117 PENFIELD CT S | AFTON | MN | 55001 | |||||
| HIGH QUALITY MEDICAL EDUCATION | ||||||||||||
| N/A | PC | POINT-OF-CARE ULTRASOUND (POCUS) TRAINING FOR MINNESOTA RURAL PROVIDERS | $2,112,639 | 4117 PENFIELD CT S | AFTON | MN | 55001 | |||||
| HILLEL YAFFE MEDICAL CENTER | ||||||||||||
| HA-SHALOM ST | HADERA | IS | N/A | GOV | EYE INSTITUTE AND AMBULATORY SURGERY CENTER | $3,158,400 | ||||||
| HUMBOLDT COUNTY MEMORIAL HOSPITAL | ||||||||||||
| N/A | GOV | TELE-EMERGENCY SERVICES AT HUMBOLDT COUNTY MEMORIAL HOSPITAL | $39,438 | 1000 N 15TH ST | HUMBOLDT | IA | 50548 | |||||
| HUMBOLDT COUNTY MEMORIAL HOSPITAL | ||||||||||||
| N/A | GOV | TELE-EMERGENCY SERVICES AT HUMBOLDT COUNTY MEMORIAL HOSPITAL | $15,775 | 1000 N 15TH ST | HUMBOLDT | IA | 50548 | |||||
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ||||||||||||
| N/A | PC | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES: MOUNT SINAI STUDIES | $220,000 | 1 GUSTAVE L LEVY PL | NEW YORK CITY | NY | 10029 | |||||
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ||||||||||||
| N/A | PC | PROMOTE BIRTH EQUITY THROUGH COMMUNITY-BASED DOULA CARE, AN ADAPTATION FOR NYCS COMMUNITY MEMBERS, HOMELESS AND JUSTICE-INVOLVED PREGNANT PERSONS. | $779,716 | 1 GUSTAVE L LEVY PL | NEW YORK CITY | NY | 10029 | |||||
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ||||||||||||
| N/A | PC | DEFINING THE PRE-DISEASE PHASE OF CROHNS DISEASE: PREDICT AND PREVENT | $1,974,021 | 1 GUSTAVE L LEVY PL | NEW YORK CITY | NY | 10029 | |||||
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ||||||||||||
| N/A | PC | SPATIAL MAPPING OF FIBROMUSCULAR CROHNS DISEASE: FROM GENETIC TO SENESCENT SIGNALS | $920,802 | 1 GUSTAVE L LEVY PL | NEW YORK CITY | NY | 10029 | |||||
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ||||||||||||
| N/A | PC | DEFINING THE PRE-DISEASE PHASE OF CROHNS DISEASE: PREDICT AND PREVENT | $587,152 | 1 GUSTAVE L LEVY PL | NEW YORK CITY | NY | 10029 | |||||
| IDA COUNTY IOWA COMMUNITY HOSPITAL | ||||||||||||
| N/A | PC | TELE-EMERGENCY SERVICES AT HORN MEMORIAL HOSPITAL | $44,685 | 701 EAST SECOND STREET | IDA GROVE | IA | 51445 | |||||
| IDA COUNTY IOWA COMMUNITY HOSPITAL | ||||||||||||
| N/A | PC | TELE-EMERGENCY SERVICES AT HORN MEMORIAL HOSPITAL | $17,875 | 701 EAST SECOND STREET | IDA GROVE | IA | 51445 | |||||
| INNODIA | ||||||||||||
| HERESTRAAT 49 | LEUVEN | BE | N/A | PC | INNODIA NONPROFIT LAUNCH | $434,183 | ||||||
| INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG | ||||||||||||
| 1 RUE LOUIS RECH | DUDELANGE | LU | N/A | GOV | GPPAD BIOBANK - SINT1A | $108,203 | ||||||
| INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG | ||||||||||||
| 1 RUE LOUIS RECH | DUDELANGE | LU | N/A | GOV | BIOBANKING FOR THE PRIMARY ORAL INSULIN TRIAL | $164,873 | ||||||
| INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG | ||||||||||||
| 1 RUE LOUIS RECH | DUDELANGE | LU | N/A | GOV | GPPAD BIOBANK - SINT1A | $113,757 | ||||||
| INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG | ||||||||||||
| 1 RUE LOUIS RECH | DUDELANGE | LU | N/A | GOV | GPPAD BIOBANK - SINT1A | $109,309 | ||||||
| INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG | ||||||||||||
| 1 RUE LOUIS RECH | DUDELANGE | LU | N/A | GOV | GPPAD BIOBANK - SINT1A | $114,864 | ||||||
| INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG | ||||||||||||
| 1 RUE LOUIS RECH | DUDELANGE | LU | N/A | GOV | GPPAD BIOBANK - SINT1A | $112,522 | ||||||
| INSTITUTE FOR COMMUNITY LIVING INC | ||||||||||||
| N/A | PC | PILOTING A THREE-YEAR IMT/ACT STEP-DOWN PROJECT | $749,790 | 125 BROAD STREET | NEW YORK CITY | NY | 10004 | |||||
| INSTITUTE FOR COMMUNITY LIVING INC | ||||||||||||
| N/A | PC | PILOTING A THREE-YEAR IMT/ACT STEP-DOWN PROJECT | $749,790 | 125 BROAD STREET | NEW YORK CITY | NY | 10004 | |||||
| INTERNATIONAL ALLIANCE FOR DIABETES ACTION INC | ||||||||||||
| N/A | PC | SEED FUNDING SUPPORT | $893,663 | 75 STATE STREET | BOSTON | MA | 02109 | |||||
| INTERNATIONAL ALLIANCE FOR DIABETES ACTION INC | ||||||||||||
| N/A | PC | SEED FUNDING SUPPORT | $971,684 | 75 STATE STREET | BOSTON | MA | 02109 | |||||
| INTERNATIONAL BOWEL ULTRASOUND GROUP EV | ||||||||||||
| HARKORTSTR 1 | MUNSTER | GM | N/A | NC | THE EXTENT STUDY (CALCULATING THE LEMANN INDEX USING INTESTINAL ULTRASOUND) | $488,553 | ||||||
| INTERNATIONAL BOWEL ULTRASOUND GROUP EV | ||||||||||||
| HARKORTSTR 1 | MUNSTER | GM | N/A | NC | DEVELOPMENT OF ELEARNING PLATFORM FOR STANDARDIZATION AND DISSEMINATION OF INTESTINAL ULTRASOUND EDUCATION GLOBALLY (IBUS EIUS ED) | $645,000 | ||||||
| INTERNATIONAL BOWEL ULTRASOUND GROUP EV | ||||||||||||
| HARKORTSTR 1 | MUNSTER | GM | N/A | NC | THE EXTENT STUDY (CALCULATING THE LEMANN INDEX USING INTESTINAL ULTRASOUND) | $688,466 | ||||||
| INTERNATIONAL BOWEL ULTRASOUND GROUP EV | ||||||||||||
| HARKORTSTR 1 | MUNSTER | GM | N/A | NC | DEVELOPMENT OF ELEARNING PLATFORM FOR STANDARDIZATION AND DISSEMINATION OF INTESTINAL ULTRASOUND EDUCATION GLOBALLY (IBUS EIUS ED) | $296,500 | ||||||
| INTERNATIONAL WATER MANAGEMENT INSTITUTE | ||||||||||||
| 127 SUNIL MAWATHA | BATTARAMULLA | CE | N/A | PC | DIGITAL INNOVATIONS FOR A WATER SECURE AFRICA | $2,449,440 | ||||||
| INTERNATIONAL WATER MANAGEMENT INSTITUTE | ||||||||||||
| 127 SUNIL MAWATHA | BATTARAMULLA | CE | N/A | PC | DIGITAL INNOVATIONS FOR A WATER SECURE AFRICA | $1,550,680 | ||||||
| ISRAEL CENTER ON ADDICTION RA | ||||||||||||
| 2 HATZORAN ST | NETANYA | IS | N/A | PC | ICA'S EMERGENCY MENTAL HEALTH SUPPORT | $55,000 | ||||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | ||||||||||||
| N/A | PC | EXERCISE IN DIABETES INITIATIVE: LARGE ADULT STUDY | $159,838 | 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | |||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | ||||||||||||
| N/A | PC | EVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CONTINUOUS GLUCOSE MONITORING WITH DIABETIC RETINOPATHY | $410,774 | 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | |||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | ||||||||||||
| N/A | PC | VIRTUAL DIABETES SPECIALTY CLINIC (VDISC) - A STUDY EVALUATING REMOTE INITIATION OF CONTINUOUS GLUCOSE MONITORING | $273,882 | 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | |||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | ||||||||||||
| N/A | PC | EDUCATIONAL INTERVENTION TO SUPPORT DIABETES GUIDANCE FOR EXERCISE (EDGE) | $805,385 | 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | |||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | ||||||||||||
| N/A | PC | EVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CONTINUOUS GLUCOSE MONITORING WITH DIABETIC RETINOPATHY | $413,871 | 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | |||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | ||||||||||||
| N/A | PC | PREGNANCY DATA REPOSITORY TO ASSESS MANAGEMENT OF TYPE 1 DIABETES WITH DIABETES TECHNOLOGY (PRAM-T1D) | $1,256,044 | 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | |||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | ||||||||||||
| N/A | PC | LEVERAGING NEW ULTRA-RAPID INSULINS WITH AID FOR EXERCISE MANAGEMENT WITH T1D | $191,816 | 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | |||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | ||||||||||||
| N/A | PC | EVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CONTINUOUS GLUCOSE MONITORING WITH DIABETIC RETINOPATHY | $357,597 | 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | |||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | ||||||||||||
| N/A | PC | PREGNANCY DATA REPOSITORY TO ASSESS MANAGEMENT OF TYPE 1 DIABETES WITH DIABETES TECHNOLOGY (PRAM-T1D) | $1,223,066 | 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | |||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | ||||||||||||
| N/A | PC | EVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CONTINUOUS GLUCOSE MONITORING WITH DIABETIC RETINOPATHY | $188,007 | 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | |||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | ||||||||||||
| N/A | PC | LEVERAGING NEW ULTRA-RAPID INSULINS WITH AID FOR EXERCISE MANAGEMENT WITH T1D | $1,025,846 | 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | |||||
| JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC | ||||||||||||
| N/A | PC | VIRTUAL DIABETES SPECIALTY CLINIC (VDISC) - A STUDY EVALUATING REMOTE INITIATION OF CONTINUOUS GLUCOSE MONITORING | $194,126 | 15310 AMBERLY DRIVE SUITE 350 | TAMPA | FL | 33647 | |||||
| JDRF AUSTRALIA | ||||||||||||
| 80-84 CHANDOS STREET ST LEONARDS | SYDNEY | AS | N/A | PC | ENDIA FOLLOW UP 2023-2025 + SAMPLES ANALYSIS RFA | $1,196,912 | 2065 NSW AUSTRALIA | |||||
| JDRF AUSTRALIA | ||||||||||||
| 80-84 CHANDOS STREET ST LEONARDS | SYDNEY | AS | N/A | PC | ENDIA FOLLOW UP 2023-2025 + SAMPLES ANALYSIS RFA | $997,843 | 2065 NSW AUSTRALIA | |||||
| JDRF INTERNATIONAL | ||||||||||||
| N/A | PC | CO-FUNDED DEVELOPMENT OF A MICRONEEDLE SENSOR FOR SIMULTANEOUS CONTINUOUS MONITORING OF KETONES AND GLUCOSE | $133,332 | 200 VESEY STREET | NEW YORK | NY | 10281 | |||||
| JDRF INTERNATIONAL | ||||||||||||
| N/A | PC | CO-FUNDED DEVELOPMENT OF A 3--HYDROXYBUTYRATE BINDING PROTEIN BASED CONTINUOUS KETONE MONITORING MICROSENSOR | $200,000 | 200 VESEY STREET | NEW YORK | NY | 10281 | |||||
| JDRF INTERNATIONAL | ||||||||||||
| N/A | PC | HELMSLEY AND JDRF CO-FUNDED WORKSHOPS | $105,404 | 200 VESEY STREET | NEW YORK | NY | 10281 | |||||
| JDRF INTERNATIONAL | ||||||||||||
| N/A | PC | JOINING FORCES: BUILDING A SHARED 'GRAND ACCESS STRATEGY' FOR SAVING T1D LIVES | $250,000 | 200 VESEY STREET | NEW YORK | NY | 10281 | |||||
| JDRF INTERNATIONAL | ||||||||||||
| N/A | PC | CO-FUNDED DEVELOPMENT OF A MICRONEEDLE SENSOR FOR SIMULTANEOUS CONTINUOUS MONITORING OF KETONES AND GLUCOSE | $133,334 | 200 VESEY STREET | NEW YORK | NY | 10281 | |||||
| JDRF INTERNATIONAL | ||||||||||||
| N/A | PC | HELMSLEY AND JDRF CO-FUNDED WORKSHOPS | $145,404 | 200 VESEY STREET | NEW YORK | NY | 10281 | |||||
| JDRF INTERNATIONAL | ||||||||||||
| N/A | PC | JOINING FORCES: BUILDING A SHARED 'GRAND ACCESS STRATEGY' FOR SAVING T1D LIVES | $250,000 | 200 VESEY STREET | NEW YORK | NY | 10281 | |||||
| JERUSALEM COLLEGE OF TECHNOLOGY | ||||||||||||
| 21 HAVAAD HALEUMI ST | JERUSALEM | IS | N/A | PC | EMERGENCY SUPPORT FOR STUDENTS AT THE JERUSALEM COLLEGE OF TECHNOLOGY. | $100,000 | ||||||
| JOHNS HOPKINS UNIVERSITY | ||||||||||||
| N/A | PC | ENGINEERED CYTOKINE/ANTIBODY FUSION PROTEIN TO TREAT CROHNS DISEASE | $750,000 | 733 NORTH BROADWAY MRB 117 | BALTIMORE | MD | 21205 | |||||
| JOHNS HOPKINS UNIVERSITY | ||||||||||||
| N/A | PC | DEVELOPMENT OF AN APTAMER-BASED BIOSENSOR FOR CONTINUOUS INSULIN MONITORING | $742,901 | 733 NORTH BROADWAY MRB 117 | BALTIMORE | MD | 21205 | |||||
| JOHNS HOPKINS UNIVERSITY | ||||||||||||
| N/A | PC | TARGETED, SUSTAINED RELEASE ANTIFIBROTIC THERAPIES FOR CROHNS DISEASE PATIENTS | $571,287 | 733 NORTH BROADWAY MRB 117 | BALTIMORE | MD | 21205 | |||||
| JOSLIN DIABETES CENTER INC | ||||||||||||
| N/A | PC | AN INTEGRATED CARE MODEL FOR OLDER ADULTS WITH INSULIN-TREATED DIABETES | $287,280 | ONE JOSLIN PLACE | BOSTON | MA | 02215 | |||||
| JOSLIN DIABETES CENTER INC | ||||||||||||
| N/A | PC | AN INTEGRATED CARE MODEL FOR OLDER ADULTS WITH INSULIN-TREATED DIABETES | $569,990 | ONE JOSLIN PLACE | BOSTON | MA | 02215 | |||||
| KAISER FOUNDATION HEALTH PLAN OF GEORGIA INC | ||||||||||||
| N/A | PC | EXPANSION OF THE T1DES PILOT TO A PUBLIC HOSPITAL | $255,687 | 1375 PEACHTREE STREET NE | ATLANTA | GA | 30309 | |||||
| KATHOLIEKE UNIVERSITEIT TE LEUVEN | ||||||||||||
| WAAISTRAAT 6 BOX 5105 | LEUVEN | BE | N/A | PC | FAT AS A VILLAIN IN CROHN'S DISEASE. | $1,456,556 | ||||||
| KATHOLIEKE UNIVERSITEIT TE LEUVEN | ||||||||||||
| WAAISTRAAT 6 BOX 5105 | LEUVEN | BE | N/A | PC | EMBODY: EFFECTS OF A MINDFULNESS BASED INTERVENTION ON IBD DISABILITY | $221,407 | ||||||
| KATHOLIEKE UNIVERSITEIT TE LEUVEN | ||||||||||||
| WAAISTRAAT 6 BOX 5105 | LEUVEN | BE | N/A | PC | IDS 2024 BRUGES | $50,000 | ||||||
| KATHOLIEKE UNIVERSITEIT TE LEUVEN | ||||||||||||
| WAAISTRAAT 6 BOX 5105 | LEUVEN | BE | N/A | PC | COMBINATION THERAPY OF DIET WITH BIOLOGICALS FOR CROHNS DISEASE: THE OATS STUDY | $490,041 | ||||||
| KATHOLIEKE UNIVERSITEIT TE LEUVEN | ||||||||||||
| WAAISTRAAT 6 BOX 5105 | LEUVEN | BE | N/A | PC | EDENT1FI | $1,551,603 | ||||||
| KATHOLIEKE UNIVERSITEIT TE LEUVEN | ||||||||||||
| WAAISTRAAT 6 BOX 5105 | LEUVEN | BE | N/A | PC | FAT AS A VILLAIN IN CROHN'S DISEASE. | $1,344,948 | ||||||
| KATHOLIEKE UNIVERSITEIT TE LEUVEN | ||||||||||||
| WAAISTRAAT 6 BOX 5105 | LEUVEN | BE | N/A | PC | EMBODY: EFFECTS OF A MINDFULNESS BASED INTERVENTION ON IBD DISABILITY | $199,460 | ||||||
| KATHOLIEKE UNIVERSITEIT TE LEUVEN | ||||||||||||
| WAAISTRAAT 6 BOX 5105 | LEUVEN | BE | N/A | PC | EMBODY: EFFECTS OF A MINDFULNESS BASED INTERVENTION ON IBD DISABILITY | $205,983 | ||||||
| KATHOLIEKE UNIVERSITEIT TE LEUVEN | ||||||||||||
| WAAISTRAAT 6 BOX 5105 | LEUVEN | BE | N/A | PC | EDENT1FI | $1,574,759 | ||||||
| KATHOLIEKE UNIVERSITEIT TE LEUVEN | ||||||||||||
| WAAISTRAAT 6 BOX 5105 | LEUVEN | BE | N/A | PC | EDENT1FI | $1,018,620 | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| 150 STAMFORD STREET | LONDON | UK | N/A | PC | T CELL RECEPTOR SEQUENCING IN TYPE 1 DIABETES - BIOMARKER DISCOVERY AND TECHNOLOGY DEVELOPMENT | $115,097 | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| 150 STAMFORD STREET | LONDON | UK | N/A | PC | CHARACTERISING NOGO AUTOIMMUNITY IN GENETICALLY PROTECTED (HLA-DQ6+) SUBJECTS | $278,644 | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| 150 STAMFORD STREET | LONDON | UK | N/A | PC | PRENATAL DRIVERS OF INFANT ISLET AUTOIMMUNITY (PISA STUDY) | $825,146 | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| 150 STAMFORD STREET | LONDON | UK | N/A | PC | RESOLVING HARMFUL ACCUMULATION OF INNATE LYMPHOID CELLS DURING CROHNS DISEASE. | $384,292 | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| 150 STAMFORD STREET | LONDON | UK | N/A | PC | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | $369,984 | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| 150 STAMFORD STREET | LONDON | UK | N/A | PC | HYPO - RESOLVE - EVALUATION OF BIOLOGICAL, SOCIAL AND ECONOMIC IMPACT OF HYPOGLYCEMIA | $307,779 | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| 150 STAMFORD STREET | LONDON | UK | N/A | PC | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | $1,147,254 | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| 150 STAMFORD STREET | LONDON | UK | N/A | PC | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | $1,296,483 | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| 150 STAMFORD STREET | LONDON | UK | N/A | PC | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | $1,325,562 | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| 150 STAMFORD STREET | LONDON | UK | N/A | PC | CHARACTERISING NOGO AUTOIMMUNITY IN GENETICALLY PROTECTED (HLA-DQ6+) SUBJECTS | $208,787 | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| 150 STAMFORD STREET | LONDON | UK | N/A | PC | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | $778,535 | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| 150 STAMFORD STREET | LONDON | UK | N/A | PC | PRENATAL DRIVERS OF INFANT ISLET AUTOIMMUNITY (PISA STUDY) | $781,151 | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| 150 STAMFORD STREET | LONDON | UK | N/A | PC | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | $1,069,889 | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| 150 STAMFORD STREET | LONDON | UK | N/A | PC | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | $1,079,926 | ||||||
| KING'S COLLEGE LONDON | ||||||||||||
| 150 STAMFORD STREET | LONDON | UK | N/A | PC | RESOLVING HARMFUL ACCUMULATION OF INNATE LYMPHOID CELLS DURING CROHNS DISEASE. | $325,389 | ||||||
| KLINIKUM DER LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN | ||||||||||||
| FEODOR-LYNEN-STRABE 17 | MUNCHEN | GM | N/A | GOV | FECAL MICROBIOTA TRANSFER FOR MAINTENANCE OF REMISSION AFTER INDUCTION TREATMENT WITH EXCLUSIVE ENTERAL NUTRITION IN CROHNS DISEASE | $925,603 | ||||||
| KLINIKUM DER LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN | ||||||||||||
| FEODOR-LYNEN-STRABE 17 | MUNCHEN | GM | N/A | GOV | FECAL MICROBIOTA TRANSFER FOR MAINTENANCE OF REMISSION AFTER INDUCTION TREATMENT WITH EXCLUSIVE ENTERAL NUTRITION IN CROHNS DISEASE | $931,293 | ||||||
| LIVING WATER INTERNATIONAL | ||||||||||||
| N/A | PC | SCALING INTEGRATED WASH SERVICES | $2,574,349 | 4001 GREENBRIAR DRIVE | STAFFORD | VA | 77477 | |||||
| LIVING WATER INTERNATIONAL | ||||||||||||
| N/A | PC | SCALING INTEGRATED WASH SERVICES | $2,432,337 | 4001 GREENBRIAR DRIVE | STAFFORD | VA | 77477 | |||||
| MACCABI HEALTHCARE SERVICES | ||||||||||||
| 27 HAMERED ST | TEL AVIV | IS | N/A | PC | MOBILE MAMMOGRAPHY UNIT | $31,500 | ||||||
| MAINEHEALTH | ||||||||||||
| N/A | PC | TRANSFORMING RURAL DIABETES CARE IN MAINE | $596,795 | 22 BRAMHALL STREET | PORTLAND | ME | 04102 | |||||
| MAINEHEALTH | ||||||||||||
| N/A | PC | TRANSFORMING RURAL DIABETES CARE IN MAINE | $848,894 | 22 BRAMHALL STREET | PORTLAND | ME | 04102 | |||||
| MASS GENERAL BRIGHAM FOR THE MASSACHUSETTS GENERAL HOSPITAL | ||||||||||||
| N/A | PC | MICROBES, MOLECULES, AND CHEMISTRY: DYSBIOSIS IN CROHNS DISEASE | $1,722,621 | 55 FRUIT STREET | BOSTON | MA | 021142696 | |||||
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | ||||||||||||
| N/A | PC | COMPUTATIONAL MODELING TO IMPROVE GLUCOSE-RESPONSIVE GLUCAGON DESIGNS | $348,553 | 77 MASSACHUSETTS AVENUE | CAMBRIDGE | MA | 02139 | |||||
| MAYO CLINIC | ||||||||||||
| N/A | PC | FEASIBILITY OF OFF-SITE REMOTE CONTROL ROBOTIC PERCUTANEOUS CORONARY INTERVENTIONS: A PILOT ANIMAL FEASIBILITY STUDY | $385,906 | 200 FIRST STREET SW | ROCHESTER | MN | 55905 | |||||
| MAYO CLINIC | ||||||||||||
| N/A | PC | DEVELOPMENT OF A NEXT-GENERATION BIOMARKER TOOL TO ACCELERATE THE DEVELOPMENT OF EFFECTIVE ANTI-FIBROTIC THERAPIES | $151,705 | 200 FIRST STREET SW | ROCHESTER | MN | 55905 | |||||
| MEDICAL UNIVERSITY OF SOUTH CAROLINA | ||||||||||||
| N/A | GOV | ENGINEERED DENDRITIC CELL BASED ROBUST ANTIGEN SPECIFIC THERAPY FOR TYPE 1 DIABETES | $275,000 | 179 ASHLEY AVENUE | CHARLESTON | SC | 29425 | |||||
| MEDICAL UNIVERSITY OF SOUTH CAROLINA | ||||||||||||
| N/A | GOV | ENGINEERED DENDRITIC CELL BASED ROBUST ANTIGEN SPECIFIC THERAPY FOR TYPE 1 DIABETES | $137,500 | 179 ASHLEY AVENUE | CHARLESTON | SC | 29425 | |||||
| MEDICINES FOR HUMANITY INC | ||||||||||||
| N/A | PC | MAI MBELEKI II EXPANSION | $322,909 | 800 HINGHAM STREET | ROCKLAND | MA | 02370 | |||||
| MILLE LACS HEALTH SYSTEM | ||||||||||||
| N/A | PC | TELE-PHARMACY AT MILLE LACS HEALTH SYSTEM | $17,020 | 200 ELM STREET NORTH | ONAMIA | MN | 56359 | |||||
| MILLE LACS HEALTH SYSTEM | ||||||||||||
| N/A | PC | TELE-PHARMACY AT MILLE LACS HEALTH SYSTEM | $6,809 | 200 ELM STREET NORTH | ONAMIA | MN | 56359 | |||||
| MINNESOTA ACADEMY OF FAMILY PHYSICIANS FOUNDATION | ||||||||||||
| N/A | PC | POINT-OF-CARE ULTRASOUND (POCUS) TRAINING FOR MINNESOTA RURAL PROVIDERS | $2,016,319 | 1400 VANBUREN ST STE 215 | MINNEAPOLIS | MN | 55413 | |||||
| MINNESOTA ACADEMY OF FAMILY PHYSICIANS FOUNDATION | ||||||||||||
| N/A | PC | POINT-OF-CARE ULTRASOUND (POCUS) TRAINING FOR MINNESOTA RURAL PROVIDERS | $1,801,545 | 1400 VANBUREN ST STE 215 | MINNEAPOLIS | MN | 55413 | |||||
| MINNESOTA RURAL HEALTH ASSOCIATION | ||||||||||||
| N/A | PC | SONOGRAPHER AND TECHNOLOGIST TRAINING FOR RURAL MINNESOTA | $318,700 | 27011 460TH AVE | HENNING | MN | 56551 | |||||
| MINNESOTA RURAL HEALTH ASSOCIATION | ||||||||||||
| N/A | PC | SONOGRAPHER AND TECHNOLOGIST TRAINING FOR RURAL MINNESOTA | $378,700 | 27011 460TH AVE | HENNING | MN | 56551 | |||||
| MINNESOTA STATE COLLEGES AND UNIVERSITIES | ||||||||||||
| N/A | GOV | EXPANDING RURAL SONOGRAPHY EXPERTISE IN MINNESOTA | $217,428 | 30 E 7TH STREET | ST PAUL | MN | 55101 | |||||
| MINNESOTA STATE COLLEGES AND UNIVERSITIES | ||||||||||||
| N/A | GOV | EXPANDING RURAL SONOGRAPHY EXPERTISE IN MINNESOTA | $205,285 | 30 E 7TH STREET | ST PAUL | MN | 55101 | |||||
| MONTANA PEDIATRICS | ||||||||||||
| N/A | PC | CREATING A STATEWIDE MODEL OF CARE FOR CHILDREN WITH T1D | $536,186 | 259 W FRONT STREET | MISSOULA | MT | 59802 | |||||
| NATIONAL ACADEMY OF SCIENCES | ||||||||||||
| N/A | PC | STRENGTHENING MINORITY SERVING INSTITUTIONS | $150,000 | 500 5TH STREET NW | WASHINGTON | DC | 20001 | |||||
| NATIONAL ASSOCIATION OF SCHOOL NURSES INC | ||||||||||||
| N/A | PC | PROVIDING COORDINATED CARE AND CAPTURING OUTCOMES FOR STUDENTS WITH T1D SCHOOL NURSE-LED PILOT PROJECT | $946,275 | 1100 WAYNE AVE | SILVER SPRING | MD | 20910 | |||||
| NATIONAL ASSOCIATION OF SCHOOL NURSES INC | ||||||||||||
| N/A | PC | PROVIDING COORDINATED CARE AND CAPTURING OUTCOMES FOR STUDENTS WITH T1D SCHOOL NURSE-LED PILOT PROJECT | $927,791 | 1100 WAYNE AVE | SILVER SPRING | MD | 20910 | |||||
| NATIONAL COMMITTEE FOR QUALITY ASSURANCE | ||||||||||||
| N/A | PC | NCQA DIABETES RECOGNITION PROGRAM REFRESH & DIABETES MEASURE DEVELOPMENT | $621,487 | 1100 13TH ST NW | WASHINGTON | DC | 20005 | |||||
| NATIONAL COMMITTEE FOR QUALITY ASSURANCE | ||||||||||||
| N/A | PC | NCQA DIABETES RECOGNITION PROGRAM REFRESH & DIABETES MEASURE DEVELOPMENT | $753,478 | 1100 13TH ST NW | WASHINGTON | DC | 20005 | |||||
| NATURAL AREAS CONSERVANCY INC | ||||||||||||
| N/A | PC | ACTIVATING AND SUSTAINING NYC NATURE TRAIL NETWORK (PHASE 3) | $363,328 | 1234 FIFTH AVENUE | NEW YORK | NY | 10029 | |||||
| NCD ALLIANCE | ||||||||||||
| 31-33 AVENUE GIUSEPPE MOTTA | GENEVA | SZ | N/A | PC | 2023-2025 PARTNERSHIP | $1,582,350 | ||||||
| NEVADA DEPARTMENT OF HEALTH AND HUMAN SERVICES | ||||||||||||
| N/A | GOV | NEVADA VIRTUAL CRISIS CARE | $1,239,092 | 4126 TECHNOLOGY WAY | CARSON CITY | NV | 89706 | |||||
| NEVADA DEPARTMENT OF HEALTH AND HUMAN SERVICES | ||||||||||||
| N/A | GOV | NEVADA FIRST RESPONDER AED PROJECT | $60,670 | 4126 TECHNOLOGY WAY | CARSON CITY | NV | 89706 | |||||
| NEVADA HEALTH CENTERS INC | ||||||||||||
| N/A | PC | QUALITY ULTRASOUND SERVICES AND TRAINING PROGRAM | $14,249 | 3325 RESEARCH WAY | CARSON CITY | NV | 89706 | |||||
| NEVADA RURAL HOSPITAL PARTNERS FOUNDATION INC | ||||||||||||
| N/A | PC | SONOGRAPHER AND TECHNOLOGIST TRAINING FOR RURAL NEVADA HOSPITALS | $27,500 | 4600 KIETZKE LANE | RENO | NV | 89502 | |||||
| NEW DESTINY HOUSING CORPORATION | ||||||||||||
| N/A | PC | PILOTING AFTERCARE INTERVENTIONTO IMPROVE HOUSING AND HEALTH STABILITYFOR FORMERLY HOMELESS DOMESTIC VIOLENCE SURVIVORS | $183,350 | 12 W 37TH STREET 7TH FLOOR | NEW YORK | NY | 10018 | |||||
| NEW YORK CITY HEALTH AND HOSPITALS CORPORATION | ||||||||||||
| N/A | PC | EXPRESSCARE TELE-BEHAVIORAL HEALTH SERVICE LAUNCH AND TAILORED SERVICE STRATEGIES FOR HIGH NEEDS PATIENTS IN NYC | $614,668 | 125 WORTH STREET | NEW YORK | NY | 10013 | |||||
| NEW YORK UNIVERSITY SCHOOL OF MEDICINE | ||||||||||||
| N/A | PC | TAMALE EDUCATION AND INNOVATION CENTER FOR HEALTH | $2,756,847 | 550 1ST AVENUE | NEW YORK | NY | 10016 | |||||
| NEW YORK UNIVERSITY SCHOOL OF MEDICINE | ||||||||||||
| N/A | PC | TAMALE EDUCATION AND INNOVATION CENTER FOR HEALTH | $1,360,453 | 550 1ST AVENUE | NEW YORK | NY | 10016 | |||||
| NORTHERN WESTCHESTER HOSPITAL ASSOCIATION | ||||||||||||
| N/A | PC | EMERGENCY DEPARTMENT RAPID ACCESS EXPANSION | $400,000 | 400 EAST MAIN STREET | MOUNT KISCO | NY | 10549 | |||||
| OAKLAND UNIVERSITY | ||||||||||||
| N/A | GOV | A COMPREHENSIVE STUDY OF T1D EXOMES (PHASE 2) | $1,139,629 | 2200 NORTH SQUIRREL ROAD | ROCHESTER | MI | 48309 | |||||
| OAKLAND UNIVERSITY | ||||||||||||
| N/A | GOV | A COMPREHENSIVE STUDY OF T1D EXOMES (PHASE 2) | $1,019,181 | 2200 NORTH SQUIRREL ROAD | ROCHESTER | MI | 48309 | |||||
| OAKLAND UNIVERSITY | ||||||||||||
| N/A | GOV | A COMPREHENSIVE STUDY OF T1D EXOMES (PHASE 2) | $1,129,765 | 2200 NORTH SQUIRREL ROAD | ROCHESTER | MI | 48309 | |||||
| OREGON HEALTH & SCIENCE UNIVERSITY | ||||||||||||
| N/A | GOV | AN MDI DECISION SUPPORT SYSTEM WITH CDCES AND BEHAVIORAL HEALTH SUPPORT | $1,783,316 | 3181 SW SAM JACKSON PARK ROAD | PORTLAND | OR | 972393098 | |||||
| OREGON HEALTH & SCIENCE UNIVERSITY | ||||||||||||
| N/A | GOV | AN MDI DECISION SUPPORT SYSTEM WITH CDCES AND BEHAVIORAL HEALTH SUPPORT | $1,795,816 | 3181 SW SAM JACKSON PARK ROAD | PORTLAND | OR | 972393098 | |||||
| PALO ALTO VETERANS INSTITUTE FOR RESEARCH | ||||||||||||
| N/A | PC | CELL ATLAS OF HUMAN INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S DISEASE | $318,978 | 3801 MIRANDA AVENUE | PALO ALTO | CA | 943040038 | |||||
| PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY | ||||||||||||
| N/A | PC | UNDERSTANDING AUTOIMMUNE DIABETES FOLLOWING CERTAIN CANCER IMMUNOTHERAPIES. | $358,140 | 1 LETTERMAN DRIVE | SAN FRANCISCO | CA | 94129 | |||||
| PATH | ||||||||||||
| N/A | PC | THE DIABETES CAREPAK PROJECT: ENABLING HIGH-QUALITY DIABETES SELF-CARE | $871,123 | 2201 WESTLAKE AVENUE | SEATTLE | WA | 98121 | |||||
| PENNINGTON COUNTY HEALTH AND HUMAN SERVICES | ||||||||||||
| N/A | GOV | PENNINGTON COUNTY CRISIS STABILIZATION UNIT | $1,000,000 | 321 KANSAS CITY STREET | RAPID CITY | SD | 57701 | |||||
| PERKINS COUNTY HOSPITAL DISTRICT | ||||||||||||
| N/A | GOV | TELE-EMERGENCY SERVICES FOR PERKINS COUNTY HEALTH SERVICES | $14,706 | 900 LINCOLN AVE | GRANT | NE | 69140 | |||||
| PHILLIPS COUNTY HOSPITAL ASSOCIATION | ||||||||||||
| N/A | PC | TELE-EMERGENCY AND TELE-PHARMACY AT PHILLIPS COUNTY | $25,448 | 311 S 8TH AVENUE EAST | MALTA | MT | 59538 | |||||
| PIONEER MEDICAL CENTER | ||||||||||||
| N/A | PC | TELE-PHARMACY AT PIONEER MEDICAL CENTER | $9,988 | 301 WEST 7TH AVE | BIG TIMBER | MT | 59011 | |||||
| PROJECT CONCERN ZAMBIA LIMITED | ||||||||||||
| PLOT 37/1P | LUSAKA | ZA | N/A | PC | EMPOWERED CHILDREN AND ADOLESCENTS PROGRAM PLUS | $1,004,026 | ||||||
| PROJECT CONCERN ZAMBIA LIMITED | ||||||||||||
| PLOT 37/1P | LUSAKA | ZA | N/A | PC | EMPOWERED CHILDREN AND ADOLESCENTS PROGRAM PLUS | $1,590,680 | ||||||
| RAMBAM HEALTH CORPORATION | ||||||||||||
| HAALIA HASNIA 8 | HAIFA | IS | N/A | PC | MICROBIAL AND DIETARY EFFECTS ON IMMUNE COMPOSITION AND FUNCTION IN PATIENTS WITH CROHN'S | $746,990 | ||||||
| REACHANOTHER FOUNDATION | ||||||||||||
| N/A | PC | EXPANDING PEDIATRIC NEUROSURGERY CAPACITY IN ETHIOPIA | $627,684 | 1900 NE 3RD ST STE 106-307 | BEND | OR | 97701 | |||||
| REACHANOTHER FOUNDATION | ||||||||||||
| N/A | PC | EXPANDING PEDIATRIC NEUROSURGERY CAPACITY IN ETHIOPIA | $190,186 | 1900 NE 3RD ST STE 106-307 | BEND | OR | 97701 | |||||
| REGENTS OF THE UNIVERSITY OF MICHIGAN | ||||||||||||
| N/A | PC | EVALUATION OF A GUT-SPECIFIC ANTIFIBROTIC THERAPEUTIC IN PRE-CLINICAL MODELS OF CROHNS DISEASE | $92,033 | 3003 SOUTH STATE STREET | ANN ARBOR | MI | 48109 | |||||
| REGENTS OF THE UNIVERSITY OF MICHIGAN | ||||||||||||
| N/A | PC | HEALTH ECONOMIC ANALYSIS OF AUTOMATED INSULIN DELIVERY SYSTEMS | $458,831 | 3003 SOUTH STATE STREET | ANN ARBOR | MI | 48109 | |||||
| REGENTS OF THE UNIVERSITY OF MICHIGAN | ||||||||||||
| N/A | PC | EVALUATION OF A GUT-SPECIFIC ANTIFIBROTIC THERAPEUTIC IN PRE-CLINICAL MODELS OF CROHNS DISEASE | $92,033 | 3003 SOUTH STATE STREET | ANN ARBOR | MI | 48109 | |||||
| REGENTS OF THE UNIVERSITY OF MINNESOTA | ||||||||||||
| N/A | GOV | MINNESOTA FIRST RESPONDER AED PROJECT | $1,296,918 | 401 EAST RIVER ROAD | MINNEAPOLIS | MN | 554552070 | |||||
| REGENTS OF THE UNIVERSITY OF MINNESOTA | ||||||||||||
| N/A | GOV | ENGINEERING ANTIGEN-SPECIFIC REGULATORY T CELLS FOR USE IN TYPE 1 DIABETES (PHASE 3) | $502,750 | 401 EAST RIVER ROAD | MINNEAPOLIS | MN | 554552070 | |||||
| REGENTS OF THE UNIVERSITY OF MINNESOTA | ||||||||||||
| N/A | GOV | STANDARDIZED MICROBIOTA TRANSPLANT THERAPY IN CROHNS DISEASE. PILOT TRIAL. | $1,454,586 | 401 EAST RIVER ROAD | MINNEAPOLIS | MN | 554552070 | |||||
| REGENTS OF THE UNIVERSITY OF MINNESOTA | ||||||||||||
| N/A | GOV | THERAPEUTIC USE OF PEPTIDE:MHC MABS FOR T1D | $220,565 | 401 EAST RIVER ROAD | MINNEAPOLIS | MN | 554552070 | |||||
| REGENTS OF THE UNIVERSITY OF MINNESOTA | ||||||||||||
| N/A | GOV | ENGINEERING ANTIGEN-SPECIFIC REGULATORY T CELLS FOR USE IN TYPE 1 DIABETES (PHASE 3) | $502,750 | 401 EAST RIVER ROAD | MINNEAPOLIS | MN | 554552070 | |||||
| REGENTS OF THE UNIVERSITY OF MINNESOTA | ||||||||||||
| N/A | GOV | THERAPEUTIC USE OF PEPTIDE:MHC MABS FOR T1D | $166,880 | 401 EAST RIVER ROAD | MINNEAPOLIS | MN | 554552070 | |||||
| REGENTS OF THE UNIVERSITY OF MINNESOTA | ||||||||||||
| N/A | GOV | STANDARDIZED MICROBIOTA TRANSPLANT THERAPY IN CROHNS DISEASE. PILOT TRIAL. | $585,172 | 401 EAST RIVER ROAD | MINNEAPOLIS | MN | 554552070 | |||||
| REGENTS OF UNIVERSITY OF CALIFORNIA BERKELEY | ||||||||||||
| N/A | PC | DEVELOPING MICROBIOME EDITING TOOLS TO ADVANCE UNDERSTANDING OF THE MICROBIAL INFLUENCE ON CROHN'S DISEASE | $1,054,179 | 190 DOE | BERKELEY | CA | 94720 | |||||
| REGION HOVEDSTADEN | ||||||||||||
| KONGENS VNGE 2 | HILLEROD | DA | N/A | GOV | CAN MICROCHIMERISM EXPLAIN DIFFERENCES IN PARENTAL TYPE 1 DIABETES CONFERRED RISK OF OFFSPRING TYPE 1 DIABETES? | $375,228 | ||||||
| REGION HOVEDSTADEN | ||||||||||||
| KONGENS VNGE 2 | HILLEROD | DA | N/A | GOV | CAN MICROCHIMERISM EXPLAIN DIFFERENCES IN PARENTAL TYPE 1 DIABETES CONFERRED RISK OF OFFSPRING TYPE 1 DIABETES? | $113,358 | ||||||
| RENOWN HEALTH FOUNDATION | ||||||||||||
| N/A | PC | RENOWN HEALTH TO BRING EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) TO NORTHERN NEVADA | $1,091,987 | 1155 MILL ST | RENO | NV | 89502 | |||||
| RENOWN HEALTH FOUNDATION | ||||||||||||
| N/A | PC | RENOWN HEALTH TO BRING EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) TO NORTHERN NEVADA | $243,019 | 1155 MILL ST | RENO | NV | 89502 | |||||
| RESEARCH TRIANGLE INSTITUTE | ||||||||||||
| N/A | PC | USING GENOME SEQUENCING AND GENETIC RISK SCORES TO IDENTIFY NEWBORNS WITH SERIOUS HEALTH CONDITIONS: A STATEWIDE IMPLEMENTATION STUDY | $1,110,288 | 3040 EAST CORNWALLIS ROAD | RESEARCH TRIANGLE PARK | NC | 277092194 | |||||
| RESEARCH TRIANGLE INSTITUTE | ||||||||||||
| N/A | PC | USING GENOME SEQUENCING AND GENETIC RISK SCORES TO IDENTIFY NEWBORNS WITH SERIOUS HEALTH CONDITIONS: A STATEWIDE IMPLEMENTATION STUDY | $826,376 | 3040 EAST CORNWALLIS ROAD | RESEARCH TRIANGLE PARK | NC | 277092194 | |||||
| RIVER'S EDGE HOSPITAL AND CLINIC | ||||||||||||
| N/A | GOV | TELE-EMERGENCY SERVICES FOR RIVER'S EDGE HOSPITAL | $17,567 | 1900 N SUNRISE DRIVE | ST PETER | MN | 56082 | |||||
| SAGE BIONETWORKS | ||||||||||||
| N/A | PC | EXTENSION OF VEOIBD DATA COORDINATION TO ACCELERATE DISCOVERY OF PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES | $75,165 | 2901 THIRD AVE | SEATTLE | WA | 981213014 | |||||
| SAINT LOUIS UNIVERSITY | ||||||||||||
| N/A | PC | IDENTIFY AND VALIDATE POTENTIAL THERAPEUTIC TARGETS TO PREVENT HYPOGLYCEMIA IN TYPE 1 DIABETES | $608,523 | 221 NORTH GRAND BOULEVARD | SAINT LOUIS | MI | 63103 | |||||
| SANFORD RESEARCH | ||||||||||||
| N/A | PC | PLEDGE PHASE 3 | $1,118,635 | 1305 W 18TH ST | SIOUX FALL | SD | 571040569 | |||||
| SANFORD RESEARCH | ||||||||||||
| N/A | PC | PLEDGE PHASE 3 | $1,086,430 | 1305 W 18TH ST | SIOUX FALL | SD | 571040569 | |||||
| SAPIR ACADEMIC COLLEGE | ||||||||||||
| DN HOF ASHKELON | REGIONAL COUNCIL SHAAR HA | IS | N/A | PC | PLANNING FOR SAPIR ACADEMIC COLLEGE LAW SCHOOL BUILDING | $303,000 | ||||||
| SCRIPPS HEALTH | ||||||||||||
| N/A | PC | CROHNS FISTULIZING PROGRAM INVESTIGATOR INITIATED CLINICAL TRIALS | $1,262,800 | 10140 CAMPUS POINT DRIVE | LA JOLLA | CA | 92121 | |||||
| SCRIPPS HEALTH | ||||||||||||
| N/A | PC | CROHNS FISTULIZING PROGRAM INVESTIGATOR INITIATED CLINICAL TRIALS | $1,636,800 | 10140 CAMPUS POINT DRIVE | LA JOLLA | CA | 92121 | |||||
| SCRIPPS HEALTH | ||||||||||||
| N/A | PC | CROHNS FISTULIZING PROGRAM INVESTIGATOR INITIATED CLINICAL TRIALS | $888,800 | 10140 CAMPUS POINT DRIVE | LA JOLLA | CA | 92121 | |||||
| SEATTLE CHILDREN'S HOSPITAL | ||||||||||||
| N/A | PC | EXPANDING USE OF ENGINEERED TREGS IN T1D THERAPY (PHASE 4) | $609,141 | PO BOX 5731 M/S S-200 | SEATTLE | WA | 981455005 | |||||
| SEATTLE CHILDREN'S HOSPITAL | ||||||||||||
| N/A | PC | EXPANDING USE OF ENGINEERED TREGS IN T1D THERAPY (PHASE 4) | $616,923 | PO BOX 5731 M/S S-200 | SEATTLE | WA | 981455005 | |||||
| SHAARE ZEDEK MEDICAL CENTER | ||||||||||||
| 12 SHMUEL BAIT STREET | JERUSALEM | IS | N/A | PC | DEVELOPMENT OF THE HELMSLEY SURGICAL WING | $5,000,000 | ||||||
| SHAARE ZEDEK MEDICAL CENTER | ||||||||||||
| 12 SHMUEL BAIT STREET | JERUSALEM | IS | N/A | PC | ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: COMBINING MULTI-TIER ADMINISTRATIVE DATA FOR FACILITATING DISEASE FREE MANAGEMENT | $989,083 | ||||||
| SHAARE ZEDEK MEDICAL CENTER | ||||||||||||
| 12 SHMUEL BAIT STREET | JERUSALEM | IS | N/A | PC | DEVELOPMENT OF THE HELMSLEY SURGICAL WING | $3,500,000 | ||||||
| SHARE TRUST INC | ||||||||||||
| N/A | PC | BUILDING COMMUNITY DRIVEN COLLECTIVE ACTION | $1,540,658 | 310 DEDHAM ST | DOVER | MA | 02030 | |||||
| SHARE TRUST INC | ||||||||||||
| N/A | PC | BUILDING COMMUNITY DRIVEN COLLECTIVE ACTION | $1,540,658 | 310 DEDHAM ST | DOVER | MA | 02030 | |||||
| SHATTERPROOF A NONPROFIT CORP | ||||||||||||
| N/A | PC | GENERAL OPERATING SUPPORT | $200,000 | 101 MERRITT 7 CORPORATE PARK 1ST | NORWALK | CT | 06851 | FLOOR | ||||
| SHATTERPROOF A NONPROFIT CORP | ||||||||||||
| N/A | PC | GENERAL OPERATING SUPPORT | $170,000 | 101 MERRITT 7 CORPORATE PARK 1ST | NORWALK | CT | 06851 | FLOOR | ||||
| SIMULATION IN MOTION MONTANA INC | ||||||||||||
| N/A | PC | SIM-MT BUSINESS DEVELOPMENT AND SUSTAINABILITY | $100,000 | C/O MONTANA MEDICAL ASSOCIATION | HELENA | MT | 59601 | |||||
| SIMULATION IN MOTION MONTANA INC | ||||||||||||
| N/A | PC | SIM-MT BUSINESS DEVELOPMENT AND SUSTAINABILITY | $100,000 | C/O MONTANA MEDICAL ASSOCIATION | HELENA | MT | 59601 | |||||
| SIMULATION IN MOTION MONTANA INC | ||||||||||||
| N/A | PC | SIM-MT BUSINESS DEVELOPMENT AND SUSTAINABILITY | $100,000 | C/O MONTANA MEDICAL ASSOCIATION | HELENA | MT | 59601 | |||||
| SOCIAL SCIENCE RESEARCH COUNCIL | ||||||||||||
| N/A | PC | DATA2GO.NYC REVAMP AND DATA CLINIC | $336,025 | ONE PIERREPONT PLAZA 15TH FLOOR | BROOKLYN | NY | 11201 | |||||
| SOLIDARIDAD NETWORK FOUNDATION LIMITED | ||||||||||||
| 163 KUDU ROAD | LUSAKA | ZA | N/A | PC | HOOVES FOR SUSTAINABILITY (H4S) | $468,562 | ||||||
| SOLIDARIDAD NETWORK FOUNDATION LIMITED | ||||||||||||
| 163 KUDU ROAD | LUSAKA | ZA | N/A | PC | HOOVES FOR SUSTAINABILITY (H4S) | $273,384 | ||||||
| SOUTH LINCOLN HOSPITAL DISTRICT | ||||||||||||
| N/A | GOV | TELE-EMERGENCY AT SOUTH LINCOLN MEDICAL CENTER | $10,791 | 711 ONYX ST | KEMMERER | WY | 83101 | |||||
| SOUTHCENTRAL FOUNDATION | ||||||||||||
| N/A | PC | FWWI NU'IJU TRANSFORMATIONAL LIVING COMMUNITY PROGRAM | $818,171 | 4501 DIPLOMACY DR | ANCHORAGE | AK | 99508 | |||||
| ST LUKE HEALTH CARE FOUNDATION | ||||||||||||
| N/A | PC | HOPE CENTER FOR WOMEN AND CHILDREN | $5,201,874 | 28W609 HICKORY LN | WEST CHICAGO | IL | 60185 | |||||
| ST LUKE HEALTH CARE FOUNDATION | ||||||||||||
| N/A | PC | HOPE CENTER FOR WOMEN AND CHILDREN | $4,790,316 | 28W609 HICKORY LN | WEST CHICAGO | IL | 60185 | |||||
| ST ROSE DOMINICAN HEALTH FOUNDATION | ||||||||||||
| N/A | SOI | DIGNITY HEALTH - ST. ROSE DOMINICAN - SIENA CAMPUS ECMO PROGRAM | $124,981 | 102 E LAKE MEAD PARKWAY | HENDERSON | NV | 89015 | |||||
| ST ROSE DOMINICAN HEALTH FOUNDATION | ||||||||||||
| N/A | SOI | DIGNITY HEALTH-ST. ROSE DOMINICAN - SIENA CAMPUS CATH LAB REVITALIZATION PROJECT | $172,840 | 102 E LAKE MEAD PARKWAY | HENDERSON | NV | 89015 | |||||
| ST ROSE DOMINICAN HEALTH FOUNDATION | ||||||||||||
| N/A | SOI | DIGNITY HEALTH - ST. ROSE DOMINICAN - SIENA CAMPUS ECMO PROGRAM | $101,195 | 102 E LAKE MEAD PARKWAY | HENDERSON | NV | 89015 | |||||
| ST ROSE DOMINICAN HEALTH FOUNDATION | ||||||||||||
| N/A | SOI | DIGNITY HEALTH-ST. ROSE DOMINICAN - SIENA CAMPUS CATH LAB REVITALIZATION PROJECT | $87,671 | 102 E LAKE MEAD PARKWAY | HENDERSON | NV | 89015 | |||||
| ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH | ||||||||||||
| 9 PRINCES ST | MELBOURNE | AS | N/A | PC | WHICH CHECKPOINTS MAINTAIN IMMUNE TOLERANCE TO BETA-CELLS IN GENETICALLY AT-RISK PEOPLE WHO DONT HAVE T1D? | $298,224 | ||||||
| ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH | ||||||||||||
| 9 PRINCES ST | MELBOURNE | AS | N/A | PC | WHICH CHECKPOINTS MAINTAIN IMMUNE TOLERANCE TO BETA-CELLS IN GENETICALLY AT-RISK PEOPLE WHO DONT HAVE T1D? | $255,857 | ||||||
| STATE OF NEVADA DEPARTMENT OF DIVISION OF STATE PARKS | ||||||||||||
| N/A | GOV | VALLEY OF FIRE VISITOR CENTER | $3,500,000 | 901 S STEWART ST SUITE 5005 | CARSON CITY | NV | 89701 | |||||
| STICHTING HEALTH ACTION INTERNATIONAL | ||||||||||||
| OVERTOOM 60/II | AMSTERDAM | NL | N/A | PC | ADDRESSING THE CHALLENGE AND CONSTRAINTS OF INSULIN SOURCES AND SUPPLY (ACCISS) STUDY PHASE IV | $1,300,026 | ||||||
| STICHTING HEALTH ACTION INTERNATIONAL | ||||||||||||
| OVERTOOM 60/II | AMSTERDAM | NL | N/A | PC | ADDRESSING THE CHALLENGE AND CONSTRAINTS OF INSULIN SOURCES AND SUPPLY (ACCISS) STUDY PHASE IV | $998,988 | ||||||
| STICHTING HEALTH ACTION INTERNATIONAL | ||||||||||||
| OVERTOOM 60/II | AMSTERDAM | NL | N/A | PC | ADDRESSING THE CHALLENGE AND CONSTRAINTS OF INSULIN SOURCES AND SUPPLY (ACCISS) STUDY PHASE IV | $1,200,977 | ||||||
| STICHTING PHARMACCESS INTERNATIONAL | ||||||||||||
| AHTC TOWER C4 PAASHEUVELWEG 25 | AMSTERDAM | NL | N/A | PC | SAFECARE: A BUSINESS MODEL FOR HEALTHCARE QUALITY | $686,565 | ||||||
| STICHTING PHARMACCESS INTERNATIONAL | ||||||||||||
| AHTC TOWER C4 PAASHEUVELWEG 25 | AMSTERDAM | NL | N/A | PC | SAFECARE: A BUSINESS MODEL FOR HEALTHCARE QUALITY | $538,692 | ||||||
| STICHTING THE OCEAN CLEANUP | ||||||||||||
| BATAVIERENSTRAAT 15 | ROTTERDAM | NL | N/A | PC | DEVELOP AND SCALE TECHNOLOGIES TO RID THE OCEANS OF PLASTICS | $5,000,000 | ||||||
| STICHTING THE OCEAN CLEANUP | ||||||||||||
| BATAVIERENSTRAAT 15 | ROTTERDAM | NL | N/A | PC | DEVELOP AND SCALE TECHNOLOGIES TO RID THE OCEANS OF PLASTICS | $5,000,000 | ||||||
| STIFTELSEN FOR UTBILDNING (IOIBD) | ||||||||||||
| DEPT OF GASTROENTEROLOGY | OREBRO | SW | N/A | PC | THE IOIBD CLINICAL EXPERIENCE EXCHANGE TO FOSTER INVESTIGATIVE CAREERS IN IBD | $132,000 | ||||||
| STIFTELSEN FOR UTBILDNING (IOIBD) | ||||||||||||
| DEPT OF GASTROENTEROLOGY | OREBRO | SW | N/A | PC | THE IOIBD CLINICAL EXPERIENCE EXCHANGE TO FOSTER INVESTIGATIVE CAREERS IN IBD | $132,000 | ||||||
| SUPPORTIVE HOUSING NETWORK OF NEW YORK INC | ||||||||||||
| N/A | PC | TRAINING ACADEMY AND COMMUNITY OF PRACTICE FOR SUPPORTIVE HOUSING PROVIDERS | $300,000 | 247 W 37TH ST | NEW YORK CITY | NY | 10018 | |||||
| SUPPORTIVE HOUSING NETWORK OF NEW YORK INC | ||||||||||||
| N/A | PC | TRAINING ACADEMY AND COMMUNITY OF PRACTICE FOR SUPPORTIVE HOUSING PROVIDERS | $200,000 | 247 W 37TH ST | NEW YORK CITY | NY | 10018 | |||||
| T1D EXCHANGE INC | ||||||||||||
| N/A | PC | EQUITABLE HEALTH AND PSYCHOSOCIAL OUTCOMES FOR INDIVIDUALS LIVING WITH T1D THROUGH THE T1D EXCHANGE QUALITY IMPROVEMENT COLLABORATIVE AND REGISTRY | $633,709 | 101 FEDERAL STREET SUITE 440 | BOSTON | MA | 02110 | |||||
| T1D EXCHANGE INC | ||||||||||||
| N/A | PC | EQUITABLE HEALTH AND PSYCHOSOCIAL OUTCOMES FOR INDIVIDUALS LIVING WITH T1D THROUGH THE T1D EXCHANGE QUALITY IMPROVEMENT COLLABORATIVE AND REGISTRY | $2,567,417 | 101 FEDERAL STREET SUITE 440 | BOSTON | MA | 02110 | |||||
| T1D EXCHANGE INC | ||||||||||||
| N/A | PC | EQUITABLE HEALTH AND PSYCHOSOCIAL OUTCOMES FOR INDIVIDUALS LIVING WITH T1D THROUGH THE T1D EXCHANGE QUALITY IMPROVEMENT COLLABORATIVE AND REGISTRY | $650,000 | 101 FEDERAL STREET SUITE 440 | BOSTON | MA | 02110 | |||||
| T1D EXCHANGE INC | ||||||||||||
| N/A | PC | EQUITABLE HEALTH AND PSYCHOSOCIAL OUTCOMES FOR INDIVIDUALS LIVING WITH T1D THROUGH THE T1D EXCHANGE QUALITY IMPROVEMENT COLLABORATIVE AND REGISTRY | $1,917,417 | 101 FEDERAL STREET SUITE 440 | BOSTON | MA | 02110 | |||||
| TECHNISCHE UNIVERSITAET MUENCHEN | ||||||||||||
| ARCISSTRABE 21 | MUNCHEN | GM | N/A | GOV | COST-EFFECTIVENESS OF PUBLIC HEALTH SCREENING FOR PRE-SYMPTOMATIC TYPE 1 DIABETES WITH AND WITHOUT TREATMENT FOR PREVENTION OF TYPE 1 DIABETES | $151,947 | ||||||
| TEL AVIV SOURASKY MEDICAL CENTER - ICHILOV HOSPITAL | ||||||||||||
| WEIZMAN 6 | TEL AVIV | IS | N/A | GOV | GENETICS INSTITUTE AND GENOMICS CENTER | $1,118,516 | ||||||
| TEL AVIV SOURASKY MEDICAL CENTER - ICHILOV HOSPITAL | ||||||||||||
| WEIZMAN 6 | TEL AVIV | IS | N/A | GOV | IBD GENETICS RESEARCH ROLE OF PROTEASE-ACTIVATED RECEPTOR 2 (PAR2) IN INFLAMMATORY GASTROINTESTINAL DISORDERS | $268,340 | ||||||
| TEL AVIV SOURASKY MEDICAL CENTER - ICHILOV HOSPITAL | ||||||||||||
| WEIZMAN 6 | TEL AVIV | IS | N/A | GOV | GENETICS INSTITUTE AND GENOMICS CENTER | $1,420,270 | ||||||
| TEL-AVIV UNIVERSITY | ||||||||||||
| TEL AVIV UNIVERSITY | TEL AVIV | IS | N/A | PC | HELMSLEY MEDICAL SIMULATION CENTER | $6,828,500 | ||||||
| TEL-AVIV UNIVERSITY | ||||||||||||
| TEL AVIV UNIVERSITY | TEL AVIV | IS | N/A | PC | HELMSLEY MEDICAL SIMULATION CENTER | $1,524,350 | ||||||
| TEL-AVIV UNIVERSITY | ||||||||||||
| TEL AVIV UNIVERSITY | TEL AVIV | IS | N/A | PC | HELMSLEY MEDICAL SIMULATION CENTER | $1,324,350 | ||||||
| THE ACADEMIC COLLEGE AT TEL-HAI | ||||||||||||
| TEL-HAI COLLEGE | UPPER GALILEE | IS | N/A | PC | THE HELMSLEY RESEARCH AND INNOVATION WING IN THE TEL-HAI COMPUTER SCIENCE BUILDING. | $2,600,000 | ||||||
| THE ACADEMIC COLLEGE AT TEL-HAI | ||||||||||||
| TEL-HAI COLLEGE | UPPER GALILEE | IS | N/A | PC | THE HELMSLEY FELLOWSHIPS FOR SUSTAINABILITY AND HEALTH | $2,664,333 | ||||||
| THE ACADEMIC COLLEGE AT TEL-HAI | ||||||||||||
| TEL-HAI COLLEGE | UPPER GALILEE | IS | N/A | PC | THE HELMSLEY FELLOWSHIPS FOR SUSTAINABILITY AND HEALTH | $2,078,769 | ||||||
| THE ASSOCIATION FOR THE RESIDENT AND COMMUNITY IN RAMAT HANEGEV | ||||||||||||
| 2012100 HALUTZ | RAMAT HANEGEV | IS | N/A | PC | RAMAT HANEGEV SENIOR CITIZEN CENTER | $2,775,467 | ||||||
| THE ASSOCIATION FOR THE RESIDENT AND COMMUNITY IN RAMAT HANEGEV | ||||||||||||
| 2012100 HALUTZ | RAMAT HANEGEV | IS | N/A | PC | RAMAT HANEGEV SENIOR CITIZEN CENTER | $699,190 | ||||||
| THE BROAD INSTITUTE INC | ||||||||||||
| N/A | PC | UNCOVERING CROHN'S GENETIC RISK IN AFRICAN-AMERICAN AND HISPANIC/LATINO POPULATIONS | $971,014 | 415 MAIN STREET | CAMBRIDGE | MA | 02142 | |||||
| THE BROAD INSTITUTE INC | ||||||||||||
| N/A | PC | UNCOVERING CROHN'S GENETIC RISK IN AFRICAN-AMERICAN AND HISPANIC/LATINO POPULATIONS | $1,129,976 | 415 MAIN STREET | CAMBRIDGE | MA | 02142 | |||||
| THE CITY OF HOPE | ||||||||||||
| N/A | PC | THE HELMSLEY CHARITABLE TRUST GEORGE S. EISENBARTH NPOD AWARD FOR TEAM SCIENCE | $300,000 | 1500 E DUARTE RD | DUARTE | CA | 91010 | |||||
| THE CITY OF HOPE | ||||||||||||
| N/A | PC | CD318 MEDIATED REGULATION OF ISLET AUTOANTIGEN SPECIFIC T CELL IMMUNITY | $368,500 | 1500 E DUARTE RD | DUARTE | CA | 91010 | |||||
| THE CITY OF HOPE | ||||||||||||
| N/A | PC | GENETIC PROTECTION BY HLA-DQ6 IN T1D | $235,681 | 1500 E DUARTE RD | DUARTE | CA | 91010 | |||||
| THE CITY OF HOPE | ||||||||||||
| N/A | PC | CD318 MEDIATED REGULATION OF ISLET AUTOANTIGEN SPECIFIC T CELL IMMUNITY | $371,800 | 1500 E DUARTE RD | DUARTE | CA | 91010 | |||||
| THE CLEVELAND CLINIC FOUNDATION | ||||||||||||
| N/A | PC | DEVELOPMENT OF A NEXT-GENERATION BIOMARKER TOOL TO ACCELERATE THE DEVELOPMENT OF EFFECTIVE ANTI-FIBROTIC THERAPIES | $1,321,210 | 9500 EUCLID AVENUE | CLEVELAND | OH | 44195 | |||||
| THE CLEVELAND CLINIC FOUNDATION | ||||||||||||
| N/A | PC | THE MILESTONE INITIATIVE: EDUCATION INNOVATION FOR ADVANCED IBD FELLOWS IN THE USA | $236,313 | 9500 EUCLID AVENUE | CLEVELAND | OH | 44195 | |||||
| THE CLEVELAND CLINIC FOUNDATION | ||||||||||||
| N/A | PC | MECHANOBIOLOGY OF THE INTESTINAL EPITHELIAL BARRIER DISRUPTION IN CROHNS DISEASE | $387,615 | 9500 EUCLID AVENUE | CLEVELAND | OH | 44195 | |||||
| THE CLEVELAND CLINIC FOUNDATION | ||||||||||||
| N/A | PC | ENDPOINT DEVELOPMENT FOR OSTOMY CLINICAL TRIALS (ENDO-TRIAL) CONSORTIUM | $869,476 | 9500 EUCLID AVENUE | CLEVELAND | OH | 44195 | |||||
| THE CLEVELAND CLINIC FOUNDATION | ||||||||||||
| N/A | PC | MECHANOBIOLOGY OF THE INTESTINAL EPITHELIAL BARRIER DISRUPTION IN CROHNS DISEASE | $342,955 | 9500 EUCLID AVENUE | CLEVELAND | OH | 44195 | |||||
| THE CLEVELAND CLINIC FOUNDATION | ||||||||||||
| N/A | PC | ENDPOINT DEVELOPMENT FOR OSTOMY CLINICAL TRIALS (ENDO-TRIAL) CONSORTIUM | $719,051 | 9500 EUCLID AVENUE | CLEVELAND | OH | 44195 | |||||
| THE GOVERNORS OF THE UNIVERSITY OF CALGARY | ||||||||||||
| 2500 UNIVERSITY DRIVE NW | CALGARY | CA | N/A | PC | INTERLEUKIN-4 ACTIVATED MACROPHAGES (M(IL4)) FOR PERSONALIZED CELLULAR IMMUNOTHERAPY TO TREAT IBD | $127,077 | ||||||
| THE GOVERNORS OF THE UNIVERSITY OF CALGARY | ||||||||||||
| 2500 UNIVERSITY DRIVE NW | CALGARY | CA | N/A | PC | INTERLEUKIN-4 ACTIVATED MACROPHAGES (M(IL4)) FOR PERSONALIZED CELLULAR IMMUNOTHERAPY TO TREAT IBD | $137,417 | ||||||
| THE HOSPITAL FOR SICK CHILDREN | ||||||||||||
| 555 UNIVERSITY AVE | TORONTO | CA | N/A | PC | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES-TORONTO STUDIES | $555,480 | ||||||
| THE HOSPITAL FOR SICK CHILDREN | ||||||||||||
| 555 UNIVERSITY AVE | TORONTO | CA | N/A | PC | IMMUNE RESPONSES TO GUT MICROBES ASSOCIATED WITH T1D RISK AND PROGRESSION | $248,621 | ||||||
| THE HOSPITAL FOR SICK CHILDREN | ||||||||||||
| 555 UNIVERSITY AVE | TORONTO | CA | N/A | PC | IMMUNE RESPONSES TO GUT MICROBES ASSOCIATED WITH T1D RISK AND PROGRESSION | $250,415 | ||||||
| THE IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE | ||||||||||||
| EXHIBITION RD | LONDON | UK | N/A | PC | UNRAVELING THE IMMUNOPATHOLOGY OF PERIANAL FISTULIZING CROHNS DISEASE | $1,032,574 | ||||||
| THE IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE | ||||||||||||
| EXHIBITION RD | LONDON | UK | N/A | PC | IMMUNOLOGICAL MECHANISMS UNDERLYING THE GENETIC BASIS FOR NATURAL T1D PROTECTION | $391,212 | ||||||
| THE IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE | ||||||||||||
| EXHIBITION RD | LONDON | UK | N/A | PC | UNRAVELING THE IMMUNOPATHOLOGY OF PERIANAL FISTULIZING CROHNS DISEASE | $1,081,289 | ||||||
| THE IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE | ||||||||||||
| EXHIBITION RD | LONDON | UK | N/A | PC | IMMUNOLOGICAL MECHANISMS UNDERLYING THE GENETIC BASIS FOR NATURAL T1D PROTECTION | $340,788 | ||||||
| THE LANIADO KIRIAT SANZ HOSPITAL | ||||||||||||
| DIVREI KHAYIM ST 16 | NATANIYA | IS | N/A | PC | NEW MATERNITY FLOOR | $1,350,000 | ||||||
| THE MILKEN INSTITUTE | ||||||||||||
| N/A | PC | FASTERCURES LEADERSLINK PROGRAM EXPANSION | $250,000 | 1250 FOURTH STREET | SANTA MONICA | CA | 90401 | |||||
| THE NATURE CONSERVANCY | ||||||||||||
| N/A | PC | FUTURE FOREST NYC PHASE III | $347,804 | 4245 NORTH FAIRFAX DRIVE SUITE 100 | ARLINGTON | VA | 22203 | |||||
| THE RECTOR AND VISITORS OF THE UNIVERSITY OF VIRGINIA | ||||||||||||
| N/A | PC | TYPE 1 DIABETES RISK PREDICTION: INTEGRATION OF PHYSIOLOGY WITH GENETICS | $115,896 | OFFICE OF SPONSORED PROGRAMS | CHARLOTTESVILLE | VA | 229044195 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA AT IRVINE | ||||||||||||
| N/A | PC | DEVELOPMENT OF A MULTI-ANALYTE SENSOR - GLUCOSE, LACTATE, OXYGEN, KETONES, INSULIN FOR PEOPLE WITH T1D | $1,729,516 | 120 THEORY SUITE 200 | IRVINE | CA | 926971050 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES | ||||||||||||
| N/A | PC | GLUCOSE RESPONSIVE GLUCAGON (GRG) FOR THE REDUCTION OF HYPOGLYCEMIA FOR PEOPLE WITH T1D | $568,027 | UCLA OFFICE OF CONTRACTS AND GRANTS | LOS ANGELES | CA | 900951406 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO | ||||||||||||
| N/A | PC | THE DRUGGABLE GPCROME IN CROHNS DISEASE | $1,091,471 | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO | ||||||||||||
| N/A | PC | MECHANISM OF ACTION AND SAFETY STUDY OF LIVER TARGETED INSULIN | $471,131 | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO | ||||||||||||
| N/A | PC | THE DRUGGABLE GPCROME IN CROHNS DISEASE | $1,092,733 | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO | ||||||||||||
| N/A | PC | PREGNANCY IN INFLAMMATORY BOWEL DISEASE AND NEONATAL OUTCOMES (PIANO) | $269,368 | 490 ILLINOIS STREET FOURTH FLOOR | SAN FRANCISCO | CA | 94143 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO | ||||||||||||
| N/A | PC | PREGNANCY IN INFLAMMATORY BOWEL DISEASE AND NEONATAL OUTCOMES (PIANO) | $269,368 | 490 ILLINOIS STREET FOURTH FLOOR | SAN FRANCISCO | CA | 94143 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO | ||||||||||||
| N/A | PC | IDENTIFICATION AND ANALYSIS OF EXTREME FORMS OF TYPE 1 DIABETES, ESTABLISHMENT OF A DATA COMMONS | $433,333 | 490 ILLINOIS STREET FOURTH FLOOR | SAN FRANCISCO | CA | 94143 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO | ||||||||||||
| N/A | PC | IDENTIFICATION AND ANALYSIS OF EXTREME FORMS OF TYPE 1 DIABETES, ESTABLISHMENT OF A DATA COMMONS | $217,916 | 490 ILLINOIS STREET FOURTH FLOOR | SAN FRANCISCO | CA | 94143 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SANTA BARBARA | ||||||||||||
| N/A | PC | EXERCISE SPECIFIC AID ALGORITHM FOR TYPE 1 DIABETES | $1,027,327 | UC SANTA BARBARA | SANTA BARBARA | CA | 93106 | |||||
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SANTA BARBARA | ||||||||||||
| N/A | PC | EXERCISE SPECIFIC AID ALGORITHM FOR TYPE 1 DIABETES | $1,116,996 | UC SANTA BARBARA | SANTA BARBARA | CA | 93106 | |||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| N/A | PC | COMPLEMENT SYSTEM IN THE INITIATION AND PROGRESSION OF ISLET AUTOIMMUNITY | $124,200 | UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| N/A | PC | EXPLORING THE GENOMIC MECHANISM BEHIND THE MATERNAL PROTECTION FROM T1D | $200,584 | UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| N/A | PC | PRENATAL AND OBSTETRIC MATERNAL EXPOSURES AND ISLET AUTOIMMUNITY IN EARLY LIFE (PROMISE) | $994,996 | UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| N/A | PC | IMPACT OF MENSTRUATION ON GLYCEMIC RESPONSE AND EXERCISE | $809,568 | UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| N/A | PC | IMPLEMENTATION OF EARLY STAGE T1D EDUCATION AND SUPPORT (ESTES) | $1,023,372 | UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| N/A | PC | PREPARE 4 AID: PRIMARY CARE PRAGMATIC, REAL WORLD EXPERIENCE FOR AUTOMATED INSULIN DELIVERY | $1,945,286 | UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| N/A | PC | T AND B CELL RECEPTOR ATLAS ACROSS TISSUES AND STAGES OF TYPE 1 DIABETES | $501,000 | UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| N/A | PC | MAPPING THE B CELL HETEROGENEITY IN TYPE 1 DIABETES AT THE SINGLE-CELL LEVEL | $300,000 | UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| N/A | PC | CGM IN PRIMARY CARE - REFER OR LEARN: IMPLEMENTATION AND EVALUATION | $332,512 | UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| N/A | PC | SEEDS PATHWAY: SHARED EMPOWERMENT FOR EARLY DEVICE SUCCESS OF DIABETES TECHNOLOGY | $686,820 | UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| N/A | PC | PRENATAL AND OBSTETRIC MATERNAL EXPOSURES AND ISLET AUTOIMMUNITY IN EARLY LIFE (PROMISE) | $835,489 | UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| N/A | PC | IMPACT OF MENSTRUATION ON GLYCEMIC RESPONSE AND EXERCISE | $1,239,503 | UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| N/A | PC | IMPLEMENTATION OF EARLY STAGE T1D EDUCATION AND SUPPORT (ESTES) | $994,512 | UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| N/A | PC | PREPARE 4 AID: PRIMARY CARE PRAGMATIC, REAL WORLD EXPERIENCE FOR AUTOMATED INSULIN DELIVERY | $1,161,486 | UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| N/A | PC | T AND B CELL RECEPTOR ATLAS ACROSS TISSUES AND STAGES OF TYPE 1 DIABETES | $501,000 | UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| N/A | PC | IMPLEMENTATION OF EARLY STAGE T1D EDUCATION AND SUPPORT (ESTES) | $506,760 | UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | F428 | ||||
| THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER | ||||||||||||
| N/A | PC | SEEDS PATHWAY: SHARED EMPOWERMENT FOR EARLY DEVICE SUCCESS OF DIABETES TECHNOLOGY | $598,309 | UCD GRANTS AND CONTRACTS MAIL STOP | AURORA | CO | 800452571 | F428 | ||||
| THE SCRIPPS RESEARCH INSTITUTE | ||||||||||||
| N/A | PC | GUT-RETAINED NRF2/ARE ACTIVATORS FOR IBD | $1,836,022 | 10550 NORTH TORREY PINES ROAD | LA JOLLA | CA | 92037 | |||||
| THE SDEROT DEVELOPMENT FOUNDATION | ||||||||||||
| 6 BAR LEV STREET | SDEROT | IS | N/A | PC | SDEROT MEDICAL CENTER | $993,626 | ||||||
| THE SHEBA FUND FOR HEALTH SERVICES AND RESEARCH (RA) | ||||||||||||
| TEL-HASHOMER | RAMAT GAN | IS | N/A | PC | ISRAEL IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: CAPSULE & OMICS FOR PREDICTING EXACERBATION OF CROHNS DISEASE (CORE-CD) | $756,699 | ||||||
| THE SHEBA FUND FOR HEALTH SERVICES AND RESEARCH (RA) | ||||||||||||
| TEL-HASHOMER | RAMAT GAN | IS | N/A | PC | ISRAEL IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: CAPSULE & OMICS FOR PREDICTING EXACERBATION OF CROHNS DISEASE (CORE-CD) | $188,118 | ||||||
| THE SONIA NABETA FOUNDATION INC | ||||||||||||
| N/A | PC | WORLD OF WARRIORS | $514,210 | 4705 5TH STREET UNIT 405 | LONG ISLAND CITY | NY | 11101 | |||||
| THE SONIA NABETA FOUNDATION INC | ||||||||||||
| N/A | PC | WORLD OF WARRIORS | $578,470 | 4705 5TH STREET UNIT 405 | LONG ISLAND CITY | NY | 11101 | |||||
| THE SONIA NABETA FOUNDATION INC | ||||||||||||
| N/A | PC | WORLD OF WARRIORS | $482,110 | 4705 5TH STREET UNIT 405 | LONG ISLAND CITY | NY | 11101 | |||||
| THE TEL AVIV JAFFA ACADEMIC COLLEGE | ||||||||||||
| RABENU YERUHAM ST 2 POB 8401 | TEL AVIV YAFFO | IS | N/A | PC | NEED-BASED SCHOLARSHIPS FOR NURSING STUDENTS | $266,667 | ||||||
| THE TEL AVIV JAFFA ACADEMIC COLLEGE | ||||||||||||
| RABENU YERUHAM ST 2 POB 8401 | TEL AVIV YAFFO | IS | N/A | PC | NEED-BASED SCHOLARSHIPS FOR NURSING STUDENTS | $266,666 | ||||||
| THE TREVOR PROJECT INC | ||||||||||||
| N/A | PC | LGBTQ+ YOUTH SUICIDE PREVENTION PROJECT | $1,536,740 | PO BOX 69232 | WEST HOLLYWOOD | CA | 90069 | |||||
| THE TREVOR PROJECT INC | ||||||||||||
| N/A | PC | LGBTQ+ YOUTH SUICIDE PREVENTION PROJECT | $1,282,735 | PO BOX 69232 | WEST HOLLYWOOD | CA | 90069 | |||||
| THE TREVOR PROJECT INC | ||||||||||||
| N/A | PC | LGBTQ+ YOUTH SUICIDE PREVENTION PROJECT | $2,081,072 | PO BOX 69232 | WEST HOLLYWOOD | CA | 90069 | |||||
| THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | ||||||||||||
| N/A | PC | COMBINATORIAL PERTURBATION OF CELLULAR NETWORK IN CROHNS DISEASE | $429,646 | 615 WEST 131ST STREET | NEW YORK | NY | 100273922 | |||||
| THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | ||||||||||||
| N/A | PC | SUPPORT FOR T1D TRANSITION PROGRAMS | $200,000 | 615 WEST 131ST STREET | NEW YORK | NY | 100273922 | |||||
| THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | ||||||||||||
| N/A | PC | ADDING HEALTH QUESTIONS TO THE POVERTY TRACKER TO SURVEY THEHEALTHCARE NEEDS AND UTILIZATION PREFERENCES OF LOW-INCOMENEW YORKERS | $146,689 | 615 WEST 131ST STREET | NEW YORK | NY | 100273922 | |||||
| THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | ||||||||||||
| N/A | PC | COMBINATORIAL PERTURBATION OF CELLULAR NETWORK IN CROHNS DISEASE | $413,263 | 615 WEST 131ST STREET | NEW YORK | NY | 100273922 | |||||
| THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | ||||||||||||
| N/A | PC | SUPPORT FOR T1D TRANSITION PROGRAMS | $150,000 | 615 WEST 131ST STREET | NEW YORK | NY | 100273922 | |||||
| THE UNIVERSITY OF ADELAIDE | ||||||||||||
| THE UNIVERSITY OF ADELAIDE | ADELAIDE | AS | N/A | PC | PANCREATIC EXOCRINE FUNCTION AND THE PROGRESSION TO TYPE 1 DIABETES IN YOUNG CHILDREN | $54,351 | ||||||
| THE UNIVERSITY OF ADELAIDE | ||||||||||||
| THE UNIVERSITY OF ADELAIDE | ADELAIDE | AS | N/A | PC | PANCREATIC EXOCRINE FUNCTION AND THE PROGRESSION TO TYPE 1 DIABETES IN YOUNG CHILDREN | $44,540 | ||||||
| THE UNIVERSITY OF CHICAGO | ||||||||||||
| N/A | PC | DEVELOPMENT AND DISSEMINATION OF AN IBD MONITORING AND PREVENTION PROGRAM WITH A FOCUS ON INTESTINAL ULTRASOUND | $333,042 | 5801 SOUTH ELLIS AVENUE | CHICAGO | IL | 60637 | |||||
| THE UNIVERSITY OF EDINBURGH | ||||||||||||
| BHF CENTRE FOR CARDIOVASCULAR | EDINBURGH | UK | N/A | PC | HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHN'S DISEASE | $209,222 | SCIENCES | |||||
| THE UNIVERSITY OF EDINBURGH | ||||||||||||
| BHF CENTRE FOR CARDIOVASCULAR | EDINBURGH | UK | N/A | PC | MITOCHONDRIAL DAMPS AS MECHANISTIC BIOMARKERS OF MUCOSAL INFLAMMATION IN CROHNS DISEASE (MUSIC) | $682,311 | SCIENCES | |||||
| THE UNIVERSITY OF MANCHESTER | ||||||||||||
| OXFORD RD | MANCHESTER | UK | N/A | PC | A MAP OF THE INTESTINE FOLLOWING REGULATORY T CELL INFUSION INTO PATIENTS WITH ACTIVE CROHNS DISEASE AT SINGLE-CELL AND SPATIAL RESOLUTION | $692,839 | ||||||
| THE UNIVERSITY OF QUEENSLAND | ||||||||||||
| CUMBRAE STEWART BUILDING 72 | BRISBANE | AS | N/A | NC | GUT MICROBIAL METABOLITES DURING EARLY-LIFE DEVELOPMENT AS PREDICTORS OF ISLET AUTOIMMUNITY | $69,271 | ||||||
| THE UNIVERSITY OF WESTERN AUSTRALIA | ||||||||||||
| 35 STIRLING HIGHWAY | CRAWLEY | AS | N/A | PC | CGM ASSESSMENTS OF ENDIA CHILDREN | $35,866 | ||||||
| THE WEIZMANN INSTITUTE OF SCIENCE | ||||||||||||
| 234 HERZEL ST | REHOVOT | IS | N/A | PC | EARLY CHILDHOOD DEVELOPMENT AND COMMUNITY CENTER AT THE WEIZMANN INSTITUTE OF SCIENCE | $3,000,000 | ||||||
| THE WEIZMANN INSTITUTE OF SCIENCE | ||||||||||||
| 234 HERZEL ST | REHOVOT | IS | N/A | PC | EARLY CHILDHOOD DEVELOPMENT AND COMMUNITY CENTER AT THE WEIZMANN INSTITUTE OF SCIENCE | $3,000,000 | ||||||
| THE WEIZMANN INSTITUTE OF SCIENCE | ||||||||||||
| 234 HERZEL ST | REHOVOT | IS | N/A | PC | QUANTUM COMPUTING AND SENSING WITH ATOMS, ELECTRONS, AND PHOTONS | $300,000 | ||||||
| TRUSTEES OF INDIANA UNIVERSITY | ||||||||||||
| N/A | GOV | TARGETING METABOLIC DRIVERS OF B CELL DIFFERENTIATION IN TYPE 1 DIABETES | $58,372 | 509 E 3RD ST | BLOOMINGTON | ID | 474013654 | |||||
| TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | ||||||||||||
| N/A | PC | ENGINEERING CAR REGULATORY T CELLS TO PROVIDE DURABLE TOLERANCE TO ALLOGENIC ISLET TRANSPLANTS | $407,000 | OFFICE OF RESEARCH SERVICES | PHILADELPHIA | PA | 191046205 | |||||
| UNITED JEWISH APPEAL FEDERATION OF JEWISH PHILANTHROPIES OF NY INC | ||||||||||||
| N/A | PC | GENERAL OPERATING SUPPORT | $5,000 | 130 EAST 59TH STREET | NEW YORK | NY | 10022 | |||||
| UNITED STATES FUND FOR UNICEF | ||||||||||||
| N/A | PC | ACCELERATING GLOBAL FOCUS ON NCDS AND PEN-PLUS COUNTRY PROGRAMS | $869,232 | 125 MAIDEN LANE | NEW YORK | NY | 10038 | |||||
| UNIVERSITE CATHOLIQUE DE LOUVAIN | ||||||||||||
| PLACE DE LUNIVERSITE 1 | LOUVAINLANEUVE | BE | N/A | PC | LONGITUDINAL STUDY OF THE GLUCAGON RESPONSE TO HYPOGLYCEMIA IN CHILDREN AND ADOLESCENTS WITH NEW-ONSET T1D: CHARACTERISTICS AND PREDICTIVE BIOMARKERS | $62,567 | ||||||
| UNIVERSITE CATHOLIQUE DE LOUVAIN | ||||||||||||
| PLACE DE LUNIVERSITE 1 | LOUVAINLANEUVE | BE | N/A | PC | SEARCH FOR MECHANISMS RESPONSIBLE FOR THE IMPAIRED GLUCAGON SECRETION IN T1D AND FOR STRATEGIES TO CORRECT THEM | $304,033 | ||||||
| UNIVERSITE CATHOLIQUE DE LOUVAIN | ||||||||||||
| PLACE DE LUNIVERSITE 1 | LOUVAINLANEUVE | BE | N/A | PC | SEARCH FOR MECHANISMS RESPONSIBLE FOR THE IMPAIRED GLUCAGON SECRETION IN T1D AND FOR STRATEGIES TO CORRECT THEM | $152,546 | ||||||
| UNIVERSITE DE GENEVE | ||||||||||||
| RUE MICHEL SERVET 1 | GENEVE | SZ | N/A | GOV | PRECLINICAL TESTING OF S100A9 TO IMPROVE GLYCEMIC CONTROL IN TYPE 1 DIABETES | $1,112,238 | ||||||
| UNIVERSITE LIBRE DE BRUXELLES | ||||||||||||
| AVENUE FRANKLIN ROOSEVELT 50 | BRUSSELS | BE | N/A | GOV | GENERATION OF NEW ANTI- FXYD2A PROBES AND PRECLINICAL VALIDATION FOR HUMAN BETA CELL IMAGING | $213,602 | ||||||
| UNIVERSITY AT BUFFALO PEDIATRIC ASSOCIATES P C | ||||||||||||
| N/A | PC | FINANCIAL VIABILITY OF TELEHEALTH SERVICES FOR UNDERSERVED T1D PEDIATRIC POPULATIONS | $537,700 | 1001 MAIN STREET | BUFFALO | NY | 14203 | |||||
| UNIVERSITY HOSPITALS HEALTH SYSTEM INC | ||||||||||||
| N/A | PC | TYPE 1 DIABETES FINANCIAL TOOLKIT FOR EMERGING ADULTS | $866,199 | 11100 EUCLID AVENUE | CLEVELAND | OH | 44106 | |||||
| UNIVERSITY HOSPITALS HEALTH SYSTEM INC | ||||||||||||
| N/A | PC | TYPE 1 DIABETES FINANCIAL TOOLKIT FOR EMERGING ADULTS | $677,700 | 11100 EUCLID AVENUE | CLEVELAND | OH | 44106 | |||||
| UNIVERSITY MEDICAL CENTER OF SOUTHERN NEVADA | ||||||||||||
| N/A | GOV | DEVELOPMENT OF AN EXTRACORPOREAL LIFE SUPPORT (ECLS) PROGRAM AT UNIVERSITY MEDICAL CENTER OF SOUTHERN NEVADA | $387,094 | 1800 W CHARLESTON BLVD | LAS VEGAS | NV | 89102 | |||||
| UNIVERSITY MEDICAL CENTER OF SOUTHERN NEVADA | ||||||||||||
| N/A | GOV | DEVELOPMENT OF AN EXTRACORPOREAL LIFE SUPPORT (ECLS) PROGRAM AT UNIVERSITY MEDICAL CENTER OF SOUTHERN NEVADA | $84,783 | 1800 W CHARLESTON BLVD | LAS VEGAS | NV | 89102 | |||||
| UNIVERSITY OF BIRMINGHAM | ||||||||||||
| INSTITUTE OF IMMUNOLOGY AND | BIRMINGHAM | UK | N/A | PC | CREATING AN OPTIMISED ANTIGEN-SPECIFIC IMMUNOTHERAPY FOR TYPE 1 DIABETES | $479,888 | IMMUNOTHERAPY | |||||
| UNIVERSITY OF BIRMINGHAM | ||||||||||||
| INSTITUTE OF IMMUNOLOGY AND | BIRMINGHAM | UK | N/A | PC | DEFINING THE EFFICACY AND MECHANISMS OF PEPTIDE IMMUNOTHERAPY FOR TYPE 1 DIABETES: AN EXPERIMENTAL MEDICINE STUDY | $152,801 | IMMUNOTHERAPY | |||||
| UNIVERSITY OF BRISTOL | ||||||||||||
| SENATE HOUSE | BRISTOL | UK | N/A | PC | TYPE 1 DIABETES RISK IN ADULTS (T1DRA) A GENERAL POPULATION STUDY | $431,779 | ||||||
| UNIVERSITY OF BRISTOL | ||||||||||||
| SENATE HOUSE | BRISTOL | UK | N/A | PC | TYPE 1 DIABETES RISK IN ADULTS (T1DRA) A GENERAL POPULATION STUDY | $358,900 | ||||||
| UNIVERSITY OF CAMBRIDGE | ||||||||||||
| THE OLD SCHOOLS | OXFORD | UK | N/A | PC | CLOSED LOOP INSULIN DELIVERY IN NEWLY DIAGNOSED YOUTH WITH TYPE 1 DIABETES AGES 10 TO 18 YEARS (PART 2) | $353,223 | ||||||
| UNIVERSITY OF CAMBRIDGE | ||||||||||||
| THE OLD SCHOOLS | OXFORD | UK | N/A | PC | DOES THE WESTERN DIET TRIGGER CROHN'S DISEASE VIA OSMOTIC STRESS? | $808,734 | ||||||
| UNIVERSITY OF CAMBRIDGE | ||||||||||||
| THE OLD SCHOOLS | OXFORD | UK | N/A | PC | EPIGENETIC REGULATION OF INTESTINAL EPITHELIAL MHC CLASS 1 SIGNALLING - ANOVEL MECHANISM IN THE PATHOGENESIS OF CROHNS DISEASE | $718,215 | ||||||
| UNIVERSITY OF CAMBRIDGE | ||||||||||||
| THE OLD SCHOOLS | OXFORD | UK | N/A | PC | DOES BIOCHEMISTRY AT THE CENTRE OF LIFE DRIVE CROHN'S DISEASE? | $820,911 | ||||||
| UNIVERSITY OF CAMBRIDGE | ||||||||||||
| THE OLD SCHOOLS | OXFORD | UK | N/A | PC | DOES THE WESTERN DIET TRIGGER CROHN'S DISEASE VIA OSMOTIC STRESS? | $726,752 | ||||||
| UNIVERSITY OF CAMBRIDGE | ||||||||||||
| THE OLD SCHOOLS | OXFORD | UK | N/A | PC | DOES BIOCHEMISTRY AT THE CENTRE OF LIFE DRIVE CROHN'S DISEASE? | $851,645 | ||||||
| UNIVERSITY OF CINCINNATI | ||||||||||||
| N/A | GOV | STUDIES ON THE ROLE OF C-PEPTIDE TO REGULATE BLOOD GLUCOSE DURING SLEEP AND EXERCISE | $416,500 | 51 GOODMAN DRIVE SUITE 500 | CINCINNATI | OH | 45221 | |||||
| UNIVERSITY OF CINCINNATI | ||||||||||||
| N/A | GOV | STUDIES ON THE ROLE OF C-PEPTIDE TO REGULATE BLOOD GLUCOSE DURING SLEEP AND EXERCISE | $429,700 | 51 GOODMAN DRIVE SUITE 500 | CINCINNATI | OH | 45221 | |||||
| UNIVERSITY OF DUNDEE | ||||||||||||
| NETHERGATE | DUNDEE | UK | N/A | PC | HYPO-RESOLVE - UNDERSTANDING ORGAN SPECIFIC CONSEQUENCES OF HYPOGLYCEMIA | $133,804 | ||||||
| UNIVERSITY OF EXETER | ||||||||||||
| NORTHCOTE HOUSE THE QUEENS DRIVE | EXETER | UK | N/A | PC | EXTREMELY EARLY ONSET TYPE 1 DIABETES (EXE T1D) PHASE 2: FROM OBSERVATION TO MECHANISM | $672,028 | ||||||
| UNIVERSITY OF EXETER | ||||||||||||
| NORTHCOTE HOUSE THE QUEENS DRIVE | EXETER | UK | N/A | PC | ADVANCING -CELL SPECIFIC THERAPY BY IDENTIFYING -CELL REACTIVE HIGH AFFINITY T CELL RECEPTORS | $126,104 | ||||||
| UNIVERSITY OF EXETER | ||||||||||||
| NORTHCOTE HOUSE THE QUEENS DRIVE | EXETER | UK | N/A | PC | B CELL SIGNATURES IN TYPE 1 DIABETES | $235,821 | ||||||
| UNIVERSITY OF EXETER | ||||||||||||
| NORTHCOTE HOUSE THE QUEENS DRIVE | EXETER | UK | N/A | PC | UNCOVERING NEW GENETIC MECHANISMS UNDERLYING EXTREME EARLY-ONSET TYPE 1 DIABETES | $692,073 | ||||||
| UNIVERSITY OF EXETER | ||||||||||||
| NORTHCOTE HOUSE THE QUEENS DRIVE | EXETER | UK | N/A | PC | STIMULATED GLUCAGON LEVELS AS A BIOMARKER OF HYPOGLYCEMIA RISK IN TYPE 1 DIABETES | $95,777 | ||||||
| UNIVERSITY OF EXETER | ||||||||||||
| NORTHCOTE HOUSE THE QUEENS DRIVE | EXETER | UK | N/A | PC | UNCOVERING NEW GENETIC MECHANISMS UNDERLYING EXTREME EARLY-ONSET TYPE 1 DIABETES | $189,671 | ||||||
| UNIVERSITY OF EXETER | ||||||||||||
| NORTHCOTE HOUSE THE QUEENS DRIVE | EXETER | UK | N/A | PC | B CELL SIGNATURES IN TYPE 1 DIABETES | $313,168 | ||||||
| UNIVERSITY OF FLORIDA | ||||||||||||
| N/A | GOV | HUMAN ATLAS OF NEONATAL DEVELOPMENT AND EARLY LIFE-IMMUNITY (HANDEL-I) CONTINUATION | $665,910 | 219 GRINTER HALL | GAINESVILLE | FL | 326115500 | |||||
| UNIVERSITY OF FLORIDA | ||||||||||||
| N/A | GOV | GENERATING AUTOANTIGEN-SPECIFIC ANTIBODY-PRODUCING HYBRIDOMAS AS A RENEWABLE SOURCE OF ISLET AUTOANTIBODIES | $64,043 | 219 GRINTER HALL | GAINESVILLE | FL | 326115500 | |||||
| UNIVERSITY OF FLORIDA | ||||||||||||
| N/A | GOV | UNDERSTANDING T1D AND INSULIN-REQUIRING DIABETES IN FEDERALLY QUALIFIED HEALTH CENTERS (FQHC): A NATIONAL NEEDS ASSESSMENT | $757,160 | 219 GRINTER HALL | GAINESVILLE | FL | 326115500 | |||||
| UNIVERSITY OF FLORIDA | ||||||||||||
| N/A | GOV | HUMAN ATLAS OF NEONATAL DEVELOPMENT AND EARLY LIFE-IMMUNITY (HANDEL-I) CONTINUATION | $569,086 | 219 GRINTER HALL | GAINESVILLE | FL | 326115500 | |||||
| UNIVERSITY OF GLASGOW COURT | ||||||||||||
| UNIVERSITY AVENUE | GLASGOW | UK | N/A | PC | COMBINATION THERAPY WITH BIOLOGICS AND PARTIAL ENTERAL NUTRITION IN ADULTS WITH ACTIVE ILEOCOLONIC CROHNS DISEASE: THE BIOPIC STUDY | $176,239 | ||||||
| UNIVERSITY OF IOWA | ||||||||||||
| N/A | GOV | SUPPORTING THE RUPRI HEALTH PANEL TO BRING RESEARCH AND EXPERTISE TO INFORM POLICY DEVELOPMENT AND IMPLEMENTATION | $199,968 | DIVISION OF SPONSORED PROGRAMS | IOWA CITY | IA | 52442 | |||||
| UNIVERSITY OF IOWA | ||||||||||||
| N/A | GOV | SUPPORTING THE RUPRI HEALTH PANEL TO BRING RESEARCH AND EXPERTISE TO INFORM POLICY DEVELOPMENT AND IMPLEMENTATION | $204,566 | DIVISION OF SPONSORED PROGRAMS | IOWA CITY | IA | 52442 | |||||
| UNIVERSITY OF IOWA | ||||||||||||
| N/A | GOV | SIMULATION IN MOTION IOWA (SIM-IA) | $714,411 | DIVISION OF SPONSORED PROGRAMS | IOWA CITY | IA | 52442 | |||||
| UNIVERSITY OF KANSAS CENTER FOR RESEARCH INC | ||||||||||||
| N/A | PC | PRECLINICAL DEVELOPMENT TO ADVANCE A TYPE 1 DIABETES ANTIGEN-SPECIFIC IMMUNOTHERAPY CALLED SAGA-T1D | $579,370 | 2385 IRVING HILL ROAD | LAWRENCE | KS | 66045 | |||||
| UNIVERSITY OF KANSAS CENTER FOR RESEARCH INC | ||||||||||||
| N/A | PC | PRECLINICAL DEVELOPMENT TO ADVANCE A TYPE 1 DIABETES ANTIGEN-SPECIFIC IMMUNOTHERAPY CALLED SAGA-T1D | $706,324 | 2385 IRVING HILL ROAD | LAWRENCE | KS | 66045 | |||||
| UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | ||||||||||||
| N/A | GOV | DIETA ANTI-INFLAMATORIA: A CROHNS DISEASE MANAGEMENT STRATEGY TAILORED FOR PUERTO RICANS | $473,409 | 55 LAKE AVENUE NORTH | WORCESTER | MA | 01655 | |||||
| UNIVERSITY OF MELBOURNE | ||||||||||||
| LEVEL 4 ALAN GILBERT BUILDING | VICTORIA | AS | N/A | PC | USE OF WHEY PROTEIN TO REDUCE RISK OF HYPOGLYCEMIA DURING EXERCISE FOR PEOPLE WITH T1D | $405,066 | ||||||
| UNIVERSITY OF MELBOURNE | ||||||||||||
| LEVEL 4 ALAN GILBERT BUILDING | VICTORIA | AS | N/A | PC | USE OF WHEY PROTEIN TO REDUCE RISK OF HYPOGLYCEMIA DURING EXERCISE FOR PEOPLE WITH T1D | $490,922 | ||||||
| UNIVERSITY OF MIAMI | ||||||||||||
| N/A | PC | THE GEORGE S. EISENBARTH NPOD AWARD FOR TEAM SCIENCE | $326,055 | 1320 SOUTH DIXIE HIGHWAY SUITE 650 | CORAL GABLES | FL | 33146 | |||||
| UNIVERSITY OF MIAMI | ||||||||||||
| N/A | PC | THE GEORGE S. EISENBARTH NPOD AWARD FOR TEAM SCIENCE | $328,238 | 1320 SOUTH DIXIE HIGHWAY SUITE 650 | CORAL GABLES | FL | 33146 | |||||
| UNIVERSITY OF MIAMI | ||||||||||||
| N/A | PC | DEVELOP A NEW METHOD OF STUDYING ALPHA CELL FUNCTION IN PANCREATIC SLICES | $286,197 | 1320 SOUTH DIXIE HIGHWAY SUITE 650 | CORAL GABLES | FL | 33146 | |||||
| UNIVERSITY OF MIAMI | ||||||||||||
| N/A | PC | DEVELOP A NEW METHOD OF STUDYING ALPHA CELL FUNCTION IN PANCREATIC SLICES | $242,826 | 1320 SOUTH DIXIE HIGHWAY SUITE 650 | CORAL GABLES | FL | 33146 | |||||
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | ||||||||||||
| N/A | GOV | DEVELOPMENT OF A CONTINUOUS INSULIN SENSOR | $1,027,184 | 104 AIRPORT DRIVE SUITE 2200 CB | CHAPEL HILL | NC | 275991350 | 1350 | ||||
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | ||||||||||||
| N/A | GOV | PILOTING INTEGRATION OF PORTABLE ULTRASOUNDS | $1,038,654 | 104 AIRPORT DRIVE SUITE 2200 CB | CHAPEL HILL | NC | 275991350 | 1350 | ||||
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | ||||||||||||
| N/A | GOV | DEVELOPMENT OF A CONTINUOUS INSULIN SENSOR | $1,116,830 | 104 AIRPORT DRIVE SUITE 2200 CB | CHAPEL HILL | NC | 275991350 | 1350 | ||||
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | ||||||||||||
| N/A | GOV | FREQUENCY AND TITER OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AUTO-ANTIBODIES IN PATIENTS WITH CD OF THE POUCH | $336,550 | 104 AIRPORT DRIVE SUITE 2200 CB | CHAPEL HILL | NC | 275991350 | 1350 | ||||
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | ||||||||||||
| N/A | GOV | PILOTING INTEGRATION OF PORTABLE ULTRASOUNDS | $1,058,738 | 104 AIRPORT DRIVE SUITE 2200 CB | CHAPEL HILL | NC | 275991350 | 1350 | ||||
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | ||||||||||||
| N/A | GOV | GENOMIC AND MICROBIAL SIGNATURES PREDICT POST-OPERATIVE CROHNS DISEASE OUTCOMES | $149,796 | 104 AIRPORT DRIVE SUITE 2200 CB | CHAPEL HILL | NC | 275991350 | 1350 | ||||
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | ||||||||||||
| N/A | GOV | FREQUENCY AND TITER OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AUTO-ANTIBODIES IN PATIENTS WITH CD OF THE POUCH | $71,233 | 104 AIRPORT DRIVE SUITE 2200 CB | CHAPEL HILL | NC | 275991350 | 1350 | ||||
| UNIVERSITY OF NORTH DAKOTA | ||||||||||||
| N/A | GOV | SIMULATION IN MOTION (SIM) CONSORTIUM | $74,153 | SCHOOL OF MEDICINE HEALTH SCIENCES | GRAND FORKS | ND | 58202 | |||||
| UNIVERSITY OF NORTH DAKOTA | ||||||||||||
| N/A | GOV | SIMULATION IN MOTION (SIM) CONSORTIUM | $27,496 | SCHOOL OF MEDICINE HEALTH SCIENCES | GRAND FORKS | ND | 58202 | |||||
| UNIVERSITY OF NOTRE DAME DU LAC | ||||||||||||
| N/A | PC | GLUCOSE-BINDING MOTIFS FROM DYNAMIC COMBINATORIAL LANDSCAPES | $671,881 | 940 GRACE HALL | NOTRE DAME | ID | 465565708 | |||||
| UNIVERSITY OF NOTRE DAME DU LAC | ||||||||||||
| N/A | PC | DEVELOPMENT OF A NOVEL GLUCOSE-RESPONSIVE GLUCAGON DELIVERY SYSTEM | $705,510 | 940 GRACE HALL | NOTRE DAME | ID | 465565708 | |||||
| UNIVERSITY OF OULU | ||||||||||||
| PO BOX 8000 | OULU | FI | N/A | PC | MATERNAL AND PATERNAL TYPE 1 DIABETES MECHANISMS FOR THE DISTINCT RECURRENCE RISK IN THE OFFSPRING | $135,549 | ||||||
| UNIVERSITY OF OULU | ||||||||||||
| PO BOX 8000 | OULU | FI | N/A | PC | MATERNAL AND PATERNAL TYPE 1 DIABETES MECHANISMS FOR THE DISTINCT RECURRENCE RISK IN THE OFFSPRING | $274,391 | ||||||
| UNIVERSITY OF PITTSBURGH | ||||||||||||
| N/A | PC | SINGLE CELL MULTIMODAL OMICS ANALYSIS OF COLONOSCOPIC BIOPSY-DERIVED IMMUNE CELLS IN CROHNS DISEASE | $237,102 | 3420 FORBES AVENUE | PITTSBURGH | PA | 152603203 | |||||
| UNIVERSITY OF TEXAS SYSTEM FOR THE UNIVERSITY OF TEXAS AT AUSTIN | ||||||||||||
| N/A | GOV | INCREASING ACCESS TO CROHNS DISEASE CLINICAL CARE FOR THE IBD CENTER AT UT HEALTH AUSTIN | $198,646 | 3925 WEST BRAKER LANE | AUSTIN | TX | 787595316 | |||||
| UNIVERSITY OF TEXAS SYSTEM FOR THE UNIVERSITY OF TEXAS AT AUSTIN | ||||||||||||
| N/A | GOV | INCREASING ACCESS TO CROHNS DISEASE CLINICAL CARE FOR THE IBD CENTER AT UT HEALTH AUSTIN | $200,927 | 3925 WEST BRAKER LANE | AUSTIN | TX | 787595316 | |||||
| UNIVERSITY OF TEXAS SYSTEM FOR THE UNIVERSITY OF TEXAS AT AUSTIN | ||||||||||||
| N/A | GOV | INCREASING ACCESS TO CROHNS DISEASE CLINICAL CARE FOR THE IBD CENTER AT UT HEALTH AUSTIN | $200,927 | 3925 WEST BRAKER LANE | AUSTIN | TX | 787595316 | |||||
| UNIVERSITY OF UTAH | ||||||||||||
| N/A | PC | INDUCTION OF PERIPHERAL TOLERANCE TO BETA CELL ANTIGENS BY SPECIFIC TARGETING OF LANGERIN+ DENDRITIC CELLS | $290,806 | 201 S PRESIDENTS CIRCLE | SALT LAKE CITY | UT | 84112 | |||||
| UNIVERSITY OF WASHINGTON | ||||||||||||
| N/A | GOV | DESIGN OF ISLET TARGETED AGONISTS OF PD1 AND CTLA4 | $387,576 | OFFICE OF SPONSORED PROGRAMS | SEATTLE | WA | 981959472 | |||||
| UNIVERSITY OF WESTERN ONTARIO | ||||||||||||
| 339 WINDERMERE RD | LONDON | CA | N/A | PC | ENDPOINT DEVELOPMENT FOR OSTOMY CLINICAL TRIALS (ENDO-TRIAL) CONSORTIUM | $756,873 | ||||||
| UNIVERSITY OF WESTERN ONTARIO | ||||||||||||
| 339 WINDERMERE RD | LONDON | CA | N/A | PC | ENDPOINT DEVELOPMENT FOR OSTOMY CLINICAL TRIALS (ENDO-TRIAL) CONSORTIUM | $606,448 | ||||||
| UNIVERSITY OF WYOMING FOUNDATION | ||||||||||||
| N/A | PC | ULTRASOUND TRAINING INITIATIVE IN WYOMING | $458,857 | 222 S 22ND ST | LARAMIE | WY | 82070 | |||||
| UNIVERSITY OF WYOMING FOUNDATION | ||||||||||||
| N/A | PC | ULTRASOUND TRAINING INITIATIVE IN WYOMING | $458,857 | 222 S 22ND ST | LARAMIE | WY | 82070 | |||||
| UPPSALA UNIVERSITY HOSPITAL | ||||||||||||
| BOX 256 | UPPSALA | SW | N/A | PC | IMMUNE-EVASIVE ISLETS FOR TRANSPLANTATION | $1,139,284 | ||||||
| UPPSALA UNIVERSITY HOSPITAL | ||||||||||||
| BOX 256 | UPPSALA | SW | N/A | PC | IMMUNE-EVASIVE ISLETS FOR TRANSPLANTATION | $360,374 | ||||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| N/A | PC | EXPANSION OF PANCREATLAS CONNECTIVITY PLATFORM AND PHENOTYPING OF HANDEL SAMPLES BY CUTTING-EDGE SINGLE CELL MULTIOME TECHNOLOGY | $513,936 | OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | |||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| N/A | PC | ADAPTING FAMS TO OPTIMIZE CGM USE AMONG EMERGING ADULTS WITH TYPE 1 DIABETES | $121,999 | OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | |||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| N/A | PC | ISOLATING ISLETS TO UNDERSTAND HYPOGLYCEMIA IN TYPE 1 DIABETES | $163,405 | OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | |||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| N/A | PC | DEFINING MOLECULAR MECHANISMS OF CELL DYSFUNCTION IN TYPE 1 DIABETES TO DEVELOP NEWAPPROACHES TO PREVENT HYPOGLYCEMIA | $275,000 | OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | |||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| N/A | PC | ADAPTING FAMS TO OPTIMIZE CGM USE AMONG EMERGING ADULTS WITH TYPE 1 DIABETES | $232,525 | OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | |||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| N/A | PC | DEFINING MOLECULAR MECHANISMS OF CELL DYSFUNCTION IN TYPE 1 DIABETES TO DEVELOP NEWAPPROACHES TO PREVENT HYPOGLYCEMIA | $104,599 | OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | |||||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||||
| N/A | PC | ADAPTING FAMS TO OPTIMIZE CGM USE AMONG EMERGING ADULTS WITH TYPE 1 DIABETES | $182,168 | OFFICE OF SPONSORED PROGRAMS | NASHVILLE | TN | 37203 | |||||
| VANDERBILT UNIVERSITY | ||||||||||||
| N/A | PC | NORMALIZING HYPOGLYCEMIA-INDUCED GLUCAGON SECRETION IN T1D THROUGH PHARMACOLOGICAL RESTORATION OF ALPHA-CELL CALCIUM HANDLING | $275,000 | SPONSORED PROGRAMS ADMINISTRATION | NASHVILLE | TN | 372032417 | |||||
| VAYU HEALTH | ||||||||||||
| N/A | PC | VAYU HEALTH PHASE 2 - SCALE AND SPREAD OF VALUE BASED PAYMENT ECOSYSTEM FOR MEDICAID BENEFICIARIES LIVING WITH TYPE 1 AND TYPE 2 DIABETES | $2,978,657 | 19 ALISO WAY | PORTOLA VALLEY | CA | 94028 | |||||
| VAYU HEALTH | ||||||||||||
| N/A | PC | FEASIBILITY PILOT TO DESIGN A VALUE BASED PAYMENT ECOSYSTEM TO IMPROVE HEALTH AND EQUITY FOR MEDICAID BENEFICIARIES LIVING WITH T1D AND T2D. | $318,000 | 19 ALISO WAY | PORTOLA VALLEY | CA | 94028 | |||||
| VAYU HEALTH | ||||||||||||
| N/A | PC | VAYU HEALTH PHASE 2 - SCALE AND SPREAD OF VALUE BASED PAYMENT ECOSYSTEM FOR MEDICAID BENEFICIARIES LIVING WITH TYPE 1 AND TYPE 2 DIABETES | $3,039,905 | 19 ALISO WAY | PORTOLA VALLEY | CA | 94028 | |||||
| VAYU HEALTH | ||||||||||||
| N/A | PC | VAYU HEALTH PHASE 2 - SCALE AND SPREAD OF VALUE BASED PAYMENT ECOSYSTEM FOR MEDICAID BENEFICIARIES LIVING WITH TYPE 1 AND TYPE 2 DIABETES | $4,336,124 | 19 ALISO WAY | PORTOLA VALLEY | CA | 94028 | |||||
| VAYU HEALTH | ||||||||||||
| N/A | PC | VAYU HEALTH PHASE 2 - SCALE AND SPREAD OF VALUE BASED PAYMENT ECOSYSTEM FOR MEDICAID BENEFICIARIES LIVING WITH TYPE 1 AND TYPE 2 DIABETES | $2,203,040 | 19 ALISO WAY | PORTOLA VALLEY | CA | 94028 | |||||
| VIVLI INC | ||||||||||||
| N/A | PC | DATA SHARING PLATFORM FOR T1-DEXI DATASETS | $74,348 | 101 MIDDLESEX TURNPIKE SUITE 6 | BURLINGTON | MA | 018034914 | |||||
| WARREN MEMORIAL HOSPITAL | ||||||||||||
| N/A | GOV | TELE-EMERGENCY SERVICES AT FRIEND COMMUNITY HEALTHCARE SYSTEM | $11,027 | 905 2ND ST | FRIEND | NE | 68359 | |||||
| WASHINGTON UNIVERSITY | ||||||||||||
| N/A | PC | CELLULAR BIOMARKERS FOR PEDIATRIC CROHNS DISEASE | $488,300 | CAMPUS BOX 1054 | SAINT LOUIS | MI | 631304862 | |||||
| WASHINGTON UNIVERSITY | ||||||||||||
| N/A | PC | RESTORATION OF NORMAL GLUCAGON SECRETORY DYNAMICS BY DIRECT MANIPULATION OF ALPHA CELL SIGNALING | $330,000 | CAMPUS BOX 1054 | SAINT LOUIS | MI | 631304862 | |||||
| WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY | ||||||||||||
| N/A | PC | TARGETING THE MYCOBIOME IN PATIENTS WITH CROHNS DISEASE | $863,618 | 1300 YORK AVENUE | NEW YORK | NY | 100654805 | |||||
| WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY | ||||||||||||
| N/A | PC | TARGETING THE MYCOBIOME IN PATIENTS WITH CROHNS DISEASE | $202,620 | 1300 YORK AVENUE | NEW YORK | NY | 100654805 | |||||
| WEIZMANN INSTITUTE OF SCIENCE | ||||||||||||
| POB 26 | REHOVOT | IS | N/A | PC | QUANTUM COMPUTING AND SENSING WITH ATOMS, ELECTRONS, AND PHOTONS | $2,700,000 | ||||||
| WORLD HEALTH ORGANIZATION | ||||||||||||
| AVENUE APPIA 20 | GENEVA | SZ | N/A | PC | STRENGTHENING INTEGRATED PREVENTION AND CONTROL OF CHRONIC AND SEVERE NCDS IN THE WHO AFRICAN REGION, USING T1D, SCD, ARF, AND RHD AS ENTRY POINTS | $3,477,889 | ||||||
| WORLD HEALTH ORGANIZATION | ||||||||||||
| AVENUE APPIA 20 | GENEVA | SZ | N/A | PC | STRENGTHENING THE CAPACITY OF THE GLOBAL DIABETES COMPACT | $3,521,461 | ||||||
| WORLD HEALTH ORGANIZATION | ||||||||||||
| AVENUE APPIA 20 | GENEVA | SZ | N/A | PC | STRENGTHENING INTEGRATED PREVENTION AND CONTROL OF CHRONIC AND SEVERE NCDS IN THE WHO AFRICAN REGION, USING T1D, SCD, ARF, AND RHD AS ENTRY POINTS | $2,658,639 | ||||||
| WORLD HEALTH ORGANIZATION | ||||||||||||
| AVENUE APPIA 20 | GENEVA | SZ | N/A | PC | STRENGTHENING THE CAPACITY OF THE GLOBAL DIABETES COMPACT | $2,738,915 | ||||||
| YALE UNIVERSITY | ||||||||||||
| N/A | PC | TARGETING NEWLY DISCOVERED HOST-MICROBIOTA INTERACTION NODES TO TREAT OR PREVENT CROHNS DISEASE | $599,035 | OFFICE OF SPONSORED PROJECTS | NEW HAVEN | CT | 065208327 | |||||
| YALE UNIVERSITY | ||||||||||||
| N/A | PC | TARGETING NEWLY DISCOVERED HOST-MICROBIOTA INTERACTION NODES TO TREAT OR PREVENT CROHNS DISEASE | $605,522 | OFFICE OF SPONSORED PROJECTS | NEW HAVEN | CT | 065208327 | |||||
| YEHUDA ABARBANEL GOVERNMENT HOSPITAL | ||||||||||||
| 15 KEREN KAYEMET ST | BAT YAM | IS | N/A | GOV | MODERNIZATION OF ABARBANELS INFORMATION TECHNOLOGY AND SECURITY SYSTEMS | $454,960 | ||||||
| YITZHAK SHAMIR MEDICAL CENTER | ||||||||||||
| BEER YAAKOV | TZRIFIN | IS | N/A | GOV | EXPANSION AND RENOVATION OF THE CANCER INSTITUTE AT SHAMIR MEDICAL CENTER | $1,978,286 | ||||||
| YOUTH DEVELOPMENT ORGANIZATION INC | ||||||||||||
| N/A | PC | CAPACITY BUILDING PROJECT SUPPORT 2024-2026 | $200,000 | 15 UNION STREET 563 | LAWRENCE | MA | 01840 | |||||
| YOUTH DEVELOPMENT ORGANIZATION INC | ||||||||||||
| N/A | PC | CAPACITY BUILDING PROJECT SUPPORT 2024-2026 | $200,000 | 15 UNION STREET 563 | LAWRENCE | MA | 01840 | |||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Grant Or Contri Apprv Fut | $586,831,945 | TotalGrantOrContriApprvFutAmt |
Analysis Income Producing Acty AnalysisIncomeProducingActyGrp
Int On Sav And Temp Cash Invst IntOnSavAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Exclusion | 14 | ExclusionCd |
| Exclusion | $4,018,817 | ExclusionAmt |
Dividends And Interest From Sec Dtl DividendsAndInterestFromSecDtl
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business | 901101 | BusinessCd |
| Unrelated Business Taxbl Incm | $5,123,477 | UnrelatedBusinessTaxblIncmAmt |
| Exclusion | 14 | ExclusionCd |
| Exclusion | $61,972,395 | ExclusionAmt |
Other Investment Income OtherInvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business | 901101 | BusinessCd |
| Unrelated Business Taxbl Incm | $23,232,266 | UnrelatedBusinessTaxblIncmAmt |
| Exclusion | 14 | ExclusionCd |
| Exclusion | $28,425,875 | ExclusionAmt |
Gain Sales Ast Oth Than Invntry GainSalesAstOthThanInvntryGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business | 901101 | BusinessCd |
| Unrelated Business Taxbl Incm | $5,858,689 | UnrelatedBusinessTaxblIncmAmt |
| Exclusion | 18 | ExclusionCd |
| Exclusion | $228,845,211 | ExclusionAmt |
Other Revenue Described OtherRevenueDescribedGrp (2 entries)
| DescDesc | ExclusionExclusionCd | ExclusionExclusionAmt |
|---|---|---|
| GRANT RECOVERIES | 01 | $7,742,742 |
| OTHER NON-TAXABLE INCOME | 01 | $9,058 |
Subtotals Incm Producing Acty SubtotalsIncmProducingActyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Unrelated Business Taxbl Incm | $34,214,432 | UnrelatedBusinessTaxblIncmAmt |
| Exclusion | $331,014,098 | ExclusionAmt |
| Related Or Exempt Function Incm | $0 | RelatedOrExemptFunctionIncmAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Income Producing Acty | $365,228,530 | TotalIncomeProducingActyAmt |
Trnsfr Trans Rln Nonchrtbl EO TrnsfrTransRlnNonchrtblEOGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Trnsfr Of Cash To Nonchrtbl EO | Yes (1) | TrnsfrOfCashToNonchrtblEOInd |
| Trnsfr Other Asset Nonchrtbl EO | 0 | TrnsfrOtherAssetNonchrtblEOInd |
| Sales Or Exchanges Of Assets | 0 | SalesOrExchangesOfAssetsInd |
| Purchase Of Assets Nonchrtbl EO | 0 | PurchaseOfAssetsNonchrtblEOInd |
| Rental Of Facilities Oth Assets | 0 | RentalOfFacilitiesOthAssetsInd |
| Reimbursement Arrangements | 0 | ReimbursementArrangementsInd |
| Loans Or Loan Guarantees | 0 | LoansOrLoanGuaranteesInd |
| Performance Of Services Etc | 0 | PerformanceOfServicesEtcInd |
| Sharing Of Facilities Etc | 0 | SharingOfFacilitiesEtcInd |
Transfer Schedule Detail TransferScheduleDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Line Number | 1a(1) | LineNumberTxt |
| Involved | $831,327 | InvolvedAmt |
Noncharitable Exempt Org Name NoncharitableExemptOrgName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTS | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Transfers Trans And Shr Arrngm | GRANT IN SUPPORT OF EXPANSION OF THE DANATECH PLATFORM TO IMPROVE T1D CARE | TransfersTransAndShrArrngmDesc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Relationships Nonchrtbl EO | 0 | RelationshipsNonchrtblEOInd |
Schedule B IRS990ScheduleB
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization501c3 Exempt PF | Yes (X) | Organization501c3ExemptPFInd |
| General Rule | Yes (X) | GeneralRuleInd |
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | 1 | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ESTATE OF LEONA M HELMSLEY | BusinessNameLine1Txt |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 230 PARK AVENUE SUITE 659 | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10169 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | $20,000,000 | TotalContributionsAmt |
| Person Contribution | Yes (X) | PersonContributionInd |
Accounting Fees Schedule AccountingFeesSchedule
Accounting Fees Detail AccountingFeesDetail (3 entries)
| CategoryCategoryTxt | AmtAmt | Net Investment IncomeNetInvestmentIncomeAmt | Disbursements Charitable PrpsDisbursementsCharitablePrpsAmt |
|---|---|---|---|
| AUDIT AND TAX PREPARATION | $250,826 | $112,329 | $160,305 |
| BOOKKEEPING | $66,736 | $3,901 | $69,049 |
| OTHER ACCOUNTING SERVICES | $109,527 | $0 | $116,371 |
All Oth Prog Rltd Investments Sch AllOthProgRltdInvestmentsSch
All Other Program Related Invst AllOtherProgramRelatedInvstGrp (2 entries)
| DescDesc | AmtAmt |
|---|---|
| BIORASIS, INC. - EARLY FEASIBILITY STUDIES OF THE GLUCOWIZZARD IN CARE FOR T1D | $687,500 |
| PERCUSENSE, INC. - DEVELOPMENT OF CONTINUOUS GLUCOSE AND KETONE METER TO IMPROVE CARE OF T1D | $500,000 |
Expenditure Responsibility Stmt ExpenditureResponsibilityStmt
Expenditure Responsibility ExpenditureResponsibilityGrp (25 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | GrantGrantDt | GrantGrantAmt | Purpose Of GrantPurposeOfGrantTxt | Expended By GranteeExpendedByGranteeAmt | Any Diversion By GranteeAnyDiversionByGranteeTxt | Dates Of Reports By GranteeDatesOfReportsByGranteeTxt | Address Line1ForeignAddress/AddressLine1Txt | CityForeignAddress/CityNm | Province Or StateForeignAddress/ProvinceOrStateNm | CountryForeignAddress/CountryCd | Address Line2USAddress/AddressLine2Txt | Address Line2ForeignAddress/AddressLine2Txt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A GLIMMER OF HOPE FOUNDATION | |||||||||||||||
| 3103 BEE CAVES ROAD SUITE 201 | AUSTIN | TX | 78746 | 2018-02-20 | $5,000,000 | INTEGRATED COMMUNITY DEVELOPMENT IN AMHARA, ETHIOPIA | $5,000,000 | NONE | 1/2019, 1/2020, 2/2021, 1/2022, 1/2023, 1/2024 | ||||||
| A GLIMMER OF HOPE FOUNDATION | |||||||||||||||
| 3103 BEE CAVES ROAD SUITE 201 | AUSTIN | TX | 78746 | 2019-09-09 | $7,923,870 | INTEGRATED COMMUNITY DEVELOPMENT IN ODA BULTUM, ETHIOPIA | $7,923,870 | NONE | PRIOR+7/2021, 1/2022, 7/2022, 1/2023, 1/2024, 4/2024, 5/2024 | ||||||
| A GLIMMER OF HOPE FOUNDATION | |||||||||||||||
| 3103 BEE CAVES ROAD SUITE 201 | AUSTIN | TX | 78746 | 2022-12-20 | $4,800,000 | EMPOWERING FAMILIES TO BUILD RESILIENCE AND REDUCE POVERTY | $968,479 | NONE | 1/2024 | ||||||
| ABVANCE THERAPEUTICS INC | |||||||||||||||
| 38 BENNINGTON COURT | RENO | NV | 89511 | 2024-06-18 | $3,920,820 | DEVELOPMENT OF ABV100, A FIXED-RATIO COFORMULATION OF INSULIN AND GLUCAGON TO IMPROVE THE LIVES OF THOSE LIVING WITH T1D. | $0 | NONE | PENDING | ||||||
| AKSTON BIOSCIENCES CORPORATION | |||||||||||||||
| 100 CUMMINGS CENTER SUITE 454C | BEVERLY | MA | 01915 | 2017-03-01 | $6,194,000 | PRECLINICAL TRIAL OF INSULIN-FUSION TO END AUTOIMMUNITY & IMPROVE QUALITY OF LIFE FOR PEOPLE LIVING WITH T1D | $5,843,336 | NONE | PRIOR+2/2021, 6/2022, 3/2023, 6/2023, 12/2023, 3/2024, 6/2024 | ||||||
| ALIMENTIV INC (FKA ROBARTS) | |||||||||||||||
| 2018-11-20 | $3,390,428 | STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH (STAR) CONSORTIUM TO IMPROVE CARE OF CD PATIENTS | $2,751,742 | NONE | PRIOR+6/2021, 12/2021, 6/2022, 2/2023, 7/2023, 11/2023, 3/2024 | 100 DUNDAS STREET | LONDON | ONTARIO | CA | ||||||
| ALIMENTIV INC (FKA ROBARTS) | |||||||||||||||
| 2022-02-10 | $894,043 | DEVELOP AN INTESTINAL MUCOSAL AND IMAGING BIOMARKER FOR STRICTURING CD AND IMPROVE HEALTH OUTCOMES FOR PATIENTS | $287,504 | NONE | 2/2023, 6/2023, 3/2024 | 100 DUNDAS STREET | LONDON | ONTARIO | CA | ||||||
| ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTS | |||||||||||||||
| 125 S WACKER DRIVE SUITE 600 | CHICAGO | IL | 60606 | 2021-11-20 | $2,500,000 | EXPANSION OF THE DANATECH PLATFORM TO IMPROVE T1D CARE | $1,270,333 | NONE | 1/2022, 5/2022, 12/2022, 1/2023, 12/2023, 1/2024 | ||||||
| AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD | |||||||||||||||
| 2020-07-23 | $3,560,371 | FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE: THE MIRO STUDY TO IMPROVE HEALTH OUTCOMES | $2,296,388 | NONE | PRIOR +2/2022, 7/2022, 8/2022, 2/2023, 8/2023, 3/2024, 8/2024 | 55 VICTORIA PARADE LEVEL 2 | FITZROY | AS | |||||||
| BIORASIS INC | |||||||||||||||
| 1392 STORRS RD U4213 ATL ROOM 106 | STORRS | CT | 06269 | 2018-02-06 | $3,016,000 | EARLY FEASIBILITY STUDIES OF THE GLUCOWIZZARD IN CARE FOR T1D | $1,988,500 | NONE | PRIOR+ 2/2021, 7/2021, 5/2022, 11/2022, 5/2023, 6/2024, 7/2024 | ||||||
| BREAKTHROUGH T1D (FKA JDRF INTERNATIONAL) | |||||||||||||||
| 200 VESEY STREET 28TH FLOOR | NEW YORK | NY | 10281 | 2012-05-21 | $8,200,000 | ORTHOGONALLY REDUNDANT GLUCOSE SENSOR TO IMPROVE CARE OF T1D | $8,200,000 | NONE | PRIOR + 7/2016, 6/2017, 6/2019, 11/2019, 5/2020, 8/2020 | ||||||
| CAPILLARY BIOMEDICAL INC | |||||||||||||||
| 2 WRIGLEY | IRVINE | CA | 92617 | 2020-09-02 | $1,500,000 | ADVANCED EXTENDED INFUSION SET TO IMPROVE CARE OF T1D | $1,428,325 | NONE | PRIOR + 1/2022, 5/2022, 6/2022, 3/2023, 8/2023, 8/2024 | ||||||
| DIABETOMICS INC | |||||||||||||||
| 2345 NE OVERLOOK DRIVE SUITE 140 | HILLSBORO | OR | 97006 | 2018-01-11 | $4,031,900 | POINT-OF-CARE RAPID TESTS FOR TID SCREENING AND INTERVENTION | $4,031,900 | NONE | PRIOR+ 4/2022, 9/2022, 10/2022, 7/2023, 10/2023, 7/2024 | ||||||
| DREAMED DIABETES LTD | |||||||||||||||
| 2023-02-23 | $2,850,000 | INCREASING ACCESS TO DECISION SUPPORT TOOLS FOR IMPROVED INSULIN DOSING FOR PEOPLE WITH DIABETES | $0 | NONE | 5/2023 | 14 KAPLAN ST | PETAH TIKVA | TEL AVIV | IS | ||||||
| FEROX THERAPEUTICS | |||||||||||||||
| 111 TOWN SQUARE PLACE SUITE 1203 | JERSEY CITY | NJ | 07310 | 2018-11-20 | $872,300 | INSULIN INDUCED HYPOGLYCEMIA PREVENTION PROGRAM TO IMPROVE CARE OF T1D | $872,300 | NONE | PRIOR + 4/2020, 7/2020, 12/2020, 1/2021, 4/2021, 7/2021 | PMB 1034 | |||||
| GRAND CANYON UNIVERSITY | |||||||||||||||
| 3300 WEST CAMELBACK ROAD | PHOENIX | AZ | 85017 | 2019-06-26 | $2,274,027 | DEVELOPMENT OF A CONTINUOUS INSULIN-GLUCOSE SENSOR TO IMPROVE T1D CARE | $2,274,027 | NONE | 6/2020, 7/2020, 7/2021, 4/2022, 1/2023 | ||||||
| INTERNATIONAL BOWEL ULTRASOUND GROUP EV | |||||||||||||||
| 2023-11-08 | $1,614,000 | DEVELOPMENT OF ELEARNING PLATFORM FOR STANDARDIZATION AND DISSEMINATION OF INTESTINAL ULTRASOUND EDUCATION. | $0 | NONE | PENDING | HARKORTSTR 1 | MUNSTER | GM | |||||||
| INTERNATIONAL BOWEL ULTRASOUND GROUP EV | |||||||||||||||
| 2020-10-22 | $4,752,086 | DEVELOPMENT OF AN INTESTINAL ULTRASOUND SCORE TO EVALUATE INFLAMMATION AND TREATMENT RESPONSE IN CROHNS DISEASE. | $2,141,708 | NONE | 6/2021, 12/2021, 8/2022, 11/2022, 12/2022, 8/2023, 2/2024 | HARKORTSTR 1 | MUNSTER | GM | |||||||
| INTERNATIONAL BOWEL ULTRASOUND GROUP EV | |||||||||||||||
| 2022-03-23 | $342,387 | POINT-OF-CARE INTESTINAL ULTRASOUND TRAINING IN THE UNITED STATES: INTRODUCTION TO INTESTINAL ULTRASONOGRAPHY FOR CD PATIENTS | $172,967 | NONE | 3/2023 | HARKORTSTR 1 | MUNSTER | GM | |||||||
| INTERNATIONAL BOWEL ULTRASOUND GROUP EV | |||||||||||||||
| 2023-06-22 | $1,556,119 | THE EXTENT STUDY TO IMPROVE THE CARE OF CROHN'S DISEASE. | $338,377 | NONE | 5/2024, 8/2024 | HARKORTSTR 1 | MUNSTER | GM | |||||||
| PERCUSENSE INC | |||||||||||||||
| 25134 RYE CANYON LOOP | VALENCIA | CA | 91355 | 2020-09-02 | $2,500,000 | DEVELOPMENT OF CONTINUOUS GLUCOSE AND KETONE METER TO IMPROVE CARE OF T1D | $1,850,000 | NONE | PRIOR + 4/2023, 5/2023, 7/2023, 8/2023, 10/2023, 6/2024 | ||||||
| STARTUP HEALTH T1D PRI LP | |||||||||||||||
| 2000 BROADWAY 18TH FLOOR | NEW YORK | NY | 10023 | 2023-01-30 | $5,000,000 | CATALYZING SEED AND EARLY-STAGE COMPANIES DEVELOPING INNOVATIVE T1D CARE SOLUTIONS | $2,573,260 | NONE | 3/2023, 11/2023, 6/2024, 9/2024 | ||||||
| THE UNIVERSITY OF QUEENSLAND | |||||||||||||||
| 2021-09-08 | $2,493,864 | LIPOSOMAL ANTIGEN-SPECIFIC IMMUNOTHERAPY OF RECENT-ONSET TYPE 1 DIABETES | $865,466 | NONE | 1/2023, 3/2024 | CUMBRAE STEWART BUILDING 72 THE | BRISBANE | QUEENSLAND | AS | UNIVERSITY OF QUEENSLAND | |||||
| THE UNIVERSITY OF QUEENSLAND | |||||||||||||||
| 2023-05-22 | $226,017 | GUT MICROBIAL METABOLITES DURING EARLY-LIFE DEVELOPMENT AS PREDICTORS OF ISLET AUTOIMMUNITY | $45,564 | NONE | 3/2024 | CUMBRAE STEWART BUILDING 72 THE | BRISBANE | QUEENSLAND | AS | UNIVERSITY OF QUEENSLAND | |||||
| THETIS PHARMACEUTICALS LLC | |||||||||||||||
| 54 DANBURY ROAD SUITE 285 | RIDGEFIELD | NJ | 06877 | 2022-02-24 | $5,069,660 | DEVELOPMENT OF A NOVEL RESOLVIN E1 THERAPY FOR TREATMENT OF CROHNS DISEASE | $3,934,500 | NONE | PRIOR+5/2023,9/2023, 12/2023, 2/2024, 4/2024, 6/2024, 7/2024 | ||||||
General Explanation Attachment GeneralExplanationAttachment
General Explanation GeneralExplanationGrp (2 entries)
| IdentifierIdentifierTxt | Form And Line ReferenceFormAndLineReferenceDesc | Medium ExplanationMediumExplanationTxt |
|---|---|---|
| CONTROLLED ENTITIES | FORM 990-PF, PART VI-A, LINE 11: | THE FOLLOWING CONTROLLED ENTITIES ARE NOT EXCESS BUSINESS HOLDINGS:CHATHAM CO-INVEST26 MAIN STREET, SUITE 204CHATHAM, NJ 07928EIN# 85-0651355ESTATE OF LEONA M. HELMSLEY230 PARK AVENUE, SUITE 659NEW YORK, NY 10169EIN# 20-7535047HELMSLEY ENTERPRISES, INC.230 PARK AVENUE, SUITE 659NEW YORK, NY 10169EIN# 13-2665914LACM WORLD SMALL CAP EQUITY FUND, L.P.11150 SANTA MONICA BLVD., STE. 200LOS ANGELES, CA 90025EIN# 83-2888004MARATHON-LONDON GLOBAL SELECTORION HOUSE, 5 UPPER ST. MARTIN'S LANELONDON, UK WC2H 9EAEIN# 61-1915057MHR LONGEVITY PARTNERS1345 AVENUE OF THE AMERICAS 42ND FLOORNEW YORK, NY 10105EIN# 98-1471155NEWMARKET INTERNATIONAL INFRASTRUCTURE FINANCE COMPANY FEEDER, L.P.2929 ARCH STREET 17TH FLOORPHILADELPHIA, PA 19104EIN# 98-1142649PITANGO SPVBEIT ACKERSHTEIN - BLDG. B, 11 HAMENOFIM ST. 11TH FL.HERZLIYA, ISRAELEIN# 98-1492234STARTUP HEALTH T1D PRI LP2000 BROADWAY, 18TH FLOORNEW YORK, NY 10023EIN# 93-2618051 |
| FORM 990-PF, PART VII, LINE 1 AND 2, COLUMN (C), COMPENSATION: | ALL REPORTED COMPENSATION AMOUNTS INCLUDE "SALARY, FEES, BONUSES AND SEVERANCE PAYMENTS RECEIVED BY EACH PERSON LISTED," AS WELL AS CURRENT YEAR PAYMENTS OF AMOUNTS REPORTED OR REPORTABLE AS DEFERRED COMPENSATION IN CURRENT OR PRIOR YEARS. |
Investments Corp Stock Schedule InvestmentsCorpStockSchedule
Investments Corporate Stock InvestmentsCorporateStockGrp (118 entries)
| StockStockNm | EOY Book ValueEOYBookValueAmt | EOYFMVEOYFMVAmt |
|---|---|---|
| ALPHABET INC, 45,079 SHRS | $6,863,729 | $6,863,729 |
| AMAZON.COM INC, 62,440 SHRS | $11,262,927 | $11,262,927 |
| ANSYS INC, 16,010 SHRS | $5,558,032 | $5,558,032 |
| ATLASSIAN CORP, 7,353 SHRS | $1,434,644 | $1,434,644 |
| BIO-TECHNE CORP, 70,579 SHRS | $4,968,056 | $4,968,056 |
| CBRE GROUP INC, 65,438 SHRS | $6,363,191 | $6,363,191 |
| CARMAX INC, 22,974 SHRS | $2,001,265 | $2,001,265 |
| COSTAR GROUP INC, 37,037 SHRS | $3,577,774 | $3,577,774 |
| CROWDSTRIKE HOLDINGS INC, 4,441 SHRS | $1,423,740 | $1,423,740 |
| DANAHER CORP, 25,903 SHRS | $6,468,497 | $6,468,497 |
| ECOLAB INC, 20,961 SHRS | $4,839,895 | $4,839,895 |
| FASTENAL CO, 32,549 SHRS | $2,510,830 | $2,510,830 |
| GUIDEWIRE SOFTWARE INC, 45,210 SHRS | $5,276,459 | $5,276,459 |
| HEICO CORP, 40,957 SHRS | $6,304,921 | $6,304,921 |
| INTUIT INC, 5,110 SHRS | $3,321,500 | $3,321,500 |
| INTUITIVE SURGICAL INC, 12,879 SHRS | $5,139,880 | $5,139,880 |
| KINSALE CAPITAL GROUP INC, 6,921 SHRS | $3,631,726 | $3,631,726 |
| MARKEL GROUP INC, 2,553 SHRS | $3,884,338 | $3,884,338 |
| MASTERCARD INC, 17,212 SHRS | $8,288,783 | $8,288,783 |
| MICROSOFT CORP, 16,736 SHRS | $7,041,170 | $7,041,170 |
| MONOLITHIC POWER SYSTEMS INC, 5,448 SHRS | $3,690,584 | $3,690,584 |
| MOODY'S CORP, 11,080 SHRS | $4,354,772 | $4,354,772 |
| OLD DOMINION FREIGHT LINE INC, 24,254 SHRS | $5,319,145 | $5,319,145 |
| S&P GLOBAL INC, 16,804 SHRS | $7,149,262 | $7,149,262 |
| SHERWIN-WILLIAMS CO/THE, 11,066 SHRS | $3,843,554 | $3,843,554 |
| SITEONE LANDSCAPE SUPPLY INC, 21,900 SHRS | $3,822,645 | $3,822,645 |
| SPROUT SOCIAL INC, 41,508 SHRS | $2,478,443 | $2,478,443 |
| THERMO FISHER SCIENTIFIC INC, 9,077 SHRS | $5,275,643 | $5,275,643 |
| TRANSDIGM GROUP INC, 7,112 SHRS | $8,759,139 | $8,759,139 |
| VEEVA SYSTEMS INC, 24,036 SHRS | $5,568,901 | $5,568,901 |
| VERALTO CORP, 59,355 SHRS | $5,262,414 | $5,262,414 |
| VISA INC, 29,616 SHRS | $8,265,233 | $8,265,233 |
| VULCAN MATERIALS CO, 25,753 SHRS | $7,028,509 | $7,028,509 |
| WASTE CONNECTIONS INC, 28,597 SHRS | $4,918,970 | $4,918,970 |
| WEST PHARMACEUTICAL SERVICES I, 10,068 SHRS | $3,984,008 | $3,984,008 |
| WILLSCOT MOBILE MINI HOLDINGS, 63,928 SHRS | $2,972,652 | $2,972,652 |
| WORKIVA INC, 21,421 SHRS | $1,816,501 | $1,816,501 |
| ZOETIS INC, 14,278 SHRS | $2,415,980 | $2,415,980 |
| ASML HOLDING NV, 2,389 SHRS | $2,318,453 | $2,318,453 |
| ARCH CAPITAL GROUP LTD, 31,860 SHRS | $2,945,138 | $2,945,138 |
| SCHLUMBERGER LTD, 38,086 SHRS | $2,087,494 | $2,087,494 |
| FRESENIUS MEDICAL CARE AG, 105,911 SHRS | $2,041,964 | $2,041,964 |
| EATON CORP PLC, 7,035 SHRS | $2,199,704 | $2,199,704 |
| SONY GROUP CORP, 56,877 SHRS | $4,876,634 | $4,876,634 |
| FERGUSON PLC, 33,211 SHRS | $7,254,279 | $7,254,279 |
| KONINKLIJKE PHILIPS NV, 130,914 SHRS | $2,618,280 | $2,618,280 |
| SMITH & NEPHEW PLC, 89,859 SHRS | $2,278,824 | $2,278,824 |
| UNILEVER PLC, 81,279 SHRS | $4,079,393 | $4,079,393 |
| ALPHABET INC, 43,685 SHRS | $6,593,377 | $6,593,377 |
| AVERY DENNISON CORP, 25,477 SHRS | $5,687,740 | $5,687,740 |
| BERKSHIRE HATHAWAY INC, 15,142 SHRS | $6,367,514 | $6,367,514 |
| BLACKROCK INC, 3,156 SHRS | $2,631,157 | $2,631,157 |
| BOOKING HOLDINGS INC, 1,484 SHRS | $5,383,774 | $5,383,774 |
| CDW CORP/DE, 12,394 SHRS | $3,170,137 | $3,170,137 |
| CARLISLE COS INC, 13,377 SHRS | $5,241,777 | $5,241,777 |
| CARMAX INC, 62,091 SHRS | $5,408,747 | $5,408,747 |
| CARRIER GLOBAL CORP, 71,175 SHRS | $4,137,403 | $4,137,403 |
| DOLLAR GENERAL CORP, 25,941 SHRS | $4,048,352 | $4,048,352 |
| DOLLAR TREE INC, 23,960 SHRS | $3,190,274 | $3,190,274 |
| MASCO CORP, 72,819 SHRS | $5,743,963 | $5,743,963 |
| MICRON TECHNOLOGY INC, 43,584 SHRS | $5,138,118 | $5,138,118 |
| NORTHERN TRUST CORP, 39,309 SHRS | $3,495,356 | $3,495,356 |
| OMNICOM GROUP INC, 37,610 SHRS | $3,639,144 | $3,639,144 |
| PROGRESSIVE CORP/THE, 19,411 SHRS | $4,014,583 | $4,014,583 |
| QUEST DIAGNOSTICS INC, 29,141 SHRS | $3,878,959 | $3,878,959 |
| CHARLES SCHWAB CORP/THE, 92,922 SHRS | $6,721,977 | $6,721,977 |
| SYSCO CORP, 48,254 SHRS | $3,917,260 | $3,917,260 |
| TJX COS INC/THE, 15,463 SHRS | $1,568,257 | $1,568,257 |
| UNITEDHEALTH GROUP INC, 8,091 SHRS | $4,002,618 | $4,002,618 |
| RB GLOBAL INC, 197,129 SHRS | $15,015,316 | $15,015,316 |
| AON PLC, 34,711 SHRS | $11,583,755 | $11,583,755 |
| NINTENDO CO LTD, 165,000 SHRS | $8,935,478 | $8,935,478 |
| NOVARTIS AG, 92,230 SHRS | $8,946,525 | $8,946,525 |
| NESTLE SA, 52,246 SHRS | $5,554,074 | $5,554,074 |
| CIE FINANCIERE RICHEMONT SA, 46,562 SHRS | $7,108,110 | $7,108,110 |
| UNILEVER PLC, 149,110 SHRS | $7,491,525 | $7,491,525 |
| RECKITT BENCKISER GROUP PLC, 185,024 SHRS | $10,545,968 | $10,545,968 |
| INFORMA PLC, 903,750 SHRS | $9,489,496 | $9,489,496 |
| GSK PLC, 446,812 SHRS | $9,643,941 | $9,643,941 |
| BOOKING HOLDINGS INC, 2,779 SHRS | $10,081,879 | $10,081,879 |
| BRISTOL-MYERS SQUIBB CO, 208,007 SHRS | $11,280,220 | $11,280,220 |
| CORTEVA INC, 213,075 SHRS | $12,288,035 | $12,288,035 |
| EBAY INC, 151,642 SHRS | $8,003,665 | $8,003,665 |
| ELECTRONIC ARTS INC, 64,871 SHRS | $8,606,436 | $8,606,436 |
| FOX CORP, 243,057 SHRS | $7,600,392 | $7,600,392 |
| FOX CORP, 92,047 SHRS | $2,634,385 | $2,634,385 |
| INTERCONTINENTAL EXCHANGE INC, 87,691 SHRS | $12,051,374 | $12,051,374 |
| JOHNSON & JOHNSON, 60,279 SHRS | $9,535,535 | $9,535,535 |
| ESTEE LAUDER COS INC/THE, 35,524 SHRS | $5,476,025 | $5,476,025 |
| NEWS CORP, 422,306 SHRS | $11,055,971 | $11,055,971 |
| NEWS CORP, 151,503 SHRS | $4,099,671 | $4,099,671 |
| ORACLE CORP, 81,611 SHRS | $10,251,158 | $10,251,158 |
| REVVITY INC, 27,855 SHRS | $2,924,775 | $2,924,775 |
| TKO GROUP HOLDINGS INC, 39,152 SHRS | $3,383,124 | $3,383,124 |
| TRANSUNION, 114,304 SHRS | $9,121,459 | $9,121,459 |
| ZILLOW GROUP INC, 32,498 SHRS | $1,555,354 | $1,555,354 |
| ZILLOW GROUP INC, 180,747 SHRS | $8,816,839 | $8,816,839 |
| PDD HOLDINGS INC, 216,396 SHRS | $25,156,035 | $25,156,035 |
| STRUCTURE THERAPEUTICS INC, 1,336 SHRS | $57,261 | $57,261 |
| NU HOLDINGS LTD/CAYMAN ISLANDS, 708,356 SHRS | $8,450,687 | $8,450,687 |
| CHINA RENAISSANCE HOLDINGS LTD, 127,556 SHRS | $118,487 | $118,487 |
| YUBICO AB, 73,585 SHRS | $1,311,683 | $1,311,683 |
| AFFIRM HOLDINGS INC, 21,250 SHRS | $791,775 | $791,775 |
| AIRBNB INC, 89,793 SHRS | $14,812,253 | $14,812,253 |
| BILL HOLDINGS INC, 6,110 SHRS | $419,879 | $419,879 |
| COINBASE GLOBAL INC, 62,036 SHRS | $16,446,984 | $16,446,984 |
| CONFLUENT INC, 27,537 SHRS | $840,429 | $840,429 |
| CROWDSTRIKE HOLDINGS INC, 14,711 SHRS | $4,716,199 | $4,716,199 |
| DOORDASH INC, 22,663 SHRS | $3,121,148 | $3,121,148 |
| META PLATFORMS INC, 9,000 SHRS | $4,370,220 | $4,370,220 |
| FRESHWORKS INC, 2,700 SHRS | $49,167 | $49,167 |
| GUARDANT HEALTH INC, 4,000 SHRS | $82,520 | $82,520 |
| MAPLEBEAR INC, 13,360 SHRS | $498,194 | $498,194 |
| ROBLOX CORP, 72,000 SHRS | $2,748,960 | $2,748,960 |
| SNOWFLAKE INC, 57,211 SHRS | $9,245,298 | $9,245,298 |
| TOAST INC, 7,000 SHRS | $174,440 | $174,440 |
| UBER TECHNOLOGIES INC, 5,921 SHRS | $455,858 | $455,858 |
| UIPATH INC, 128,002 SHRS | $2,901,805 | $2,901,805 |
Investments Other Schedule2 InvestmentsOtherSchedule2
Investments Other InvestmentsOtherGrp (193 entries)
| Category Or ItemCategoryOrItemTxt | Listed At Cost Or FMVListedAtCostOrFMVCd | Book ValueBookValueAmt | EOYFMVEOYFMVAmt |
|---|---|---|---|
| JPM US LARGE CAP | FMV | $177,279,037 | $177,279,037 |
| SPDR TRUST SERIES I | FMV | $115,257,951 | $115,257,951 |
| JPM CORE BOND | FMV | $1,228,783,297 | $1,228,783,297 |
| JPM SHORT DURATION BOND | FMV | $311,100,609 | $311,100,609 |
| CHATHAM | FMV | $119,844,821 | $119,844,821 |
| CHATHAM OFFSHORE | FMV | $118,008,474 | $118,008,474 |
| CAMBER | FMV | $136,629,017 | $136,629,017 |
| ORBIMED GENESIS FUND | FMV | $49,036,762 | $49,036,762 |
| SEQUOIA CAP GLOBAL | FMV | $189,217,984 | $189,217,984 |
| ACADIAN FRONTIER | FMV | $176,593 | $176,593 |
| HIGHCLERE INTL SC | FMV | $134,358,764 | $134,358,764 |
| HIGHCLERE INTL SMID | FMV | $66,330,787 | $66,330,787 |
| LA CAPITAL GLOBAL | FMV | $95,462,096 | $95,462,096 |
| LACM WORLD SMALL CAP | FMV | $97,962,582 | $97,962,582 |
| MARATHON GLOBAL | FMV | $181,832,660 | $181,832,660 |
| SILCHESTER INTL | FMV | $151,839,703 | $151,839,703 |
| BLACKROCK US DEBT | FMV | $141,112,373 | $141,112,373 |
| BAYVIEW | FMV | $856,754 | $856,754 |
| EIG ENERGY FUND XVI | FMV | $36,496,509 | $36,496,509 |
| EIG ENERGY XV | FMV | $3,317,372 | $3,317,372 |
| FDAF DISLOCATED II | FMV | $25,362,236 | $25,362,236 |
| FDAF DISLOCATED III | FMV | $35,430,388 | $35,430,388 |
| FDAF DISLOCATED IV | FMV | $30,533,776 | $30,533,776 |
| GSO CAPITAL SOLS II | FMV | $2,361,684 | $2,361,684 |
| HIG BAYSIDE III | FMV | $3,377,026 | $3,377,026 |
| MHR AXIOM | FMV | $243,605,491 | $243,605,491 |
| MHR INST PARTNERS IV | FMV | $63,010,246 | $63,010,246 |
| NEWMARKET IIFC | FMV | $19,137,487 | $19,137,487 |
| ORBIMED ROYALTY II | FMV | $1,544,922 | $1,544,922 |
| ACCEL GROWTH FUND IV | FMV | $17,738,020 | $17,738,020 |
| ACCEL GROWTH II | FMV | $13,189,479 | $13,189,479 |
| ACCEL GROWTH III | FMV | $11,522,052 | $11,522,052 |
| ACCEL GROWTH V | FMV | $28,308,899 | $28,308,899 |
| ACCEL GROWTH VI | FMV | $13,248,632 | $13,248,632 |
| ACCEL INDIA V | FMV | $12,618,661 | $12,618,661 |
| ACCEL INDIA VI | FMV | $7,927,095 | $7,927,095 |
| ACCEL INDIA VII | FMV | $2,587,355 | $2,587,355 |
| ACCEL LEADERS 4 | FMV | $7,723,401 | $7,723,401 |
| ACCEL LEADERS FUND | FMV | $13,610,357 | $13,610,357 |
| ACCEL LEADERS II | FMV | $7,980,029 | $7,980,029 |
| ACCEL LEADERS III | FMV | $25,691,472 | $25,691,472 |
| ACCEL XI | FMV | $5,501,339 | $5,501,339 |
| ACCEL XII | FMV | $24,441,487 | $24,441,487 |
| ACCEL XIII | FMV | $12,686,251 | $12,686,251 |
| ACCEL XIV | FMV | $8,403,040 | $8,403,040 |
| ACCEL XV | FMV | $4,891,255 | $4,891,255 |
| AH BIO FUND I | FMV | $6,215,300 | $6,215,300 |
| AH BIO FUND II | FMV | $16,332,915 | $16,332,915 |
| AH BIO III | FMV | $17,539,078 | $17,539,078 |
| AH BIO IV | FMV | $5,164,862 | $5,164,862 |
| AH CNK IV | FMV | $9,973,313 | $9,973,313 |
| AH CNK SEED I | FMV | $1,812,964 | $1,812,964 |
| AH FUND VII | FMV | $10,637,499 | $10,637,499 |
| AH FUND VIII | FMV | $4,792,855 | $4,792,855 |
| AH III | FMV | $37,063,336 | $37,063,336 |
| AH III PARALLEL | FMV | $8,022,513 | $8,022,513 |
| AH IV | FMV | $42,823,557 | $42,823,557 |
| AH IV PARALLEL | FMV | $16,791,658 | $16,791,658 |
| AH LSV FUND II | FMV | $17,482,444 | $17,482,444 |
| AH LSV FUND III | FMV | $11,279,330 | $11,279,330 |
| AH LSV I | FMV | $18,669,497 | $18,669,497 |
| AH V | FMV | $41,678,594 | $41,678,594 |
| AH V PARALLEL | FMV | $27,081,839 | $27,081,839 |
| AH VI | FMV | $25,593,295 | $25,593,295 |
| ANGELENO INV III | FMV | $17,678,812 | $17,678,812 |
| ARBORETUM III | FMV | $2,731,511 | $2,731,511 |
| ARBORETUM IV | FMV | $9,848,177 | $9,848,177 |
| ARBORETUM V | FMV | $16,692,098 | $16,692,098 |
| ARBORETUM VI | FMV | $3,110,754 | $3,110,754 |
| COLLER VI | FMV | $3,508,788 | $3,508,788 |
| COLLER VII | FMV | $25,558,568 | $25,558,568 |
| COLLER VIII | FMV | $30,577,456 | $30,577,456 |
| CONGRUENT CONTINUITY | FMV | $5,628,815 | $5,628,815 |
| CRESTVIEW ELO | FMV | $7,079,890 | $7,079,890 |
| CRESTVIEW III | FMV | $38,332,056 | $38,332,056 |
| CRESTVIEW IV | FMV | $28,522,754 | $28,522,754 |
| EIG ENERGY XVII | FMV | $11,459,284 | $11,459,284 |
| EMERGENCE III | FMV | $49,402,869 | $49,402,869 |
| EMERGENCE IV | FMV | $22,667,037 | $22,667,037 |
| EMERGENCE OPP I | FMV | $6,474,026 | $6,474,026 |
| EMERGENCE V | FMV | $22,820,659 | $22,820,659 |
| EMERGENCE VI | FMV | $9,697,673 | $9,697,673 |
| EPIRIS ELEC CO INV | FMV | $12,983,712 | $12,983,712 |
| EPIRIS II | FMV | $24,549,597 | $24,549,597 |
| EPIRIS III | FMV | $9,507,394 | $9,507,394 |
| FORTISSIMO IV | FMV | $22,466,775 | $22,466,775 |
| FORTISSIMO V | FMV | $24,897,842 | $24,897,842 |
| FORTISSIMO VI | FMV | $2,052,354 | $2,052,354 |
| FRAZIER GTH BUYOUT X | FMV | $14,157,034 | $14,157,034 |
| FRAZIER IX | FMV | $8,527,401 | $8,527,401 |
| FRAZIER OVERAGE | FMV | $17,432,536 | $17,432,536 |
| FRAZIER PUBLIC FUND | FMV | $23,859,182 | $23,859,182 |
| FRAZIER SUNMD CO INV | FMV | $19,746,931 | $19,746,931 |
| FRAZIER X | FMV | $14,892,171 | $14,892,171 |
| FRAZIER XI | FMV | $7,591,048 | $7,591,048 |
| GAVEA IV | FMV | $1,493,387 | $1,493,387 |
| GAVEA V | FMV | $3,630,248 | $3,630,248 |
| GAVEA V PLUS | FMV | $423,181 | $423,181 |
| GENERL ATLANTIC 2013 | FMV | $61,406,512 | $61,406,512 |
| GENERL ATLANTIC 2018 | FMV | $80,379,997 | $80,379,997 |
| HIG BIOVENTURE II | FMV | $12,556,914 | $12,556,914 |
| HIG BRAZIL | FMV | $4,342,221 | $4,342,221 |
| HIG BRAZIL LATAM B | FMV | $18,846,817 | $18,846,817 |
| HIG BRAZIL LATAM C | FMV | $18,846,817 | $18,846,817 |
| HIG CAPITAL V | FMV | $9,219,459 | $9,219,459 |
| HIG GROWTH B&E F II | FMV | $16,876,670 | $16,876,670 |
| HIG GROWTH III | FMV | $5,450,751 | $5,450,751 |
| HIG MID MARKET II | FMV | $13,318,133 | $13,318,133 |
| HIG MID MARKET III | FMV | $18,405,040 | $18,405,040 |
| HONGSHAN GROWTH III | FMV | $86,634,726 | $86,634,726 |
| HONGSHAN GROWTH IV | FMV | $26,626,078 | $26,626,078 |
| HONGSHAN GROWTH V | FMV | $30,316,741 | $30,316,741 |
| HONGSHAN GROWTH VI | FMV | $19,761,283 | $19,761,283 |
| HONGSHAN GROWTH VII | FMV | $1,825,297 | $1,825,297 |
| HONGSHAN VTR IV | FMV | $10,645,322 | $10,645,322 |
| HONGSHAN VTR IX | FMV | $695,717 | $695,717 |
| HONGSHAN VTR V | FMV | $8,875,329 | $8,875,329 |
| HONGSHAN VTR VI | FMV | $8,235,075 | $8,235,075 |
| HONGSHAN VTR VII | FMV | $5,713,480 | $5,713,480 |
| HONGSHAN VTR VIII | FMV | $4,486,252 | $4,486,252 |
| IDG BREYER | FMV | $6,442,626 | $6,442,626 |
| IDG CHINA CAP III | FMV | $28,060,681 | $28,060,681 |
| IDG CHINA VTR IV | FMV | $24,022,389 | $24,022,389 |
| IDG CHINA VTR V | FMV | $37,326,845 | $37,326,845 |
| IDG-ACCEL CHINA CAP | FMV | $13,923,874 | $13,923,874 |
| IDG-ACCEL CHINA GWTH | FMV | $12,018,748 | $12,018,748 |
| IRON POINT IV | FMV | $17,995,936 | $17,995,936 |
| JPM PEG SECONDRY III | FMV | $5,480,557 | $5,480,557 |
| ORBIMED ASIA III | FMV | $51,045,883 | $51,045,883 |
| ORBIMED ASIA IV | FMV | $20,890,121 | $20,890,121 |
| ORBIMED ISRAEL | FMV | $3,103,591 | $3,103,591 |
| ORBIMED ISRAEL II | FMV | $22,413,588 | $22,413,588 |
| ORBIMED PI IX | FMV | $6,998,250 | $6,998,250 |
| ORBIMED PI VI | FMV | $11,171,826 | $11,171,826 |
| ORBIMED PI VII | FMV | $22,808,946 | $22,808,946 |
| ORBIMED PI VIII | FMV | $21,470,500 | $21,470,500 |
| ORBMIED ASIA V | FMV | $4,180,666 | $4,180,666 |
| PEAK XV GWTH III | FMV | $10,938,427 | $10,938,427 |
| PEAK XV GWTH IV | FMV | $955,224 | $955,224 |
| PEAK XV SEA I | FMV | $1,381,998 | $1,381,998 |
| PEAK XV V | FMV | $12,918,796 | $12,918,796 |
| PEAK XV VI | FMV | $12,207,222 | $12,207,222 |
| PEAK XV VIII | FMV | $758,109 | $758,109 |
| PEAK XV VTR VII | FMV | $3,097,553 | $3,097,553 |
| PEP IV CORE | FMV | $19,860 | $19,860 |
| PEP IV SUPPL | FMV | $4,324 | $4,324 |
| PEP VI | FMV | $19,858,804 | $19,858,804 |
| PIATNGO VTR IX | FMV | $447,234 | $447,234 |
| PITANGO GROWTH | FMV | $58,225,338 | $58,225,338 |
| PITANGO GROWTH II | FMV | $21,071,726 | $21,071,726 |
| PITANGO HEALTH II | FMV | $2,472,759 | $2,472,759 |
| PITANGO HEALTHTECH I | FMV | $12,704,126 | $12,704,126 |
| PITANGO SPV | FMV | $22,027,563 | $22,027,563 |
| PITANGO VI, LP | FMV | $28,484,864 | $28,484,864 |
| PITANGO VTR VII | FMV | $29,265,006 | $29,265,006 |
| PITANGO VTR VIII | FMV | $15,198,039 | $15,198,039 |
| RIDGEWOOD III | FMV | $39,922,324 | $39,922,324 |
| RIDGEWOOD IV | FMV | $28,352,131 | $28,352,131 |
| S CAPITAL | FMV | $23,742,984 | $23,742,984 |
| S CAPITAL II | FMV | $12,692,175 | $12,692,175 |
| S CAPITAL III | FMV | $2,427,909 | $2,427,909 |
| SCF LIQUID PORTFOLIO | FMV | $55,363,184 | $55,363,184 |
| SEQUOIA GBL GRTH III | FMV | $96,303,980 | $96,303,980 |
| SEQUOIA GG 3 CH ANX | FMV | $14,267,485 | $14,267,485 |
| SEQUOIA GLB GROWTH | FMV | $26,574,063 | $26,574,063 |
| SEQUOIA GLB GRWTH II | FMV | $39,413,558 | $39,413,558 |
| SEQUOIA ISRAEL V | FMV | $7,408,714 | $7,408,714 |
| SEQUOIA SCOUT III | FMV | $2,374,137 | $2,374,137 |
| SEQUOIA SCOUT IV | FMV | $1,103,113 | $1,103,113 |
| SEQUOIA US ECO I | FMV | $502,600 | $502,600 |
| SEQUOIA US EXP I | FMV | $5,623,411 | $5,623,411 |
| SEQUOIA US GROWTH V | FMV | $1,208,181 | $1,208,181 |
| SEQUOIA US GRTH VIII | FMV | $9,628,750 | $9,628,750 |
| SEQUOIA US GRWTH VII | FMV | $3,868,124 | $3,868,124 |
| SEQUOIA US GWTH IX | FMV | $7,461,815 | $7,461,815 |
| SEQUOIA US GWTH VI | FMV | $2,618,668 | $2,618,668 |
| SEQUOIA US GWTH X | FMV | $1,377,016 | $1,377,016 |
| SEQUOIA US SEED V | FMV | $283,543 | $283,543 |
| SEQUOIA US VENT XVI | FMV | $7,864,806 | $7,864,806 |
| SEQUOIA US VTR XIV | FMV | $7,614,201 | $7,614,201 |
| SEQUOIA US VTR XV | FMV | $4,735,787 | $4,735,787 |
| SEQUOIA US VTR XVII | FMV | $4,034,175 | $4,034,175 |
| SEQUOIA US VTR XVIII | FMV | $408,452 | $408,452 |
| SQUOIA GG 3 US IN AX | FMV | $14,028,615 | $14,028,615 |
| STARWOOD X | FMV | $16,895,377 | $16,895,377 |
| STARWOOD XI | FMV | $43,811,791 | $43,811,791 |
| STARWOOD XII | FMV | $27,488,966 | $27,488,966 |
| TAURUS RESOURCES II | FMV | $36,588,660 | $36,588,660 |
| WTI VLL IX | FMV | $12,826,350 | $12,826,350 |
| WTI VLL VII | FMV | $7,696,800 | $7,696,800 |
| WTI VLL VIII | FMV | $11,849,425 | $11,849,425 |
| WTI VLL X | FMV | $6,300,263 | $6,300,263 |
| YORK CO INVEST 1 | FMV | $1,002,040 | $1,002,040 |
Land Etc Schedule2 LandEtcSchedule2
Land Etc LandEtcGrp (3 entries)
| Category Or ItemCategoryOrItemTxt | Cost Or Other BasisCostOrOtherBasisAmt | Accumulated DepreciationAccumulatedDepreciationAmt | Book ValueBookValueAmt | EOYFMVEOYFMVAmt |
|---|---|---|---|---|
| FURNITURE, FIXTURES AND EQUIPMENT | $3,070,395 | $1,934,123 | $1,136,272 | $1,136,272 |
| LEASEHOLD IMPROVEMENTS | $7,420,501 | $1,927,641 | $5,492,860 | $5,492,860 |
| WORK IN PROGRESS | $41,130 | $0 | $41,130 | $41,130 |
Legal Fees Schedule LegalFeesSchedule
Legal Fees LegalFeesGrp (3 entries)
| CategoryCategoryTxt | Legal FeesLegalFeesAmt | Net Investment IncomeNetInvestmentIncomeAmt | Disbursements Charitable PrpsDisbursementsCharitablePrpsAmt |
|---|---|---|---|
| LEGAL FEES - INVESTMENTS | $113,927 | $113,927 | $0 |
| LEGAL FEES - PROGRAMS | $131,480 | $0 | $154,619 |
| LEGAL FEES - GENERAL ADMINISTRATIVE | $177,853 | $0 | $173,296 |
Other Assets Schedule OtherAssetsSchedule
Other Assets Schedule OtherAssetsScheduleGrp (7 entries)
| DescDesc | BOY Book ValueBOYBookValueAmt | EOY Book ValueEOYBookValueAmt | EOYFMVEOYFMVAmt |
|---|---|---|---|
| ACCRUED INCOME RECEIVABLE | $1,995,290 | $1,416,200 | $1,416,200 |
| DUE FROM BROKER | $12,161,295 | $25,945,689 | $25,945,689 |
| RETIREMENT PLAN ASSET | $1,969,036 | $2,162,642 | $2,162,642 |
| ADVANCES AND OTHER RECEIVABLES | $64,252 | $6,037 | $6,037 |
| PREPAID FEDERAL EXCISE TAX | $5,573,002 | ||
| PROGRAM RELATED INVESTMENTS | $25,653,304 | $18,971,538 | $18,971,538 |
| OPERATING LEASE RIGHT OF USE ASSET | $8,596,861 | $7,359,283 | $7,359,283 |
Other Decreases Schedule OtherDecreasesSchedule
Other Decreases Detail OtherDecreasesDetail (3 entries)
| DescDesc | AmtAmt |
|---|---|
| UNREALIZED LOSS ON PRI | $2,973,465 |
| PROVISION FOR DEFERRED FEDERAL EXCISE TAX | $2,587,525 |
| PROVISION FOR CREDIT LOSSES - RELATED TO PROGRAM RELATED INVESTMENTS | $8,923,492 |
Other Expenses Schedule OtherExpensesSchedule
Other Expenses Schedule OtherExpensesScheduleGrp (8 entries)
| DescDesc | Revenue And Expenses Per BooksRevenueAndExpensesPerBooksAmt | Net Investment IncomeNetInvestmentIncomeAmt | Disbursements Charitable PrpsDisbursementsCharitablePrpsAmt |
|---|---|---|---|
| AMERICAN DEPOSITARY RECEIPT FEE | $16,670 | $16,670 | $0 |
| CONSULTING REIMBURSEMENTS | $83,574 | $0 | $91,313 |
| CUSTODY, BANK, & PERFORMANCE REPORTING FEES | $577,640 | $577,640 | $0 |
| STATE FILING FEES AND PENALTIES | $1,550 | $0 | $1,500 |
| INFORMATION TECHNOLOGY/COMPUTERS | $1,574,939 | $242,796 | $1,096,012 |
| INSURANCE | $432,434 | $39,929 | $397,200 |
| OFFICE EXPENSES | $1,330,082 | $400,414 | $841,353 |
| PORTFOLIO DEDUCTIONS | $14,699,662 | $55,993,792 | $0 |
Other Income Schedule2 OtherIncomeSchedule2
Other Income Detail OtherIncomeDetail (7 entries)
| DescDesc | Revenue And Expenses Per BooksRevenueAndExpensesPerBooksAmt | Net Investment IncomeNetInvestmentIncomeAmt | Adjusted Net IncomeAdjustedNetIncomeAmt |
|---|---|---|---|
| FX TRANSACTION NET GAIN | $75,679 | $107,230 | $75,679 |
| CLASS ACTION PROCEEDS, NET | $27,425 | $27,425 | $27,425 |
| OTHER PARTNERSHIP INCOME | $51,555,006 | $18,797,169 | $51,555,006 |
| SECTION 951(A) INCOME INCLUSION | $12,869,467 | ||
| OTHER INVESTMENT INCOME | $31 | $31 | $31 |
| GRANT RECOVERIES | $7,742,742 | $7,742,742 | |
| OTHER NON-TAXABLE INCOME | $9,058 | $9,058 |
Other Increases Schedule OtherIncreasesSchedule
Other Increases Detail OtherIncreasesDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | UNREALIZED GAIN ON INVESTMENTS | Desc |
| Amt | $186,800,511 | Amt |
Other Liabilities Schedule OtherLiabilitiesSchedule
Other Liabilities Detail OtherLiabilitiesDetail (7 entries)
| DescDesc | BOY Book ValueBOYBookValueAmt | EOY Book ValueEOYBookValueAmt |
|---|---|---|
| DEFERRED FEDERAL EXCISE TAX | $22,248,640 | $24,836,165 |
| RETIREMENT PLAN LIABILITY | $2,748,166 | $2,432,030 |
| ACCRUED VACATION | $890,327 | $1,168,550 |
| GRANT REFUNDS PENDING MODIFICATION | $6,355,762 | $3,852,387 |
| OPERATING LEASE LIABILITIES | $9,441,992 | $8,365,590 |
| FEDERAL EXCISE TAX PAYABLE | $0 | $4,555,771 |
| ALLOWANCE FOR CREDIT LOSSES | $0 | $646,935 |
Other Professional Fees Schedule OtherProfessionalFeesSchedule
Other Professional Fees Detail OtherProfessionalFeesDetail (9 entries)
| CategoryCategoryTxt | AmtAmt | Net Investment IncomeNetInvestmentIncomeAmt | Disbursements Charitable PrpsDisbursementsCharitablePrpsAmt |
|---|---|---|---|
| GRANTS MANAGEMENT CONSULTING | $187,909 | $0 | $169,633 |
| HUMAN RESOURCE CONSULTING | $59,283 | $6,250 | $66,833 |
| INFORMATION TECHNOLOGY CONSULTING | $431,360 | $42,495 | $390,141 |
| INVESTMENT ADVISORY | $495,009 | $495,009 | $0 |
| INVESTMENT MANAGEMENT | $3,744,150 | $3,744,150 | $0 |
| MANAGEMENT CONSULTING | $53,667 | $385 | $23,291 |
| PROGRAM CONSULTING | $1,401,182 | $0 | $1,313,020 |
| PUBLIC RELATIONS | $537,596 | $0 | $502,546 |
| RECRUITMENT | $236,412 | $75,000 | $166,096 |
Taxes Schedule TaxesSchedule
Taxes Detail TaxesDetail (4 entries)
| CategoryCategoryTxt | AmtAmt | Net Investment IncomeNetInvestmentIncomeAmt | Disbursements Charitable PrpsDisbursementsCharitablePrpsAmt |
|---|---|---|---|
| STATE UBI AND OTHER TAXES | $2,344,680 | $0 | $0 |
| FOREIGN TAXES WITHHELD | $513,757 | $2,384,774 | $0 |
| FEDERAL EXCISE TAX | $5,128,773 | $0 | $0 |
| FEDERAL UNRELATED BUSINESS INCOME TAX | $1,600,000 | $0 | $0 |
Transfers Frm Controlled Entities TransfersFrmControlledEntities
Transfers From Controlled Ent TransfersFromControlledEntGrp (4 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | DescDesc | AmtAmt | Address Line2USAddress/AddressLine2Txt |
|---|---|---|---|---|---|---|---|
| CHATHAM CO-INVEST | |||||||
| 26 MAIN STREET SUITE 204 | CHATHAM | NJ | 07928 | 850651355 | DISTRIBUTION FROM PARTNERSHIP | $0 | |
| ESTATE OF LEONA M HELMSLEY | |||||||
| 230 PARK AVENUE SUITE 659 | NEW YORK | NY | 10169 | 207535047 | CONTRIBUTION | $0 | |
| MHR LONGEVITY PARTNERS | |||||||
| 1345 AVENUE OF THE AMERICAS 42ND | NEW YORK | NY | 10105 | 981471155 | DISTRIBUTION FROM PARTNERSHIP | $60,730,000 | FLOOR |
| NEWMARKET INTERNATIONAL INFRASTRUCTURE FINANCE COMPANY FEEDER LP | |||||||
| 2929 ARCH STREET 17TH FLOOR | PHILADELPHIA | PA | 19104 | 981142649 | DISTRIBUTION | $720,114 | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $69,727,290 | TotalAmt |
Transfers To Controlled Entities TransfersToControlledEntities
Transfers To Controlled Ent TransfersToControlledEntGrp (5 entries)
| Address Line1ForeignAddress/AddressLine1Txt | CityForeignAddress/CityNm | CountryForeignAddress/CountryCd | Foreign PostalForeignAddress/ForeignPostalCd | EINEIN | DescDesc | AmtAmt | Address Line1USAddress/AddressLine1Txt | Address Line2USAddress/AddressLine2Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Address Line2ForeignAddress/AddressLine2Txt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUST | ||||||||||||
| ORION HOUSE 5 UPPER ST MARTINS LANE | LONDON | UK | WC2H 9EA | 611915057 | CONTRIBUTION OF CAPITAL | $50,000,000 | ||||||
| MHR LONGEVITY PARTNERS | ||||||||||||
| 981471155 | CONTRIBUTION OF CAPITAL | $60,730,000 | 1345 AVENUE OF THE AMERICAS 42ND | FLOOR | NEW YORK | NY | 10105 | |||||
| NEWMARKET INTERNATIONAL INFRASTRUCTURE FINANCE COMPANY FEEDER LP | ||||||||||||
| 981142649 | MANAGEMENT FEE | $720,114 | 2929 ARCH STREET 17TH FLOOR | PHILADELPHIA | PA | 19104 | ||||||
| PITANGO SPV | ||||||||||||
| BEIT ACKERSHTEIN - BLDG B 11 | HERZLIYA | IS | 981492234 | CONTRIBUTION OF CAPITAL | $377,510 | HAMENOFIM ST 11TH FL | ||||||
| STARTUP HEALTH T1D PRI LP | ||||||||||||
| 932618051 | CONTRIBUTION OF CAPITAL | $5,000,000 | 2000 BROADWAY 18TH FLOOR | NEW YORK | NY | 10023 | ||||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $116,827,624 | TotalAmt |